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Abstract 
Ligand–mediated coupling between metal centres is of fundamental importance in 
inorganic and materials chemistry. Bridging ligands involving azo groups as coordinating π–
acceptors can yield complexes with interesting properties.  
This thesis describes the synthesis of a series of N–heterocyclic compounds containing 
the azo functionality, designed for potential coordination to the metal through the azo 
nitrogen and a N–heterocyclic ring. The azo ligands are divided into four categories; ligands 
based on azobispyridines, ligands containing pyrimidine and fused aromatic azine groups and 
ligands capable of coordinating in a bis–tridentate fashion to the metal centre. Ligands 
containing flexible imine subunits connected directly, or through different spacers, are also 
discussed. Overall twenty one ligands were synthesised, six of which are new compounds. 
The coordination and metallosupramolecular chemistry of these ligands with 
ruthenium(II) and silver(I) metal atoms was investigated. A total of thirty five ruthenium(II) 
and eleven silver(I) complexes were prepared, of which thirty eight were characterised by X–





 (L = azo ligand and TL = bpy or terpy), were 
synthesised and characterised by a combination of spectroscopic and structural techniques. 
UV/Visible absorption studies and electrochemical methods were used to investigate the 
nature of metal–ligand and metal–metal interactions.  
In the mononuclear Ru(II) complexes, N–heterocyclic azo ligands act as chelating 
ligands forming five–membered chelate rings involving azo–N and heterocyclic–N atoms. 
The non–coordinated pyridine ring of the azo ligand is twisted with respect to the azo–N 
atom and is directed towards the adjacent bipyridine rings. Studies reveal that these azo 
ligands posses extremely low–lying π*–orbitals and are electron deficient. X–Ray structural 
analysis of the dinuclear complexes revealed short inter–metal separations of ca. 4.9 Å and 
electrochemical studies indicate that these ligands mediate very strong interactions between 




), due to the excellent π*–
acceptor properties of the azo functionality. 
Varying the pyridine ring of the azo ligand to pyrimidines and fused N–aromatic rings 
has a considerable effect on the electronic properties of these complexes. Incorporation of a 
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(bpy)2](PF6)3, 3.12, bridged by radical species. The X–ray crystal structures of both 
these complexes were determined.  
The use of the hexadentate ligands azobis[6–(2,2’–bipyridine)], 4.1, and azobis[2–
(1,10–phenanthroline)], 4.2, coordinating in a bis–tridentate manner mediate even stronger 
communication between the two ruthenium centres with Kc values greater than 10
13
. 
Ligands containing bis–pyridylimines result in weaker coupling between the metal 
centres in dinuclear ruthenium(II) species. A complete absence in the inter–metal 
communication was observed with increasing the distance and/or flexibility between the two 
pyridylimine units, contrary to a previous reported claim. 
Reaction with different silver(I) salts afforded an array of one–dimensional 
coordination polymers and a discrete dinuclear complex depending on the coordination 
strengths of the anions. The metallosupramolecular assemblies obtained were characterised 
mainly by X–ray crystallography, elemental analysis and mass spectrometry.  
 
 


















Atom Colour Scheme 
 Silver   Fluorine 
 Ruthenium   Oxygen 
 Bromine   Nitrogen 
 Chlorine   Carbon 
 Sulfur   Hydrogen 
 
BL bridging ligand 
bpy 2,2’–bipyridine 
bpym 2,2’–bipyrimidine 
CIS coordination induced shift 
2,3–dpp 2,3–di(2’–pyridyl)pyrazine 
2,5–dpp 2,5–di(2’–pyridyl)pyrazine 
DPV differential pulse voltammetry 
ESI–MS electron spray ionisation mass spectrometry 
eV electron volts 
gCOSY gradient correlation spectroscopy 
HMBC heteronuclear multiple–bond correlation spectroscopy 
HOMO highest occupied molecular orbital 
HSQC heteronuclear single–quantum correlation spectroscopy 
Kc comproportionation constant 
LUMO lowest unoccupied molecular orbital 
MLCT metal–to–ligand charge transfer 
mV millivolts 
NMR nuclear magnetic resonance 
NOE nuclear overhauser effect 
NOESY nuclear overhauser spectroscopy 
phen 1,10–phenanthroline 
ROESY rotating frame overhauser spectroscopy 
SCE standard calomel electrode 
terpy 2,2’:6’,2’’–terpyridine 
TL terminal ligands 
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1. Introduction 
Ruthenium(II) polypyridyl complexes have received continuous attention for several 
decades.
[1–3]
 Due to their combination of chemical inertness in different oxidation states, 
photophysical characteristics and redox properties,
[4–7]
 they are widely used in photochemical 
molecular devices,
[8–11]
 solar energy conversion schemes
[12–16]




The tris(2,2’–bipyridine)ruthenium(II) dication, [Ru(1.1)3]
2+
 (Figure 1.1a) is one of the 
most well known and extensively studied compounds due to its important redox, 
photophysical and photochemical properties.
[7],[10],[20–22]
 Since the early discovery of 
[Ru(1.1)3]
2+
 to act as a photocatalyst in the splitting of water into hydrogen and oxygen,
[23]
 
there has been considerable interest in ruthenium(II)–bipyridine type complexes.
[1],[10],[11],[24]
 
Replacement of ligand 1.1 by 1,10’–phenanthroline (1.2) in [Ru(1.2)3]
2+
, showed new excited 


























Figure 1.1. (a) [Ru(1.1)3]
2+
, (b) six–membered chelating bidentate ligands and 
(c) chelating ligands containing other heterocycles. 
The ground and excited–state properties of such complexes can be systematically tuned 
by varying the structures of the chelating ligands.
[13],[27],[28]
 Replacement of the pyridine rings 
by other heterocycles further modifies the properties of the resulting complexes due to the 
different donor–acceptor properties of the ligands involved. For example, homoleptic 
complexes of 2–(1’–pyrazolyl)pyridine, 1.3 ([Ru(1.3)3]
2+
) and 2–(1’–pyrazolyl)pyrimidine, 




), as shown in Figure 1.1, show significant changes in the absorption 




Ligands with multiple nitrogen donor sites that can coordinate to more than one metal 
have been used to bridge two or more metals with the emphasis on the nature and magnitude 
of metal–metal interactions in such complexes. Since the discovery of the mixed–valence 
Creutz–Taube ion [(H3N)5Ru(μ–pyz)Ru(NH3)5]
5+
 1.5 (Figure 1.2),
[31]
 there has been an 
increased interest towards the study of electronic interactions between multinuclear metal 
centres linked by a bridging ligand.
[32–35]
 The interactions between the metal centres are of 
















Figure 1.2. The Creutz–Taube Ion.  
In a symmetrical dinuclear system, the two metal centres undergo oxidation at the same 
potential in the absence of electronic coupling; however, the existence of two different 
oxidation redox potentials is a clear indication of a metal–metal interaction. The magnitude of 
separation between the two successive oxidation potentials (ΔEox), gives a direct measure of 

























The equilibrium constant Kc can be measured spectroscopically or electrochemically 
and may be related to thermodynamic parameters and can be obtained from the 
electrochemical data as shown above.
[37]
 If there is no interaction between the metal centres, 
at a statistical level Kc = 4 and it will be higher if there is a reasonable interaction between the 
metal centres. The values are often found to be sensitive to the solvent and the electrolyte 




 Spectral measurements of the IVCT transitions, if observed, serve as a better 
indicator to probe the degree of electronic coupling.
[33],[40]
 In spite of this, electrochemically–
derived Kc and ΔEox values for a homodinuclear system are often used to measure the extent 
of communication between the metal centres.
[37],[41–43]
 
1.1. Binucleating Ligands 
Bridging aromatic N–heterocyclic ligands are well known to facilitate communication 
between the metal centres via the π–system of the ligand.
[36],[37],[44]
 The degree of these 
interactions can be controlled by varying (i) the electronic properties of the ligand, (ii) the 
distance between the metal centres, and (iii) the degree of conjugation between the metal 
centres.
[44],[45]
 The π–deficient six–membered aromatic N–heterocycles have relatively low–
lying π*–orbitals and are good acceptors of metal d–orbital electron density. In contrast, five–
membered N–heterocycles are good π–donors and the removal of the proton of an acidic N–
hydrogen generates an N–anion.
[46]
 The interactions between the metal and the ligand are 
governed by the specific metal and the ligand involved. Therefore, the design of the bridging 
ligand is one of the key steps in the spatial organisation and electronic interaction between 
the active metal components.  
1.1.1. Monodentate ligands 
The majority of early work on diruthenium complexes involved symmetrical 
monodentate azine–bridges such as pyrazine 1.6,
[31],[47],[48]
 pyrimidine 1.7, and 4,4’–






1.6 1.7 1.8  
Figure 1.3. Monodentate ligands. 
The Creutz–Taube ion 1.5 is perhaps the most well–studied binuclear azine–bridged 
complex and thus still has considerable attention. Structural analogues of the Creutz–Taube 
ion such as substitution of the monodentate ammine groups with pyridine, bipyridine, chloro 
or aqua groups have provided substantial understanding of the factors governing internuclear 
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interactions in Ru(II) complexes.
[51–55]
 Many X–ray crystallographic structures of pyrazine–



























Figure 1.4. Structural analogues of the Creutz–Taube ion involving pyrazine 
1.9 and pyrimidine 1.10. 
Studies on pyrimidine–bridged complexes by Taube et al.
[60]
 indicate weaker metal–
metal interactions, despite being closer in space (ca. 6.0 Å) than in pyrazine–bridged 
complexes (ca. 6.9 Å).
[49],[50]
 Meyer et al. observed electrochemically equal interactions for 
[(bpy)2ClRu(1.6)RuCl(bpy)2]
2+
 (1.9), and the corresponding pyrimidine–bridged complex 
[(bpy)2ClRu(1.7)RuCl(bpy)2]
2+ 
(1.10), as shown in Figure 1.4.
[61]
 Molecular orbital 
calculations on the free ligand display the lowest π*–level at a lower energy for pyrazine 
compared to pyrimidine and this difference might account for equal electronic coupling. 
Similarly, studies on the 4,4’–bipyridine 1.8, bridged analogue of the Creutz–Taube ion 
exhibit a reduced level of interaction for symmetric systems.
[62],[63]
 The replacement of a 




1.1.2. Bidentate Ligands 
The binuclear complexes bridged by monodentate ligands are often unstable. On the 
other hand, bidentate coordination improves stability at each metal coordination site because 
of the chelate effect and also imparts conformational rigidity to the complex. 2,2’–
Bipyrimidine 1.11, is a classic example of a doubly–chelating bridging ligand. Numerous 
homobinuclear and heterobinuclear ruthenium(II) complexes have been described where 1.11 
bridges two metals at a distance of ca. 5.5 Å and this mediates a very strong communication 
between the metal centres.
[64–69]
 































Figure 1.5. Examples of bridging bidentate ligands. 
There have been no reports of diruthenium complexes of 2,2’–biquinazoline 1.12, 
however, metallosupramolecular assemblies with late transition metals have been reported 
recently.
[70]
 The complexes of the bibenzimidazolate ligand 1.13 were more stable than the 
corresponding complexes of 1.11, due to the π–excessive donor properties of the ligand and 
the reduction of electrostatic repulsion between the positively charged metal centres.
[71],[72]
 In 
spite of structural similarities, ruthenium(II) complexes of the binucleating ligand 2,3–bis(2’–
pyridyl)pyrazine 1.14
[73]
 exhibit excellent inter–metal communication, compared to the 
pyrimidine ligand 4,6–bis(2’–pyridyl)pyrimidine 1.15,
[74]
 since pyrazine is a better π–
acceptor than pyrimidine. Tetrazine derivatives 3,6–bis(2’–pyridyl)–1,2,4,5–tetrazine 1.16 
and 3,6–(2’–pyrimidyl)–1,2,4,5–tetrazine 1.17, bridge metal centres in a transoid manner and 
have very low–lying π*–orbitals, which therefore make them excellent π–acceptors.
[75]
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1.2. Stereochemistry of Ruthenium(II) Complexes 





been of great interest because of their favourable photophysical and redox properties. 
However, when bidentate ligands are involved, stereochemical complexity exists which 
































Figure 1.6. Enantiomers of [Ru(bpy)3]
2+
 with symmetrical bidentate ligands. 
A tris(bidentate) complex cation, such as [Ru(bpy)3]
2+
, exists in two enantiomeric 
forms i.e. Λ and Δ forms, as shown in Figure 1.6. If the bpy ligands are unsymmetrically 
substituted, then additional isomers, i.e. facial and meridional geometrical isomers are found 
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In dinuclear complexes, where the metal centres are tris(bidentate) in nature, each 
centre may possess left–handed (Λ) or right–handed (Δ) chirality giving rise to 
diastereoisomeric forms; meso (ΔΛ) and racemic (consisting of ΔΔ/ΛΛ enantiomeric pairs) 
isomers, as shown in Figure 1.8.
[79],[83]
  
































NN Bridging Ligand (BL)
N
N




RuII RuII RuII RuII RuII RuII
 
Figure 1.8. Diastereoisomeric forms of [(TL)2Ru(μ–BL)Ru(TL)2]
n+
. 
In symmetrical dinuclear complexes such as [(TL)2Ru(μ–BL)Ru(TL)2]
4+
, where BL is a 
symmetrical bridging ligand and TL is a bidentate terminal ligand, the meso and racemic 
isomer differ only in the orientation of the terminal ligands above and below the plane. Figure 
1.9 shows examples of bridging ligands which can be categorised as linear (1.11), stepped–
parallel (2,5–bis(2’–pyridyl)pyrazine, 1.17) and angular (1.15) on the basis of the 












1.11 1.17 1.15  
Figure 1.9. Bridging ligands exhibiting different arrangements about the coordination sites. 
In the case of bridging ligands having a linear or stepped–parallel relationship between 
the axes of the bites of the two coordination sites, the terminal ligands above and below the 
plane of the bridge are orthogonal in the meso (ΔΛ) isomer and approximately parallel in the 
racemic (ΔΔ/ΛΛ) diastereoisomer. However, if the bites are angular, terminal ligands are 
approximately parallel and orthogonal for the meso and racemic forms, respectively. The 
diaseteroisomeric (meso and rac) forms of the dinuclear Ru(II) complex of 1.11 are shown in 
Figure 1.10. 




























Figure 1.10. Diastereoisomeric forms of [(bpy)2Ru(μ–1.11)Ru(bpy)2]
4+
. 
1.2.1. Strategies to control the stereochemistry 
In general, the number of isomers increases with the number of metals involved and, 
therefore, the formation of polynuclear complexes becomes a real issue. A number of 
different approaches have been employed to address this stereochemical problem.
[80],[84–86]
 







 (resolved using O,O’–dibenzoyltartrate, arsenyl–(+)–tartrate and 
antimony(+) tartrate anions, respectively) have been used to synthesise polynuclear species 
with predetermined stereochemistry (such as ΔΔ, ΛΛ, ΔΛ).
[87–89]
 A second strategy by von 
Zelewsky and coworkers involves the use of ligands called chiragens 1.18 and 1.19 in which 
two bidentate ligands are linked by a chiral connecting group, as shown in Figure 1.11.
[90–92]
 















Figure 1.11. Chiragen ligands used for stereospecific synthesis. 
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Another approach pioneered by Keene and coworkers, has been extensively used in our 
laboratory, and involves the use of cation exchange chromatography on a SP Sephadex C–25 
support using sodium chloride or sodium tosylate as the eluent.
[83],[84],[93–100]
 The separation of 
stereoisomers is based on the differential interaction of the eluent anions with the relative 

















Figure 1.12. Mode of coordination in 2,2’:6’,2’’–terpyridine 1.20 and the 
Ru(II) complex containing terpy units 1.21. 
The stereochemical problem may also be avoided by the use of tridentate ligands of the 
type 2,2’:6’2’’–terpyridine (terpy) 1.20, which coordinates to an octahedral metal centre in a 
meridional manner creating a single isomer of the achiral [Ru(terpy)2]
2+
 1.21 complex cation, 
as shown in Figure 1.12.
[6],[101]
 The use of two symmetrical tridentate ligand components 
coordinated to metal centres eliminates the possibility of stereoisomerism. In addition, the 
presence of two chelate rings per ligand makes [Ru(terpy)2]
2+
 more stable than [Ru(bpy)3]
2+
. 

















Figure 1.13. Examples of commonly used doubly–tridentate ligands. 
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The bischelating ligand 2,3,5,6–tetrakis(2–pyridyl)pyrazine, 1.22 has been extensively 
used as a bridging ligand to prepare homo– and hetero–nuclear complexes with a range of 
terminal ligands such as bpy and terpy.
[102–104]
 Complexes of this ligand with octahedral 
transition metal ions, such as Ru(II) and Os(II), have been studied for their redox, 
luminescence and mixed–valence properties by several groups.
[105–111]
 In these complexes the 
metal centres are extremely close and exhibit a high degree of electronic coupling and 
mediate electron transfer through multiple redox states of the metal ions. A series of 
dinuclear complexes with bridging ligands containing two terpy units joined by different 
spacers, as in 1.23, gives rise to a linear connectivity and display well defined control over 
the geometry.
[112],[113]
 While terpy ligands enable the synthesis of defined polymetallic 
complexes, [Ru(terpy)2]
2+




 A number of different 
strategies have been used to increase the photophysical properties of Ru–terpy 
complexes.
[114–117]
 For example, cyclometallated ligands, such as 1.24, where one of the 
pyridine ring is replaced by a phenyl ring, increases the σ–donating properties of the ligand 
and therefore coordinates strongly to the metal centre, which subsequently increases the 
lifetime of the excited state.
[118],[119]
 
These ligands, therefore, offer great potential for the preparation of polymetallic 
complexes. However, to fully understand the influence of stereochemistry on the 
intramolecular electron and energy transfer, the use of tris(bidentate) species is required.  
1.3. Azobispyridines as Bridging Ligands 
Aromatic azo compounds have extensive applications in materials chemistry due to 
their unique combination of electronic and geometrical structures, which lead to intriguing 
properties.
[120–125]
 This class of compounds possesses extremely low–lying azo–centred π*–
orbitals, which result in intense long–wavelength absorptions responsible for making them 
ideal for their use in dyes and pigments.
[126],[127]
 Their efficient and fully reversible cis–trans 
isomerisation under appropriate radiation also makes them excellent candidates to function as 
molecular switches.
[128],[129]
 In addition, azo compounds have recently been targeted for 
potential applications in drug delivery,
[130–132]





















Figure 1.14. Structural representation of three bidentate ligands. 
Azo compounds based on N–containing heterocycles, such as 2–phenylazopyridine 
1.25 (Figure 1.14) and its analogues are extensively studied bidentate ligands,
[139–145]
 
involving coordination to the metal centre through the pyridine and azo nitrogen atoms 
forming a stable five–membered chelate ring.
[146–148]
 The weak σ–donor and intermediate π–
acceptor properties of the pyridine nitrogen atoms of 1.25 make it similar to 2,2’–bipyridine, 
1.1, in its coordination properties. However, the π–acceptor ability of the azo nitrogen atom is 
much stronger than the bpy–N atoms. The symmetrical azobispyridine ligand, 2,2’–
azobispyridine, 2.1, is related to 1.25 by replacing the phenyl ring with a pyridine ring and 
1.1 by insertion of an azo bridge between the two pyridine rings (Figure 1.14). As a matter of 


































Figure 1.15. Structure of 2.1 in (a) gas–phase; (b) solid–state; (c) and (d) 
interactions responsible for the preferred solid state conformation. 
In both solution
[150]
 and the gas phase,
[151]
 the free ligand 2.1 exists in a twisted 
conformation, however, the single crystal X–ray structure of 2.1 displays s–trans/E/s–trans 
conformation,
[151]
 as shown in Figure 1.15a and b, respectively. In the solid state structure the 
stabilising C–H∙∙∙:N azo–N lone pair interaction is preferred over the destabilising pyridyl–N 
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and azo–N lone pairs N:∙∙∙:N (Figure 1.15c and d). There are also a number of other factors 
which are responsible for planar conformations with colinear adjacent nitrogen atoms.
[152]
 
Ligand 2.1 was first described in 1927 by Kirpal et al.
[153]
 and later in 1969 was 
recognised by Baldwin et al.
[154]
 to exhibit strong interactions with low–valent metal centres 
such as iron(II). The presence of two equivalent metal centres in the 2.1–bridged ruthenium 
complex, [(bpy)2Ru(μ–2.1)Ru(bpy)2]
4+
 enables the formation of two diastereoisomers, meso 
and racemic. This feature was exploited by Kelso et al.,
[93]
 who have reported the synthesis of 
a series of dinuclear α–azodiimine bridged ruthenium(II) complexes and their separation into 
diastereoisomers, i.e. meso (ΔΛ) and racemic (ΔΔ/ΛΛ) forms, as shown in Figure 1.16.
 
Electronic spectral and electrochemical studies indicated differences in the communication 



















































Figure 1.16. Diastereoisomers of [(bpy)2Ru(μ–2.1)Ru(bpy)2]
4+
. 
As reviewed by Kaim et al.,
[155]
 the ability of 2.1 and its analogues to bridge two metal 
centres at a distance of about 5 Å via two five–membered chelate rings and relatively low–
lying π*–orbitals makes it a suitable ligand to study interactions between metal centres across 
an unsaturated molecular bridge.
[150],[155],[156]
 A more detailed investigation of this ligand will 
be discussed in Chapter 2. 
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1.4. The Model System 
The coordination chemistry of 2.1 has been of interest mainly to develop an 
understanding of ligand–mediated intramolecular metal–to–metal communication. As seen 
from the literature studies and previous work in the group,
[74],[99],[100],[157],[158]
 subtle changes 
in the ligand structure can have a dramatic effect on the physicochemical properties of the 
subsequent complex. Accordingly, we were drawn towards the investigation of substituted 












Figure 1.17. Other possible coordination modes of 2.1. 
Ligands with multiple binding sites have led to the formation of coordination networks 
with greater structural diversity.
[159],[160]
 Multinodal ligands have been used to prepare a large 
array of discrete one–, two– and three–dimensional metallosupramolecular assemblies.
[161]
 
The azo N–aromatic ligands, in addition to the bis(chelating) coordination mode, are also 
capable of several other possible coordination modes, as shown in Figure 1.17.
[162–164]
 Interest 
in silver(I) complexes of azo aromatic compounds as building blocks for coordination 
polymers
[165],[166]
 and our interest in silver(I) chemistry,
[167–173]
 inspired us to also explore the 
metallosupramolecular self–assembly of azo N–aromatic ligands.  
1.5. Metallosupramolecular Chemistry 
The concepts of complex formation may be extended to form one of the central 
principles in supramolecular chemistry.
[174]
 Metallosupramolecular chemistry is considered to 
represent a “generalized coordination chemistry extending beyond the coordination of 
transition metal ions by organic and inorganic ligands” to “the chemistry of molecular 
assemblies and of intermolecular bonds.”
[175],[176]
 In general, supramolecular chemistry 
concerns non–covalent bonding interactions like ion–ion interactions, ion–dipole interactions, 
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dipole–dipole interactions, hydrogen bonding, cation–π interactions, anion–π interactions, π–








 (a) (b) 
Figure 1.18. Two of the most common non–covalent interactions (a) Hydrogen 
bonding between acceptor atom (A) and hydrogen atom of the donor atom (D). 
(b) The π–π interactions between two benzene molecules face–to–face (left) 
and edge–to–face (right). 
Hydrogen bonding interactions, shown in Figure 1.18a, are commonly encountered in 
supramolecular assemblies between the hydrogen donor atoms and the electronegative or 
electron–deficient acceptor atoms.
[179–181]
 These interactions are relatively weak (5–50 kJ 
mol
–1
) and are generally directional.
[179],[180]
 Other interactions commonly observed in 
supramolecular species involve face–to–face and edge–to–face π–π stacking interactions, as 
shown in Figure 1.18b.
[182]
 These are categorised as weak electrostatic interactions
[177]
 with 
energies ranging between 0–20 kJ mol
–1
. Typically, these interactions are relatively weak 
individually; however, a combination of multiple interactions can act as a ‘glue’ to build up 
large supramolecular aggregates. 
The construction of supramolecular architectures from a combination of organic ligands 
and metal ions is described as metallosupramolecular chemistry, a term first introduced by 
Constable,
[183],[184]
 which makes use of the interactions between metal ions and donor groups 
in the organic molecule. A diverse range of discrete and polymeric aggregates can be 
obtained by simply mixing metal and ligand building blocks.
[185]
  
Transition metal ions have characteristic and preferred coordination numbers and 
geometries. Some of the common metal geometries are shown in Figure 1.19. Therefore, the 
choice of metal can have a large effect on the structure of the metallosupramolecular system. 
Silver(I) is a d
10
 transition metal with a flexible coordination number and geometry, with a 
preference for two–coordinate (linear or bent), three–coordinate (trigonal) and four–
coordinate (tetrahedral) geometries.
[186]
 Unlike the robust Ru(II) complexes, due to the weak 
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nature of the silver–ligand interactions, such complexes are often influenced by weaker 


















Figure 1.19. Some of the common coordination geometries and the angles for metals. 
The ligand design also plays an important role in determining the shape of the overall 
structure. Aromatic N–heterocycles are commonly used for the construction of 
metallosupramolecular assemblies as the spatial arrangement, the spacing between the donor 
atoms, electronic and steric properties can easily be modified.
[167],[190–195]
 The two commonly 
used ligands 2,2’–bipyridine 1.1
[196]
 and 4,4’–bipyridine 1.8
[197–201]
 behave as ‘convergent’ 
and ‘divergent’ donor atoms, respectively, as shown in Figure 1.20. Ligands such as 2,2’–
bipyrazine 1.26
[161],[202]
 and 2,2’–bi–1,5–naphthyridine 1.27
[159]
 can interact with metals in 












Figure 1.20. Potential coordination modes for symmetrical N–heterocycles. 
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The coordination requirements of the metal ions are matched with the bonding 










 The combination of bidentate ligands and two–coordinate 
metal ions can often lead to one–dimensional coordination polymers,
[190]
 where the ligands 







 and the donor groups are linked by a rigid spacer group.  
N N N N N N
1.6 1.8 1.28  
  7 Å  11 Å  15 Å 
Figure 1.21. Some common linear bridging ligands and their corresponding 
M–M separations. 
The coordination of rigid ligand 1.8 to linear bridging metal ions such as silver(I) as 
shown in Figure 1.22a, leads to a one–dimensional coordination polymer.
[219],[223]
 Fujita et 
al.’s two–dimensional molecular square, as shown in Figure 1.22b, comprises of square 
planar cis–coordinated platinum(II) or palladium(II) centres with 1.8 as the rigid linear 
bridges.
[200]
 A three–dimensional polyhedron, such as a molecular cube (Figure 1.22c), can be 
constructed by using 1.8 and a facially capped ruthenium precursor.
[201]
 The dimensionality 
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Figure 1.22. Structural representation of (a) 1D coordination polymer; (b) 2D 
molecular square and (c) 3D molecular cube.
[201]
 
In addition to these, the choice of anion and solvent used can also influence the 
formation and type of the metallosupramolecular assembly.
[189]
 Non–coordinating anions, 
such as hexafluorophosphate (PF6¯) and tetrafluoroborate (BF4¯) anions, occupy the free sites 
around the metal centre and allow maximum interaction between the ligand and the metal 
ions. Coordinating anions, such as nitrate (NO3¯), triflate (CF3SO3¯) and trifluoroacetate 
(CF3CO2¯), affect the coordination number and geometry of the metal by interacting with the 
metal centre in a chelating, bridging or terminating manner. As a result, the choice of anions 
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1.6. Thesis Coverage 
Ligand–bridged dinuclear complexes have been the subject of extensive research with 
considerable attention on the nature and magnitude of metal–metal interactions in such 
complexes. These interactions are mediated by the bridging ligand and in the case of N–
heterocyclic rings, communication between the metal centres takes place through the π–
system of the ligand. Therefore, this project involves the synthesis and study of bridging 
ligands, capable of mediating strong communication between the metal centres. The high 
degree of metal–metal interaction within the dinuclear complexes of azobispyridine 2.1, 
prompted us towards the investigation of dinuclear ruthenium(II) complexes with N–
heterocyclic azo compounds as the bridge.  
Chapter 2 investigates the synthesis and coordination chemistry of azobispyridine, 2.1, 
and its substituted derivatives. The ligands vary by substitution in the pyridine ring. A range 
of mono– and dinuclear Ru(II) complexes were synthesised and will be discussed in detail. 
The nature of the metal–ligand and metal–metal interactions was probed by UV/Visible 
spectroscopy and electrochemistry. 
Chapter 3 concentrates on the synthesis and Ru(II) complexes of ligands with azo units 
between different N–heterocyclic cores. The ligands were classified into two groups, 
depending on the core structure. The first class of ligands contain pyrimidine–based azo 
compounds and the second one involves azo compounds based on fused N–heterocyclic rings 
such as quinoline, quinazoline, quinoxaline and naphthyridines. These ligands were used to 
investigate the effect of different rings on the electronic coupling between the metal centres.  
The synthesis and coordination chemistry of hexadentate azo compounds coordinating 




C NMR spectroscopy and X–ray structure analysis. 
Chapter 5 involves the synthesis of bis–pyridylimine ligands, where the two 
pyridylimine units are connected either directly or through a spacer of variable length, 
between the two imine units. The influence of these flexible imine moieties on the electronic 
coupling between the metal centres in dinuclear ruthenium complexes is probed using 
electrochemistry. 
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In Chapter 6, different coordination modes of the azo ligands with a range of different 
silver(I) salts are discussed. Depending on the coordinating strength of the anions a variety of 
discrete or polymeric chains were obtained. The structures were confirmed by X–ray 
crystallographic analysis.  




C NMR spectroscopy, mass spectrometry, elemental analysis and infrared spectroscopy. 
Ruthenium(II) complexes were also characterised by UV/Visible spectroscopy, 
electrochemistry and X–ray crystallography where possible. The structures of silver(I) 
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2. Bidentate ligands based on azobis(pyridines) 
2.1. Introduction 
Azo compounds based on N–containing heterocycles, such as 2–phenylazopyridine 
(pap), 1.25, and its analogues are extensively studied ligands,
[139–142],[144],[145]
 in which an 
additional donor substituent allows a stabilising chelate coordination mode.
[146–148]
 The 
mononuclear complexes of azobispyridine are similar to the corresponding compounds with 
pap ligands.
[143],[144],[149]
 The symmetrical azobispyridine ligands, such as 2,2’–
azobispyridine, 2.1, is related to the widely studied 2,2’–bipyridine, 1.1, by insertion of an 














Figure 2.1. Three closely related ligands that form five–membered chelate rings. 
2,2’–Azobispyridine, 2.1, was recognized by Baldwin et al.
[154]
 to exhibit strong 
interaction with low–valent metal centers such as iron(II) and to have a potential for several 
different coordination modes.
 
The structurally established alternatives include mono– and 
dinuclear coordination situations with five–membered (NNCNM) chelate ring formation, as 
illustrated in Figure 2.2. 
 




















Figure 2.2. Different coordination modes of 2.1. 
The modes of coordination (I) and (II) possess the most favourable five–membered 
chelate rings that are preferred over the seven–membered possibility (III). The non–chelate 
bonding of bis–monodentate 2.1 (IV) and (V) are feasible, however, evidence for only (IV), 
shown in Figure 2.3 has been documented to date.
[162]
 Although, the ligand cannot function as 
a tridentate ligand without experiencing considerable strain, Tsurugi et al.
[229]
 have shown 
that a tungsten(IV) complex can form as shown in Figure 2.4. 
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Interestingly, in the [Os4(μ–H)2(CO)10{μ–η
3
–(2.1)] cluster, both pyridine and azo 
nitrogens were found to coordinate to the cluster core, as shown in Figure 2.5a.
[230]
 Dogan et 
al.
[164]
 showed that in the dinuclear complex, [(2.1)PtCl](ZnCl4), two platinum(II) centres are 




–coordination mode of 2.1, as shown 
in Figure 2.5b with the counterions removed for clarity. 
 















(Ia) (I) (Ib)  
Scheme 2.1 
In mononuclear complexes, where one of the 2–pyridyl rings remains non–coordinated, 
two conformations (Ia) and (Ib) are possible (Scheme 2.1). Due to the repulsion effects 
between the azo N–atom lone pairs, twisting of the 2–pyridyl ring from (Ia) to (Ib) occurs. 
This diminishes the non–bonding contacts between the terminal ligands (L) on the metal and 





Figure 2.6. The X–ray crystal structures of some mononuclear complexes 
showing the Ib form as reported in previous studies.
[232–235]
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 are closer to the structure (Ib) with the pyridyl–N 
directed towards the metal centre, as shown in Figure 2.6. An example of the rare s–cis/E/s–









However, in the dinuclear complexes, such interactions are inevitable and the μ–2.1 
ligand twists in order to chelate to both metals. The “S–frame” conformation of the ligand 
(Scheme 2.2), with the two five–membered chelate rings sharing a common bridge enables a 















The X–ray crystal structure for (μ–2.1)[Re(CO)3Cl]2 reported by Hartmann et al.,
[231]
 
exhibits a Re–Re distance of 5.033(7) Å, which is considerably shorter than the inter–metal 
separation observed in conventional bridging ligands, such as 2,2’–bpym (ca. 5.6 Å) and 
pyrazine (ca. 6.9 Å).
[65],[236–238]
 The π–molecular orbital perturbation calculation carried out 
by Kaim et al.
[156]
 on the complex (μ–2.1)[Mo(CO)4]2 indicates substantial stabilisation of the 
π* (LUMO) levels in 2.1, which strongly facilitates reduction of the complexes and causes 
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intense shifts in the MLCT absorption bands to the near–infrared region. These spectral 
results strongly suggest the use of 2.1 as a useful bridging ligand for studies relevant to the 
ligand mediated electronic interactions between metal centres. 
The capability of 2.1 to bridge two metals at a rather close distance has proven 
exceptional in stabilizing mixed–valent dimetal configurations, as well as radical 
intermediates of the multistep reduction process.
[150]
 As an abundantly studied example, the 
step–wise metal–centered one–electron oxidation of [(bpy)2Ru(μ–2.1)Ru(bpy)2]
4+
 occurs 




 and hence it exhibits a very high degree of metal–metal interaction.
[93],[150]
 The Kc 
values for other commonly used bridging ligands such as 2,2’–bpym or 2,5–dpp are much 




 The fact that the diosmium 
analogue [(bpy)2Os(μ–2.1)Os(bpy)2]
4+
 has a Kc value greater than 10
17
, further supports the 


































Figure 2.8. Diastereoisomers of [(bpy)Ru(2.1)2]
2+
. 
The unsymmetrical nature of the five–membered chelate rings formed by ligand 2.1 and 
its capability to bind to two metal centres gives rise to different kinds of isomerism in 
complexes with octahedral metal centres. The three diastereoisomers of [(bpy)Ru(2.1)2]
2+
, 




H NMR spectroscopy and the crystal structure 
information from precursor complexes (Figure 2.8). 
The absence of a centre or plane of symmetry for the metal sites in complexes such as 
[(bpy)2Ru(μ–2.1)Ru(bpy)2]
4+
 enable the formation of two diastereoisomers, meso and 
racemic forms. This feature was exploited by Kelso et al.,
[93]
 who have also reported the 
synthesis of a series of dinuclear α–azodiimine bridged ruthenium(II) complexes and their 
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separation into diastereoisomers, i.e. meso (ΔΛ) and racemic (ΔΔ/ΛΛ) forms, shown in 
Figure 2.9.
 
Electronic spectral and electrochemical studies indicate differences in the 






















































The Steel group has considerable expertise in the study of metal–metal 
interactions.
[74],[98],[100],[243],[244]
 Examples of some ligands previously synthesised in the group 
are shown in Figure 2.10. These ligands were complexed with ruthenium(II) metal to 
investigate the inter–metal interactions. It is clearly evident from the comproportionation 
constant Kc, that small modifications in the bridging ligands can drastically alter the 










K c = 500 X = O (K c = 800,000)
S (K c = 25,000)
N- (K c = 1,200,000)
R = H (K c = 750,000)
Ph (Kc = 46,000)
 
Figure 2.10. Examples of ligands synthesised previously in the Steel group. 
Therefore, we were interested in investigating the dinuclear ruthenium(II) complexes 
with azobispyridine ligands as the bridge. This chapter details the synthesis of a series of 
mono– and dinuclear complexes containing ligands based on azobispyridine, as shown in 
Figure 2.11. The influence of different substituents in the bridging ligand on the metal–metal 
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2.4 2.5 2.6  
Figure 2.11. The ligands based on symmetrical azobispyridine. 
2.2. Syntheses of the ligands  
To analyse the influence of different substituents on the inter–metal communication, 
the parent ligand 2.1 with no substituent and three methyl substituted derivatives 2.2 – 2.4 
were synthesised. These ligands were all synthesised starting from commercially available 
amine precursors. The precursor amines required for the synthesis of electron–donating 
halogen substituted derivatives 2.5 and 2.6 were synthesised in the laboratory and are 
discussed below.  
Oxidative coupling of the corresponding aminopyridines using sodium hypochlorite, as 
outlined in Scheme 2.3, gave the required azo ligands 2.1 – 2.4.
[93]
 The trans isomer is 
thermodynamically preferred, and in 
1
H NMR studies no evidence for the cis product was 
found. 
















Commercially available, 2–aminopyridine was first converted to the chloro amine 
precursor using N–chlorosuccinimide.
[245]
 This was then subjected to oxidative coupling 
using sodium hypochlorite to give the corresponding ligand 2.5 in moderate yield, as shown 












The bromo–substituted ligand 2.6, was similarly synthesised, as outlined in Scheme 
2.5. The synthesis involves reaction of 2–aminopyridine with N–bromosuccinimide,
[246]
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2.3. Coordination chemistry of azobis(pyridines)  
The ruthenium(II) complexes were synthesised by reaction of the bridging ligand with a 
ruthenium(II) precursor in 50% aqueous methanol/ethanol solution. The complexes were 
isolated as the hexafluorophosphate salts. The purification techniques used involved either 
silica gel column chromatography using 7:1 acetonitrile/saturated potassium nitrate as the 
eluent or ion exchange chromatography on SP Sephadex C–25 via a gradient elution process 
using 0.1–0.5 mol L
–1
 sodium chloride solution as the eluent. 
2.3.1. Complexes of 2.1 
The mono– and dinuclear ruthenium(II) complexes of ligand 2.1 have been previously 
synthesised and characterised by Kelso et al.
[93]
 and Kaim et al.
[155]
 using solution studies; 
however, at the time this work was carried out the crystal structures were not known. Thus, to 
elucidate the crystal structures of the complexes 2.7 and 2.8, the ligand 2.1 was refluxed with 
three equivalents of [Ru(bpy)2Cl2] in 50% aqueous methanol for 3 days, as shown in Scheme 
2.6.  
The crude product was loaded onto a SP Sephadex C–25 column and separation of the 
mononuclear and dinuclear products from the crude mixture was achieved via a gradient 
elution procedure using aqueous 0.1–0.5 mol L
–1
 sodium chloride as the eluent.
[93]
 Three 
bands were eluted: Band 1 (dark red, 0.1 mol L
–1
 NaCl), Band 2: (purple, 0.2 mol L
–1
) and 
Band 3: (green, 0.3 mol L
–1
). The fractions were precipitated by addition of a saturated 
solution of ammonium hexafluorophosphate to each band. The resultant products were 
extracted into dichloromethane and the solvent was removed under reduced pressure. The 
solid residues were recrystallised from acetone/diethyl ether. The composition of Bands 1, 2 
and 3 were established by electrospray mass spectrometry and 
1
H NMR. Analysis of Band 1 
revealed the presence of a mononuclear ruthenium species, Band 2 as unreacted 
ruthenium(II) precursor and Band 3 as a dinuclear ruthenium species. 

















































When a ligand forms a transition metal complex, subtle or drastic differences in the 
NMR spectra of the ligand and complex are seen. The differences are described as the 
coordination induced shifts (CIS = δcomplex – δligand). A number of factors have been previously 
identified that are responsible for the sign and magnitude of CIS values in ruthenium(II) 
complexes, such as ligand–to–metal σ donation, metal–to–ligand π donation, conformational 
changes due to chelation and through–space ring–current anisotropy effects.
[247]
 The 
contribution of these factors is included in the discussion which follows.  
The 
1
H NMR spectrum of 2.7 shows 24 non–equivalent proton signals, some of which 
are overlapping, as shown in Figure 2.12. Six different pyridine ring environments exist 
within the complex. Since the ligand 2.1 is unsymmetrical after coordination, its two pyridine 
rings are non–equivalent. The remaining four rings correspond to the bipyridine rings, which 
were easily identified by a gCOSY experiment. The pyridine rings corresponding to the bpy 
ligands were identified by 1D TOCSY and ROESY experiments. The H3’ proton (8.88 ppm) 
corresponding to the free pyridyl ring of the ligand 2.1 is highly deshielded by the nearby azo 
nitrogen, whereas the H3 proton (7.59 ppm) of the coordinated ring is in a strongly shielded 
environment due to metal–to–ligand π back–donation. The H6 protons of the ligand 2.1 in the 
coordinated as well as the free pyridyl ring (7.92 and 7.91 ppm, respectively) are strongly 
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shielded when compared to the H6 proton (8.75 ppm) in the free ligand 2.1, due to through–
space ring–current effects, which is also evident from the crystal structure shown in Figure 
2.13. The CIS values, given in Table 2.1, are also in accordance with this observation. 
 
Figure 2.12. The 
1
H NMR spectrum of complex 2.7. 
Table 2.1. The 
1
H NMR chemical shifts
a
 and CIS values
b
 (italics) for 2.1 and 2.7. 
 H3 H4 H5 H6 
2.1 8.00 8.01 7.54 8.75 
2.7
c
 7.59 7.90 7.38 7.92 
CIS –0.41 –0.11 –0.16 –0.83 
2.7
d
 8.88 8.28 7.70 7.91 
CIS +0.88 +0.27 +0.16 –0.84 
a
In acetonitrile–d3.  
b
CIS = δcomplex – δligand.  
c
Coordinated pyridyl ring of 2.1.  
d
Free pyridyl ring of 2.1. 
 
Crystal Structure of 2.7 
A single crystal suitable for X–ray analysis was grown by diffusing petroleum ether 
into a solution of the complex in acetone. The complex 2.7 crystallises in the triclinic space 
group P–1 with three bidentate ligands, one ruthenium atom, two hexafluorophosphate anions 
and one acetone molecule in the asymmetric unit, as shown in Figure 2.13. 
ppm 
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Figure 2.13. The asymmetric unit of compound 2.7. The counterions and 
solvate molecules are omitted for clarity. Selected bond distances (Å) and bond 
angles (°): Ru1–N1 2.072(4), Ru1–N2 2.099(4), Ru1–N3 2.066(4), Ru1–N4 
2.065(4), Ru1–N5 2.034(4), Ru1–N7 1.993(4), N6–N7 1.288(5), N1–Ru1–N2 
78.16(14), N3–Ru1–N1 93.13(16), N3–Ru1–N2 87.84(14), N4–Ru1–N1 
168.18(14), N4–Ru1–N2 92.55(14), N4–Ru1–N3 79.08(16), N5–Ru1–N1 
90.24(15), N5–Ru1–N2 98.35(15), N5–Ru1–N3 173.45(15), N5–Ru1–N4 
98.41(15), N7–Ru1–N1 96.05(15), N7–Ru1–N2 172.35(15), N7–Ru1–N3 
97.54(15), N7–Ru1–N4 93.81(15), N7–Ru1–N5 76.51(15). 
The ruthenium(II) atom binds to ligand 2.1 using the azo nitrogen atom N7 and the 
pyridine ring nitrogen atom N5, forming a stable five–membered chelate ring, with the 
chelate bite angles being 76.51(15)° (N5–Ru1–N7), 78.16(14)° (N1–Ru1–N2), and 
79.08(16)° (N3–Ru1–N4). The ruthenium atom possesses a distorted octahedral geometry. 
The Ru–Nazo distance of 1.993(4) Å (Ru1–N7), is shorter than that of the Ru–Npy distance of 
2.034(4) Å (Ru1–N5), due to the ability of the azo functionality to act as a π−acceptor unit 
with effective π−backbonding, Ru(dπ) → azo(π*). The azo bond is almost in the same plane 
as the coordinated pyridine ring with the torsion angle being 2.0(6)
o
 (N7−N6−C25−N5), 
while that of the non–coordinated pyridine ring is –35.3(6)
o
 (N6−N7−C26−C27). This 
implies that the non–coordinated pyridine ring is significantly rotated, adopting a structure 
closer to the Ib form discussed previously in Scheme 2.1. 
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The Nazo–Nazo distance in this complex is 1.288(5) Å (N6–N7), comparable to those in 
structurally related complexes.
[164],[232–234],[248]
 Since this structure was determined, the X–ray 
structure of the corresponding perchlorate salt has been reported,
[249]
 with almost identical 
structural features. The crystal structure also gives a better understanding of the 
1
H NMR 
spectrum of complex 2.7, shown in Figure 2.12. The H3 proton (H27) of the free pyridyl 
ligand is highly deshielded due to the twist. The H6 proton (H21 and H30) of ligand 2.1 lies 
directly over or in the plane of the pyridyl ring of an ancillary bipyridine. The H6 proton 
(H20) from one of the bipyridine ligands is strongly shielded since it is positioned over the 
pyridyl ring of 2.1, and hence experiences ring–current anisotropic interacions from the 
adjacent ring. 
1
H NMR of 2.8 
The 
1
H NMR spectrum for the dinuclear complex 2.8 (Figure 2.14) shows 20 non–
equivalent proton signals, corresponding to five different pyridine rings. Compared to 2.7, the 
number of signals for the bridging ligand is halved in 2.8 due to the higher symmetry of the 
dinuclear complex. Thus, both the pyridine rings corresponding to the ligand 2.1 are 
equivalent. The signals corresponding to the bridging ligand and the bipyridines are easily 
identified by a combination of gCOSY, 1D TOCSY and NOESY experiments.  
 
Figure 2.14. The 
1
H NMR spectrum for complex 2.8. 
Table 2.2 lists the 
1
H NMR chemical shifts and the CIS values in acetonitrile for 2.1 
and 2.8. The CIS value for the H3 proton (8.00 ppm) indicates the presence of strong metal–
to–ligand π back–donation into the low lying π*–orbital of the ligand. This reduces the strong 
ppm 
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positive CIS effect of ligand–to–metal σ donation as seen in 2.7. The H6 proton (7.83 ppm) is 
strongly shielded due to the through–space ring–current anisotropic effects, as it lies over the 
pyridyl ring of a bipyridine ligand. 
Table 2.2. The 
1
H NMR chemical shifts
a
 and CIS values
b
 (italics) for 2.1 and 2.8. 
 H3 H4 H5 H6 
2.1 8.00 8.01 7.54 8.75 
2.8 8.05 7.77 7.66 7.89 
CIS +0.05 –0.24 +0.10 –0.86 
a 
In acetonitrile–d3.  
b 
CIS = δcomplex – δligand. 
 
Crystal Structure of 2.8 
Crystals of 2.8 were obtained by vapour diffusion of diethyl ether into an acetonitrile 
solution of the complex. The complex crystallised in the triclinic centrosymmetric space 
group P−1. The asymmetric unit contains half a ligand 2.1, two bpy ligands and one 
ruthenium atom, along with two hexafluorophosphate anions and two molecules of 
acetonitrile. This confirms the formation of the complex in a 1:2 (ligand to metal) ratio. The 
structure, as determined by X−ray crystallography, is depicted in Figure 2.15. 
The complex possesses a crystallographic inversion symmetry about the azo bridge, in 
such a way that the terminal bipyridine ligands ‘above’ and ‘below’ the plane of the azo 
ligand are approximately orthogonal indicating the formation of the meso diastereoisomer, as 
illustrated in Figure 2.16. The chelate bite angles are 78.40(9)° (N1–Ru1–N12), 78.42(9)° 
(N13–Ru1–N24) and 76.42(8)° (N25–Ru1–N31A). The Ru–Ru bond distance is 4.883(4) Å 
(Ru31–Ru31A) which is shorter than the distance reported for the dinuclear complexes (μ–
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Figure 2.15. The asymmetric unit of complex 2.8. The counterions and the 
solvate molecules are omitted for clarity. Selected bond distances (Å) and bond 
angles (°): Ru1–N1 2.094(2), Ru1–N12 2.063(2), Ru1–N13 2.066(2), Ru1–
N24 2.072(2), Ru1–N25 2.021(2), Ru1–N31A 2.049(2), N31–N31A 1.343(4), 
N25–Ru1–N31A 76.42(8), N25–Ru1–N12 96.63(9), N25–Ru1–N1 173.75(9), 
N25–Ru1–N13 88.73(9), N25–Ru1–N24 95.90(8), N31A–Ru1–N12 91.98(8), 
N31A–Ru1–N1 107.31(8), N31A–Ru1–N13 95.29(9), N31A–Ru1–N24 
170.29(9), N12–Ru1–N1 78.40(9), N12–Ru1–N13 171.83(8), N12–Ru1–N24 
94.84(9), N13–Ru1–N24 78.42(9), N13–Ru1–N1 95.82(9), N24–Ru1–N1 
80.88(8). 
 
Figure 2.16. Two perspective views of 2.8 indicating the formation of the meso 
isomer. Counterions and solvent molecules are omitted for clarity. 
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The Ru–Nazo bond distance 2.049(2) Å (Ru1–N31) is shorter than the bond length for 
Ru–Npy 2.072(2) Å (Ru1–N25), similar to 2.7. The Nazo–Nazo distance in the dinuclear 
complex N31–N31A is 1.343(4) Å, which is slightly longer than the value observed for 2.7 
[1.286(6) Å]. This lengthening might be due to the increased backbonding into the N=N π*–
orbital. The average Ru–N bond lengths (ca. 2.063 Å) are similar and correlate with those 
published for related structures.
[232],[234]
 The X–ray crystal structure of the corresponding 





Figure 2.17. A perspective view of 2.8 with three hydrogen atoms being 
labelled and the counterions and solvent molecules omitted for clarity.  
As discussed for the previous complex 2.7, the X–ray analysis unambiguously allows 
the establishment of the exact structure. If we correlate the previously shown 
1
H NMR 
(Figure 2.10), with the crystal structure, shown in Figure 2.17, the H3 proton (H29) of the 
bridging ligand is considerably deshielded compared to the mononuclear complex 2.7, 
however, the H6 proton (H26) experiences similar ring–current effects. The H6 proton (H11) 
of the pyridine ring from one of the bipyridines lies directly over the pyridyl ring of 2.1, and 
is strongly shielded.  
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2.3.2. Complex of 2.2 
Ligand 2.2, a potentially doubly–bidentate ligand, reacts with [Ru(bpy)2Cl2], as shown 
in Scheme 2.7, to form only the mononuclear complex 2.9, which was characterised as 
[(bpy)2Ru(2.2)](PF6)2 by 
1





















































All attempts to synthesise the dinuclear complex, with increased equivalents of the 
ruthenium precursor or different reaction conditions, such as heating at a higher temperature, 
were unsuccessful. The use of the microwave assisted synthesis with the isolated 
mononuclear complex 2.9, also did not show any evidence of the dinuclear complex. This is 
almost certainly due to the steric bulk of the methyl group at the 3–position. Unfortunately, 
attempts to grow crystals of the complex 2.9 were also unsuccessful. 
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Figure 2.18. The 
1
H NMR spectrum of complex 2.9. 
The aromatic region of the 
1
H NMR spectrum of 2.9 is shown in Figure 2.18. The 
1
H 
NMR chemical shifts and the CIS values for 2.2 and 2.9 are summarised in Table 2.3. The 
spectrum shows 22 non–equivalent aromatic proton signals, corresponding to six different 
pyridine ring environments. When compared to complex 2.7, the addition of a methyl 
substituent to the bridging ligand 2.2, simplifies the spin–spin coupling for the ligand in 
complex 2.9. Hence, the identification of the pyridine ring system corresponding to the ligand 
2.2 was readily made by a gCOSY experiment, shown in Figure 2.19.  
 
Figure 2.19. The gCOSY spectrum for the complex 2.9, with the ring systems 
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The methyl group (1.43 ppm) corresponding to the coordinated pyridyl ligand of ligand 
2.2 is strongly shielded due to the chelation induced conformational change. A bpy–H6 
proton (7.48 ppm) is strongly shielded, whilst the H6 proton of the same bipyridine is 
strongly deshielded. A similar, strongly shielded proton is observed in complex 2.7 and 2.8, 
but the strongly deshielded proton was not observed in the previous complexes. 
Table 2.3. The 
1
H NMR chemical shifts
a
 and CIS values
b
 (italics) for 2.2 and 2.9. 
 3–CH3 H4 H5 H6 
2.2 2.60 7.87 7.44 8.46 
2.9
c
 1.43 7.59 7.16 8.01 
CIS –1.17 –0.28 –0.28 –0.45 
2.9
d
 2.90 8.06 7.63 7.70 
CIS +0.30 +0.19 +0.19 –0.76 
a
In acetonitrile–d3.  
b
CIS = δcomplex – δligand.  
c
Coordinated pyridyl ring of 2.2.  
d
Free pyridyl ring of 2.2. 
 
 
Figure 2.20. The ROESY spectrum for complex 2.9, showing connectivity 
between the adjacent H3 protons of the same bipyridine. 
The connectivity between the pyridyl ligands of the same bipyridine was confirmed by 
ROESY (Rotating Frame Overhauser Effect SpectroscopY) experiment, which was 
extensively used throughout this research project. This technique is similar to NOESY 
(Nuclear Overhauser Effect SpectroscopY), and is useful in determining signals which arise 
from protons that are close to each other in space even if they are not bonded. The irradiation 
ppm 
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of the H3 proton at 8.56 ppm shows a correlation to the adjacent H3 proton at 8.63 ppm on 
the connected pyridyl ligand of the same bipyridine, as shown in Figure 2.20. 
 
2.3.3. Complexes of 2.3 
Ligand 2.3 reacts with [Ru(bpy)2Cl2] in a methanol/water (1:1) mixture to give the 
mononuclear complex 2.10. The complex was isolated as the hexafluorophosphate salt and 
characterised as [(bpy)2Ru(2.3)](PF6)2 by 
1
H NMR and mass spectrometry. This was then 
used as the precursor for synthesis of the dinuclear complex 2.11. This complex was purified 
by ion exchange chromatography by the gradient elution technique using 0.1–0.5 mol L
–1
 
sodium chloride as the eluent. The dinuclear complex was characterised as [{Ru(bpy)2}2(μ–
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The aromatic region of the 
1
H NMR spectrum of complex 2.10, shown in Figure 2.21, 
displays six pyridine ring environments, four for the bipyridine pyridyl rings and two for the 
ligand 2.3. The substitution at the 4–position simplified the interpretation of the pyridyl rings 
of 2.3. The strong positive CIS value for the H3’ proton (8.71 ppm) of ligand 2.3 arises due to 
conformational changes on chelation with the metal centre. The H6 protons (7.77 ppm) and 
H6’ proton (7.72 ppm) show CIS values of –0.83 and –0.88, respectively, due to reasons 
already discussed. The 
1
H NMR chemical shifts and the CIS values for 2.3 and 2.10, are 
given in Table 2.4. 
 
Figure 2.21. A section of the 
1
H NMR spectrum for the complex 2.10. 
Table 2.4. The 
1
H NMR chemical shifts
a
 and CIS values
b
 (italics) for 2.3 and 2.10. 
 H3 4–CH3 H5 H6 
2.3 7.64 2.48 7.40 8.60 
2.10
c
 7.33 2.31 7.18 7.77 
CIS –0.31 –0.17 –0.22 –0.83 
2.10
d
 8.71 2.67 7.54 7.72 





CIS = δcomplex – δligand.  
c
Coordinated pyridyl ring of 2.3.  
d
Free pyridyl ring of 2.3. 
The pyridine rings corresponding to the bipyridine ligand were identified by the 
selective 1D–TOCSY experiment, shown in Figure 2.22. The selective 1D–TOCSY (One 
Dimensional Total Correlated SpectroscopY) experiment has also been widely used during 
ppm 
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this research. This experiment is useful for dividing the proton signals into individual spin 
systems, especially when the signals overlap. In this technique, irradiation of a single 
resolved proton can show correlations among the spins that are not directly connected but 
exist within the same spin system. The experiment was done by irradiating the H3 or H6 
proton for 5 relays with a mixing pulse of 35 msec, i.e., 0 s, 0.035 s, 0.07 s, 0.105 s and 
0.14 s. As shown in Figure 2.17, in this way the excited bipyridine H3 proton at 8.61 ppm 
transfers its magnetisation first to its 
3
J–coupled partner H4 at 8.21 ppm and then to their 
3
J–
coupled partners H5 (7.56 ppm) and H6 at (7.60 ppm) until all the members of the spin system 
are excited. 
 
Figure 2.22. Stacked plot TOCSY spectrum for complex 2.10. 
 
Crystal Structure of 2.10 
Crystals of 2.10 were grown by diffusing petroleum ether into an acetone solution of 
the complex. It crystallises in the monoclinic space group P21/c with a full cation and two 
hexafluorophosphate anions in the asymmetric unit, as shown in Figure 2.23. The trans N–
Ru–N angles greater than 171° indicate distorted octahedral geometry of the ruthenium. The 
Ru–Npy bond lengths are consistent (ca. 2.06 Å) with the Ru–Npy bond distance of the 
bridging ligand being the shortest at 2.047(2) Å (Ru1–N8). Once again, one Ru(bpy)2 
fragment coordinates to the ligand 2.3 through the azo nitrogen atom N6 and pyridine 
ppm 
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nitrogen atom N8. The coordinated pyridine ring of 2.3 lies in the plane of the azo group, 
while the non–coordinated pyridine ring adopts a twisted conformation. 
The structure supports the previously assigned 
1
H NMR signals, the H3’ proton (H22) 
of the free 2–pyridyl ring is deshielded by the lone pair of an azo nitrogen whereas, due to 
chelation induced conformation  changes, the H3 proton (H28) of the coordinated ring is no 
longer deshielded by the azo nitrogen and moves upfield. The H6 protons of both the 
coordinated and the free pyridyl ring (H31 and H25) lie over the pyridyl ring of the terminal 
bipyridine, thus experiencing similar through–space ring–current anisotropy effects. 
 
Figure 2.23. The crystal structure of the complex 2.10. The counterions, 
solvate molecules and the hydrogen atoms of the bpy ligands are omitted for 
clarity. Selected bond distances (Å) and bond angles (°): Ru1–N1 2.054(2), 
Ru1–N2 2.082(2), Ru1–N3 2.068(2), Ru1–N4 2.072(2), Ru1–N6 1.963(2), 
Ru1–N8 2.047(2), N6–N7 1.288(2), N2–Ru1–N1 78.35(6), N3–Ru1–N1 
94.99(6), N3–Ru1–N2 91.28(6), N4–Ru1–N1 171.74(6), N4–Ru1–N2 
96.41(6), N3–Ru1–N4 78.63(6), N6–Ru1–N1 98.15(6), N6–Ru1–N2 
171.23(6), N6–Ru1–N3 97.07(6), N6–Ru1–N4 87.92(6), N8–Ru1–N1 
87.97(6), N8–Ru1–N2 95.29(6), N8–Ru1–N3 173.23(6), N8–Ru1–N4 
98.94(6), N6–Ru1–N8 76.46(6). 
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1
H NMR of 2.11 
The aromatic region of the 
1
H NMR spectrum for the dinuclear complex 2.11 is shown 
in Figure 2.24. The 
1
H NMR chemical shifts and the CIS values for 2.3 and 2.11 are given in 
Table 2.5. The negative value for the H6 proton is from the inter–ligand through–space ring–
current anisotropic interactions, since these protons lie over the plane of an adjacent 
bipyridine ligand. The positive CIS values are due to the donation of electron density from 
ligand 2.3 to the metal. 
 
Figure 2.24. The 
1
H NMR spectrum for complex 2.11. 
Table 2.5. The 
1
H NMR chemical shifts
a
 and CIS values
b
 (italics) for 2.3 and 2.11. 
 H3 4–CH3 H5 H6 
2.3 7.64 2.48 7.40 8.46 
2.11 7.77 2.10 7.45 7.64 




CIS = δcomplex – δligand. 
 
Crystal Structure of 2.11 
Green crystals of complex 2.11 obtained by diffusing diisopropyl ether into an 
acetonitrile solution of the complex were suitable for X–ray analysis. The structure solved in 
the orthorhombic space group P212121, to reveal a dinuclear complex, as shown in Figure 
2.25. The asymmetric unit contains one full dinuclear cation with four hexafluorophosphate 
anions and five acetonitrile solvate molecules. The structure unambiguously confirms the 
formation of the complex in a 1:2 ligand–to–metal ratio. 
ppm 
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The coordination sphere of the ruthenium(II) ion is similar to complex 2.8. This is a 
meso isomer (ΛΔ), in which the azo ligand 2.3 acts as a planar bridge between the two 
ruthenium atoms separated by 4.863(3) Å (Ru1–Ru2). The average Ru–N bond distances are 
(ca. 2.069 Å) similar and consistent with the earlier complex 2.8. The Nazo–Nazo bond 
distance [1.334(4) Å (N2–N3)] is consistent with the previously described dinuclear complex 
2.8.  
 
Figure 2.25. A perspective view of the structure of complex 2.11. Selected 
hydrogen atoms, counterions and solvate molecules are omitted for clarity. 
Selected bond distances (Å) and bond angles (°): Ru1–N1 2.032(4), Ru1–N3 
2.038(4), Ru1–N5 2.081(4), Ru1–N6 2.085(4), Ru1–N7 2.094(4), Ru1–N8 
2.086(4), Ru2–N4 2.031(4), Ru2–N2 2.049(4), Ru2–N12 2.077(4), Ru2–N11 
2.080(4), Ru2–N10 2.086(4), Ru2–N9 2.094(4), N2–N3 1.334(5), N1–Ru1–N3 
76.03(16), N5–Ru1–N6 78.15(16), N8–Ru1–N7 78.29(16), N4–Ru1–N2 
75.83(16), N12–Ru1–N11 78.35(16), N10–Ru1–N9 77.91(16), N11–Ru2–N9 
172.87(16), N4–Ru2–N10 172.24(16), N2–Ru2–N12 169.56(16), N1–Ru1–N7 
171.92(16), N6–Ru1–N8 173.01(16), N3–Ru1–N5 172.01(16). 
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2.3.4. Complex of 2.4 
Ligand 2.4, similar to the ligand 2.2, gave only the mononuclear complex 2.12, when 
refluxed with [Ru(bpy)2Cl2], as outlined in Scheme 2.9. The mononuclear complex 2.12, was 
characterised as [(bpy)2Ru(2.4)](PF6)2 by 
1
H NMR and mass spectrometry. All attempts to 
synthesise the dinuclear complex were unsuccessful, presumably due to steric effects of the 





























The aromatic region of the 
1
H NMR spectrum of complex 2.12, is shown in Figure 
2.26. The spectrum shows four pyridine ring environments corresponding to the ancillary 
bipyridine ligands and two ring environments corresponding to ligand 2.4. The pyridine ring 
systems for the bipyridines were identified easily, however, the connectivity between the 
rings could not be determined due to the overlapping of signals. The 
1
H NMR chemical shift 
and CIS values for 2.4 and 2.12 are given in Table 2.6. A bpy–H6 proton (7.22 ppm) lies in a 
strongly shielded environment. A similar, strongly shielded bpy–H6 proton is seen for the 
complexes 2.9 and 2.10. However, the strongly deshielded bpy–H6 proton observed in 2.9 is 
missing in both 2.10 and 2.12. 
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Figure 2.26. The 
1
H NMR of complex 2.12. 
Table 2.6. The 
1
H NMR chemical shifts
a
 and CIS values
b
 (italics) for 2.4 and 2.12. 
 H3 H4 H5 6–CH3 
2.4 7.61 7.93 7.43 2.66 
2.12
c
 7.23 7.73 7.15 2.04 
CIS –0.38 –0.20 –0.28 –0.62 
2.12
d
 8.68 8.20 7.67 2.04 
CIS +1.07 +0.27 +0.24 –0.62 
a
In acetonitrile–d3.  
b
CIS = δcomplex – δligand.  
c
Coordinated pyridyl ring of 2.4.  
d
Free pyridyl ring of 2.4. 
 
2.3.5. Complexes of 2.5 
The reaction of 2.5 with one equivalent of [Ru(bpy)2Cl2] in 50% aqueous methanol 
gave the mononuclear complex, 2.13, which was characterised as [(bpy)2Ru(2.5)](PF6)2 by 
1
H NMR and mass spectrometry. The dinuclear complex 2.14 was synthesised by reacting 
ligand 2.5 with a ruthenium(II) precursor in a 1:2 ligand to metal stoichiometric ratio.  
ppm 





















































The crude product was purified by silica gel chromatography using 
acetonitrile:saturated potassium nitrate (7:1) as the eluent. The isolated complex 2.14 was 




H NMR spectra for complexes 2.13 and 2.14 are shown in Figure 2.27. The 
spectra show six distinguishable pyridine ring environments for 2.13 and five different 
pyridine rings for 2.14, which are colour coded. The unsymmetrical nature of the 
mononuclear complex 2.13 gives rise to 23 non–equivalent proton signals, whereas the Ci 
point group symmetry in 2.14 leads to 19 different aromatic proton signals. Despite the 
complexity of the spectra, the 
1
H NMR chemical shifts for the ligand 2.5 and the ancillary 
bipyridine ligands in 2.13 and 2.14, were assigned by using a combination of spin coupling 
information from the 
1
H NMR spectrum, gCOSY, 1–D TOCSY and 1–D ROESY 
experiments. The assignment of the various pyridine rings are given in Table 2.7. 
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Figure 2.27. The 
1
H NMR spectra of (a) 2.13 and (b) 2.14. The various 
pyridine rings were assigned into groups and are colour coded. 
Table 2.7. The 
1
H NMR chemical shifts
a
 for 2.13 and 2.14 in CD3CN. 




 8.84 8.29 –Cl 7.92 
d




 8.60 8.21 7.57 7.58 
A’




 8.44 8.18 7.48 7.35 
B’
bpy–py (pink) 8.32 8.01 7.30 7.46 
2.14–py (black) 7.90 7.76 –Cl 7.79 
A
bpy–py (blue) 8.62 8.25 7.55 7.48 
A’
bpy–py (yellow) 8.58 8.24 7.61 7.75 
B
bpy–py (green) 8.56 8.18 7.24 7.09 
B’
bpy–py (pink) 8.55 8.30 7.72 7.29 
a
 For atom labelling, see Scheme 2.10.  
b
 Free pyridine ring of 2.5.  
c
 The colours relate to Figure 2.27.  
d








bpy are part of the same bpy ligand. 
ppm 




H NMR chemical shifts in acetonitrile for ligand 2.5 and the ruthenium complexes 
2.13 and 2.14, along with the CIS values are shown in Table 2.8. The sign and magnitude of 
the CIS values observed for 2.13 and 2.14 indicate that the effects of coordination are similar 
for both the mononuclear and dinuclear complexes. 
Table 2.8. The 
1
H NMR chemical shifts
a
 and CIS values
b
 (italics) for 2.5, 2.13 
and 2.14. 
 H3 H4 H6 H3’ H4’ H6’ 
2.5 7.85 8.06 8.76    
2.13 7.78 7.95 7.87 8.84 8.29 7.92 
CIS –0.41 –0.11 –0.89 0.88 0.27 –0.84 
2.14 7.90 7.76 7.79    




CIS = δcomplex – δligand. 
 
Crystal Structure of 2.13 
Vapour diffusion of petroleum ether into a solution of 2.13 in acetone gave red 
coloured crystals suitable for X–ray analysis. The complex crystallises in the triclinic space 
group P–1, as shown in Figure 2.28, with one complete cation, two hexafluorophosphate 
counterions and three acetone solvate molecules in the asymmetric unit. The crystal structure 
unambiguously confirms the mononuclear nature of 2.13.  
The ruthenium atom possesses distorted octahedral geometry with five pyridine 
nitrogen atoms and one azo nitrogen atom completing the coordination sphere. The Ru–N 
(ca. 2.053 Å) and Nazo–Nazo [1.295(3) Å] bond distances are similar to the mononuclear 
complexes 2.7 and 2.10. Once again, the Ru–Npy bond distance of the ligand 2.5 is shorter 
than the bpy Ru–Npy bond distance. The azo bond is in the same plane as the coordinated 
pyridine ring with the torsion angle being –0.6(3)
o
 (N7−N6−C26−N8), while that of the non–
coordinated pyridine ring is 29.5(3)
o
 (N7−N6−C26−C27), indicating a significant rotation to 
the free pyridyl ring of the ligand 2.5. Similar observations were seen in the X–ray crystal 
structures of 2.7 and 2.10. The crystal packing shows numerous weak short contacts such as 
F∙∙∙HC and Cl∙∙∙HC which further stabilises the overall crystal structure. 
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Figure 2.28. The X–ray crystal structure of compound 2.13. The counterions 
and solvent molecules, are omitted for clarity. Selected bond distances (Å) and 
bond angles (°): Ru1–N1 2.068(2), Ru1–N2 2.060(2), Ru1–N3 2.085(2), Ru1–
N4 2.070(3), Ru1–N8 2.043(2), Ru1–N6 1.993(2), N6–N7 1.295(3), N2–Ru1–
N1 78.54(9), N1–Ru1–N3 86.85(8), N2–Ru1–N3 94.55(8), N1–Ru1–N4 
95.99(9), N2–Ru1–N4 171.47(8), N4–Ru1–N3 78.51(8), N6–Ru1–N1 
99.37(8), N6–Ru1–N2 93.73(8), N6–Ru1–N3 170.49(8), N6–Ru1–N4 
93.61(8), N8–Ru1–N1 174.86(8), N8–Ru1–N2 98.42(9), N8–Ru1–N3 
97.57(8), N8–Ru1–N4 87.49(8), N6–Ru1–N8 76.59(9). 
 
Crystal Structure of 2.14 
Crystals of 2.14 were obtained by diffusing diisopropyl ether into an acetonitrile 
solution of the complex. The structure solved in the monoclinic space group P21/c to reveal 
one ruthenium atom, half a ligand 2.5, two bipyridine ligands, two hexafluorophosphate 
anions and three acetonitrile solvate molecules in the asymmetric unit, as shown in Figure 
2.29.  
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Figure 2.29. The asymmetric unit of compound 2.14 with counterions and 
solvent molecules omitted for clarity. Selected bond distances (Å) and bond 
angles (°): Ru1–N1 2.024(2), Ru1–N2A 2.047(2), Ru1–N3 2.071(2), Ru1–N4 
2.067(2), Ru1–N5 2.086(2), Ru1–N6 2.078(2), N2–N2A 1.340(3), N1–Ru1–
N2 76.14(7), N1–Ru1–N3 95.09(7), N1–Ru1–N4 92.23(7), N1–Ru1–N5 
172.00(7), N1–Ru1–N6 93.94(7), N2A–Ru1–N3 169.80(7), N2A–Ru1–N4 
96.53(7), N2A–Ru1–N5 105.43(7), N2A–Ru1N6 89.43(7), N3–Ru1–N5 
83.98(7), N3–Ru1–N6 96.46(7), N4–Ru1–N3 78.38(7), N4–Ru1–N5 95.35(7), 
N4–Ru1–N6 172.30(7), N6–Ru1–N5 78.30(7). 
The crystal structure confirms the formation of the complex in a 1:2 ligand–to–metal 
ratio. The terminal ligands ‘above’ and ‘below’ the plane of the azo bridge are orthogonal 
indicating the formation of the meso diastereoisomer, as illustrated in Figure 2.30. The 
ruthenium(II) geometry is distorted octahedral with the bridging ligand 2.5 acting as a bridge 
with an inter–metal separation of 4.882(2) Å (Ru1∙∙∙Ru2). The chelate bite angles are 
consistent with the previously described binuclear complexes 2.8 and 2.11. The average Ru–
N bond distances (ca. 2.062 Å) are within the expected range. 
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Figure 2.30. A perspective view of complex 2.14, showing the approximately 
orthogonal orientation of the terminal bipyridine ‘above’ and ‘below’ the azo 
bridge. 
 
2.3.6. Complexes of 2.6 
Reaction of 2.6 with [Ru(bpy)2Cl2] in 50% aqueous methanol, as shown in Scheme 
2.11, gave a brownish green solution, which was separated into the mononuclear and 
dinuclear products by silica gel column chromatography using acetonitrile:saturated 
potassium nitrate (7:1) as the eluent. The aqueous solution was precipitated as 
hexafluorophosphate salts and extracted with dichloromethane. The organic layer was 
separated, dried over anhydrous magnesium sulfate and concentrated under vacuum. The red 
solid was characterised as the mononuclear complex 2.15, [(bpy)2Ru(2.6)](PF6)2, by ESI–MS 
and 
1
H NMR.  










































































The green solid was, however, characterised by ESI–MS and X–ray analysis, as the 
dinuclear complex [{Ru(bpy)2}2(μ–2.5)](PF6)4 instead of [{Ru(bpy)2}2(μ–2.6)](PF6)4. The 
bromo substituents on the bridging ligand 2.6 were replaced by the chloride ion present in the 
reaction mixture. The mass spectrum did not show any evidence for the bromo–substituted 
dinuclear complex, shown in Figure 2.31a. 
This was a highly surprising result. We are unaware of any literature example where a 
chloride anion released from the [Ru(bpy)2Cl2] precursor effects an aromatic nucleophilic 
substitution (SNAr) on a coordinated ligand. Reactions of coordinated ligands are common in 
coordination chemistry, but not of this type.
[251]
 Clearly the coordination of the ruthenium to 
the dibromo ligand 2.6 facilitates this reaction. A possible reason for this comes from 
inspection of the NMR CIS values for the dinuclear complex of the parent unsubstituted 
ligand 2.1. The H5 proton of its dinuclear complex 2.8 experiences a significant downfield 
shift upon coordination, indicating that C5 is more electropositive and hence more 
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Figure 2.31. ESI–MS spectra for the (a) chloro–substituted dinuclear by–
product, and (b) isotopic pattern for 2.16.  
In order to circumvent this complication, a different approach was employed using 
[Ru(bpy)2(OTf)2] as the precursor instead of [Ru(bpy)2Cl2]. The reaction of 2.6 with two 
equivalents of [Ru(bpy)2(OTf)2] in ethylene glycol gave the dinuclear bromo–substituted 
complex 2.16. This was characterised as [{Ru(bpy)2}2(μ–2.6)](PF6)4 by ESI–MS, 
1
H NMR 
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and X–ray analysis. The mass spectrum was consistent with 2.16 and no evidence for the 
chloro–substituted dinuclear complex was observed, as shown in Figure 2.31b. A similar 
observation was made with ligand 3.2, which will be discussed later in Chapter 3. 
Table 2.9. 
1
H NMR chemical shifts
a
 and CIS values
b
 (italics) for 2.6, 2.15 and 2.16. 
 H3 H4 H6 H3’ H4’ H6’ 
2.6 7.79 8.20 8.86    
2.15 7.72 8.09 7.97 8.76 8.42 7.98 
CIS –0.07 –0.11 –0.89 +0.97 +0.22 –0.88 
2.16 7.92 7.81 7.87    
CIS +0.13 –0.39 –0.99    
a 
In acetonitrile–d3.  
b 
CIS = δcomplex – δligand. 
 
Figure 2.32. The 
1
H NMR spectra for (a) 2.15 and (b) 2.16. The pyridine rings 




H NMR spectra of 2.15 and 2.16 are illustrated in Figure 2.32. The spectra show 
distinguishable pyridine ring environments in both the complexes and are colour coded. The 
assignments were made by using spin–spin coupling information, gCOSY and 1D–ROESY 
experiments. The 
1
H NMR chemical shifts for ligand 2.6 and the ruthenium complexes 2.15 
and 2.16 in acetonitrile, are given in Table 2.9, along with the CIS values. 
ppm 
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Crystal Structure of 2.15 
Crystals of 2.15 were grown by diffusing petroleum ether into an acetone solution of 
the complex. The complex crystallises in the triclinic space group P–1 with one full cation, 
two hexafluorophosphate anions and two and a half acetone solvate molecules in the 
asymmetric unit, as shown in Figure 2.33. The crystal structure determination confirms the 
mononuclear nature of the complex. The free pyridyl ligand is twisted at an angle of 29.7(3)° 
to avoid the non–bonding contact with the ancillary bipyridine ligand, similar to the 
mononuclear complexes 2.7, 2.10 and 2.13. The coordination geometry of the ruthenium 
atom is distorted with the trans N–Ru–N greater than 170°. The average Ru–N bond (ca. 
2.052 Å) distances are similar and consistent with 2.7, 2.10 and 2.13.  
 
Figure 2.33. The X–ray crystal structure of compound 2.15. The counterions 
and solvate molecules are omitted for clarity. Selected bond distances (Å) and 
bond angles (°): Ru1–N1 2.060(2), Ru1–N2 2.071(2), Ru1–N3 2.086(2), Ru1–
N4 2.067(2), Ru1–N5 2.042(2), Ru1–N7 1.991(2), N6–N7 1.301(3), N1–Ru1–
N2 78.29(8), N1–Ru1–N3 94.40(8), N2–Ru1–N3 86.81(8), N1–Ru1–N4 
171.26(8), N4–Ru1–N2 96.15(8), N4–Ru1–N3 78.44(8), N5–Ru1–N1 
98.61(8), N5–Ru1–N2 174.54(8), N5–Ru1–N3 97.96(8), N5–Ru1–N4 
87.45(8), N7–Ru1–N1 94.00(8), N7–Ru1–N2 99.09(8), N7–Ru1–N3 
170.57(8), N7–Ru1–N4 93.54(8), N7–Ru1–N5 76.53(8). 
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Crystal Structure of 2.16 
Crystals of 2.16 were obtained by diffusing diisopropyl ether into an acetonitrile 
solution of the complex. The complex crystallises in the monoclinic space group P21/c. The 
asymmetric unit contains one ruthenium atom, half a ligand 2.6, two bipyridine ligands, two 
hexafluorophosphate anions and three acetonitrile solvate molecules, confirming the 
formation of the complex in a 1:2 ligand to metal stoichiometric ratio. The other half of the 
molecule is related by a crystallographic centre of inversion at the centre of the bridge. The 
complex is the meso isomer with two [Ru(bpy)2]
2+
 moieties bridged by 2.6, which acts as a 
doubly–chelating ligand, as shown in Figure 2.34. Each ruthenium atom possesses a slightly 
distorted octahedral geometry with a separation of 4.882(4) Å between the ruthenium atoms. 
 
Figure 2.34. The X–ray crystal structure of compound 2.16. Hydrogen atoms, 
counterions and solvate molecules are omitted for clarity. Selected bond 
distances (Å): Ru1–N1 2.072(2), Ru1–N2 2.070(2), Ru1–N3 2.092(2), Ru1–N4 
2.080(2), Ru1–N5 2.080(2), Ru1–N6A 2.046(2), N6–N6A 1.401(3). Selected 
bond angles (°): N1–Ru1–N3 94.90(9), N1–Ru1–N4 171.88(9), N2–Ru1–N1 
78.38(9), N2–Ru1–N4 96.23(9), N2–Ru1–N3 83.85(9), N4–Ru1–N3 78.38(9), 
N5–Ru1–N1 92.60(9), N5–Ru1–N2 95.30(9), N5–Ru1–N3 172.11(9), N5–
Ru1–N4 93.95(9), N5–Ru1–N6A 75.97(9), N6A–Ru1–N1 96.47(9), N6A–
Ru1–N2 169.77(9), N6A–Ru1–N3 105.53(9), N6A–Ru1–N4 89.77(9). 
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2.4. Electronic Absorption Spectroscopy and Electrochemistry 
The UV/Visible absorption spectra and redox potentials give information about the 
metal–ligand interactions in mononuclear complexes and metal–metal interactions in 
dinuclear complexes. The complexes exhibit strong absorption bands in the UV region which 
is attributed to the ligand–centered (π → π*) transition, while bands in the visible region are 
most likely metal–to–ligand (dπ → π*) transitions.  
 
Figure 2.35. The UV/Visible spectra for the mononuclear complexes 2.7, 2.9, 
2.10, 2.12, 2.13 and 2.15. 
The mononuclear complexes all exhibit lowest–energy maxima at ca. 510 nm, with an 
associated shoulder at ca. 370 nm, as shown in Figure 2.35. The electronic absorption spectra 
and redox potentials for the mononuclear complexes in acetonitrile solution are listed in 
Table 2.10. Previous studies have confirmed that the azo ligand is more π–accepting than the 
terminal bpy ligands
[156]
 and, therefore, the lowest energy transition is assigned as the Ru(dπ) 
→ azo(π*) transition.  




 the higher energy absorption is associated 
with the Ru(dπ) → bpy(π*) charge transfer. Thus, mononuclear ruthenium complexes of 
azobispyridine posses small HOMO–LUMO energy gaps. The energy corresponding to the 
MLCT transition into the bridging ligand (EMLCT) increases with electron–donating 
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substituents on the bridging ligand, while it decreases in the presence of electron–
withdrawing substituents. 
Table 2.10. Absorption maxima
a
 and redox potentials
b,c
 for the mononuclear complexes. 
Mononuclear 
complexes 















2.44 1.95 +1.24 –0.71 –1.42 –2.03 




2.46 2.08 +1.23 –0.85 –1.56 –2.07 
2.10 508 (3.79) 
280 (4.63) 
244 (4.28) 
2.44 1.96 +1.19 –0.77 –1.46 –1.77 




2.45 1.96 +1.21 –0.75 –1.44 –2.05 




2.40 1.90 +1.32 –0.58 –1.25 –2.00 




2.37 1.88 +1.31 –0.57 –1.23 –2.00 
a 
In acetonitrile (±2 nm).  
b 
In V vs. Ag/AgNO3 in CH3CN/0.1M [(n–C4H9)4]ClO4. 
c 
Calculated from DPV measurements. 
d 
Energy for the lowest MLCT absorption. 
e 
Difference between the first oxidation and first reduction potentials. 
 
The electrochemical studies give additional insights into the electron–transfer processes 
in such complexes. An example of a differential pulse voltammogram for complex 2.15 is 
shown in Figure 2.36. The mononuclear complexes all displayed one reversible metal–
centered oxidation, Ru(II)/Ru(III), and at least three well resolved reversible reductions of the 
ligands. Compared to [Ru(bpy)3]
2+
 (+1.26 V vs SCE),
[1]
 these complexes are significantly 
easier to reduce, indicative of a relatively low–energy π*–orbital (LUMO) of the 
azobispyridine. Thus, the first reduction occurs on the azo bridging ligand, with the second 
and third reductions corresponding to the ancillary bpy ligands.
[93]
 The potential difference 
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between the first ligand–based reduction couple and the metal–based oxidation couple, 
ΔEox/red, correlates well with the energy associated with the lowest MLCT absorption, EMLCT, 




Figure 2.36. The differential pulse voltammogram of 2.15. 
Substituting the parent ligand with electron–donating methyl groups, as in 2.9, 2.10 and 
2.12, shifts the reduction potential by 40–140 mV compared to 2.7. For complexes 2.13 and 
2.15, the ruthenium oxidation potentials are shifted ca. 75 mV more positive and the ligand 
becomes ca. 130 mV easier to reduce.  
 
Figure 2.37. The UV/Visible spectra of 2.8, 2.11, 2.14 and 2.16. 
Potential (V) 
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 data for the dinuclear 
complexes. 
























2.09 1.94 0.16 2.70 




1.64 1.42 0.49 8.28 




1.63 1.42 0.48 8.11 





1.64 1.39 0.48 8.11 





1.62 1.40 0.50 8.45 
a 
In acetonitrile (±2 nm).  
b 
In V vs. Ag/AgNO3 in CH3CN/0.1M [(n–C4H9)4]ClO4.  
c 
Calculated from DPV measurements.  
d 
Energy for the lowest MLCT absorption.  
e 
Difference between the first oxidation and first reduction potential.  
f 
Difference between the two successive oxidation potentials.  
g 
Comproportionation constant, Kc = exp{ΔEoxF/RT}, where F/RT = 38.92 V
–1
 at 298 K. 
The dinuclear complexes 2.8, 2.11, 2.14 and 2.16 all exhibit strong ligand–centered 
absorptions at ca. 280 nm and 247 nm and metal–to–ligand charge transfer bands at λ>350 
nm. Figure 2.37 shows the electronic absorption spectra of the dinuclear complexes. The 
lowest energy absorptions at ca. 760 nm are assigned as the MLCT transition into the 
bridging ligand [Ru(dπ) → BL(π*)] and represent relatively low HOMO–LUMO energy 
gaps. The large bathochromic shift (  250 nm) of these absorptions, compared to the 
mononuclear ruthenium(II) complexes, has been observed regularly for dinuclear 
complexes.
[1],[6],[156]
 This red shift is due to the lowering of the π*–orbital of the bridging 
ligand on coordination of a second [Ru(bpy)2]
2+
 moiety. The other bands in the visible region 
are assigned as the MLCT transitions into the ancillary bpy ligands [Ru(dπ) → bpy(π*)]. The 
large red–shift of the lowest–energy MLCT absorptions indicates very strong interactions 
between the metal centres in these dinuclear complexes. The extent of these interactions is 
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revealed by electrochemical studies using differential pulse voltammetry. Table 2.11 lists the 
absorption maxima and electrochemical data for the dinuclear complexes 2.8, 2.11, 2.14 and 
2.16. 
The dinuclear complexes all exhibit two separate reversible metal–centered one–
electron oxidations and four reversible ligand–based reductions. The splitting between the 
two metal–centered oxidation potentials measures the metal–metal interaction across the 
bridge. The difference in the two successive oxidation potentials (ΔEox) gives a direct 
measure of the comproportionation constant (Kc), which has been extensively used to 
quantify the extent of communication between two metal centres.
[33],[41],[244]
 
The dinuclear complexes each display ΔEox values of approximately 500 mV 
equivalent to Kc values of   2 x 10
9
 and hence exhibit a very high degree of metal–metal 




 X–ray crystal structure analysis of the 
binuclear complexes (Section 2.3) indicates an inter–metal distance of ca. 4.9 Å in these 




 are 5.6 Å and 
6.2 Å, respectively. Short internuclear metal–metal distances along with a number of other 
important factors, such as the electronic properties of the ligand and the metal, electron 
density of the LUMO at the coordinating sites, have been proposed as governing factors 
responsible for the interaction between the metal centres. More recently, it has been shown 
that the nature of the counterion also plays a role.
[39],[40]
 In the present work the anion was 
maintained constant. 
Table 2.12. Redox potentials
a
 for 2.8, 2.11, 2.14 and 2.16. 





 +1.69 +1.53 –0.41 –1.08    
2.8 +1.85 +1.36 –0.06 –0.71 –1.83
b
   
2.11 +1.74 +1.26 –0.16 –0.81 –1.85 –1.91  
2.14 +1.84 +1.36 –0.03 –0.65 –1.19 –1.73 –1.86 
2.16 +1.87 +1.37 –0.03 –0.63 –1.84 –2.14 –2.23 
a 
Calculated from DPV measurements. 
b 
Two electron reduction. 
The redox potentials for the dinuclear complexes are listed in Table 2.12. The first 
oxidation potential for the dinuclear complexes occurs at a slightly more positive potential 
than the corresponding mononuclear complexes, since coordination of a second ruthenium 
ion reduces the electron density on the bridging ligand and as a result on the coordinated 
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metal. For example, the dinuclear complex 2.16 exhibits two separate one–electron metal–
centered oxidation potentials at +1.37 and +1.87, whereas the mononuclear complex 2.15 
oxidises at +1.31 V. Figure 2.38 shows differential pulse voltammogram for 2.16.  
 
Figure 2.38. Differential pulse voltammogram for 2.16. 
Earlier work on 2.8 has assigned the first two reductions as bridge–centered and the 
subsequent reductions are bpy–centered.
[93]
 The potential shift of the first reduction potential 
in the binuclear complexes when compared to the mononuclear complexes is due to the 
lowering of the π*–orbital of the bridging ligand through double [Ru(bpy)2]
2+
 coordination, 
which facilitates the electron uptake.  
Substituents on the bridging ligand have similar effects on the redox couple as observed 
for the mononuclear complexes. The electron–donating methyl substituents donate electron 
density to the Ru–centre making them easier to oxidise but more difficult to reduce as they 
raise the π*–orbital of the bridging ligand, as seen in 2.11. Conversely, electron–withdrawing 
halide substituents, in 2.14 and 2.16, destabilise the Ru(III) in comparison to Ru(II) making 
them difficult to oxidise but easier to reduce, due to the lowering of the π*–orbital of the 
bridging ligand. 
2.5. Summary 
This chapter has described the synthesis and characterization of a series of bidentate 
bridging ligands based on azobispyridine. Ligand 2.1 was prepared by oxidative coupling of 
2–aminopyridine using sodium hypochlorite. Ligands 2.2, 2.3 and 2.4 were synthesised from 
methyl–substituted amines to study the effect of electron–donating groups on the bridge. This 
Potential (V) 
Chapter 2 Bidentate ligands based on azobis(pyridines) 74 
 
chapter also describes the synthesis of electron–withdrawing halogen substituted ligands 2.5 
and 2.6.  
The coordination chemistry of these bidentate ligands with ruthenium(II) metal ions 
was investigated by synthesising mononuclear and binuclear complexes with [Ru(bpy)2Cl2]. 
All the doubly–bidentate ligands readily bridged two ruthenium metal atoms, except 2.2 and 
2.4, which is probably due to the steric interference of the methyl group at the 3– and 6–
positions. Surprisingly, reaction of ligand 2.6 with [Ru(bpy)2Cl2] resulted in the chloro–
substituted dinuclear product, which was avoided by using [Ru(bpy)2(OTf)2] to give the 
corresponding bromo–substituted complex 2.16. These complexes were characterised by 
NMR spectroscopy and X–ray crystallography. Crystal structures of the mononuclear 
complexes show that the ruthenium atom binds to the azobispyridine ligand using the azo 
nitrogen atom and the pyridine ring nitrogen atom, forming a stable five–membered chelate 
ring. In all cases the Ru–Nazo bond is the shortest Ru–N bond and the Ru–Npy bond of the 
bridging ligand is shorter than those to the bpy ligands. The visible absorption spectroscopy 
and differential pulse voltammetry reveal that these complexes possess small HOMO–LUMO 
energy gaps.  
In the dinuclear complexes selective formation of only one diastereoisomer, the meso 
form, was observed. The X–ray crystal structures indicate that the azo ligand acts as a planar 
bridge between the two ruthenium atoms separated by ca. 4.9 Å. Electronic absorption 
spectroscopy in acetonitrile exhibit MLCT absorption bands extending to ca. 760 nm 
indicating a low–lying π*–orbital in the bridging ligand. The electrochemical measurements 
reveal two widely separated one–electron metal–centred oxidation processes, indicating very 
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3. Bidentate ligands based on azobis(N–heterocycles) 
3.1. Introduction 
Ruthenium(II) complexes involving polypyridyl ligands have attracted extensive 
attention with emphasis on their stereochemical, electrochemical and photophysical 
properties. In such complexes, the ground and excited–state properties can be tuned by 
varying the structure of the ligand.
[13],[28]
 Replacement of the pyridine rings of bpy with 
different heterocycles can have significant effects on the physical properties of the resulting 
ruthenium complexes.
[27],[196]
 Previous investigations in the Steel group has shown that 
certain heterocycles can have quite dramatic effects on the physicochemical properties of the 
metal complexes.
[195]
 As shown in Figure 3.1, replacement of the pyrazine ring in 2,3’–dpp
[73]
 
by a pyrimidine ring as in 4,6–di(2’–pyridyl)pyrimidine (dppm)
[74]
 slightly reduces the 
interaction between the metal centres. However, electrochemical studies of dinuclear 


















Figure 3.1. Ruthenium complexes with varying heterocyclic groups and their 
corresponding Kc values.  
 
This chapter describes a series of polydentate ligands containing metal–binding 
substituents at the N=N unit, as shown in Figure 3.2. The ligands are divided into two 
categories: (i) ligands in which the pyridine ring of the azobispyridines, as discussed in 
Chapter 2, is replaced by a pyrimidine ring; (ii) ligands involving increased delocalisation 
through fused aromatic rings.  
























































Figure 3.2. The series of ligands discussed in this chapter. 
3.2. Pyrimidine–based ligands 
The ability of azobispyridine–based ligands to mediate strong metal–metal interactions 
has been discussed in Chapter 2. The replacement of the pyridine ring with a pyrimidine ring 
and the introduction of electron withdrawing substituents on the ligand was done to lower the 
energy of the π*–orbital of the ligand. In addition, the pyrimidine ligands also possess 
additional sites for coordination. The ruthenium chemistry of pyrimidine–based ligands 3.1 –
3.3 and their effect on the communication between the metal centres is investigated in this 
chapter. The supramolecular chemistry of these ligands with silver(I) was also investigated 
and is discussed in Chapter 6. 
Ligand 3.1, first described by Doslik et al.,
[255]
 is an exceptionally strong π–accepting 
bidentate ligand, when compared to the well studied ligand 2.1. The spectroelectrochemistry 
and high–field EPR studies of ruthenium, rhodium and copper complexes of 3.1 indicate high 
metal/ligand orbital mixing in these complexes.
[256]
 The most unexpected result is the 
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formation and high stability of the dinuclear complexes containing the ligand 3.1 as a radical 
anion. The introduction of chlorine substituents and additional nitrogen functionalities further 
lowers the π*–level of the bridging ligand. Ye et al.
[257]
 established a synthetic approach for 
the preparation of low valence triruthenium clusters by substituting the acetate bridge in the 
Ru3(OAc)6 core with 3.1. This substitution dramatically modifies the electronic and redox 
properties in the triruthenium derivatives. A recent study by Jana et al.
[258]
 involves the 
structural characterization of a 3.1–bridged oligonuclear Fe2Cu2 complex.  
There have been numerous investigations on the structural and spectroscopic properties 
for complexes containing ligand 3.1, however, pyrimidine–based azo ligands containing 
substituents other than chlorine are not known. In an attempt to design new azo ligands based 
on pyrimidine units, we synthesised a ligand containing electron–withdrawing bromo 
substituents 3.2, and an example of a ligand containing both electron–withdrawing chloro and 
electron–donating methyl substituents, 3.3. 
3.2.1. Syntheses of the ligands  
The pyrimidine–based ligands 3.1 and 3.3 were synthesised by chlorinating oxidative 
coupling of the precursor amines, while 3.2 was obtained by oxidative coupling of the bromo 
amine using sodium hypochlorite. The starting material for 3.1 was commercially available, 
whereas the precursors for 3.2 and 3.3 were synthesised as discussed below. 
Ligand 3.1 has been previously prepared by chlorinating oxidative coupling of 2–
aminopyrimidine using lithium hypochlorite.
[255]
 In this case, 3.1 was synthesised by 
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Ligand 3.2 was synthesised by oxidative coupling of 2–amino–5–bromo pyrimidine 
using sodium hypochlorite as shown in Scheme 3.2. The bromo precursor was synthesised 























A microwave–assisted cyclisation reaction, following the method of Goswami et 
al.,
[259]
 gave the precursor dimethyl aminopyrimidine, which on coupling using sodium 
































3.2.2. Ruthenium(II) Complexes of 3.1 
Ligand 3.1 reacted with [Ru(bpy)2Cl2] in aqueous ethanol to give the mononuclear 
complex 3.9, which was characterised as [(bpy)2Ru(3.1)](PF6)2. The dinuclear complex 3.10 
was obtained by refluxing an ethanolic mixture of 3.1 and [Ru(bpy)2Cl2] in a 1:2 
stoichiometric ratio, as shown in Scheme 3.4. The precipitation of complex 3.10 as 
hexafluorophosphate salts gave a paramagnetic 3+ complex indicating the formation of a 
radical anion. The 
1
H NMR spectrum was able to be obtained by addition of a small amount 
of oxidising agent, m–chloroperbenzoic acid to the acetonitrile–d3 solution. 






















































H NMR spectrum of 3.9, shown in Figure 3.3, exhibits 20 proton signals with the 
signals corresponding to 3.1 identified easily due to the chloride substituents and additional 
N–atom in the pyrimidine ring. The four pyridine rings corresponding to the terminal bpy 
units were also identified and are color coded into groups; however, due to overlapping of 
signals, individual bpy rings could not be identified. Table 3.1 lists the 
1
H chemical shifts and 
CIS values for the free ligand 3.1 and complex 3.9. The coordinated pyrimidine ring of 3.1 
shows two different proton environments for the H4 and H6 protons. Based on the strong 
negative CIS value for the H6 proton it could be concluded that it must be shielded due to the 
through–space ring–current effects from the adjacent bpy ring. Unfortunately, all attempts to 
grow crystals of 3.9 were unsuccessful. 
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Figure 3.3. The 
1
H NMR spectrum of 3.9. 
Table 3.1. The 
1
H NMR chemical shifts
a
 and CIS values
b
 for 3.1 and 3.9. 
 H4 H6 
3.1 9.02 9.02 
3.9
c
 (black) 9.23 8.33 
CIS +0.21 –0.69 
3.9
d
 (red) 8.58 8.58 
CIS –0.44 –0.44 
a
In acetonitrile–d3.  
b
CIS = δcomplex–δligand.  
c
Coordinated pym ring of 3.1.  
d
Free pym ring of 3.1. 
 
Crystal Structure of 3.10 
Vapour diffusion of diisopropyl ether into an acetonitrile solution of the complex gave 
green crystals of complex 3.10, which were suitable for X–ray analysis. The complex 
crystallises in the monoclinic space group C2/c with one Ru(bpy)2 fragment, half of ligand 
3.1, one and a half hexafluorophosphate anions and one acetonitrile molecule in the 
asymmetric unit, as shown in Figure 3.4.  
The overall structure of 3.10 grows into the dinuclear complex in which the ligand 3.1 
forms five–membered chelate rings with two Ru(bpy)2 fragments separated at a distance of 
ppm 
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4.881(5) Å. The trans N–Ru–N angles are   173° which indicate a slight distortion in the 
ruthenium octahedral geometry. The Ru–Npy bond lengths are similar (ca. 2.06 Å) and 
consistent with those found in Chapter 2.  
 
Figure 3.4. The asymmetric unit of complex 3.10 with atom–labelling. 
Counterions and solvate molecules are omitted for clarity. Selected bond 
lengths (Å): Ru1–N1 2.053(3), Ru1–N2 2.057(3), Ru1–N3 2.067(4), Ru1–N4 
2.074(3), Ru1–N5 2.035(3), Ru1–N7A 2.050(3), N7–N7A 1.373(6), N7–C24 
1.362(4), N5–C24 1.364(5), N6–C24 1.344(5), N5–C21 1.341(4), N6–C23 
1.326(6). Selected bond angles (°): N1–Ru1–N2 78.41(17), N1–Ru1–N3 
174.52(13), N1–Ru1–N4 96.37(13), N2–Ru1–N3 99.05(15), N2–Ru1–N4 
85.85(12), N3–Ru1–N4 78.54(13), N5–Ru1–N1 97.17(14), N5–Ru1–N2 
174.65(14), N5–Ru1–N3 85.60(13), N5–Ru1–N4 97.73(12), N5–Ru1–N7 
76.82(12), N7A–Ru1–N1 90.52(13), N7A–Ru1–N2 100.04(12), N7A–Ru1–N3 
94.72(13), N7A–Ru1–N4 171.74(12). 
The charge state in ruthenium complexes containing azo ligands can be correlated to 
the Nazo–Nazo bond length. As reviewed by Kaim et al.
[249]
 the N=N bond length (ca. 1.25 Å) 
tends to increase to about 1.36 Å in the azo anion radical form. Further reduction of the azo 
function to hydrazine/hydrazo results in a further lengthening of the N–N distance to about 
1.40 Å. In the previously reported dicopper(I) complex of 3.1, the non–reduced azo ligand 
exhibits a N=N bond length of 1.248(11) Å in [{Cu(PPh3)2}2(3.1)](PF6)2, whereas the 
reduced azo–aromatic ligand in [(Cu(PPh3)2}2(3.1)](PF6) displays a longer Nazo–Nazo bond 
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length of 1.345(7) Å and shorter C–N(–N) bond length of 1.360(5) Å.
[250],[255]
 Interestingly, 
3.10 also displays a longer N–N bond length [N7–N7A 1.373(6) Å] and shorter C–Nazo bond 
length [N7–C24 1.362(4) Å]. This indicates that the ligand 3.1 exists as a reduced anion 
radical. The presence of three hexafluorophosphate anions and the electrochemical studies 
(Section 3.5) further support this observation. 
3.2.3. Ruthenium(II) Complexes of 3.2 
Reaction of ligand 3.2 with [Ru(bpy)2Cl2] in aqueous methanol gave the mononuclear 
complex 3.11, which was characterised as [(bpy)2Ru(3.2)](PF6)2, as shown in Scheme 3.5. 
Ligand 3.2 reacts with two equivalents of [Ru(bpy)2Cl2] in aqueous methanol to give a chloro 




































































The product was characterised as [{Ru(bpy)2}2(μ–3.1)](PF6)4 by ESI–MS as shown in 
Figure 3.5. No evidence for the bromo substituted dinuclear species was obtained. 
Interestingly, the dinuclear chloro–product obtained by this method was a diamagnetic 4+ 
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charged compound, unlike the paramagnetic 3+ charged dinuclear complex 3.10 obtained 
from ligand 3.1. 
 
Figure 3.5. The mass spectrum of the chloro–substituted dinuclear product. 
Reaction of the free ligand 3.2 with an excess of LiCl did not show any evidence for the 
chloro–substituted ligand 3.1. Furthermore, the presence of only the mononuclear bromo 
product 3.11 on reacting 3.2 and [Ru(bpy)2Cl2] suggests that the dibromo pyrimidine ligand 
3.2 promotes aromatic nucleophilic substitution only after coordination to two metals. Like 
2.6 discussed in Chapter 2, this is possibly due to the increased electropositive character of 
the C5 atom in the dinuclear complex. Therefore to overcome this substitution reaction 
[Ru(bpy)2Cl2] was replaced with [Ru(bpy)2(OTf)2]. The reaction of 3.2 with two equivalents 
of [Ru(bpy)2(OTf)2] in ethylene glycol gave the dinuclear bromo–substituted complex 3.12. 
This was characterised as a singly reduced complex [{Ru(bpy)2}2(μ–3.2)](PF6)3 by X–ray 
analysis. The mass spectrum was consistent with 3.12 and no evidence for the chloro–
substituted dinuclear complex was observed, as shown in Figure 3.6. 
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Figure 3.6. The mass spectrum and the isotopic pattern of 3.12. 
1
H NMR of 3.11 
Figure 3.7 shows the 
1
H NMR spectrum for 3.11, which shows chemical shifts similar 
to 3.9. The spectrum shows 20 aromatic proton signals with four pyridine ring environments 
corresponding to the bpy ligands. The individual bipyridine rings were identified by 1D 
ROESY experiments, where the H3 protons of the pyridyl rings connected on the same bpy 
show an NOE. In the bridging ligand, the peak corresponding to the H6 proton (8.41 ppm) is 
more shielded when compared to the H4 proton (9.31 ppm), since it is close in space to the 
adjacent bpy rings and hence experiences through–space ring–current effects. Contrary to 
this, the H6’ and H4’ protons (8.87 ppm) of the free pyrimidine ring experience similar shifts 
as they are not effected much by the coordination. Attempts to grow crystals of the complex 
were unsuccessful. 
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Figure 3.7. The 
1
H NMR spectrum of 3.11. 
Crystal Structure of 3.12 
Crystals of 3.12 were obtained by diffusion of diisopropyl ether into an acetonitrile 
solution of the complex. The complex crystallised in the triclinic space group P–1, with half a 
cation, one and a half hexafluorophosphate anions and one acetonitrile solvate molecule in 
the asymmetric unit. The one and half hexafluorophosphate anions indicates that the complex 
exists as the reduced complex [{Ru(bpy)2}2(μ–3.2)](PF6)3. The complex lies on a 
crystallographic centre of inversion and is the meso isomer. 
The complex adopts an “S–frame” coordination mode with the Ru–coordination sphere 
being unexceptional, as shown in Figure 3.8. The azo bridge acts as a planar bridge with a 
separation of 4.882(4) Å between the metals. Interestingly, 3.12 also displays a longer Nazo–
Nazo [N7–N7A 1.374(5) Å] bond length and shorter C–Nazo [C21–N7 1.366(4) Å] bond 
length, indicative of a reduced azo–aromatic ligand.
[255]
 The coordination geometry of 
ruthenium is normal with consistent Ru–N bond lengths. The formation of the anion radical 
ligand is also supported by the oxidation state of the ligand which is discussed further in 
Section 3.5. 
ppm
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Figure 3.8. X–ray crystal structure of 3.12 showing three PF6¯ anions. All 
hydrogen atoms and solvate molecules are omitted for clarity. Selected bond 
distances (Å): Ru1–N1 2.051(3), Ru1–N2 2.065(3), Ru1–N3 2.061(3), Ru1–N4 
2.067(3), Ru1–N5 2.042(3), Ru1–N7A 2.054(3), N7–N7A 1.374(5), N7–C21 
1.366(4). Selected bond angles (°): N1–Ru1–N2 79.01(11), N1–Ru1–N3 
96.63(11), N1–Ru1–N4 173.61(10), N1–Ru1–N7A 89.18(11), N2–Ru1–N4 
96.72(11), N3–Ru1–N2 88.83(10), N3–Ru1–N4 78.43(11), N5–Ru1–N1 
99.91(11), N5–Ru1–N2 176.00(10), N5–Ru1–N3 95.13(10), N5–Ru1–N4 
84.67(11), N5–Ru1–N7A 76.65(10), N7A–Ru1–N2 99.45(10), N7A–Ru1–N3 
170.68(10), N7A–Ru1–N4 96.25(11). 
 
3.2.4. Ruthenium(II) Complexes of 3.3 
Ligand 3.3 was refluxed with [Ru(bpy)2Cl2] in aqueous methanol to give 3.13 and 3.14, 
characterised as [(bpy)2Ru(3.3](PF6)2 and [{Ru(bpy)2}2(μ–3.3)](PF6)4 respectively, as shown 
in Scheme 3.6.  






















































Due to the substituents on 3.3, complex 3.13 shows aromatic proton signals 
corresponding to the bpy pyridine rings only, as shown in Figure 3.9a. The individual 
pyridine rings were identified by gCOSY experiments as shown in Figure 3.9b. 
Unfortunately, due to overlapping of signals the individual pyridine rings could not be 
identified. One of the bpy–H6 protons (7.01 ppm) experiences strong ring–current effects as 
it is positioned directly over an adjacent pyrimidine ring, which correlates with the X–ray 
structure discussed below. The methyl substituents on the bridging ligand 3.3 exhibit three 
different signals for the coordinated and the free pym ring. The 6–CH3 of the coordinated ring 
is shifted upfield since it is in close proximity to an adjacent bpy ring,  






Figure 3.9. The 
1
H NMR (a) and gCOSY (b) spectra of 3.13 displaying the bpy 
pyridine rings, color–coded in groups. 
Crystal Structure of 3.13 
Red needles of 3.13 suitable for X–ray analysis were obtained by diffusing petroleum 
ether into an acetone solution of the complex. The complex crystallised in the monoclinic 
space group P21/c, with one full cation and two hexafluorophosphate anions in the 
asymmetric unit, as shown in Figure 3.10. The X–ray crystal structure confirms the 
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Figure 3.10. The X–ray crystal structure of 3.13. The bipyridine hydrogen 
atoms are omitted for clarity. Selected bond distances (Å): Ru1–N1 2.053(3), 
Ru1–N2 2.062(3), Ru1–N3 2.103(3), Ru1–N4 2.080(3), Ru1–N5 2.079(3), 
Ru1–N8 1.972(3), N7–N8 1.291(4). Selected bond angles (°): N8–Ru1–N4 
93.69(12), N1–Ru1–N4 171.99(12), N8–Ru1–N1 92.99(12), N5–Ru1–N4 
86.43(12), N8–Ru1–N5 75.97(13), N1–Ru1–N5 99.48(12), N2–Ru1–N4 
95.31(12), N8–Ru1–N2 102.12(12), N1–Ru1–N2 78.95(12), N2–Ru1–N5 
177.52(12), N4–Ru1–N3 77.76(12), N8–Ru1–N3 171.16(12), N1–Ru1–N3 
95.70(12), N5–Ru1–N3 100.95(12), N2–Ru1–N3 81.17(12). 
Ligand 3.3 forms a five–membered chelate ring involving a pyrimidine N–atom (N5) 
and an azo N–atom (N8). The ruthenium atom possesses a distorted octahedral geometry with 
the average Ru–Npy bond distances (ca. 2.07 Å) consistent with similar complexes. Once 
again the Ru–Nazo bond distance [Ru1–N8 1.972(3)] is shorter than the Ru–Npym bond 
distance [Ru1–N5 2.079(3)] indicating the better π*–accepting ability of the azo group when 
compared to the pyrimidine ring. However, unlike the pyrimidine–based dinuclear complexes 
3.10 and 3.12, the Nazo–Nazo bond length [N7–N8 1.291(4) Å] in 3.13 is within the range of 
dNN values (1.23–1.32 Å) for compounds containing an unreduced azo ligand.
[249]
 As seen in 
the mononuclear complexes in Chapter 2, the free pyrimidine ring is considerably twisted 
with the torsion angle (N7–N8–C27–N9) being –21.2(5)° and the coordinated ring is in the 
same plane as the azo with a torsion angle (N8–N7–C21–N5) of 4.2(5)°. The crystal packing 
shows numerous weak interactions, such as F∙∙∙HC and N∙∙∙HC, at a range > 2.4 Å. 
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Crystal Structure of 3.14 
Crystals of 3.14 were obtained by vapour diffusion of diisopropyl ether into an 
acetonitrile solution of the complex. The complex crystallises in the triclinic space group P–
1. The asymmetric unit contains one ruthenium atom, half of ligand 3.3 and two bpy ligands 
with two hexafluorophosphate anions and two acetonitrile molecules, as shown below. 
 
(a) (b) 
Figure 3.11. (a) Asymmetric unit of 3.14. (b) A perspective view of the X–ray 
structure of 3.14. Selected bond lengths (Å): Ru1–N1 2.053(5), Ru1–N2 
2.049(6), Ru1–N3 2.089(5), Ru1–N4 2.079(5), Ru1–N5 2.076(6), Ru1–N7A 
1.995(5), N7–N7A 1.355(10), N7–C21 1.414(8). Selected bond angles (°): N1–
Ru1–N3 94.4(2), N1–Ru1–N4 171.7(2), N1–Ru1–N5 100.8(2), N2–Ru1–N1 
78.6(2), N2–Ru1–N3 81.9(2), N2–Ru1–N4 96.7(2), N2–Ru1–N5 177.2(2), 
N4–Ru1–N3 78.1(2), N5–Ru1–N3 100.9(2), N5–Ru1–N4 84.3(2), N7A–Ru1–
N1 91.8(2), N7A–Ru1–N2 100.4(2), N7A–Ru1–N3 173.7(2), N7A–Ru1–N4 
95.8(2), N7A–Ru1–N5 76.8(2). 
The X–ray crystal structure unambiguously confirms the crystallised complex as the 
meso isomer with the terminal ligands above and below the plane of the bridge, as shown in 
Figure 3.11b. The trans angles of 177.2(2)° (N2–Ru1–N5), 171.7(2)° (N1–Ru1–N4), 
173.7(2)° (N3–Ru1–N7) indicate a slightly distorted octahedral geometry at the metal centre. 
As expected, ligand 3.3 exhibits the conventional “S–frame” conformation with each 
(
a) 
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Ru(bpy)2 coordinated through the Nazo atom and Npym atom on either sides. The bridge 
separates the two metal centres at a distance of 4.790(1) Å [Ru∙∙∙Ru]. The Ru–Npy bond 
lengths are consistent with those found in structurally related compounds. Contrary to 
complexes 3.10 and 3.12, the shorter Nazo–Nazo bond distance [N7–N7A 1.355(10) Å] and 
longer C–Npym bond distance [N7–C21 1.414(8) Å], along with four hexafluorophosphate 
anions indicate the presence of the azopyridyl ligand 3.3 as a non–reduced species. 
 
3.3. Ligands based on fused aromatic azines 
The metallosupramolecular chemistry of symmetrical aromatic bibenzodiazines has 
been previously investigated in our group.
[70],[159]
 Although ligand 3.4 has been known for a 
long time,
[260–262]
 its coordination chemistry has been ignored. In this section, a series of 
ligands 3.4 – 3.8 based on azo linked fused aromatic azines are described. These ligands were 
designed to introduce delocalisation in the ligand backbone through fused aromatic rings, 
which could be used to tune redox properties and absorption spectra. 
3.3.1. Syntheses of the ligands 
The fused aromatic azo ligands 3.4 – 3.8 were synthesised from their precursor amines 
by oxidative coupling using sodium hypochlorite. The required amines, 2–aminoquinoline 
(Scheme 3.7), 2–aminoquinazoline (Scheme 3.8) and 2–aminoquinoxaline (Scheme 3.9), 2–
amino–1,8–naphthyridine (Scheme 3.10) and 2–amino–1,5–naphthyridine (Scheme 3.11) 
were not readily available and were synthesised from literature procedures. 
Ligand 3.4 has previously been synthesised by oxidation of the hydrazo compound 
using FeCl3
[262]
 or oxides of nitrogen, obtained by the action of nitric acid on copper.
[261]
 
Instead, 3.4 was conveniently synthesised by oxidative coupling of 2–aminoquinoline, as 
shown in Scheme 3.7. The precursor amine was synthesised by heating 2–chloroquinoline 
with acetamide and potassium carbonate under solvent free conditions using the method of 
Ferenc Kóródi
[263]
 in reasonably good yield (78%). The chloro derivative was prepared in two 
steps starting from quinoline using a literature procedure.
[264],[265]
 















Copper–catalysed coupling of 2–bromobenzaldehyde with guanidine hydrochloride, 
following a method by Huang et al.
[266]
 gave the 2–aminoquinazoline in moderate yield 
(53%). This was then subjected to oxidative coupling using sodium hypochlorite to give the 





















Ligand 3.6 has been reported by Krieger et al.
[267]
 as the product obtained from 2(1H)–
quinoxalinone oxime by the template effect of Co(II) and Ni(II) ions. Alternatively, 3.6 was 
synthesised by oxidative coupling of the precursor amine in moderate yield, as shown in 
Scheme 3.9. The 2–amino quinoxaline precursor was prepared by aminolysis of 2–
chloroquinoxaline
[268]
 using the method of Rawua et al.
[269]
 



















The naphthyridine–based ligands 3.7 and 3.8 were also synthesised by oxidative 
coupling of their precursor naphthyridine amines. The starting amines were synthesised via 
Skraup reactions of the corresponding diamines using methods from Campbell et al.
[270]
 The 
condensation of commercially available pyridine–2,6–diamine with sodium m–
nitrobenzenesulfonate and glycerol gave 2–amino–1,8–naphthyridine in 19% yield, which 
then undergoes coupling to give ligand 3.7, as shown in Scheme 3.10. 
N N N
N N N









Ligand 3.8 was synthesised by oxidative coupling of 2–amino–1,5–naphthyridine using 
sodium hypochlorite in moderate yield. The precursor amine, as shown in Scheme 3.11, was 
prepared following the method of Campbell et al.
[270]
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3.3.2. Ruthenium(II) Complexes of 3.4 
Ligand 3.4 is structurally similar to azobis(2–pyridine) 2.1, however, the fused benzene 
ring should increase the delocalisation of electrons as well as the steric effects in the region of 







Figure 3.12. The structural similarity between 3.4 and 2.1. 
The mononuclear complex 3.15 was obtained by refluxing 3.4 with [Ru(bpy)2Cl2] in 
aqueous methanol. The complex was precipitated as the hexafluorophosphate salts to give a 
red powder, which was characterised as [(bpy)2Ru(3.4)](PF6)2. The dinuclear complex 3.16 
was obtained as a green powder by refluxing a suspension of ligand 3.4 with two equivalents 
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Figure 3.13. The 
1
H NMR spectrum of 3.15 with the ring systems being identified. 
The 
1
H NMR spectrum of 3.15 displays 28 non–equivalent proton signals, as shown in 
Figure 3.13, corresponding to four pyridine rings and two quinoline ring environments. Due 
to the unsymmetrical nature of the coordinated ligand 3.4 the two quinoline rings are 
different. The quinoline ring systems were identified using a combination of gCOSY and 1D 
ROESY, as shown in Figure 3.14. Table 3.2 summarises the 
1
H NMR chemical shifts and 
CIS values for 3.4 and 3.15 in acetonitrile. The negative values for the H8 protons of the 
coordinated ring (–0.68 ppm) and free ring (–0.63 ppm) indicate similar through–space ring–
current effects. It can be clearly seen from the crystal structure described below that both 
these protons are positioned over adjacent bpy rings. However, the H8 proton (H28A) of the 
coordinated ring lies directly over the pyridyl N–atom and hence experiences stronger ring–
current effect when compared to the free ring (H34A). The H3 proton (8.16 ppm) of the 
coordinated ring is deshielded due to chelation induced conformational change, whereas the 
H3’ proton (8.87 ppm) (H31A) of the non–coordinated ring is deshielded by the azo N–atom. 
Similar to the previous complexes, a strongly shielded bpy–H6 proton (7.29 ppm) (H1A) is 
observed in 3.15 also. 
ppm 






Figure 3.14. (a) gCOSY and (b) 1D ROESY spectra of 3.15 
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Table 3.2. The 
1
H NMR chemical shifts
a
 and CIS values
b
 of 3.4 and 3.15 
 H3 H4 H5 H6 H7 H8 





 8.16 8.48 7.97 7.66 7.73 7.42 
CIS +0.07 –0.09 –0.33 –0.26 –0.02 –0.68 
3.15
e
(red) 8.87 8.77 8.16 7.84 7.46 7.47 
CIS +0.78 +0.20 –0.14 –0.08 –0.29 –0.63 
a
In CD3CN.  
b
CIS = δcomplex – δligand.  
c
Coordinated ring of 3.4.  
d
For colours, see Figure 3.12.  
e
Non–coordinated ring of 3.4. 
 
Crystal Structure of 3.15 
Vapour diffusion of n–hexane into a solution of the complex in acetone gave 3.15 as 
red needles suitable for X–ray analysis. The complex solved in the monoclinic space group 
P21/c. The asymmetric unit contains one full cation with two hexafluorophosphate anions and 
one acetone molecule, as shown in Figure 3.15. The X–ray structure confirms the 
mononuclear nature of the complex with one Ru(bpy)2 fragment coordinated to 3.4 using the 
Nazo (N7) and Nquinoline (N5) atom. The coordinated quinoline ring is in the same plane as the 
azo with the torsion angle being 3.3(4)° (N5–C21–N6–N7), however, the non–coordinated 
ring is twisted with an angle of –37.7(4)° (N6–N7–C30–C31) to avoid non–bonding 
interactions with the ancillary ligands. 
The Ru–N bond lengths are comparable with the previous complexes and once again 
the Ru–Nazo [Ru1–N7 1.957(2) Å] bond distance is the shortest of all. In the molecular 
packing, each molecule of 3.15 displays weak π – π interactions with an adjacent molecule 
through the benzene ring of the non–coordinated quinoline ring. Numerous other weaker 
interactions such as F∙∙∙HC and acetone O∙∙∙HC also exist, which stabilise the crystal packing. 
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Figure 3.15. The X–ray structure of 3.15 with atom labelling. Counterions and 
the solvate molecule are omitted for clarity. Selected bond distances (Å): Ru1–
N1 2.062(3), Ru1–N2 2.050(3), Ru1–N3 2.077(3), Ru1–N4 2.100(3), Ru1–N5 
2.095(3), Ru1–N7 1.957(3), N6–N7 1.307(3). Selected bond angles (°): N7–
Ru1–N2 97.91(10), N7–Ru1–N1 91.29(10), N2–Ru1–N1 78.48(11), N7–Ru1–
N3 95.91(10), N2–Ru1–N3 97.84(11), N1–Ru1–N3 172.33(10), N7–Ru1–N5 
76.31(10), N2–Ru1–N5 174.19(10), N1–Ru1–N5 100.85(10), N3–Ru1–N5 
83.49(10), N7–Ru1–N4 173.35(11), N2–Ru1–N4 82.16(10), N1–Ru1–N4 
95.23(10), N3–Ru1–N4 77.52(11), N5–Ru1–N4 103.65(10). 
 
Crystal Structure of 3.16 
A single crystal of 3.16 suitable for X–ray structure analysis was obtained by diffusing 
diisopropyl ether into an acetonitrile solution of the complex. The complex crystallised in the 
centrosymmetric triclinic space group P–1 with one ruthenium metal, three bidentate ligands, 
two hexafluorophosphate anions and three acetonitrile molecules in the asymmetric unit.  
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Figure 3.16. A perspective view of 3.16 with atom labelling. Hydrogen atoms, 
anions and solvate molecules are omitted for clarity. Selected bond distances 
(Å): Ru1–N1 2.069(3), Ru1–N2A 2.019(3), Ru1–N3 2.069(3), Ru1–N4 
2.078(3), Ru1–N5 2.098(3), Ru1–N6 2.084(3), N2–N2A 1.346(6). Selected 
bond angles (°): N1–Ru1–N3 100.63(13), N1–Ru1–N4 179.26(13), N1–Ru1–
N5 97.52(13), N1–Ru1–N6 83.44(13), N2A–Ru1–N1 76.55(13), N2A–Ru1–
N3 94.95(13), N2A–Ru1–N4 103.08(13), N2A–Ru1–N5 169.26(13), N2A–
Ru1–N6 92.20(13), N3–Ru1–N4 78.74(14), N3–Ru1–N5 94.94(13), N3–Ru1–
N6 172.43(13), N4–Ru1–N5 82.94(13), N4–Ru1–N5 97.25(14), N6–Ru1–N5 
78.12(13). 
The molecular structure and selected bond parameters are shown in Figure 3.16. The 
crystallised complex is the meso (ΔΛ) isomer in which 3.4 acts as a non–planar bridge with 
the intramolecular Ru∙∙∙Ru distance being 4.784(7) Å. Ligand 3.4 within the complex exhibits 
the usual s–cis/E/s–cis binding mode, chelating each ruthenium atom through azo and 
quinoline nitrogen donors. The torsion angle due to the twist is 10.122(2)°. The Ru–N 
distances are in the normal range with Ru–Nazo [Ru1–N2A 2.019(3) Å] being the shortest, 
arising from strong π back–bonding into the azo group from the Ru metal centre. The Nazo–
Nazo [N2–N2A 1.346(6) Å] distance is in the normal range (1.26 – 1.37 Å] as observed in 
previous complexes containing non–reduced azo ligand. The crystal packing involves 
numerous weak interactions between the various components, such as C–H∙∙∙π (ca. 3.15 Å), 
C–H∙∙∙F (> 2.5 Å) and N∙∙H–C (> 2.6 Å). 
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3.3.3. Ruthenium(II) Complexes of 3.5 
In quinazoline subunits, shown in Figure 3.17a, the benzene ring fused to the d–bond of 
the pyrimidine ring distinguishes the nitrogen atoms into sterically ‘more hindered’ and ‘less 
hindered’. This aspect of quinazoline was previously explored in our group using 2,2’–
biquinazoline.
[70]
 As shown in Figure 3.17b, the mononuclear complexes of 2,2’–















Figure 3.17. (a) Two types of nitrogen atoms in quinazoline and (b) preferred 
coordination in the complexes of 2,2’–biquinazoline 
Ligand 3.5 can chelate and bridge metal centres using the azo N–atom and the more or 
less sterically hindered alternatives, as shown in Figure 3.18. To investigate the coordination 



















(a) (b) (c)  
Figure 3.18. Possible coordination modes of 3.5 
Reaction of 3.5 with [Ru(bpy)2Cl2] in aqueous ethanol, as shown in Scheme 3.13, gave 
a mixture of 3.17 and 3.18 in a 1:10 ratio. The complexes were separated by ion exchange 
chromatography on a Sephadex C–25 column using a 0.1 mol L¯
1
 sodium chloride solution. 
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 was found to exist as a mixture of two isomers from the 
1
H NMR spectrum as shown in Figure 3.19. Interestingly, the isomers exhibit different 
colours and were carefully separated by ion exchange chromatography into reddish orange 
3.17 and dark red 3.18 fractions. In 3.17, chelation to the ruthenium metal centre occurs via 
the sterically hindered N–atom. The complex 3.18 (dark red), involving chelation to the metal 
centre through the less hindered N–atom, was obtained as the major product.  
Table 3.3 lists the 
1
H NMR chemical shifts and CIS values for 3.5 (CDCl3), 3.17 and 
3.18 in CD3CN. In 3.17, the H8 proton (7.31 ppm) experiences maximum anisotropy due to 
the adjacent bpy rings. A similar, strongly shielded proton was observed for the coordinated 
quinoline ring in 3.15, as the coordinated quinazoline ring in 3.17 behaves similarly to the 
quinoline ring in 3.15. However, in 3.18 the H8 (8.13 ppm) and H8’ (8.11 ppm) protons 
experience similar shielding effects. In 3.17, the H4 proton (9.86 ppm) of the coordinated 
ring is strongly deshielded due to coordination induced changes in the conformation of the 
ligand. But in 3.18, the H4 proton (9.02 ppm) experiences through–space anisotropy ring–
current due to the adjacent terminal ligands. In 3.17 and 3.18, the H4’ protons (9.36 ppm and 
9.37 ppm respectively) of the non–coordinated ring exhibit similar chemical shifts. 





H NMR of an approximately 1:1 mixture and the two purified 
isomers, 3.17 and 3.18 after separation. 
Table 3.3. The 
1








 H4 H5 H6 H7 H8 
3.5 9.65 8.11 8.05 7.81 8.31 
3.17
c
 9.86 8.35 8.03 7.75 7.31 
CIS +0.21 +0.24 –0.02 –0.06 –1.00 
3.17
d
 9.36 8.12 7.83 8.06 7.74 
CIS –0.29 +0.01 –0.22 +0.25 –0.57 
3.18
c
 9.02 8.45 8.26 8.03 8.13 
CIS –0.63 +0.34 +0.21 +0.22 –0.18 
3.18
d
 9.37 7.74 8.04 7.83 8.11 






Coordinated ring of 3.5. 
d
Non–coordinated ring of 3.5. 
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Crystal Structure of 3.17 
Crystals of 3.17 were obtained by vapour diffusion of petroleum ether into a solution of 
the complex in acetone. The complex crystallises in the monoclinic space group P21/c. The 
asymmetric unit contains one ruthenium metal, two bipyridine units, one ligand 3.5 with two 
hexafluorophosphate anions and one acetone solvate molecule, as shown in Figure 3.20. The 
X–ray crystal structure clearly verifies that the bridging ligand 3.5 within the complex of 3.17 
is coordinated to the ruthenium atom using the azo nitrogen atom (N8) and the more hindered 
N–atom (N6). 
 
Figure 3.20. The X–ray structure of 3.17 with the bpy hydrogen atoms, 
counterions and solvate molecules omitted for clarity. Selected bond distances 
(Å): Ru1–N1 2.055(2), Ru1–N2 2.066(2), Ru1–N3 2.079(2), Ru1–N4 2.106(2), 
Ru1–N6 2.094(2), Ru1–N8 1.954(2), N7–N8 1.292(2). Selected bond angles 
(°): N1 Ru1–N2–78.48(6), N1–Ru1–N3 96.94(6), N1–Ru1–N4 80.87(6), N1–
Ru1–N6 173.60(6), N2–Ru1–N3 171.18(6), N2–Ru1–N4 94.08(6), N2–Ru1–
N6 100.65(6), N3–Ru1–N4 77.66(6), N3–Ru1–N6 84.73(6), N6–Ru1–N4 
105.53(6), N8–Ru1–N1 97.99(6), N8–Ru1–N2 92.10(6), N8–Ru1–N3 
96.03(6), N8–Ru1–N4 173.35(6). 
Once again, the non–coordinated ring twists with a torsion angle of 48.8(2)°, while the 
coordinated ring is in the same plane as the azo group [N6–C21–N7–N8 2.4(2)°]. The 
ruthenium geometry is consistent with the Ru–Npy bond lengths ranging from 2.05–2.10 Å. 
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The stronger π back–bonding from the Ru centre to the azo group is evident from the 
shortening of the bond distance for Ru–Nazo [Ru1–N8 1.954(2) Å] compared to that of Ru–
Nquinazoline [Ru1–N6 2.094(2) Å]. The fused benzene ring of the non–coordinated ring in each 
molecule of 3.17 displays face to face π – π interactions with an adjacent molecule and edge 
to face interactions with a bpy ring.  
As hypothesized from the 
1
H NMR of 3.17 (Figure 3.19), the H8 proton (H27) lies 
directly over the pyridyl N–atom of an adjacent bpy ring, whereas the H8’ proton (H35) is 
not affected much by the coordination. Unfortunately, attempts to grow crystals of 3.18 were 
unsuccessful. 
The dinuclear complex was synthesised by reacting 3.5 with [Ru(bpy)2Cl2] in aqueous 
ethanol at 90 °C for 3 days, as shown in Scheme 3.14. Interestingly, a mixture of 
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The diaseteroisomer separation was achieved by cation–exchange chromatography on 
SP Sephadex C–25 support using 0.1 – 0.5 mol L¯
1
 sodium tosylate solution as the eluent. 
The diastereoisomers differ in terms of the relative orientation of the terminal ligands and 
therefore interact differentially with the eluent anions.
[65]
 In this case, the minor isomer 3.19 
(racemic) eluted first followed by 3.20 (meso) as the major isomer. The structures of the two 
isomers were assigned by X–ray crystallography below. Usually, for such complexes, the 
meso isomer elutes first, however, in the case of ‘stepped–parallel’ bridging ligands, 
sometimes the reverse is possible.
[84],[93]
 
Table 3.4. The 
1
H NMR chemical shifts and approximate CIS
a
 values of 3.5 and 3.20. 
 H4 H5 H6 H7 H8 
3.5
b
 9.65 8.11 8.05 7.81 8.31 
3.20
c
 8.88 8.00 7.93 8.01 6.93 
CIS –0.77 –0.11 –0.12 +0.20 –1.38 
a
CIS = δcomplex – δligand.  
b





H NMR spectrum of 3.19 could not be obtained due to insufficient 
sample. The 
1
H NMR spectrum of 3.20 displays 21 non–equivalent proton signals with five 




H COSY NMR techniques in combination with 1D 
TOCSY, it was possible to completely assign the spectrum for 3.20, as shown in Figure 3.21. 
The 
1
H NMR chemical shifts and coordination–induced–shift values of 3.5 and 3.20 are 
given below in Table 3.4. The H4 (8.88 ppm) and H8 (6.93 ppm) protons of the bridging 
ligand 3.5 show large upfield shifts. Examination of the crystal structure shown below reveals 
that this is due to the ring–current of adjacent bpy ligands. In addition, the bpy–H6 proton 
(7.34 ppm) positioned directly over the pyridyl ring of the bridge shows the greatest 
difference in chemical shift. 
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Figure 3.21. The 
1
H NMR spectrum of 3.20. 
Crystal Structures of 3.19 and 3.20 
Crystals of 3.19 and 3.20 were obtained by vapour diffusion of diisopropyl ether into an 
acetonitrile solution of the respective complex. Complex 3.19 crystallised in the monoclinic 
space group P2/c, and 3.20 in the monoclinic space group C2/c. The asymmetric unit of each 
complex contains half of the dinuclear cation at the crystallographic centre with one full and 
two half hexafluorophosphate anions and either two or four acetonitrile molecules. 
The X–ray structures of 3.19 and 3.20 with atom labelling, shown in Figure 3.22, reveal 
that the ligand coordinates to the metal centre through the Nazo atom (N7) and the less 
hindered N–atom (N5). Contrary to the mononuclear complexes, no evidence was found for 
the dinuclear complexes involving the more hindered nitrogen atom. This suggests that 3.5 
prefers to form dinuclear complexes using the less hindered nitrogen atoms. In both 
structures, the ruthenium atom possesses distorted octahedral geometry with comparable Ru–
N bond lengths and N–Ru–N bond angles. 
ppm 






Figure 3.22. The perspective views of (a) 3.19 and (b) 3.20. Hydrogen atoms, 
counterions and solvate molecules are omitted for clarity. Selected bond 
lengths (Å) and bond angles (°): (3.19) Ru1–N1 2.062(3), Ru1–N2 2.074(3), 
Ru1–N3 2.067(4), Ru1–N4 2.070(3), Ru1–N5 2.039 (3), Ru1–N7 2.015(3), 
N7–N7A 1.329(7), N2–Ru1–N1 78.02(14), N3–Ru1–N1 173.22(13), N3–Ru1–
N2 98.01(13), N4–Ru1–N1 95.45(13), N4–Ru1–N2 86.03(14), N4–Ru1–N3 
78.70(13), N5–Ru1–N1 91.28(13), N5–Ru1–N2 96.07(14), N5–Ru1–N3 
94.62(13), N5–Ru1–N4 173.23(13), N7–Ru1–N1 96.51(13), N7–Ru1–N2 
170.93(13), N7–Ru1–N3 88.11(13), N7–Ru1–N4 101.80(14), N7–Ru1–N5 
76.68(14). (3.20) Ru1–N1 2.072(4), Ru1–N2 2.082(4), Ru1–N3 2.069(4), Ru1–
N4 2.070(4), Ru1–N5 2.061(4), Ru1–N7 2.001(4), N7–N7A 1.336(7), N1–
Ru1–N2 78.51(14), N3–Ru1–N1 93.32(14), N3–Ru1–N2 85.28(14), N3–Ru1–
N4 79.28(15), N4–Ru1 N1 170.51(15), N4–Ru1–N2 94.83(14), N5–Ru1–N1 
85.91(14), N5–Ru1–N2 95.89(14), N5–Ru1–N3 178.44(15), N5–Ru1–N4 
101.62(15), N7–Ru1–N1 95.98(14), N7–Ru1–N2 171.36(14), N7–Ru1–N3 
101.79(14), N7–Ru1–N4 91.39(15), N7–Ru1–N5 76.95(14). 
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Perspective views of 3.19 and 3.20 are shown in Figure 3.23, which show very different 
shapes of the two diastereoisomers. The terminal ligands ‘above’ and ‘below’ the plane of the 
bridging ligand are parallel in 3.19, whereas in 3.20 they are orthogonal. This accounts for 
the difference in the association of the diastereoisomers with the eluent anion and the ease of 
separation by chromatography. Interestingly, in 3.19, the bridging ligand 3.5 is substantially 
non–planar as a result of which the two cofacial bpy–pyridine rings are significantly bowed 
towards one another. The inter–metal separation is 4.826(6) Å for 3.19. However, in 3.20 the 
bridging ligand 3.5 acts as a planar bridge with a distance of 4.797(7) Å between the 
ruthenium atoms.  
 
(a) 3.19 (racemic) 
 
(b) 3.20 (meso) 
Figure 3.23. Two perspective views of 3.19 and 3.20, highlighting the different 
shapes of the two diastereoisomers. 
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3.3.4. Ruthenium(II) Complex of 3.6 
Ligand 3.6 reacts with the ruthenium precursor to give complex 3.21 which was 
characterised as [(bpy)2Ru(3.6)](PF6)2, as shown in Scheme 3.15. Despite being a doubly–























































H NMR chemical shifts and the CIS values of 3.6 and 3.21 are listed in Table 3.5. 
The proton labelling employed for the assignment of the 
1
H NMR spectrum of 3.6 is shown 
in Scheme 3.15. The 
1
H NMR chemical shifts were assigned by a combination of spin–spin 
coupling, 
1
H COSY spectrum and X–ray crystal structure as shown in Figure 3.25.  
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 and CIS values
b
 of 3.6 and 3.21. 
 H3 H5 H6 H7 H8 





 10.15 8.31 8.09 7.78 7.41 
CIS +0.66 –0.03 –0.20 –0.25 –0.60 
3.21
e
(red) 9.75 8.14 7.91 7.55 7.36 
CIS +0.26 –0.20 –0.38 –0.48 –0.65 
a
In CD3CN.  
b
CIS = δcomplex – δligand.  
c
Coordinated ring of 3.4.  
d
For colours, see Figure 3.24.  
e
Non–coordinated ring of 3.4. 
Due to the unsymmetrical nature of the coordinated ligand 3.6, the two quinoxaline 
rings are non–equivalent and give rise to six different ring systems, two from the ligand 3.6 
and four pyridine rings of the bipyridine ligands. The bridging ligand H3 and H3’ protons are 
directed away from the shielding influence of the adjacent bpy ligands and are assigned as the 
most downfield resonances at 10.15 ppm and 9.75 ppm, as shown in Figure 3.24. The former 
proton experiences a relatively greater downfield shift as a result of conformational changes 
induced due to the coordination to the metal centre. The H8 and H8’ protons of 3.6 are 
oriented over the plane of the adjacent bpy ligand and are assigned as the upfield resonances 
at 7.41 ppm and 7.36 ppm, respectively. The upfield resonances at 7.42 ppm and 7.30 ppm 
are assigned as bpy H6 protons from two different rings as these protons experience shielding 
effects from ligand 3.6. The latter experiences a greater upfield shift since it is oriented over 
the nitrogen atom of the quinoxaline ring, whereas the former bpy H6 proton lies over the azo 
bridge. 
 
Figure 3.24. The 
1
H NMR spectrum of 3.6. 
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Crystal Structure of 3.21 
Crystals of 3.21 were obtained by vapour diffusion of petroleum ether into an acetone 
solution of the complex. The complex crystallises in the monoclinic space group P21/c, with a 
full molecule of 3.21, two hexafluorophosphate anions and two molecules of acetone in the 
asymmetric unit, as shown in Figure 3.25. The structure confirms the mononuclear nature of 
3.21 and the ligand chelates to the ruthenium atom through the azo nitrogen (N8) and a 
quinoxaline nitrogen (N6). The non–coordinated quinoxaline ring is twisted with the torsion 
angle being 39.6(6)°. 
 
Figure 3.25. The asymmetric unit of 3.21 with the counterions, solvate 
molecules and the hydrogen atoms, except the ones discussed above omitted 
for clarity. Selected bond lengths (Å) and bond angles (°): Ru–N1 2.059(4), 
Ru1–N2 2.062(4), Ru1–N3 2.112(4), Ru1–N4 2.076(4), Ru1–N6 2.084(4), 
Ru1–N8 1.962(4), N7–N8 1.302(6), N1–Ru1–N2 78.84(16), N1–Ru1–N3 
93.35(15), N1–Ru1–N4 169.89(15), N1–Ru1–N6 99.84(16), N2–Ru1–N3 
83.54(15), N2–Ru1–N4 94.91(16), N2–Ru1–N6 173.31(15), N4–Ru1–N3 
77.94(15), N4–Ru1–N6 87.27(15), N6–Ru1–N3 103.11(15), N8–Ru1–N1 
94.30(16), N8–Ru1–N2 97.15(16), N8–Ru1–N3 172.30(16), N8–Ru1–N4 
94.37(16), N8–Ru1–N6 76.35(16). 
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The bonding geometry of the ruthenium atom is slightly distorted with the trans N–Ru–
N angles ca. 171.83(2)°. The bite angles of chelating ligand 3.6 and the terminal bpy ligands 
with the ruthenium atom are 73.35(16)°, 78.84(16)° and 77.94(15)°. All the Ru–N bond 
distances and N–Ru–N angles are consistent and comparable with the previously described 
complexes. The structure confirms the previously discussed 
1
H NMR (Figure 3.24). As the 
structure shows, the H3 (H22) and H3’ (H30) protons are highly deshielded as they point 
away from the shielding environment of the bpy rings. The H8 (H26) and H8’ (H34) protons 
are positioned over the bpy rings and experience through–space ring–current anisotropy 
effects. The structure also shows that two bpy H6 (H1 and H20) protons lie over the plane of 
the bridge. 
3.3.5. Ruthenium(II) Complexes of 3.7 
Complexes 3.22 and 3.23 were prepared by reaction of ligand 3.7 with two equivalents 
of [Ru(bpy)2Cl2] in refluxing ethanol/water, as shown in Scheme 3.16. The complexes were 
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The absence of symmetry in complex 3.22 gives rise to four different pyridyl rings of 
the bipyridine ligands and ten non–identical proton resonances corresponding to the ligand 
3.7 resulting in 26 non–equivalent proton signals, as shown in Figure 3.26. The assignment of 
proton resonances are made in comparison with complex 3.15 (Section 3.3.2) in combination 
with spin–spin coupling and a gCOSY experiment. The H3 and H3’ protons of ligand 3.7 
point away from the shielding environment of the bpy rings, however, the H3’ proton (8.93 
ppm) is deshielded by the azo nitrogen, while the H3 proton (7.95 ppm) experiences an 
upfield shift due to conformational changes are therefore assigned as the resonances at 8.93 
ppm and 7.95 ppm, respectively The proton resonances at 9.03 ppm and 8.29 ppm, 
respectively, are assigned as the H7 and H7’ protons with the latter experiencing relatively 
greater through–space ring–current anisotropy since it lies in close proximity to the bpy rings 
compared to the former. One of the bpy–H5 and H6 protons are significantly deshielded due 
to the anisotropic interactions with the bridging ligand.  
 
Figure 3.26. The 
1
H NMR spectrum of complex 3.22 in acetonitrile–d3. 
Crystal Structure of 3.22 
Vapour diffusion of petroleum ether into an acetone solution of the complex gave red–
needles of 3.22 suitable for X–ray crystallography. Complex 3.22 crystallised in the 
monoclinic space group P21/c. The asymmetric unit contains one molecule of 3.22, two 
hexafluorophosphate anions and one acetone molecule, as shown in Figure 3.27. As seen 
previously, the non–coordinated naphthyridine ring is twisted with a torsion angle of –
ppm 
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35.4(4)° [N7–N8–C29–C30] with respect to the azo nitrogen atom, to avoid a steric clash 
between the bpy rings as well as destabilising repulsion with the azo nitrogen atom (N7). The 
N7–N8 bond length of 1.293(4) is consistent with the Nazo–Nazo bond lengths in the 
mononuclear complexes of fused azines discussed above. 
 
Figure 3.27. The X–ray crystal structure of 3.22. Counterions, solvate 
molecules and hydrogen atoms, except the ones shown above are omitted for 
clarity. Selected bond distances (Å) and bond angles (°): Ru1–N1 2.051(3), 
Ru1–N2 2.066(3), Ru1–N3 2.088(3), Ru1–N4 2.108(3), Ru1–N5 2.075(3), 
Ru1–N8 1.968(3), N7–N8 1.293(4), N2–Ru1–N178.45(10), N3–Ru1–N1 
98.11(10), N3–Ru1–N2 171.95(10), N4–Ru1–N1 83.78(10), N4–Ru1–N2 
94.66(10), N4–Ru1–N3 77.67(10), N5–Ru1–N1 174.31(10), N5–Ru1–N2 
100.55(10), N5–Ru1–N3 83.58(10), N5–Ru1–N4 101.90(10), N8–Ru1–N1 
98.72(10), N8–Ru1–N2 92.12(10), N8–Ru1–N3 95.61(10), N8–Ru1–N4 
173.13(10), N8–Ru1–N5 75.67(10). 
The coordination sphere of the ruthenium atom involves coordination to two bpy 
ligands and one azo ligand 3.7 coordinating through the azo nitrogen and naphthyridine 
nitrogen atoms. The geometrical parameters for the ruthenium(II) atom are distorted 
octahedral with the trans N–Ru–N angles greater than 171°. As usual, the Ru–Nazo bond 
distance at 1.968(3) Å [Ru1–N8] is significantly shorter than the remaining average Ru–N 
bond distance of 2.078(3) Å. All the Ru–N bond distances and N–Ru–N bond angles are 
similar and comparable with the previous complexes.  
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3.3.6. Ruthenium(II) Complexes of 3.8 
The reaction of 3.8 with two equivalents of [Ru(bpy)2Cl2] in ethanol/water gave a red 
solution from which complex 3.24 was isolated as the hexafluorophosphate salt in reasonably 
































The assignment of the 
1





H COSY (Figure 3.29) and 1D ROESY spectra and by comparison with the 
previous complexes 3.15, 3.17 and 3.18. Four pyridine ring environments for the two 
bipyridine rings and two sets of three coupled protons and two sets of coupled doublets for 
the ligand 3.8 are observed. The bpy–H5 and H6 protons positioned over the plane of the 
ligand 3.8 experience maximum anisotropic interactions and are assigned as the upfield 
resonances at 6.98 ppm and 7.28 ppm, respectively. Unlike the previous fused azine 
complexes, two pyridyl–H6 protons (9.19 and 9.01 ppm) from two different bpy rings point 
away from the shielding influences of the adjacent rings and move downfield. Once again, 
the H8 and H8’ protons are oriented over the plane of the adjacent bpy ligand and are 
assigned as the most upfield resonances at 7.70 ppm and 7.77 ppm, respectively. 
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Figure 3.28. The 
1
H NMR spectrum of 3.24 showing the different ring systems. 
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3.4. Electronic Absorption Spectroscopy  
The electronic absorption spectra of the mononuclear complexes were recorded in 
acetonitrile and are shown in Figure 3.30. In Chapter 2, substitutions on the azopyridines did 
not have a profound effect on the Ru(dπ) → azo(π*) transitions in the subsequent complexes, 
however, the ligands discussed in this chapter show significant effects in the MLCT 
transitions. The complexes exhibit MLCT absorptions in the visible region arising from 
transitions to bpy and the azo ligand. The lowest energy absorptions are assigned as the 
Ru(dπ) → azo(π*) transitions due to the better π–accepting nature of the azo ligands. These 
complexes also display intense bands in the UV region arising from ligand–centered π → π* 
transitions. Table 3.6 lists the spectral data and extinction coefficients of the metal–to–ligand 
charge transfers. 
 
 (a) (b) 
Figure 3.30. The electronic absorption spectra of the mononuclear complexes.  
When compared to the azobispyridine complex 2.7, the pyrimidine–complexes 3.9, 
3.11 and 3.13 exhibit a slight blue–shift, whilst a red–shift in the lowest energy MLCT was 
observed in complexes containing fused aromatic azines 3.4 – 3.8 (Table 3.6). Although 
pyrimidines are known to be better π–acceptors than pyridines due to the relative energy of 
their π*–orbital,
[271]
 the blue–shift indicates that the LUMO in these complexes is centered on 
the azo group rather than the pyrimidines. In the fused azine complexes, the non–
coordinating nitrogen atoms as well as the extended conjugation influences the MLCT 
absorptions. Among the quinazoline isomers 3.17 and 3.18, the former exhibits a blue–shift 
in the lowest energy MLCT probably, due to the steric strain involved in the metal–ligand 
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framework which disrupts the conjugation. Complex 3.21 displays a substantial red–shift at   
540 nm as pyrazines are better π–acceptors and interact more strongly on 
coordination.
[271],[272]
 The MLCT absorptions arising from the transitions into the bpy ligands, 
however, do not show a noticeable change in these complexes.  
Table 3.6. The absorption spectral data
a








Ru(dπ) → azo(π*) Ru(dπ) → bpy(π*) π → π* 
2.7 508 (8250) 368 (11100) 279, 243 
3.9 493 (8690) 368 (14500) 316, 285, 269, 248 
3.11 497 (3840) 368 (7260) 314, 285, 269, 249 
3.13 491 (9680) 368 (11500) 313, 271, 247 
3.15 519 (8390) 379 (18200) 313, 275, 250 
3.17 493 (7220) 361 (12600) 314, 277, 243, 229 
3.18 513 (8060) 368 (20000) 316, 277, 236 
3.21 540 (4150) 372 (8390) 316, 280, 246 
3.22 524 (8290) 363 (21300) 313, 268, 245 
3.24 520 (6890) 368 (17100) 277, 241 
The UV/Visible spectra of the dinuclear complexes also measured in acetonitrile are 
shown in Figure 3.31 and the absorption data are summarised in Table 3.7. A colour change 
as well as red–shift in the MLCT is observed upon coordination to a second metal centre. All 
the complexes exhibit high energy absorption bands (λ below 320 nm) arising from intra–
ligand transitions (π → π*). Unlike the azobispyridine complexes in Chapter 2, these 
complexes exhibit absorption bands arising from a MLCT transition Ru(dπ) → azo (π*) at 
higher energy (λ = 600 – 690 nm), except complex 3.20, where the long wavelength 
maximum is greater than 800 nm. The MLCT band arising due to the transitions from Ru(dπ) 
to π* of bpy above 380 nm is similar to the azobispyridine complexes. In complexes 3.10 and 
3.12, a blue–shift in the MLCT absorption bands corresponding to Ru(dπ) → azo(π*) 
transition was observed. Complex 3.16 displays a red–shift at 685 nm compared to the 
pyrimidine–based ligands as a result of increased conjugation in the ligand backbone.  
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Figure 3.31. The UV/Visible absorption spectra of the dinuclear complexes in 
acetonitrile. 
 
Table 3.7. UV/Visible absorption data
a












) Ru(dπ) → azo(π*) 
3.10 616(4173) 444(7583), 384(11376), 284(37169), 245(2241) 
3.12 614(6103) 441(14506), 387(23175), 285(74312), 247(43335) 
3.14 658(19156) 493(32684), 389(45451), 287(177575), 244(139027) 
3.16 685(33149) 382(15333), 287(83093), 244(53931) 
3.20 > 800 397(36719), 280(89123), 247(72861) 
3.23 641 (10339) 498(19829), 392(28865), 289(114698), 244(72435) 
a
 In acetonitrile. 
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3.5. Electrochemistry 
The differential pulse voltammograms of some of the mononuclear complexes are 
shown in Figure 3.32. The redox potentials, summarised in Table 3.8, suggests that compared 
to the azobispyridine complex 2.7, the complexes are more difficult to oxidise and easier to 
reduce. This could be as a result of replacing the pyridine rings with other N–containing 
rings, which facilitate effective π back–bonding in the subsequent complexes, and as a 
consequence results in an increased metal–centered oxidation potential.  





) oxidation. The oxidation potential in pyrimidine complexes 3.9, 3.11 and 
3.13 is positively shifted with respect to complex 2.7. The electron–donating methyl groups 
in ligand 3.3 did not have an effect on the metal–centered oxidation in complex 3.13. 
Replacement of the pyrimidines by fused N–heterocyclic rings in the azo ligands results in a 
cathodic shift of the metal–centred oxidation potentials for 3.15, 3.18 and 3.22. Complexes 
3.21 and 3.24, however, display oxidation potentials similar to the pyrimidine complexes. 
 
Figure 3.32. Differential pulse voltammograms of 2.7, 3.11, 3.13, 3.15, 3.21 
and 3.24 in CH3CN/0.1M [(n–C4H9)4]ClO4. 
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Table 3.8. Redox potentials
a,b







E1/2ox1 E1/2red1 E1/2red2 E1/2red3 
2.7 1.95 +1.24 –0.71 –1.42 –2.03 
3.9 1.88 +1.48 –0.40 –0.96 –1.96 
3.11 1.84 +1.49 –0.35 –0.90 –1.92 
3.13 2.04 +1.50 –0.54 –1.09 –2.00 
3.15 1.88 +1.34 –0.54 –1.12 –2.05 
3.17 1.96 +1.50 –0.46 –0.89 – 
3.18 1.85 +1.31 –0.54 –1.04 –1.95 
3.21 1.82 +1.53 –0.29 –0.92 –1.99 
3.22 1.88 +1.38 –0.50 –1.00 –2.14 
3.24 1.99 +1.58 –0.41 –0.99 –2.00 
a
 In V vs Ag/AgNO3 in CH3CN/0.1M [(n–C4H9)4]ClO4. 
b
 Calculated from differential pulse voltammetry. 
c
 Difference between first oxidation and first reduction potentials. 
All the complexes exhibit three successive reversible ligand–centered reduction waves 
at relatively positive values compared to complex 2.7. Due to the greater π–accepting ability 
of the azo ligands compared to the bpy ligands, as seen in Chapter 2, the first two reductions 
are azo–centered and the third electron added to these complexes is localised on a bpy ligand. 
The pyrimidine–based complexes 3.9 and 3.11, show similar redox behaviour, while the 
addition of an electron–rich methyl group raises the π*– orbital of the azo ligand 3.3 and 
shifts the reduction potential to a more negative potential making it harder to reduce. The 
fused aromatic rings raises the energy of the Ru(dπ) orbital, but also influences the LUMO of 
the azo ligand, making complexes 3.15, 3.18 and 3.22 harder to reduce compared to the 
pyrimidine–based complexes. A reverse effect was observed in complexes 3.17, 3.21 and 
3.24 with 3.21 being easily reducible. Complex 3.17 exhibits an anodic shift for the 
oxidation, as well as the reduction when compared to the isomeric complex 3.18, as shown in 
Figure 3.33. 
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Figure 3.33. The differential pulse voltammograms of isomeric complexes 
3.17 and 3.18 showing differences in their redox potentials. 
The dinuclear complexes exhibit two reversible ruthenium–centred one–electron 
oxidation couples, as shown in Figure 3.34. The first oxidation redox couple is shifted 
cathodically when compared to the corresponding mononuclear complex, due to the 
stabilisation of the azo π–orbital upon bimetallic coordination. This also indicates an increase 
in the electron–withdrawing ability of the azo ligands in the dinuclear complexes. Unlike the 
mononuclear complexes discussed above, the first oxidation potential of these complexes is 
comparable with that of the azobispyridine complex 2.8, although complexes 3.10 and 3.20 
exhibit slight cathodic shifts. The second oxidation process in 3.14, 3.16 and 3.23 also occurs 
at potentials comparable to that of 2.8. In complexes 3.10 and 3.12, the second oxidation 
process occurs at a more positive potential due to the presence of the additional nitrogen atom 
and electron–withdrawing halogen groups. Complex 3.23 displays a cathodic shift in the 
second ruthenium centred oxidation redox couple. Table 3.9 summarises the redox potentials 
of the dinuclear complexes. 
The complexes display two successive one–electron and one two–electron redox 
couples corresponding to the reductions of the ligand. As explained previously, the first two 
electrons are attributed to a successive one–electron uptake by the azo–centered π–orbital. 
The subsequent two–electron redox couple corresponds to the reduction of the ancillary bpy 
ligands. Replacement of the pyridine ring by pyrimidines and fused N–aromatic rings in the 
azo ligand has a considerable effect on the ligand–centered redox couples in these complexes. 
Pyrimidine–containing complexes 3.10 and 3.12 show azo–based reductions at much lower 
potentials due to lowering of the π* level compared to the azobispyridine complex 2.8. This 
also accounts for the stability of the radical azo anion in these complexes. The increased σ–
donor ability of ligand 3.3 supports the cathodic shift in reduction potential of complex 3.14. 
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Figure 3.34. Differential pulse voltammograms of 3.12, 3.20 and 3.23 vs 
Ag/AgNO3 in CH3CN/0.1M [(n–C4H9)4]ClO4. 
 
Table 3.9. Redox potentials
a,b







E1/2ox2 E1/2ox1 E1/2red1 E1/2red2 E1/2red3 
2.8 1.42 +1.85 +1.36 –0.06 –0.071 –1.83(2e¯) 
3.10 1.23 +1.92 +1.28 +0.05 –0.50 –1.96(2e¯) 
3.12 1.22 +1.99 +1.35 +0.13 –0.43 –1.89(2e¯) 
3.14 1.31 +1.88 +1.31 +0.00 –0.54 –1.93(2e¯) 
3.16 1.37 +1.89 +1.36 –0.01 –0.57 –2.07(2e¯) 
3.20 1.28 +1.79 +1.24 –0.04 –0.62 –1.94(2e¯) 
3.23 1.22 +1.86 +1.30 +0.08 –0.39 –1.92(2e¯) 
a 
In V vs. Ag/AgNO3 in CH3CN/0.1M [(n–C4H9)4]ClO4.  
b 
Calculated from DPV measurements.  
c 
Difference between the first oxidation and first reduction potential. 
As seen in Chapter 2, these complexes also exhibit two widely separated ruthenium–
centered oxidation potentials. The separation between the oxidation potentials gives a 
measure of the extent of electronic coupling between the metal centres. Compared to 
azobispyridine complexes, these complexes exhibit a larger splitting between the two 
oxidation potential waves (ΔEox > 500mV), as summarised in Table 3.10.  
Potential (V) 
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2.8 8.28 0.49 +1.85 +1.36 
3.10 10.82 0.64 +1.92 +1.28 
3.12 10.82 0.64 +1.99 +1.35 
3.14 9.30 0.55 +1.88 +1.31 
3.16 8.96 0.53 +1.89 +1.36 
3.20 9.30 0.55 +1.79 +1.24 
3.23 9.46 0.56 +1.86 +1.30 
a 
Comproportionation constant, Kc = exp{ΔEoxF/RT}, where 
F/RT = 38.92 V
–1
 at 298 K. 
b 
Difference between the two successive oxidation potentials.  
The comparison of the comproportionation constant suggests that incorporation of 
pyrimidine and fused N–aromatic rings facilitate the mixing of azo–centered π*–orbitals with 
the metal dπ–orbitals resulting in an increased coupling between the metal centres. The 
strongly π–accepting pyrimidine–based complexes 3.10 and 3.12 exhibit substantially higher 
electronic coupling, Kc = 10
10
, while the σ–donating ability of ligand 3.3 in complex 3.12 
reduces the coupling (Kc = 10
9
) between the metal centres. In fused N–aromatic complex 
3.16, ligand 3.4 mediates communication comparable to that of azobispyridine complexes 
and ligands 3.5 and 3.7 results in an increased electronic interaction between the two 
ruthenium centres. 
3.6. Summary 
The synthesis and characterisation of mononuclear and dinuclear ruthenium(II) 
polypyridyl complexes 3.9 – 3.24 with bidentate azo ligands 3.1 –3.8 containing pyrimidines 
and fused N–aromatic rings were described in this chapter. In this chapter also, the bromo–
ligand 3.2 was reacted with [Ru(bpy)2(OTf)2] to avoid the chloro–substitution of the bridging 
ligand in the dinuclear complex 3.12. All attempts to synthesise the dinuclear complexes of 
3.6 and 3.8 were unsuccessful.  
The pyrimidine–based ligands facilitated the isolation and the X–ray crystallographic 
characterisation of two homodinuclear ruthenium complexes, [(bpy)2Ru(μ–
3.1)Ru(bpy)2](PF6)3, 3.10 and [(bpy)2Ru(μ–3.2)Ru(bpy)2](PF6)3, 3.12 bridged by pyrimidine–
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based azo anion radical species. Both 3.10 and 3.12 display long Nazo–Nazo bond lengths of 
ca. 1.36 Å corresponding to the reduced azo ligand.  
The monoruthenium(II) complexes 3.17 and 3.18 containing ligand 3.5 were obtained 
as a 1:10 mixture, due to the nature of the nitrogen atom involved in the chelation and were 
isolated by cation–exchange chromatography. The diastereoisomeric forms 3.19 and 3.20 of 
dinuclear ruthenium(II) complex [(bpy)2Ru(μ–3.5)Ru(bpy)2]
4+
 were separated by cation–
exchange chromatography and characterised by X–ray crystallography. The structures of 3.19 
and 3.20 show coordination of the bridging ligand 3.5 to two [Ru(bpy)2]
2+
 fragments via azo 
N–atoms and the less hindered N–atoms on each side.  
Varying the pyridine ring of the azo ligand to pyrimidines and fused N–aromatic rings 
has a considerable effect on the electronic properties of these complexes, which were probed 
by UV/Visible spectroscopy and electrochemical studies. Altering azo ligands influences the 
energy of both the Ru(dπ), as well as the π*–orbital of the azo ligands. Electrochemical 
studies reveal the complexes containing these ligands are easier to reduce than the 
azobispyridine complexes, but harder to oxidise. Comparison of the comproportionation 
constant in the dinuclear complexes suggests that incorporation of pyrimidine and fused N–
aromatic rings facilitate the mixing of azo–centered π*–orbitals with the metal dπ–orbitals 
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4. Tridentate ligands based on azobis(bidentates)  
4.1. Introduction 
Ruthenium(II) complexes based on bidentate ligands, such as bpy and phen have been 
of interest due to their photophysical and photochemical properties. However, their use in 
building polynuclear systems becomes complicated, since bpy–type ligands lead to 
stereoisomers with limited control over the geometry of the system.
[72],[84],[99]
 This 
stereochemical problem may be avoided by the use of tridentate ligands of the type 
2,2’:6’,2”–terpyridine (terpy).
[79],[101]
 These ligands coordinate to an octahedral metal centre 
in a meridional manner creating a single isomer of the achiral [Ru(terpy)2]
2+
 complex cation, 
as shown in Figure 4.1. The achiral [Ru(terpy)2]
2+
 unit simplifies the synthesis as it gives 
unique products in polynuclear species if the bridging occurs through the 4’–position of the 
central pyridyl ring of the terpy ligand. However, [Ru(terpy)2]
2+
 does not luminesce at room 
temperature.
[6],[115]
 Therefore, a number of efforts have been made to increase the lifetime of 
the [Ru(terpy)2]
2+
 chromophore, such as using electron–withdrawing groups at the 4’–


















In the context of this project, we have been interested in symmetrical terpy complexes 




(terpy)], where BL is an azo–based ligand which coordinates 
in a bis–tridentate manner. The use of two symmetric tridentate ligand components 
coordinated to metal centres eliminates the possibility of stereoisomerism. In this sense, the 
bis–tridentate 2,3,5,6–tetrakis(2–pyridyl)pyrazine (tppz) (Figure 4.2) has been extensively 
used as a bridging ligand to prepare homo–nuclear and hetero–nuclear complexes with a 
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range of terminal ligands such as bpy and terpy.
[102–104]
 Complexes of this ligand with 
octahedral transition metal ions such as Ru(II) and Os(II) have been studied for their redox, 
luminescence and mixed–valence properties by several workers.
[105–111]
 In these complexes 
the metal centres are extremely close and exhibit a high degree of electronic coupling and 














n = 0 (terpy-terpy)
n = 1 (terpy-Ph-terpy)
n = 2 (terpy-Ph2-terpy)  
Figure 4.2. Examples of bis–tridentate ligands. 
A series of dinuclear complexes with bridging ligands containing two terpy units joined 
by 0–2 phenylene (Ph) units, terpy–terpy, terpy–Ph–terpy, terpy–Ph2–terpy, were investigated 
for their photophysical properties (Figure 4.2).
[112],[113]
 The inter–metal separation in these 
complexes ranges from 11–20 Å and they exhibit decreasing metal–metal interactions in the 
order of n = 0–2. Constable et al.
[274],[275]
 have reported a number of homo and hetero–ditopic 
complexes with terpy and its functionalised derivatives, Figure 4.3a. Lehn and co–workers 
have established a classical bis–tridentate ligand series based on a central pyrimidine ring, 
shown in Figure 4.3b for the construction of ‘rack–type’ polynuclear complexes towards the 
development of inorganic molecular devices.
[276],[277]
 Thummel et al.
[278]
 have investigated a 
series of dinuclear Ru(II) complexes of tridentate ligands based on a diphen–disubstituted 
pyrazine, as shown in Figure 4.3c. 


















Figure 4.3. Examples of (a) functionalised terpy based ligands; (b) and (c) 
ligands used for ‘rack–type’ polynuclear complexes. 
Azo groups have been used as linkers between bpy and terpy units, as shown in Figure 
4.4.
[279],[280]
 The ligands coordinate to the metal centre using the pyridyl N–atoms only and 
the azo functionality is not involved in the coordination. In the dinuclear Ru complex of 
azobpy, a short metal–metal separation (8.2 Å) and a very weak intermetallic interaction (Kc 
= 21) was detected.
[279]
 However, electrochemical studies of dinuclear Ru complexes 















Figure 4.4. Tridentate ligands containing azo linkers. 
The aim of this work was to prepare ligands which can coordinate in a bis–tridentate 
manner with the azo functionality being involved in coordination, as shown in Figure 4.5. 
The first ligand 4.1, having an azo linker between two bpy subunits has been previously 
synthesised by Otsuki et al.
[279]
 However, a different approach was used to synthesise 4.1 
which is described in Section 4.2. A new ligand 4.2 was prepared in which two phen units are 
linked by the azo group.  










4.1 4.2  
Figure 4.5. Tridentate ligands investigated in this chapter. 
4.2. Syntheses of the ligands 
Azobis[6–(2,2’–bipyridine)] 4.1 has previously been synthesised by reductive 
condensation of 6–nitro–2,2’–bipyridine using Zn powder in a mixture of aqueous NaOH 
solution and THF.
[279]
 Instead, 4.1 was synthesised by oxidative coupling of 6–amino–2,2’–
bipyridine using NaOCl, as shown in Scheme 4.1. The precursor amine was synthesised by a 
one–pot conversion of 2,2’–bipyridine mono N–oxide
[281]
 using Ts2O and t–BuNH2, followed 

















The oxidative coupling of 2–amino–1,10–phenanthroline using NaOCl gave the new 
azobis(phenanthroline) ligand 4.2, as shown in Scheme 4.2. The precursor amine was 
synthesised by using the method of Engel et al.,
[283]
 which involves the heating of 2–chloro–
1,10–phenanthroline
[284]
 with acetamide in the presence of K2CO3.  


























4.3. Coordination chemistry of azobis(bidentate) ligands 
The general procedure involves refluxing a suspension of azo ligand and [Ru(terpy)Cl3] 
in ethylene glycol in a microwave oven for 10–12 minutes at intervals of 2 minutes. The 
complexes were precipitated as the hexafluorophosphate salts and purified by cation 
exchange column chromatography. 
4.3.1. Complex of 4.1 
The dinuclear complex of 4.1 with [Ru(bpy)Cl2] (Figure 4.6) has been previously 
investigated by Otsuki et al.
[279]
 for its electronic absorption and electrochemical properties. 
The metal–to–ligand charge–transfer band extends to 800 nm and the analysis of its redox 
properties indicates an intermetallic electronic interaction with a very weak 
comproportionation constant of 21.  
























Here, we report a new dinuclear ruthenium complex, 4.3, which was synthesised by 
refluxing a mixture of 4.1 with [Ru(terpy)Cl3] in ethylene glycol in a microwave oven, as 
shown in Scheme 4.3. The complex was characterised as [{Ru(terpy)}2(μ–4.1)](PF6)4 by 
ESI–MS and 
1





































H NMR and COSY spectra of 4.3 are shown in Figure 4.7. Table 4.1 lists the 
1
H 
NMR chemical shifts and coordination–induced–shift values for 4.1 and 4.3. The spectrum 
shows four different ring systems which were easily identified from the COSY spectrum and 
are color coded as shown below. The H3 proton (8.71 ppm) is slightly deshielded when 
compared to the H3’ proton (8.46 ppm) due to changes in conformation upon chelation. The 
strong negative CIS value for the H6’ proton (–1.88 ppm) indicates significant shielding due 
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to the anisotropic ring–current effects from the central terpy ring. A strongly shielded terpy–





Figure 4.7. The (a) 
1
H NMR and (b) gCOSY spectra of 4.3. 
Table 4.1. The 
1
H NMR chemical shifts
a
 and CIS values
b
 (italics) for 4.1 and 4.3. 
 H3 H4 H5 H3’ H4’ H5’ H6’ 
4.1 8.68 8.21 8.00 8.59 7.91 7.49 8.76 
4.3 8.71 8.15 7.79 8.46 8.03 7.30 6.88 
CIS +0.03 –0.06 –0.21 –0.13 +0.12 –0.19 –1.88 
a 
In acetonitrile–d3.  
b 
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Crystal Structure of 4.3 
A single crystal, suitable for X–ray structure analysis, was grown by diffusing 
diisopropyl ether into an acetonitrile solution of the complex. The complex crystallises in the 
triclinic space group P–1, with half the dinuclear cation, two PF6¯ anions and an acetonitrile 
solvate molecule in the asymmetric unit. The crystal structure confirms the dinuclear nature 
of the complex. 
 
Figure 4.8. The X–ray crystal structure of 4.3. Most of the hydrogen atoms, 
counterions and the solvate molecules are omitted for clarity. Selected bond 
distances (Å): Ru1–N1 2.072(3), Ru1–N2 2.002(3), Ru1–N3 2.082(3), Ru1–N4 
1.955(3), Ru1–N5 2.083(3), Ru1–N6A 2.030(3), N6–N6A 1.349(5). Selected 
bond angles (°): N1–Ru1–N3 156.85(12), N1–Ru1–N5 93.06(11), N2–Ru1–N1 
78.76(12), N2–Ru1–N3 78.36(12), N2–Ru1–N5 95.10(11), N2–Ru1–N6 
108.87(11), N3–Ru1–N5 92.44(11), N4–Ru1–N1 97.28(12), N4–Ru1–N2 
173.07(11), N4–Ru1–N3 105.84(12), N4–Ru1–N5 79.35(11), N4–Ru1–N6 
76.78(11), N6–Ru1–N1 92.24(11), N6–Ru1–N3 91.81(11), N6–Ru1–N5 
156.02(12). 
Figure 4.8 shows the X–ray crystal structure of 4.3, within which the azo ligand 4.1 acts 
as a hexadentate ligand coordinating to each ruthenium atom using an azo nitrogen atom and 
two N–atoms from a bipyridine unit. As seen in Chapter 2, the ligand adopts an “S–
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conformation” in complex 4.3 and acts as a planar bridge between the two ruthenium atoms 
with a short inter–metal separation of 4.823(1) Å (Ru1∙∙∙Ru1A), which is much shorter than 
that reported for [{Ru(bpy)2}2(4.1)]
4+
 by Otsuki et al. (  8.2 Å). The ruthenium atom 
possesses distorted octahedral geometry with two meridional tridentate ligands (4.1 and 
terpy) orthogonal to each other. Contrary to the dinuclear complexes described in Chapter 2, 
in this case the Ru–Npy bond distance [Ru1–N4 1.955(3) Å] is shorter when compared to the 
Ru–Nazo [Ru1–N6A 2.030(3) Å] due to geometric constraints. The Ru–N bond distance for 
the terpy is shorter for Ru–Ncentral [Ru1–N2 2.002(3) Å] than the average Ru–Nouter [2.077(3) 
Å], as is normal for terpy complexes.
[111],[285]
 
Examination of the crystal structure helps to explain the NMR chemical shifts. The H6 
proton (H15) of the terpy experiences the greatest shielding and shifts upfield since it lies 
directly above the pyridyl ring of the bridge. The H6’ proton (H25) of ligand 4.1 experiences 
a similar anisotropy effect from the adjacent terpy ring. The H5 proton (H17) also 
experiences some shielding since it lies in close proximity to an adjacent terpy ring 
 
Figure 4.9. (a) The aryl embrace motif of 4.3 showing OFF (black) and EF 
(red) interactions. (b) Space–filling diagram showing these π–π interactions. 
The crystal packing of 4.3 shows interesting aryl embraces where a pair of outer pyridyl 
rings are involved in offset face–to–face (OFF) interactions [ring∙∙∙ring 3.709(2) Å] and each 
of these rings also addresses an edge–to–face (EF) interaction with the pyridyl ring of the 
bridging ligand [H∙∙∙ring 2.770(1) Å], as shown in Figure 4.9. The features of intermolecular 
π–stacking interactions in metal complexes of terpy and related complexes have been 
described by Dance and coworkers,
[286–288]
 Constable et al.
[285],[289]
 and other authors.
[290],[291]
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These aryl embraces should propagate to generate a two–dimensional net, as shown in Figure 
4.10. The molecular packing also exhibits numerous CH∙∙∙F interactions, which contribute to 
the overall packing in the crystal structure. 
 
Figure 4.10. An arrangement of complexes showing EF and OFF interactions 
in the crystal structure. 
 
4.3.2. Complexes of 4.2 
The mononuclear complex 4.4 was synthesised by refluxing a mixture of ligand 4.2 and 
[Ru(terpy)Cl3] in a 1:1 stoichiometric ratio. The complex was precipitated as the 
hexafluorophosphate salt and characterised as [(terpy)Ru(4.2)](PF6)2. Microwave assisted 
reaction of 4.2 with a two–fold excess of [Ru(terpy)Cl3] in ethylene glycol gave the expected 
dinuclear complex 4.5, which was characterised as [{Ru(terpy)}2(4.2)](PF6)4, as shown in 
Scheme 4.4. 

































































Figure 4.11. The 
1
H NMR spectrum of 4.4. 
ppm 




H NMR spectrum of complex 4.4, in acetonitrile–d3, is shown in Figure 4.11. Due 
to the unsymmetrical nature of the coordinated ligand 4.2, the two phen rings are different 
and the spectrum shows 20 non–equivalent aromatic proton signals corresponding to eight 
different ring systems. Using a combination of spin–spin coupling, gCOSY and 1–D NOESY 
experiments, the 
1
H NMR chemical shifts for complex 4.4 were fully assigned. 
Table 4.2. The 
1
H NMR chemical shifts and CIS values
a





 H3 H4 H5 H6 H7 H8 H9 
4.2 8.57 8.50 7.94 7.94 8.34 7.72 9.32 
4.4
d
 9.33 9.03 8.42 7.96 8.65 7.61 7.64 




 8.19 8.39 7.96 7.89 8.40 7.83 9.31 
CIS –0.38 –0.11 +0.02 –0.05 0.06 +0.11 –0.01 
 
a 






Coordinated phen ring of 4.2.  
e 
Free phen ring of 4.2. 
The H3 proton (9.33 ppm) of the coordinated phen is strongly deshielded, presumably 
due to a chelation induced conformational change, whereas the H9 proton (7.64 ppm) is 
strongly shielded since it experiences ring–current anisotropy due to the nearby central terpy 
ring. The X–ray crystal structure shown in Figure 4.12 further supports these observations. 
Table 4.2 lists the 
1
H NMR chemical shifts and the approximate CIS values for 4.2 and 4.4 in 
CDCl3 and CD3CN respectively, as the free ligand 4.2 was insoluble in the same solvent as 
the complex. 
Crystal Structure of 4.4 
Crystals of 4.4 were obtained by diffusing petroleum ether into a solution of the 
complex in acetone. The complex crystallises in the monoclinic space group P21/n. The 
crystal structure confirms the mononuclear nature of the complex.  
The asymmetric unit contains one full cation along with two hexafluorophosphate 
anions and an acetone solvate molecule, as shown in Figure 4.12. As seen in the mononuclear 
complexes discussed in previous chapters, in complex 4.4, ligand 4.2 also adopts a s–cis/E/s–
trans conformation with the ruthenium atom coordinated to an azo N–atom and both of the 
N–atoms of a phen ring. The coordinated phen ring is in the same plane as the azo group with 
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a torsion angle of 1.4(1)°, while the non–coordinated phen ring twists at an angle of 30.2(1)°. 
Similar conformations for the mononuclear complexes were observed in previous chapters. 
Once again the ruthenium geometry is normal with the Ru–Ncentral bond distance [Ru–N8 
2.011(2) Å] of terpy shorter than the average Ru–Nouter [2.081(2) Å]. Also, the Ru–Nazo bond 
length is shorter than the Ru–Nphen indicating the strong π*–acceptor ability of the azo 
moiety.  
 
Figure 4.12. The asymmetric unit of 4.4. Some of the hydrogen atoms, 
counterions and the solvate molecule are omitted for clarity. Selected bond 
distances (Å): Ru1–N1 2.131(2), Ru1–N2 1.950(2), Ru1–N4 2.036(2), Ru1–N7 
2.084(2), Ru1–N8 2.011(2), Ru1–N9 2.078(2), N3–N4 1.313(3). Selected bond 
angles (°): N2–Ru1–N8 175.78(8), N2–Ru1–N4 74.96(8), N8–Ru1–N4 
108.89(8), N2–Ru1–N9 100.06(8), N8–Ru1–N9 78.20(8), N4–Ru1–N9 
93.23(7), N2–Ru1–N7 103.44(8), N8–Ru1–N7 78.15(8), N4–Ru1–N7 
95.71(8), N9–Ru1–N7 156.31(8), N2–Ru1–N1 79.26(8), N8–Ru1–N1 
96.94(8), N4–Ru1–N1 154.14(8), N9–Ru1–N1 93.11(7), N7–Ru1–N1 
88.34(8). 
Examination of the crystal structure reveals that in complex 4.4, the terpy H6 proton 
(H39) is significantly shielded since it is positioned directly over the bridging ligand and 
experiences maximum ring–current anisotropy effects. Similar anisotropy from the adjacent 
terpy ring is experienced by the H9 proton (H1) of the coordinated phen ligand. The non–
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coordinated phen ring is not affected much by the coordination, which is in agreement with 
the very small CIS values given in Table 4.2. 
Crystal Structure of 4.5 
Crystals of 4.5 were obtained by vapour diffusion of diisopropyl ether into a solution of 
the complex in acetonitrile. The complex crystallises in the triclinic space group P–1, with 
one ruthenium atom, half a bridging ligand 4.2, one terpy unit, two counterions and one 
acetonitrile solvate molecule in the asymmetric unit, as shown in Figure 4.13.  
 
Figure 4.13. The full asymmetric unit of 4.5. Selected bond distances (Å): 
Ru1–N1 2.113(3), Ru1–N2 1.947(3), Ru1–N3A 2.031(3), Ru1–N4 2.072(3), 
Ru1–N5 2.000(3), Ru1–N6 2.068(3), N3–N3A 1.374(5). Selected bond angles 
(°): N2–Ru1–N5 175.31(12), N2–Ru1–N3A 75.85(11), N5–Ru1–N3A 
108.60(11), N2–Ru1–N6 99.85(12), N5–Ru1–N6 78.67(12), N3A–Ru1–N6 
93.04(11), N2–Ru1–N4 103.32(11), N5–Ru1–N4 78.34(12), N3A–Ru1–N4 
91.18(12), N6–Ru1–N4 156.78(11), N2–Ru1–N1 79.98(12), N5–Ru1–N1 
95.58(12), N3A–Ru1–N1 155.81(11), N6–Ru1–N1 92.17(11), N4–Ru1–N1 
93.27(12).  
The structure of 4.5 exhibits a typical geometry for the ruthenium atom with the 
bridging ligand acting as a planar bridge between the two ruthenium atoms separated by 
4.848(5) Å. In this case also, at the terminal terpy ligands the Ru–Ncentral bond distance [Ru1–
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N5 2.000(3) Å] is shorter when compared to the outer Ru–N bond distances due to geometric 
constraints. For the bridging ligand, the Ru–Nazo bond distance [Ru1–N3A 2.031(3) Å] is 
shorter than the outer Ru–Nphen bond distance [Ru–N1 2.113(3) Å] as a result of the stronger 
π–acceptor nature of the azo–centered bridge. 
 
Figure 4.14. Two perspective views of the X–ray crystal structure of 4.5, 
emphasising the planarity of the bridging ligand and the distortion in the terpy 
ligand. 
The terpy ligand within the complex is surprisingly non–planar and adopts a bowed 
shape as shown in Figure 4.14, probably due to the mutual π–π interactions between the co–
facial pyridine rings of the terpy ligands. Similar to 4.3, the crystal packing of 4.5 also 
exhibits aryl embraces throughout the crystal structure, as shown in Figure 4.15. Offset face–
to–face (OFF) interactions appear between the terpy pyridyl rings with a ring centroid 
separation of 3.536(3) Å. The ring also positions an edge towards the face of a phen ring of 
the bridging ligand (H∙∙∙ring 2.684(5) Å). The crystal packing also exhibits extensive short 
F∙∙∙H–C contacts between the hexafluorophosphate anions and the pyridyl ring protons in the 
range of 2.5 – 3.3 Å, which further stabilises the solid–state structure. 
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Figure 4.15. Crystal packing of 4.5 showing intermolecular interactions. 
4.4. Electronic Absorption Spectroscopy and Electrochemistry 
The UV/Visible spectral data and redox potentials for 4.3 – 4.5 are given in Table 4.3. 
The intense bands in the UV region correspond to the π → π* and n → π* transitions of the 
ligand. The mononuclear complex 4.4 exhibits absorption bands at 406 nm and a shoulder at 
468 nm arising from Ru(dπ) → terpy(π*) and Ru(dπ) → 4.2(π*) MLCT transitions, 
respectively. In dinuclear complexes 4.3 and 4.5, the absorption bands arising from Ru(dπ) 
→ BL(π*) transitions are shifted to a lower energy ca. 772 nm as a result of the low–lying 
π*–orbitals of the azo functionality, as well as further stabilisation of its π*–accepting nature 
upon coordination to a second metal centre. The band corresponding to the Ru(dπ) → 
terpy(π*) at ca. 409 nm is relatively unchanged in both 4.3 and 4.5. 
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3.60 1.79 +1.71, 
+1.40 






1.60 1.36 > 2.0 
+1.22 






1.60 1.27 > 2.0 
+1.24 
–0.03, –0.59, –1.77,  
–1.85. 
a
 In acetonitrile (±2 nm). 
b
 In V vs SCE in CH3CN/0.1M TBAPF6. 
c
 Calculated from DPV measurement. 
d
 Energy for the lowest MLCT absorption. 
e
 Difference between first oxidation and first reduction potentials. 
g
 shoulder. 
The redox potentials indicate that these complexes are easier to oxidise and reduce than 





) at +1.29 V. The oxidation potential is cathodically shifted when compared to 
[(terpy)Ru(tppz)]
2+
. The complex displays two successive one–electron reductions, which are 
assigned to bridging ligand reduction processes, and a two–electron redox couple attributed 
to reduction of the terpy ligand. These are based on the fact that a similar potential difference 
(  500 mV) is observed between the first and the second reduction of the bridging ligand in 




The dinuclear complexes 4.3 and 4.5, exhibit a one–electron redox process 
corresponding to the oxidation of the metal centre. Unfortunately, the second oxidation wave 
could not be observed before the oxidation of the electrolyte solution at about 2.0 V 
indicating a huge comproportionation constant of Kc > 10
13
. The differential pulse 
voltammogram of complex 4.3 is shown in Figure 4.16. This increase in the communication 
between the metal centres is presumably due to the bis–chelating tridentate bridging ligand. 
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The difference in the metal–based oxidation potentials in complexes containing bischelating 
tridentate ligand tppz (ΔEox  300mV) when compared to the bidentate bridging ligand 2,3–
dpp (ΔEox  200mV) has been seen previously,
[6]
 which suggest that tridentate bridging ligands 
mediate stronger coupling between the metal centres.  
 
Figure 4.16. The differential pulse voltammogram for complex 4.3 vs Ag/AgNO3. 
The dinuclear complexes 4.3 and 4.5 exhibit two successive reversible one–electron 
reductions of the bridging ligand followed by subsequent reductions of the terminal terpy 
ligand. Replacement of bpy groups in 4.1 by phen in 4.2 did not have a profound effect on the 
redox properties of the bridging ligand in the subsequent complexes of 4.3 and 4.5. However, 
when compared to the mononuclear complex 4.4, the reduction of the bridging ligands is 
shifted anodically due to the stabilization of the π*–orbital on coordination to the second 
metal fragment.  
4.5. Summary 
This chapter has described the synthesis of azo–based ligands 4.1 and 4.2 which can 
coordinate in a bis–tridentate manner. The coordination chemistry of these ligands has been 
investigated by synthesising the mononuclear and dinuclear ruthenium(II) complexes.  
The X–ray crystal structures of the dinuclear complexes 4.3 and 4.5 reveal that the azo 
ligands coordinate to the ruthenium atom using the azo nitrogen atom and two N–atoms from 
the bpy and phen group, respectively. The average inter–metal distance in the complexes is 
similar at ca. 4.835 Å. In the crystal packing, the terminal terpy ligands are involved in aryl 
embraces with the bridging ligand and the terpy ligand of another molecule, giving rise to 
Potential (V) 
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interesting two–dimensional supramolecular motifs. In the mononuclear complex 4.4, the 
non–coordinated ring of the ligand 4.2 adopts a twisted confirmation.  
The absorption spectrum exhibits overlapping MLCT bands due to Ru(dπ) → 4.2(π*) 
and Ru(dπ) → terpy(π*) transitions in complex 4.4. In the dinuclear complexes a large red 
shift in the Ru(dπ) → BL(π*) transition was observed due to the increased stabilisation of the 
azo–centered π*–orbital upon formation of the bimetallic system. Further insights into the 
electronic transitions are obtained from electrochemical studies which reveal a more positive 
reduction potential for the bridging ligand in the dinuclear complexes 4.3 and 4.5 when 
compared to 4.4. Electrochemical studies also reveal that these ligands mediate very strong 















Bidentate ligands based on bis(pyridylimines) 
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5. Bidentate ligands based on bis(pyridylimines) 
5.1. Introduction 
This chapter describes a series of ligands that are Schiff bases derived from pyridine–2–
carboxaldehyde. These molecules consist of two N=C–C=N moieties joined directly, or 
separated by spacers of different length, rigidity and conjugation.
[292],[293]
 Transition metal 
complexes of pyridyl Schiff bases have found applications in catalysis
[294]
 and crystal 
engineering,
[295],[296]
 as these form coordination polymers
[297]
 and ‘grid–type’ complexes.
[298]
  
A large range of heterocyclic bridging ligands, with a variation at different points 
within the structure, can be represented by the generalised structure shown in Figure 5.1. The 
linker group X, can be varied by changing both the type
[299–301]
 and/or the length of 
spacer.
[292],[302–304]
 The former allows for the incorporation of different aromatic rings, while 
the latter allows for the changes in the flexibility of the ligand.
[296],[302]
 Finally, the substituent 
R on the imine units can also be altered.
[292],[303],[305]
 The ligands described in this chapter all 






Figure 5.1. The generalised structure of the ligands. 
In general, these ligands are similar to the azo ligands (discussed in previous chapters) 
as these possess low lying π*–orbitals, making them excellent π acceptors of metal d–orbital 
electron density. However, the N2 linkages in azines with N–N single bonds are much more 
flexible when compared with the rigid moiety in azo compounds (N=N). Previous studies 
have shown that such ligands also present several possible mono– and binucleating 
coordination modes due to the flexibility of the ligand around the N–N single bond.
[305],[306]
 
Recently, Cai et al.
[307]
 reported long–range electron transfer processes for binuclear 
ruthenium complexes with two imine units linked directly or via spacers. According to their 
observations, the comproportionation constant Kc decreases with an increase in the number of 
phenyl rings or with the insertion of an oxygen atom between the two phenyl rings, while a 
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saturated CH2 group increased the Kc values. Interestingly, the binuclear ruthenium complex 
containing a saturated –OCH2CH2O– unit between the two phenyl groups gave a large Kc, 
which they attributed to the fact that the two metal sites could be close in space due to the 
increased flexibility of the bridging ligand.  
It is clearly evident from previous studies that the extent of communication between 
metal centres decreases steadily as the π–overlap between the two halves of the bridging 
ligands decreases, which happens when the ligand is either lengthened, twisted or contains a 
saturated fragment. The research carried out by Chakraborty et al.
[308]
 on a similar series of 
binuclear ruthenium complexes found only one quasi–reversible two–electron oxidation 
process, indicating simultaneous one electron oxidation of both the ruthenium centres 
[Ru(II)→Ru(III)]. This indicates that the metal–metal interaction decreases as the distance 
increases between the two imine units. On this basis we had reason to doubt the validity of 
the work reported by Cai et al.
[307]
 
Thus, in order to investigate the results, a series of binuclear ruthenium complexes have 
been synthesised, in which the two pyridylimine ligands are linked at the imine nitrogen 
atom, either directly, or through a spacer of variable length, as shown in Figure 5.2. 












Figure 5.2. The doubly–bidentate pyridylimine–based bridging ligands. 
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5.2. Syntheses of the ligands 













 were prepared by literature methods with some 
modifications to the purification techniques.  




, ethanol, RT, 5h, 95%; (d)
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N N N N
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The synthesis involved the condensation of pyridine–2–carbaldehyde with the 
corresponding diamine, as shown in Scheme 5.1, in a 2:1 stoichiometric ratio in ethanol or 
methanol to give the ligands 5.1 – 5.5 in moderate to high yields. All ligands were 
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characterised by NMR spectroscopy and mass spectrometry, and were found to be consistent 
with the previously reported literature data. The 
1
H NMR spectra of the ligands show that 
both halves of the ligand are identical due to internal symmetry. The aromatic doublets 
corresponding to H6 and H3 of the pyridine ring were easily identified from the coupling 
constants and gCOSY experiments. The more downfield doublet was assigned to H6, since in 
a pyridine ring the 6–position is more electron deficient than the 3–position. The singlet 
corresponding to the azomethine proton (–HC=N–) ranges from δ  8.55 to 8.72 ppm. As an 
example, the 
1
H NMR spectrum of 5.5 is shown in Figure 5.3. 
 
Figure 5.3. The 
1
H NMR spectrum of ligand 5.5. 
5.3. Syntheses and Characterisations of the Complexes. 
The bridging ligands 5.1 – 5.5 bind to the metal in a neutral and bidentate manner, 
forming bidentate chelate rings. The ruthenium complexes were synthesised by first heating a 
mixture of the ruthenium precursor, [Ru(bpy)2Cl2]∙2H2O and silver perchlorate in ethanol for 
1 hour. The reaction mixture was filtered through Celite
®
. The ligand was then added to the 
filtrate and the mixture was heated to reflux for 16 hours. The complexes were precipitated as 
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, with the 
ligands resulted in binuclear complexes, irrespective of the stoichiometric ratio used. All 






























5.3.1. Complexes of 5.1 
During the synthesis of the binuclear complex 5.7 hydrolysis led to the in situ formation 
of the metal complex 5.6, as shown in Scheme 5.3. The transition metal mediated hydrolysis 
of some Schiff bases have been reported previously.
[309],[310]
 The hydrolysed mononuclear 
complex 5.6 was separated from the binuclear complex 5.7 on a SP Sephadex C–25 column 
via a gradient elution technique using a 0.1–0.5 M sodium chloride solution. The complex 
was then precipitated as a hexafluorophosphate salt.  












































Figure 5.4. The 
1
H NMR spectrum of complex 5.6. 
The 
1
H NMR spectrum of the complex 5.6 is illustrated in Figure 5.4. The assignments 
were made on the basis of spin–spin coupling information, gCOSY and 1–D TOCSY 
experiments. The spectrum shows five different pyridyl ring environments, four for the 
bipyridines and one for the ligand pyridyl environment, which was identified by a gCOSY 
experiment in combination with HMBC, as shown in Figure 5.5. The imine carbon shows a 
correlation to the proton at δ  8.54 ppm indicating it as the H3 proton of the pyridine ring 
belonging to the ligand 5.1. The presence of only five pyridyl ring environments and a broad 
singlet corresponding to NH2 protons at 6.64 ppm indicates the hydrolysis of the non–
coordinated imine to a free amine to give complex 5.6. The proton signal corresponding to 
the azomethine (–HC=N) in complex 5.6 is at δ  8.36 ppm, which is more shielded relative to 
ppm 
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the free ligand, δ  8.55 ppm. Unfortunately, attempts to grow crystals of 5.6 were 
unsuccessful. 
 
Figure 5.5. gCOSY spectrum of complex 5.6. 
In the binuclear complexes the presence of two–fold symmetry makes each half 
equivalent to the other. However, due to the asymmetric nature of the ligand, all five pyridine 
rings around each ruthenium centre are non–equivalent. The 
1
H NMR spectrum for complex 
5.7 in acetonitrile–d3 is shown in Figure 5.6. The spectrum consists of 21 non–equivalent 
proton signals, 16 corresponding to the ancillary bipyridine ligands and five corresponding to 
the bridging ligand 5.1.  
The 
1
H NMR spectrum shows five different pyridine ring environments, which are 
colour coded in Figure 5.6. The four rings corresponding to the ancillary bipyridines, and one 
for the ligand pyridine ring, were identified by previously discussed methods. The 
connectivity between the two pyridine rings of each bipyridine was identified by 1D ROESY 
experiments. The H3 proton (8.58 ppm) shows a correlation to the H3 proton (8.48 ppm) on 
the adjoining pyridyl ring of the same bipyridine. The azomethine singlet peak in complex 
5.7 is strongly deshielded (δ 9.28 ppm) when compared to the free ligand (δ 8.55 ppm), due 
to the donation of electron density from the metal centre. 
ppm 
ppm 
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Figure 5.6. The 
1
H NMR spectrum for the complex 5.7. 
In complex 5.7, there are four environments for the H6 protons of the ancillary ligands. 
The H6 protons of pyridine rings from two different bipyridine ligands show the greatest 
change in chemical shift. This could be due to the fact that these protons are in close 
proximity to the ancillary ligands across the bridge. In the X–ray crystal structure (Figure 
5.8), one of the protons lies directly over a pyridyl ligand of a bipyridine across the bridge, 
whereas the other one is in the plane of the ligand. The H6 proton of one of the pyridyl rings 
of bipyridine is strongly deshielded, due to the trans–effect of the metal. The fourth bpy–H6 
proton is not in close proximity to the bridging ligand and hence experiences less ring–
current anisotropy effects.  
Crystal Structure of 5.7  
Crystals of complex 5.7 were grown by vapour diffusion of diisopropyl ether into an 
acetonitrile solution of the complex. It crystallises in the triclinic space group P–1, with one 
ruthenium metal, half a ligand 5.1, two bipyridine units, two hexafluorophosphate anions and 
one acetonitrile solvate molecule in the asymmetric unit, confirming the formation of the 
complex in a 2:1 metal to ligand ratio, as shown in Figure 5.7.  
ppm 
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Figure 5.7. The asymmetric unit of complex 5.7.  
Due to the crystallographic centre of inversion at the centre of the ligand, the second 
half of the molecule is symmetry generated. The bridging ligand (5.1) binds to the ruthenium 
atom via the pyridine nitrogen (N5) and imine nitrogen (N6), as shown in Figure 5.8. The 
chelate angles are 78.65°(12) (N1–Ru1–N2), 79.15°(13) (N3–Ru1–N4) and 77.60°(11) (N5–
Ru1–N6) with the trans N–Ru–N angles are greater that 170°, indicating a slight distortion in 
the octahedral geometry. The Ru–Npy bond distances (approximately 2.06 Å) are quite similar 
and correlate with previously reported literature values. The Ru–Nimine bond distance at 
2.111(3) Å (Ru–N6) is slightly longer than the Ru–Npy bond distance of 2.066(3) Å (Ru1–
N5). The distance between the two ruthenium metals is 5.297(5) Å, longer than the Ru∙∙∙Ru 
distance in the azo containing complexes (ca. 4.9 Å), discussed in previous chapters. 
The structure and conformation of the complex support the previously allocated 
1
H 
NMR assignments. As the structure shows, the strongly shielded H3 proton (H23) of the 
pyridine ring from the bridging ligand lies directly over one of the bipyridine rings and is thus 
shielded due to through–space ring–current effects. The H6 proton (H11) of the pyridine ring 
from one bipyridine is strongly shielded, as it lies directly over the pyridyl ring of the 
bipyridine across the bridge. The significant deshielding of the H6 proton (H20) of a pyridyl 
ring is due to the trans–effect. The remaining two H6 protons, one of the pyridine ring of the 
bridging ligand and one of the ancillary ligand, are in relatively deshielded environments, 
since they are not directly over, or in the plane of the bridging ligand and hence experience 
less ring–current anisotropy. 
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Figure 5.8. The X–ray crystal structure of complex 5.7. The counterions and 
solvate molecules are omitted for clarity. Selected bond distances (Å) and bond 
angles (°): Ru1–N1 2.066(3), Ru1–N2 2.074(3), Ru1–N3 2.061(3), Ru1–N4 
2.046(3), Ru1–N5 2.066(3), Ru1–N6 2.111(3), N6–N6 1.424(6), N1–Ru1–N2 
78.65(12), N1–Ru1–N3 173.73(12), N1–Ru1–N4 96.97(12), N1–Ru1–N5 
97.35(12), N1–Ru1–N6 89.43(11), N2–Ru1–N3 95.92(12), N2–Ru1–N4 
83.28(12), N2–Ru1–N5 174.16(11), N2–Ru1–N6 106.43(11), N3–Ru1–N4 
79.15(13), N3–Ru1–N5 87.83(12), N3–Ru1–N6 95.16(12), N4–Ru1–N6 
169.32(11), N5–Ru1–N6 77.60(11). 
 
5.3.2. Complexes of 5.2 – 5.5 
Complexes 5.8 – 5.11 were all synthesised by the procedure described in Scheme 5.3. 
All the complexes were characterised by NMR spectroscopy and mass spectrometry. No 
evidence for any mononuclear complexes was seen. The 
1
H NMR spectra of 5.8 – 5.11 are 
shown in Figure 5.9. Due to the presence of symmetry, both halves are equivalent, and 
accordingly each complex shows five different pyridyl rings irrespective of the spacer 
involved. The imine proton (H7) is the most deshielded of all with the H7 proton of 5.8 being 
more shielded (8.79 ppm) when compared to 5.7, 5.9 – 5.11 (δ > 9.0 ppm). The phenyl ring 
protons in 5.8 appear as a broad singlet at 6.13 ppm. No profound difference caused by the 
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phenyl methane spacer in 5.10 and the phenyl ether spacer in 5.11 were observed. The H6 
protons of the bridging ligands 5.2 – 5.5 experience similar shielding due to the through–
space ring–current anisotropy. 
 
Figure 5.9. The 
1
H NMR spectra of 5.8 – 5.11. 
Crystal Structure of 5.8 
A single crystal suitable for X–ray analysis was obtained by diffusing diisopropyl ether 
into a solution of complex 5.8 in acetonitrile. The complex crystallises in the monoclinic 
space group P21/c, with half a molecule of 5.8, two perchlorate anions and one acetonitrile 
solvate molecule in the asymmetric unit. The X–ray crystal structure of 5.8, shown in Figure 
5.10, contains each Ru(bpy)2 fragment coordinated to the bridging ligand 5.2 through the 
imine nitrogen N6 and pyridyl nitrogen atom N5. The coordination sphere of ruthenium(II) is 
slightly distorted with the trans N–Ru–N angles greater than 172°. The Ru–N bond distances 
range between 2.05 – 2.07 Å and the terminal bipyridine chelate angles are 79.1(2)° and 
78.88(2)°, which is similar to the complex 5.7. The ligand 5.2 separates the two metal centres 
at a distance of 8.534(1) Å (Ru∙∙∙Ru) significantly longer than complex 5.7 (5.296(1) Å). The 
ppm 
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phenyl ring of the ligand 5.2 is twisted at ca. 52.30 Å and is between the cofacial bipyridine–
pyridine rings within the complex, as shown in Figure 5.10. The oxygen atoms of the non–
coordinating perchlorate anions are involved in weak hydrogen bonding with the ligand 
molecule, which stabilises the crystal packing. 
 
Figure 5.10. The X–ray crystal structure of 5.8 showing the twisted phenyl 
ring. Hydrogen atoms, counterions and solvate molecules are omitted for 
clarity. Selected bond distances (Å) and bond angles (°): Ru1–N1 2.055(3), 
Ru1–N2 2.062(2), Ru1–N3 2.047(3), Ru1–N4 2.066(3), Ru1–N5 2.059(3), 
Ru1–N6 2.069(2), N1–Ru1–N2 78.78(10), N3–Ru1–N1 90.09(12), N3–Ru1–
N2 95.46(11), N4–Ru1–N1 96.83(11), N4–Ru1–N2 172.95(12), N4–Ru1–N3 
78.93(14), N5–Ru1–N1 97.01(12), N5–Ru1–N2 89.46(10), N5–Ru1–N3 
172.04(10), N5–Ru1–N4 96.59(13), N6–Ru1–N1 174.73(11), N6–Ru1–N2 
102.03(9), N6–Ru1–N3 95.00(10), N6–Ru1–N4 82.85(10), N6–Ru1–N5 
77.83(10). 
Chapter 5 Bidentate ligands based on bis(pyridylimines) 160 
 
5.4. Electronic Absorption Spectroscopy and Electrochemistry  
The UV/Visible absorption spectra of all the complexes show strong ligand–centred 
absorptions below 300 nm and MLCT absorption bands at or above 400 nm, as shown in 
Figure 5.11. The mononuclear complex 5.6 exhibits a band at 438 nm with an associated 
shoulder at 411 nm. The visible absorption spectra for the binuclear complexes 5.7 – 5.11 are 
also shown in Figure 5.11. Complex 5.7 displays two distinct MLCT bands at 524 nm and 
420 nm. Complexes 5.8 – 5.11 show similar transition patterns, with bands in the visible 
region arising from the MLCT transitions at ca. 483 nm, associated with shoulders at ca. 427 
nm and 344 nm. Based on the intensity of these visible bands, the lowest energy band is 
assigned to the Ru(dπ) → BL(π*) transition, as this is the lowest energy gap, between the 
HOMO of the metal and LUMO of the ligand. The nature of the bridging ligands also 
influence the position of the bands. A distinct blue shift of   40 nm was observed in 
complexes 5.8 and 5.9 compared to complex 5.7, whereas a shift of only 5 nm was found 
between 5.10 and 5.11. 






































Figure 5.11. UV/Visible spectra for complexes 5.7 – 5.11 in acetonitrile at 298 K. 
The redox properties of the complexes were studied by differential pulse voltammetry 
in an acetonitrile solution. Figure 5.12 shows the differential pulse voltammogram for 5.7 – 
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5.11. The ruthenium metal–based oxidation and the ligand–based reduction potentials are 
listed in Table 5.1. The redox potentials of the complexes 5.6 –5.11 indicate that these 
complexes are easier to oxidise than [Ru(bpy)3]
2+
, except 5.7 which oxidises at a similar 
potential. The mononuclear complex 5.6 exhibits a one–electron redox couple for the 




) and two well resolved, reversible reductions of the ligand. 
The binuclear complexes 5.8 – 5.11 all show one two–electron redox couple corresponding to 
the oxidation of the metal centres, except for 5.7. Complex 5.7 exhibits two reversible one–
electron redox couples corresponding to two successive oxidations of the metal centres 
separated by 100 mV (Kc = 49), indicating weak electron–coupling between the metal 
centres. However, the simultaneous two–electron oxidation of the metal centres in 5.8 – 5.11 
suggest that the extent of communication between the metal centres decreases with increasing 
spacer length between the bis(pyridylimine) units. 
Table 5.1. Absorption maxima
a
 and reduction potentials
b,c
 for complexes 5.6 – 5.11. 





 452  +1.26 –1.33 –1.51  
5.6 438, 411  +0.98 –1.80 –2.04
d
  
5.7 524, 420, 393 +1.33 +1.23 –0.73 –1.22 –1.87
d
 



























 In acetonitrile (± 2 nm).  
b
 In V vs Ag/AgNO3 in CH3CN/0.1 M [(n–C4H9)4]ClO4. 
c
 Calculated from differential pulse voltammetry. 
d
 Two–electron reduction. 
e
 Two–electron oxidation. 
f
 Irreversible process. 
The binuclear complexes all show multiple ligand based reductions in the cathodic 
region. The first two reductions in 5.7 are assigned to reductions of the bridging ligand 5.1 in 
the low–lying π*–orbitals of the imine functionality. The introduction of both phenyl and 
naphthyl groups in 5.8 and 5.9, respectively, shifts the reduction potential to more positive 
values due to the increased π–conjugation. In 5.10 and 5.11 the insertion of a –CH2– or a 
oxygen atom, respectively, between the phenyl group makes the reduction of the ligand more 
negative. 
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Figure 5.12. The oxidation waves of the differential pulse voltammograms for 
complexes 5.7 – 5.11. 
5.5. Summary 
In summary, the bis(pyridylimine) ligands 5.1 – 5.5 were readily prepared by the 
condensation of pyridine–2–carboxaldehyde with the corresponding amine in reasonable 
yields. The binuclear ruthenium complexes 5.7 – 5.11 were synthesised by reaction of ligand 
with a ruthenium(II) precursor in a 1:2 ligand to metal ratio. A mononuclear complex 5.6 was 
also obtained as a result of the hydrolytic decomposition of ligand 5.1.  
The X–ray crystal structures of the binuclear complexes 5.7 and 5.8 show that varying 
the length of the spacer between the imine units results in an increase in the Ru∙∙∙Ru 
separation. Electrochemical studies revealed that ligand 5.1 mediates a weak interaction 
between the metal centres. However, in the binuclear complexes 5.8 – 5.11, a complete 
absence of communication between the metal centres was observed, presumably due to the 
increased distance and/or flexibility across the bridging ligand 5.2 – 5.5. These results are in 
stark contrast to those reported by Cai et al.
[307]
 and raise serious doubts as to the validity of 
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6. Metallosupramolecular Chemistry  
6.1. Introduction 
Supramolecular assemblies involving nitrogen heterocycles with different silver(I) salts 
have been extensively reported in the literature.
[167],[190–195]
 The coordination sphere of 
silver(I) is very flexible and displays a variety of coordination numbers and geometries. Due 
to the weak nature of silver–ligand bonds, non–covalent interactions and crystal packing 
forces have a greater influence on the overall structure.
[187–189]
 The self–assembly process 




In order to further explore the coordination chemistry of the azo ligands, a number of 
complexes were synthesised using different silver(I) salts in a 1L:2M ratio (where, L = ligand 
and M = metal) in an appropriate solvent. Slow evaporation of the resulting mixture gave 
crystals suitable for X–ray analysis. The complexes were also characterised by mass 
spectrometry, elemental analysis and IR spectroscopy.  
6.2. Metallosupramolecular chemistry of azo–based ligands 
6.2.1. Complex of 2.1, [Ag(2.1)](SO3CF3), 6.1 
Complex 6.1 was obtained from reaction of 2.1 with two equivalents of silver triflate. It 
crystallises in the monoclinic space group P21/n, with one silver atom, two half ligands of 2.1 
and one non–coordinated triflate anion in the asymmetric unit, revealing a M1L1 type 
coordination complex, as shown in Figure 6.1. Each of the two independent ligands lies on a 
crystallographic centre of inversion. 
The structure grows into a one–dimensional polymer, as shown in Figure 6.2, with 
four–coordinate silver atoms coordinated to two molecules of 2.1 through the Nazo and Npy 
atoms. The azo ligand 2.1 adopts an “S–frame” conformation and bridges two silver atoms at 
a distance of 5.487(2) Å. The Ag–Nazo bond distance [ca. 2.41 Å] is longer than the Ag–Npy 
bond distance [ca. 2.25 Å] due to the absence of π–backbonding and are consistent with these 
previously reported for [(CF3SO3)Ag(2.1)Ag(CF3SO3)].
[162]
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Figure 6.1. The asymmetric unit of 6.1 with atom labelling. Selected bond 
distances (Å): Ag1–N2 2.400(1), Ag1–N1 2.250(1), Ag1–N4 2.425(1), Ag1–
N3 2.246(1), N2–N2A 1.253(3), N4–N4A 1.250(3). Selected bond angles (°): 
N1–Ag1–N2 68.96(5), N2–Ag1–N4 133.91(4), N1–Ag1–N4 116.94(5), N3–
Ag1–N2 124.39(5), N3–Ag1–N1 157.46(5), N3–Ag1–N4 68.83(5). 
 
Figure 6.2. Part of the 1D polymeric structure of 6.1. Hydrogen atoms and 
non–coordinating counterions are omitted for clarity.  
 
6.2.2. Complex of 2.3, [Ag2(2.3)](CO2CF3)2, 6.2 
Slow evaporation of 2.3 and silver(I) trifluoroacetate in a mixture of acetonitrile and 
methanol gave red crystals of 6.2. The structure solved in the monoclinic space group P21/n, 
revealing a 1L:2Ag ratio or Ag2L type coordination polymer. The asymmetric unit contains 
one full molecule of 2.3, two silver atoms and two trifluoroacetate anions as shown in Figure 
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6.3. Once again, within the complex 6.2, ligand 2.5 adopts the “S–frame” conformation and 
acts as a bridge separating the silver atoms at a distance of 5.783(3) Å [Ag1∙∙∙Ag2A].  
 
Figure 6.3. The asymmetric unit of complex 6.2. All the hydrogen atoms are 
omitted for clarity. Selected bond distances (Å): Ag1–Ag2 2.925(2), Ag1–O1 
2.497(2), Ag1–O1A 2.424(2), Ag1–O3 2.299(2), Ag1–N1 2.312(2), Ag1–N4 
2.580(2), Ag2–O2 2.429(2), Ag2–O4 2.222(2), Ag2A–N2 2.625(2), Ag2A–N3 
2.232(2), N2–N4 1.247(3). Selected bond angles (°): O1–Ag1–N4 127.34(6), 
O1–Ag1–Ag2 78.11(4), O1A–Ag1–N4 140.70(6), N1–Ag1–O1A 90.72(6), 
O2–Ag2–N2A 143.14(6), O3–Ag1–O1 94.28(6), O3–Ag1–N1 163.46(6), O3–
Ag1–O1A 99.81(6), O4–Ag2–Ag1 85.33(5), O4–Ag2–N3 165.52(7), N1–
Ag1–Ag2 88.54(5), N3A–Ag2–N2A 65.27(6), N1–Ag1–O1 96.38(6), O1–
Ag1A–O1A 84.07(6), O1A–Ag1–Ag2 161.58(4), O2–Ag2–Ag1 85.09(4), 
N3A–Ag2–O2 97.15(7), O3–Ag1–Ag2 77.11(4), O3–Ag1–N4 101.41(6), O4–
Ag2–O2 95.26(7), O4–Ag2–N2A 100.26(6), N1–Ag1–N4A 65.55(6), N4–
Ag1–Ag2 70.79(4), N3A–Ag2–Ag1 103.12(5). 
The asymmetric unit grows into a dimeric unit (Figure 6.4a) which extends into a one–
dimensional coordination polymer with alternating Ag–O bonding, as shown in Figure 6.4b. 
The Ag–O bond distance within the dimeric unit [Ag1–O1 2.497(2) Å] is longer than the 
outer Ag–O bond distance [Ag1–O1A 2.424(2) Å]. 
The trifluoroacetate anions coordinate in a bidentate manner through O1, O2 and O3, 
O4 and bridge two silver atoms (Ag1–Ag2) at a relatively short distance of 2.925(3) Å. In 
addition, O1 adopts a bidentate coordination mode and bridges two silver atoms 
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(Ag1∙∙∙Ag1A) at 3.655(4) Å. Two silver environments are present in the structure; one where 
the silver atom (Ag1) is six–coordinate with one silver atom (Ag2), two nitrogen atoms (N1 
and N4) and two oxygen atoms of the trifluoroacetate anions (O3 and O1) and one oxygen 
atom from a crystallographically related anion (O1A). A second five–coordinate silver atom 
(Ag2) coordinates through one silver atom (Ag1), two nitrogen atoms (N2 and N3) and two 
oxygen atoms of the trifluoroacetate anions (O2 and O4). As expected, the average Ag–Nazo 
bond length is longer than the average Ag–Npy bond length at 2.60 and 2.27 Å, respectively. 
 
Figure 6.4. (a) Dimeric unit of 6.2. (b) A perspective view of the extended 1D 
polymer of 6.2. 
 
6.2.3. Complex of 2.5 
Reaction of silver(I) nitrate in acetonitrile with 2.5 in a mixture of 
methanol/dichloromethane resulted in a complex which was characterised by elemental 
analysis as [Ag2(2.5)](NO3)2∙CH3OH∙H2O (6.3). Slow evaporation of the reaction mixture 
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gave red crystals of 6.3, which were suitable for X–ray crystallography. The structural 
analysis revealed a one–dimensional coordination polymer in a 1:1 silver to ligand ratio.  
[Ag2(2.5)](NO3)2, 6.3  
Complex 6.3 crystallised in the tetragonal space group P42/n, with two half molecules 
of 2.5, one silver atom, and one nitrate anion in the asymmetric unit, as shown in Figure 6.5. 
The silver atom has a distorted trigonal–bipyramidal geometry, involving coordination 
through the two pyridine nitrogen atoms of two different ligand molecules, two azo nitrogen 
atoms of the crystallographically related ligand molecules, and one oxygen atom of the nitrate 
anion.  
 
Figure 6.5. The full asymmetric unit of complex 6.3. All the hydrogen atoms 
are omitted for clarity. Selected bond distances (Å) and bond angles (°): Ag1–
N1 2.269(1), Ag1–N2A 2.589(1), Ag1–N3 2.326(1), Ag1–N4A 2.414(1), Ag1–
O1 2.557(1), N2–N2A 1.249(2), N1–Ag1–N3 155.92(4), N1–Ag1–N4A 
134.87(4), N3–Ag1–N4A 68.02(4), N1–Ag1–O1 86.13(4), N3–Ag1–O1 
93.56(4), N4A–Ag1–O1 107.50(4), N1–Ag1–N2A 66.05(3), N3–Ag1–N2A 
109.07(4), N4A–Ag1–N2 97.28(3), O1–Ag1–N2A 151.43(3). 
Ligand 2.5 acts as a bidentate ligand, bridging the two silver atoms at a distance of 
5.819(3) Å. All the silver–nitrogen and silver–oxygen bond lengths are consistent with 
structurally related molecules. In complex 6.3, the Ag–Nazo bond length is longer than the 
Ag–Npy bond lengths. The overall structure is a one–dimensional coordination polymer with 
the nitrate ion alternating on opposite sides at each silver atom of the coordination polymer, 
as shown in Figure 6.6.  
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Figure 6.6. A perspective view of the 1D polymeric structure of 6.3 with 
hydrogen atoms omitted for clarity. 
 
6.2.4. Complexes of 3.1 
Ligand 3.1 gave a one–dimensional coordination polymer 6.4 and 6.5 with silver(I) 
perchlorate and silver(I) nitrate, respectively. Despite using a 1L:2M stoichiometric ratio of 
the reactants, the ratio was 1:1 as shown in Scheme 6.1. The compositions were confirmed by 















[Ag(3.1)](ClO4), 6.4 and [Ag(3.1)](NO3), 6.5 
Complex 6.4 crystallised in the triclinic space group P–1, with two half molecules of 
3.1, one silver atom and two half perchlorate anions, as shown in Figure 6.7a. The perchlorate 
ions are non–coordinating, disordered and lie on crystallographic centres of inversion.  
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Complex 6.5 crystallised in the triclinic space group P–1. The asymmetric unit contains 
one full, and two half molecules of 3.1 with two silver atoms and two non–coordinating 
nitrate anions as shown in Figure 6.7b.  
 
(a) (b) 
Figure 6.7. The asymmetric unit of (a) 6.4 and (b) 6.5. All the hydrogen atoms 
and counterions are omitted for clarity. Selected bond distances (Å) and bond 
angles (°): (6.4) Ag1–N1A 2.354(3), Ag1–N3 2.311(3), Ag1–N4 2.353(3), 
Ag1–N6 2.309(3), N1–N1A 1.234(5), N4–N4A 1.247(5), N3–Ag1–N1A 
68.19(9), N3–Ag1–N4 138.47(9), N4–Ag1–N1A 105.32(9), N6–Ag1–N1A 
133.18(9), N6–Ag1–N3 146.74(9), N6–Ag1–N4 68.11(9). (6.5) Ag1–N1 
2.272(3), Ag1–N4 2.469(3), Ag1 N10 2.302(3), Ag1 N12A 2.423(3), Ag2–N3 
2.496(3), Ag2 N6 2.312(3), Ag2 N7 2.329(3), Ag2 N9A 2.435(3), N3–N4 
1.240(5), N4–Ag1–N1 66.83(11), N10–Ag1–N12A 67.41(12), N6–Ag2–N3 
66.16(11), N7–Ag2–N9A 66.61(11), N10–Ag1–N1 160.83(12), N6–Ag2–N7 
158.76(12), N10–Ag1–N4 128.80(11), N7–Ag2–N3 122.12(11), N12A–Ag1–
N1 128.15(12), N12A–Ag1–N4 91.00(10), N3–Ag2–N9A 90.41(10), N6–
Ag2–N9A 134.62(12). 
In both 6.4 and 6.5, the silver atom is four–coordinate with two azo nitrogen atoms and 
two pyridine nitrogen atoms from two molecules of the ligand. In 6.4, the largest bond angle 
around Ag1 is between the pyridine nitrogen atoms of the two ligand molecules (N3–Ag1–
N6) with a bond angle of 146.74(9)° and the second largest bond angle is between the azo 
nitrogen N4 and pyridine nitrogen atom N3 of 138.47(9)°. In 6.5, the largest bond angle 
around Ag1 is also between the pyridine nitrogen atom N1 and N10 from two different ligand 
molecules with a bond angle of 160.83(12)° and the second largest bond angle of 128.80(11)° 
is between the pyridine nitrogen N10 and an azo nitrogen atom N4. Around Ag2, the largest 
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bond angle is between the pyridine nitrogen atom N6 and N7 from two different ligand 
molecules with a bond angle of 158.76(12)° and the second largest bond angle of 134.62(12)° 
is between the pyridine nitrogen N6 and an azo nitrogen atom N9A.The calculated τ4 
value
[311]
 of 0.53 (Ag1) in 6.4 and 0.49 (Ag1) and 0.47 (Ag2) in 6.5, reveal a seesaw 
geometry for the silver atoms.  
In spite of the different arrangement of the symmetry elements in the structure, 
complexes 6.4 and 6.5 both propagate into one–dimensional coordination polymers, as shown 
in Figure 6.8, similar to 6.1 (Figure 6.2). Ligand 3.1 bridges two silver atoms at distances of 
5.444(2) and 5.653(2) Å in 6.4 and 6.5, respectively. The Ag–N bond lengths are consistent, 





Figure 6.8. Perspective views of the 1D coordination polymers of 6.4 (a) and 
6.5 (b). Hydrogen atoms and non–coordinating counterions are omitted for 
clarity. 
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6.2.5. Complex of 3.2, [Ag2(3.2)2](SO3CF3)2, 6.6 
Reaction of silver(I) triflate in acetonitrile with 3.2 in dichloromethane gave the 
complex 6.6 as red crystals suitable for X–ray crystallography. The complex crystallises in 
the triclinic space group P–1, revealing a M2L2 type coordination complex. The asymmetric 
unit contains one full, and one half molecule of 3.2, one and a half silver atoms and one and a 
half non–coordinating triflate anions, as shown in Figure 6.9.  
 
Figure 6.9. The asymmetric unit of 6.6 with the triflate counterions being 
omitted for clarity. Selected bond lengths (Å): Ag1–N3 2.629(4), Ag1–N6 
2.215(4), Ag2–N2 2.338(4), Ag2–N4 2.282(4), Ag2–N8 2.314(4), Ag2–N9A 
2.309(4), N3–N4 1.240(6), N9–N9A 1.265(8). Selected bond angles (°): N3–
Ag1–N3A 180.0, N6–Ag1–N3 113.25(15), N6A–Ag1–N3A 66.75(15), N6–
Ag1–N6 180.0, N4–Ag2–N2 67.63(15), N8–Ag2–N2 124.17(15), N4–Ag2–N8 
140.39(15), N9A–Ag2–N2 144.52(15), N4–Ag2–N9A 126.26(15), N9A–Ag2–
N8 68.89(15). 
The two crystallographically independent silver atoms Ag1 and Ag2 are both four–
coordinate through coordination to two azo–N and two pyridine–N atoms. Interestingly, the 
silver atoms have very different coordination geometries, as shown in Figure 6.10a. The Ag1 
atom lies on an inversion centre, coordinating to two symmetry–related molecules of 3.2, 
each binding through azo–N and pyridine–N atoms (Figure 6.10b). It adopts a 
crystallographically imposed square planar geometry with trans N–Ag1–N angles, N3–Ag1–
N3A and N6–Ag1–N6A, of 180°, and the sum of the six–interbond angles Σ = 720°, which 
fits perfectly with Constable et al.’s
[312]
 model for planarity. In addition, the crystallographic 
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symmetry about Ag1 gives rise to two longer Ag–Nazo bonds and two shorter Ag–Npy bonds 
which also supports the argument.
[186]
 The coordination geometry of the second silver atom 
(Ag2), however is distorted tetrahedral (τ4 = 0.53), and is coordinated to two different 





Figure 6.10. (a) The coordination sphere of the two silver atoms, Ag1(left) and 
Ag2 (right) in complex 6.6. (b) A small section of the polymeric structure of 
6.6. 
The asymmetric unit grows into a one–dimensional coordination polymer with one 
square planar Ag1 lying between two identical tetrahedral silver atoms (Ag2 and Ag2A), as 
shown in Figure 6.11. Ligand 3.2 separates Ag1 and Ag2 by 5.573(5) Å and Ag2∙∙∙Ag2A by 
5.374(9) Å due to the longer Ag1–Nazo bond distance [Ag1–N3 2.628(4) Å]. 
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Figure 6.11. A perspective view of 6.6 emphasising the arrangement of 
components within the 1D coordination polymer. Hydrogen atoms and the 
counterions have been omitted for clarity. 
 
6.2.6. Complexes of 3.3 
Ligand 3.3 is similar to 3.1, differing only in the introduction of electron–donating 
methyl groups. It forms similar M2L2 one–dimensional coordination polymers, 6.7 and 6.8, 


















[Ag2(3.3)](NO3)2, 6.7 and [Ag2(3.3)](ClO4)2, 6.8 
Complex 6.7 crystallised in the triclinic space group P–1, with one silver atom, two half 
molecules of 3.3 and a coordinated nitrate anion in the asymmetric unit, as shown in Figure 
6.12a. Similarly, complex 6.8 crystallised in the triclinic space group P–1, with the 
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asymmetric unit containing two half molecules of 3.3, one silver atom and a coordinated 
perchlorate counterion, as shown in Figure 6.12b. The asymmetric units of 6.7 and 6.8 are 
similar to the previously described complex 6.3.  
In both 6.7 and 6.8, the silver atom is five–coordinate through the coordination of two 
azo nitrogens and two pyridine nitrogen atoms from adjacent molecules of 3.3 and an oxygen 
atom of the coordinated anion. All the silver–carbon, silver–nitrogen and silver–oxygen bond 
lengths are in the expected ranges (2.3 – 2.6 Å); however, unlike 6.3, the Ag–Nazo bond 
lengths are shorter than the Ag–Npy bond lengths in 6.7 and 6.8, presumably due to the steric 
influence of the methyl groups. 
 
 (a)      (b) 
Figure 6.12. The asymmetric unit of (a) 6.7 and (b) 6.8. Selected bond lengths 
(Å) and bond distances (°): 6.7: Ag1–N1 2.459(1), Ag1–N3A 2.410(1), Ag1–
N4 2.519(1), Ag1–N6A 2.390(1), Ag1–O2 2.373(1), N3–N3A 1.254(3), N6–
N6A 1.245(3), N3A–Ag1–N1 65.51(5), N6A–Ag1–N4 64.39(5), N3A–Ag1–
N4 111.05(4), N6A–Ag1–N1 120.55(5), N1–Ag1–N4 174.59(4), N6A–Ag1–
N3A 113.62(5), O2–Ag1–N1 88.86(5), O2–Ag1–N4 90.88(5), O2–Ag1–N3A 
132.38(5), O2–Ag1–N6A 113.97(5). 6.8: Ag1–N1 2.435(1), Ag1–N3A 
2.355(1), Ag1–N4 2.568(1), Ag1–N6A 2.316(1), Ag1–O1 2.465(1), N6–N6A 
1.248(2), N3–N3A 1.252(2), N3A–Ag1–N1 66.79(4), N6A–Ag1–N4 64.89(4), 
N3A–Ag1–N4 108.30(4), N6A–Ag1–N1 130.12(4), N1–Ag1–N4 164.88(4), 
N6A–Ag1–N3A 122.49(4), N1–Ag1–O1 81.07(4), O1–Ag1–N4 88.72(4), 
N3A–Ag1–O1 114.78(5), N6A–Ag1–O1 121.72(4).  
Similar to 6.3, the overall structures of 6.7 and 6.8 are one–dimensional coordination 
polymers, as shown in Figure 6.13, with the coordinating counterion alternating its position 
above and below each silver atom. In both complexes, ligand 3.3 acts as a chelating and 
bridging ligand with a Ag∙∙∙Ag separation of 5.610(3) Å in 6.7 and 5.474(2) Å in 6.8. The 
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crystal packing shows weak hydrogen bonding interactions between the oxygen atoms of the 
counterions and the methyl hydrogen atoms of the ligand molecule in both 6.7 and 6.8. The 
chlorine atoms of ligand 3.3 also make short contacts with the methyl hydrogen atoms of an 





Figure 6.13. Perspective views of the 1D polymeric structure of (a) 6.7 and (b) 
6.8. All of the hydrogen atoms have been omitted for clarity. 
 
6.2.7. Complexes of 3.4 
Ligand 3.4 could potentially act as a chelating ligand as well as the previously seen 
bridging mode, as previously seen in Chapter 3. To further investigate its modes of 
coordination, 3.4 was reacted with different silver(I) salts in a 2:1 metal to ligand ratio, as 
shown in Scheme 6.3.  
Reaction of silver(I) trifluoroacetate with ligand 3.4 gave complex 6.9, which was 
characterised as [Ag(3.4)](CO2CF3) by elemental analysis. Despite using a 2:1 metal to 
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ligand ratio, a 1:1 complex was obtained. X–ray analysis unambiguously confirms the 
composition of 6.9, revealing a M1L1 type one–dimensional coordination polymer, with the 
ligand bridging in a monodentate fashion. A similar 1D polymeric chain was obtained by 
reaction of 3.4 with silver(I) perchlorate. In complex 6.10, ligand 3.4 coordinates to the silver 
atom using the same coordination mode as seen in 6.9. In contrast, a discrete M2L2 binuclear 
complex 6.11 with silver(I) triflate was obtained, with a composition of 
















Complex 6.9 crystallised in the monoclinic space group C2/c. The asymmetric unit 
contains one half molecule of 3.4, half a silver atom and half a coordinated trifluoroacetate 
anion, revealing a 1L:1M ratio or M1L1 type coordination complex, as shown in Figure 6.14.  
 
Figure 6.14. The asymmetric unit of 6.9 revealing the formation of the 
complex in a 1M:1L ratio. All the hydrogen atoms are omitted for clarity. 
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The overall structure propagates into a one–dimensional polymeric chain with the 
chelating bidentate trifluoroacetate anions positioned above and below the plane of the 
polymer at each silver atom, as shown in Figure 6.15. The silver atom lies on a two–fold 
rotation axis and is four–coordinate through coordination to two quinoline nitrogen atoms of 
crystallographically related molecules of 3.2, and a bidentate trifluoroacetate anion. 
Interestingly, the azo nitrogen atoms are not involved in the coordination, unlike the previous 
complexes where the ligand adopts s–cis/E/s–cis conformation and bridges silver atoms to 
form a five–membered chelate ring. In complex 6.9, ligand 3.4 lies on a centre of inversion 
and displays s–trans/E/s–trans conformation bridging two silver atoms in monodentate 
fashion at a relatively long Ag∙∙∙Ag distance of 7.300(2) Å, as shown in Figure 6.15. A 
structurally similar binuclear gold complex [(Ph3P)Au(2.1)Au(PPh3)](CF3SO3)2 was reported 
by Bardaji et al.
[162]
, where 2.1 acts as a monodentate bridging ligand.  
 
Figure 6.15. A part of the 1D polymeric structure of complex 6.9 illustrating 
the coordination of ligand 3.4 in a monodentate manner. Hydrogen atoms have 
been omitted for clarity. Selected bond lengths (Å) and bond angles (°): Ag1–
N1 2.230(1), Ag1–O1 2.554(1), N2–N2A 1.258(2), N1–Ag1–N1A 143.72(7), 
N1–Ag1–O1 102.10(4), N1–Ag1–O1A 110.46(4), O1–Ag1–O1A 52.22(5). 
The silver–nitrogen [Ag1–N1 2.230(1) Å] and the Nazo–Nazo bond lengths [N2–N2A 
1.258(2) Å] are similar to the previous complexes. The largest bond angle around Ag1 is 
measured between the coordinated quinoline nitrogen atoms with a N1–Ag1–N1A angle of 
143.72(7)°. The second largest bond angle of 110.46(4)° [N1–Ag1–O1A] is observed 
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between the coordinated quinoline nitrogen and the oxygen atom of the counterion. The 
calculated τ4 value of 0.55 for Ag1 indicates a seesaw geometry. 
[Ag(3.4)](ClO4), 6.10 
Complex 6.10 also crystallises in the monoclinic space group C2/c, with two full 
molecules of 3.4, one full and two half silver atoms and two non–coordinating perchlorate 
anions as shown in Figure 6.16. The trans N–Ag–N angles greater than 172° denotes a linear 
geometry for the silver atoms, two of which lie on a two–fold rotation axis. Once again, 
ligand 3.4 coordinates in a monodentate fashion adopting a s–trans/E/s–trans confirmation. 
The monodentate coordination mode of the ligand bridges the two silver atoms with a 
separation of 7.103(1) Å, which is similar to 6.9, but significantly longer than complexes 
where the ligand coordinates in a chelating manner. 
 
Figure 6.16. The asymmetric unit of 6.10 with atom labelling. All hydrogen 
atoms and counterions have been omitted for clarity. Selected bond distances 
(Å) and bond angles (°):Ag1–N1 2.192(1), Ag1–N5 2.194(1), Ag2–N4 
2.209(1), Ag3–N8 2.167(1), N2–N3 1.257(2), N6–N7 1.263(2), N1–Ag1–N5 
172.25(6), N4–Ag2–N4A 174.01(8), N8–Ag3–N8A 172.51(8). 
Despite having similar linear coordination geometries, the coordination environments 
of the three silver atoms are all different. The overall structure grows into a one–dimensional 
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coordination polymer, as shown in Figure 6.17, with Ag1 coordinated to two different 
molecules of 3.4 through N1 and N5, whereas Ag2 is coordinated to identical ligands through 
N4 and N4A, and Ag3 through N8 and N8A.  
 
Figure 6.17. A perspective view of the 1D coordination polymer of complex 
6.10. Hydrogen atoms and counterions have been omitted for clarity. 
 
[Ag2(3.4)2](SO3CF3)2∙H2O, 6.11 
An acetonitrile solution of silver(I) triflate was added to a hot solution of 3.4 in 
methanol/dichloromethane. Slow evaporation of the reaction mixture over a period of time 
resulted in red crystals of complex 6.11, which were characterised as 
[Ag2(3.4)2](SO3CF3)2∙H2O by elemental analysis. The X–ray crystal structure reveals a M2L2 
discrete binuclear complex as shown in Figure 6.18. Complex 6.11 crystallised in the 
monoclinic space group Cc, with two silver atoms, two full molecules of ligand 3.4, one 
water molecule, and two non–coordinating triflate anions in the asymmetric unit. 
In complex 6.11, two crystallographically independent silver atoms Ag1 and Ag2 are 
present. The four–coordinate silver atom Ag1 coordinates to two quinoline ring nitrogens (N1 
and N8), one azo nitrogen (N6) and also forms a Ag1∙∙∙Ag2 bond at a distance of 2.899(4) Å. 
On the other hand, Ag2 is five–coordinate through coordination to an oxygen atom (O1) of 
the water molecule along with three nitrogen atoms (N2, N4 and N5) and the Ag1∙∙∙Ag2 
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bond. All of the Ag–N bond distances are consistent with the previous complexes, and range 
between 2.0 – 2.4 Å. 
 
Figure 6.18. The X–ray crystal structure of 6.11 showing the formation of a 
binuclear M2L2 complex. The aromatic hydrogen atoms and the triflate anions 
have been omitted for clarity. Selected bond distance (Å): Ag1–N1 2.190(3), 
Ag2–N2 2.389(3), Ag2–N4 2.315(3), Ag2–N5 2.223(3), Ag1–N6 2.373(3), 
Ag1–N8 2.270(3), Ag2–O1 2.574(3), Ag1–Ag2 2.899(4), N2–N3 1.251(5), 
N6–N7 1.252(4). Selected bond angles (°): N1–Ag1–N8 135.21(11), N1–Ag1–
N6 149.40(11), N1–Ag1–Ag2 87.17(8), N8–Ag1–N6 69.31(11), N8–Ag1–Ag2 
137.08(8), N6–Ag1–Ag2 74.22(8), N5–Ag2–N4 139.02(11), N5–Ag2–N2 
151.58(11), N4–Ag2–N2 68.09(11), N5–Ag2–O1 105.25(10), N4–Ag2–O1 
98.04(10), N2–Ag2–O1 71.39(10), N5–Ag2–Ag1 86.99(8), N4–Ag2–Ag1 
120.09(7), N2–Ag2–Ag1 67.14(8).  
In 6.9 and 6.10, coordination of ligand 3.4 to the silver atom involved only the 
quinoline ring nitrogen in a monodentate manner with the azo nitrogen atoms not involved. 
But in 6.11, ligand 3.4 acts as a tridentate ligand coordinating to one silver atom by chelating 
azo nitrogens (N2 or N6) and quinoline nitrogen atoms (N4 and N8) and a second silver atom 
through the quinoline nitrogen atoms (N1 and N5) in a monodentate fashion. The chelating 
Chapter 6 Metallosupramolecular Chemistry 182 
 
bite angles for the two molecules are N8–Ag1–N6 69.31(11)° and N4–Ag2–N2 68.09(11)°. 
Contrary to 6.9 and 6.10, the quinoline nitrogens of both the molecules of 3.4 involved in the 
bidentate coordination are in the same plane as the coordinated azo–nitrogen, however, the 
monodentate quinoline ring adopts a twisted conformation with a torsion angle greater than 




The oxygen atoms of the non–coordinating trifluoroacetate anions are involved in 
hydrogen bonding with the water molecule. The discrete binuclear complex is also further 
stabilised by a number of short contacts between the trifluoroacetate anions and the ligand 
molecules. 
6.3. Summary 
To conclude, in this section the metallosupramolecular chemistry of azo ligands 2.1, 
2.3, 2.5, and 3.1 – 3.4 with silver(I) metal ions and a range of counterions has been 
investigated. The self–assembly of silver(I) ions led to the formation of mostly coordination 
polymers as well as one discrete structure. The choice of anions profoundly influences the 
type of metallosupramolecular structure formed. 
Most of the complexes were isolated as one–dimensional coordination polymers with 
1:1 silver to ligand ratios with non–coordinating anions. The coordination of nitrate and 
perchlorate anions to the silver metal resulted in a similar one–dimensional coordination 
polymer with 2.5 and 3.3. Ligand 2.3 gave a coordination polymer with a different topology 
due to the coordinating trifluoroacetate anions. 
The ligands predominantly coordinate in a bidentate chelating manner adopting the 
usual “S–frame” conformation and bridging two silver atoms at a distance of approximately 
5.5 Å, except for ligand 3.4. Despite being a ditopic chelating ligand, as seen in Chapter 3, 
ligand 3.4 coordinates as a monodentate bridging ligand in complexes 6.9 and 6.10 
coordinating through the quinoline nitrogen atom. In both complexes, ligand 3.4 exhibits a s–
trans/E/s–trans conformation. It also acts as a tridentate ligand, which leads to the formation 
of dinuclear discrete complex 6.11 with a Ag∙∙∙Ag interaction of 2.899(3) Å. The 
coordination modes exhibited by the ligands are shown in Figure 6.19. 











Figure 6.19. General representation of the coordination modes employed by 
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7. Conclusions and Future Perspectives 
7.1. Conclusions 
The ability of nitrogen–containing heterocyclic ligands to function as bridges and 
control the electronic interactions between metal centres is of importance because of their 
wide applications, ranging from molecular devices to biological applications. This thesis has 
described the synthesis of sixteen symmetrical azo and five bis–pyridylimine ligands capable 
of coordinating as bis–chelating bridging ligands. The coordination and 
metallosupramolecular chemistry of these ligands with both ruthenium(II) and silver(I) has 
been investigated.  
The azo ligands discussed in this thesis are divided into three categories; (i) 
azobispyridine–based ligands with varying substituents on the pyridine rings; (ii) ligands in 
which the pyridine ring is replaced by different heterocyclic rings, (iii) hexadentate ligands 
with bis–tridentate coordination through an azo nitrogen and two ring nitrogen atoms. 
Ligands based on bis(pyridylimines) with varying spacers between the imine subunits were 
also synthesised to investigate the effect of decreased degree of conjugation and increased 
distance on the inter–metal coupling.  
In Chapter 2, the synthesis and characterisation of symmetrical azobispyridine ligands 
with different substituents on the pyridine ring was described. The mononuclear and 
dinuclear complexes of [Ru(bpy)2]
2+
 with bidentate azo ligands was investigated. Despite 
being potentially ditopic ligands, 2.2 and 2.4 afforded only mononuclear complexes, probably 
due to the steric interference of the methyl group at the 3– and 6–positions. Also, an 
unexpected substitution reaction of the bromo–ligand 2.6 in the diruthenium(II) complex was 
observed. This substitution was able to be avoided by using [Ru(bpy)2(OTf)2] to give the 
corresponding complex [(bpy)2Ru(μ–2.6)Ru(bpy)2]
4+
, 2.16.  
Structural characterisation, using X–ray crystallography, showed that the ruthenium 
atom could bind to the azobispyridine ligand using the azo–N atom and the pyridine–N atom, 
to form a stable five–membered chelate ring. In mononuclear complexes, the non–coordinated 
pyridine ring of the azo ligand is twisted with respect to the azo–N atom and directed towards the 
adjacent bipyridine rings. In the dinuclear complexes, selective formation of only one 
diastereoisomer, the meso form, was observed. The X–ray crystal structures indicate that the 
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azo ligand acts as a planar bridge between the two ruthenium atoms separated by a short 
metal–metal separation of ca. 4.9 Å. The X–ray crystal structures of complexes 
[(bpy)2Ru(2.5)](PF6)2, 2.13 and [(bpy)2Ru(μ–2.5)Ru(bpy)2](PF6)4, 2.14 are shown in Figure 
7.1 
 
Figure 7.1. Perspective views of the X–ray crystal structures of 
[(bpy)2Ru(2.5)](PF6)2, 2.13 (left) and [(bpy)2Ru(μ–2.5)Ru(bpy)2](PF6)4, 2.14 
(right). Hydrogen atoms, counterions and solvate molecules are omitted for 
clarity. 
The dinuclear complexes exhibit MLCT absorption bands corresponding to Ru(dπ) → 
azo(π*) transitions at ca. 760 nm indicating a low–lying π*–orbital in the bridging ligand. 
The electronic properties were further established by electrochemical measurements, which 
revealed that the ligands are electron–deficient and act as good π–acceptors of metal d–orbital 
electron density. The existence of two widely separated one–electron metal–centred oxidation 
processes, as shown in Figure 7.2, suggest strong communication between the metal centres 




Figure 7.2. Differential pulse voltammograms for complexes [(bpy)2Ru(μ–
2.5)Ru(bpy)2](PF6)4, 2.14 and [(bpy)2Ru(μ–2.6)Ru(bpy)2](PF6)4, 2.16. 
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Chapter 3 described the investigation of azo ligands where the pyridine ring of the 
azobispyridine ligand was replaced by other heterocyclic rings, such as pyrimidine and benzo 
fused N–heterocyclic rings. Incorporation of these groups was found to have a considerable 
effect on the electronic properties of these complexes. This chapter documents the X–ray 
crystallographic characterisation of two homodinuclear ruthenium complexes, [(bpy)2Ru(μ–
3.1)Ru(bpy)2](PF6)3, 3.10 and [(bpy)2Ru(μ–3.2)Ru(bpy)2](PF6)3, 3.12 bridged by pyrimidine–
based azo anion radical species. Both 3.10 and 3.12 display long Nazo–Nazo bond lengths of 
ca. 1.36 Å corresponding to the reduced azo ligand.
[249]
 The presence of three 
hexafluorophosphate anions, as shown in Figure 7.3, also confirms the radical nature of the 
complexes.  
 
Figure 7.3. A perspective view of the X–ray structure of [(bpy)2Ru(μ–
3.2)Ru(bpy)2](PF6)3, 3.12. Hydrogen atoms are omitted for clarity. 
The mononuclear ruthenium(II) complex [(bpy)2Ru(3.5)]
2+
 of the quinazoline azo 
ligand 3.5 was found to exist as a mixture of two isomers, 3.17 and 3.18, in a 1:10 ratio, due 
to the nature of the N–atom involved in the chelation. The X–ray crystal structure of 3.17 
shows coordination to the ruthenium atom through the azo nitrogen and the sterically more 
hindered N–atom. Absorption spectra and electrochemical studies reveal differences in the 
electronic properties of 3.17 and 3.18. The diastereoisomeric forms, 3.19 and 3.20, of the 
dinuclear ruthenium(II) complex [(bpy)2Ru(μ–3.5)Ru(bpy)2]
4+
 were separated by cation–
exchange chromatography and characterised by X–ray crystallography. The structures of 3.19 
and 3.20 show coordination of the bridging ligand 3.5 to two [Ru(bpy)2]
2+
 fragments via azo 
N–atoms and the less hindered N–atoms on each side. The ancillary bpy ligands adopt 
different shapes in the two isomers, as shown in Figure 7.4.  
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Figure 7.4. Two perspective views of the X–ray crystal structures of rac 3.19 
(top) and meso 3.20 (bottom) isomers, emphasising the coordination modes of 
the bridging ligand 3.5 and the different orientations of the terminal bpy rings 
in the two forms. 
Chapter 4 investigated the mononuclear and dinuclear [Ru(terpy)]
2+
 complexes of the 
hexadentate ligands 4.1 and 4.2, with potential coordination in a bis–chelating tridentate 
manner. The complexes were characterised by 
1
H NMR and X–ray crystallography. The 





, 4.5, exhibit interesting aryl embraces, where a pair of 
outer pyridyl rings of the terpy ligands are involved in offset face–to–face (OFF) interactions 
and each of these rings also addresses an edge–to–face (EF) interaction with the bridging 
ligands. These aryl embraces propagate in two–dimensions, as shown in Figure 7.5, giving 
rise to interesting two–dimensional supramolecular motifs. 




Figure 7.5. Crystal packing of complexes in 4.3 (a) and 4.5 (b) showing EF 
and OFF interactions. 
These green complexes exhibit a large red shift in the Ru(dπ) → azo(π*) transitions at 
ca. 772 nm due to the increased stabilisation of the azo–centered π*–orbital upon formation 
of the bimetallic system. Further insights into the electronic transitions were obtained from 
electrochemical studies, which revealed these ligands to mediate very strong communication 
between the metal centres with comproportionation constants of Kc > 10
13
.  
Chapter 5 described dinuclear ruthenium(II) complexes of five bis(pyridylimine) 
ligands. A mononuclear complex [(bpy)2Ru(5.1–NH2)](PF6)2, 5.6, was also obtained as a 
result of the hydrolytic decomposition of ligand 5.1. All the diruthenium(II) complexes were 
characterised by NMR spectroscopy. Complexes [(bpy)2Ru(μ–5.1)Ru(bpy)2](PF6)4, 5.7, and 
[(bpy)2Ru(μ–5.2)Ru(bpy)2](PF6)3, 5.8, were characterised by X–ray crystallography. The 
electronic properties of the complexes were studied by differential pulse voltammetry, which 
revealed that ligand 5.1 mediates a weak interaction between the metal centres. However, a 
complete absence of communication between the metal centres was observed in the binuclear 
complexes 5.8 – 5.11, presumably due to the increased distance and/or flexibility across the 
bridging ligands 5.2 – 5.5. The oxidation waves of the differential pulse voltammograms for 
complexes 5.7 – 5.11 are shown in Figure 7.6. These results raise serious doubts about the 
validity of Cai et al.’s
[307]
 claim that all these ligands facilitate strong metal–metal 
interactions. 
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Figure 7.6. The differential pulse voltammograms of the diruthenium(II) 
complexes containing bis(pyridylimine) ligands with different spacers between 
the imine subunits. 
In Chapter 6 the metallosupramolecular chemistry of the azo ligands with a range of 
silver(I) salts was discussed. Reaction with silver(I) ions generally led to the formation of 
coordination polymers in a 1:1 metal to ligand ratio. However, the choice of anion profoundly 
influenced the type of metallosupramolecular structure formed.  
The ligands predominantly coordinate in a bidentate chelating manner adopting the an 
“S–frame” conformation mode and bridging two silver atoms at a distance of approximately 
5.5 Å, except for ligand 3.4, as shown in Figure 7.7. Despite being a ditopic chelating ligand, 
as seen in Chapter 3, ligand 3.4 coordinates as a monodentate bridging ligand in complexes 
[Ag(3.4)](CO2CF3), 6.9, and [Ag(3.4)](ClO4), 6.10, by coordinating through the quinoline N–
atom only. In both complexes, ligand 3.4 exhibits a s–trans/E/s–trans conformation. It also 
acts as a tridentate ligand, which leads to the formation of a dinuclear discrete complex 










Figure 7.7. The coordination modes employed by most ligands (a) and by 
ligand 3.4 (b). 
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7.2. Future Perspectives 
The dinuclear complexes of bis–chelating azobis(2–pyridine) 2.1, have been the subject 
of interest for many years. The low–lying azo–centered π*–orbital, small inter–metal 
separation, strong metal–metal interactions and stable radical intermediates make it a suitable 
ligand to study metal–ligand charge transfer and mixed–valence state coupling between metal 
centres. The pyrimidine–substituted azo ligand 3.1 has also been studied in this context. 
However, the coordination chemistry of polydentate azo ligands is still in its early stages.  
In this thesis, the variation within the dinuclear ruthenium(II) complexes was limited to 
modifications on the bridging ligand. Future work towards the investigation of ligand–
mediated coupling between the metal centres could incorporate the use of different peripheral 
ligands, such as 4,4’–dimethyl–2,2’–bipyridine and 1,10–phenanthroline. In addition, 
homometallic [(TL)2M(μ–BL)M(TL’)2]
n+
 and heterometallic complexes [(TL)2M(μ–
BL)M’(TL’)2]
n+
 (TL ≠ TL’ and M ≠ M’), could be investigated, which would give an 
opportunity to study the effect of different metals and ancillary ligands towards the inter–
metal communication. The bis–chelating hexadentate azo ligands 4.1 and 4.2 show an 
intriguing increased communication between the metal centers. An interesting development 
would be to study related ligands that might allow further insights into the origin of these 
effects. 
The metallosupramolecular chemistry of the azo ligands presented in this thesis was 
predominantly studied with silver(I); further investigations could include other transition 
metals such as Cu(I) and Zn(II). Despite the numerous possible coordination modes, the five–
membered chelate ring was the most favoured coordination mode. Extension of the work 
described here could potentially include investigation of other structural variations on these 
ligands. 
Futhermore, the free azo functional group can also undergo photo–induced reversible 
cis–trans isomerisation under radiation, which makes these ligands excellent candidates for 
photoresponsive molecular devices. Therefore, complexes [Ag(3.4)](CO2CF3), 6.9, and 
[Ag(3.4)](ClO4), 6.10, coordinating only through the quinoline nitrogen atom would be 
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8. Experimental Procedures 
8.1. General Information 
Unless otherwise stated, reagents were obtained from commercial sources and used as 
received. Water was purified by reverse osmosis in–house. HPLC–grade solvents were used 
for reactions and in case of moisture–sensitive reactions, solvents were dried by literature 
procedures and freshly distilled as required. Melting points were recorded on an 
Electrothermal melting point apparatus. Elemental analysis was done by the Campbell 
Microanalytical Laboratory, University of Otago. 




C NMR spectra were recorded on Varian Unity 300, Agilent 400–MR and 
Varian 500 INOVA instruments operating for 
1
H NMR at 300, 400 and 500 MHz, 
respectively and at 75, 100 and 125 MHz, respectively, for 
13
C NMR. All the 
1
H NMR 
spectra recorded in deutrated solvents were referenced to the solvent peak and/or TMS: 
CDCl3, 7.26 ppm; CD3CN, 2.0 ppm; CD3OD, 3.3 ppm; DMSO, 2.6 ppm. 
13
C NMR were all 
referenced to their solvent peaks: chloroform, 77.0 ppm; acetonitrile, 36.8 ppm; methanol, 
49.3 ppm; DMSO, 39.6 ppm. When required, gCOSY, 1–D NOESY, 1–D TOCSY, 1–D 
ROESY, HSQC and HMBC experiments were performed using standard pulse sequences. 
The assignments for the compounds are denoted with primes to indicate the different rings of 
the multidentate ligands and with letters to distinguish the bpy and terpy rings. 
Mass Spectrometry 
Mass spectra were recorded by Dr. Marie Squire and Dr. Meike Holzenkaempfer on 
either a DIONEX Ultimate 3000 or Bruker MaXis 4G spectrometer, operated in high 
resolution positive ion electrospray mode. Samples were prepared by dissolving in an 
appropriate solvent at the required concentration.  
Infrared Spectroscopy 
Infrared spectra were recorded on a Perkin–Elmer Spectrum One FTIR instrument 
operating in diffuse reflectance mode with samples prepared as KBr pellets (KBr) or on a 
Chapter 8 Experimental 194 
 
Bruker FTIR spectrometer with Alpha’s Platinum ATR single reflection diamond where the 
neat samples were recorded. 
UV/Visible Spectroscopy   
UV/Visible spectra were recorded on a Varian CARY Probe 50 UV/Visible 
spectrometer in acetonitrile (range 200 – 800 nm) at room temperature. Samples were 
measured in quartz cuvettes of 1cm path length and approximately 3 mL volume. 
Electrochemical Studies 
Electrochemical measurements were performed using a Eco Chemie Autolab 
PGSTAT302. Measurements were recorded in acetonitrile with 0.1 M TBAPF6 or TBAClO4 
as supporting electrolyte. The working electrode was platinum (Pt), a platinum wire auxillary 
electrode and Ag/AgNO3 (0.1 mol dm
–3
 [[(n–C4H9)4]PF6/[(n–C4H9)4]ClO4 in acetonitrile) 
reference electrode. The working electrode was polished using a microcloth and 1μm alumina 
powder slurry; then sonicated in water and washed thoroughly with water and dried in 60 °C 
oven. Ferrocene was added as an internal standard on completion of each experiment. Cyclic 
voltammetry was performed with a sweep rate of 100 mVs
–1
. Differential pulse voltammetry 
was recorded with a sweep rate of 4 mVs
–1
 and a pulse amplitude, width and period of 50 
mV, 60 ms and 1s, respectively. All experiments were measured in nitrogen sparged solutions 
at room temperature. 
8.2. Synthesis of Precursors and Ligands 









































































8.2.1. Bidentate ligands based on azobis(pyridines) 
Azobis(3–methyl–2–pyridine), 2.2 
A solution of 2–amino–3–methylpyridine (2.00 g, 18.5 mmol) 
in acetonitrile:water (3:1) (20 mL) was added to an acetone/dry ice 
cooled solution of sodium hypochlorite (60.0 mL, 13.5% w/v). The 
reaction mixture was stirred at the same temperature for 30 minutes. 
After TLC analysis, the resulting orange solution was extracted 
rapidly with dichloromethane (2 x 20 mL). The organic layers were 
combined, washed with water (10 mL), dried over anhydrous magnesium sulfate and 
evaporated under reduced pressure. The residue was then purified using silica gel column 
chromatography (4% methanol:dichloromethane) to give a dark brown solid, which was 
recrystallised from petroleum ether to give 2.2 as a bright orange needles. Yield: 0.80 g 
(20%). M.p: 101°C. 
1
H NMR (400 MHz, CD3CN): δ 8.47 (d, J = 3.9 Hz, 1H, H6), 7.86 (d, J = 6.7 Hz, 1H, 
H4), 7.44–7.41 (m, 1H, H5), 2.60 (s, 3H, CH3). 
13
C NMR (100 MHz, CDCl3): δ 160.9 (C2), 
146.9 (C6), 140.2 (C4), 132.3 (C3), 125.4 (C5), 17.13 (CH3). ESI MS: Found MH
+
 
213.1136, C12H13N4 requires MH
+
 213.1135. IR: νmax 2070, 2050, 2026, 1569, 1411, 1219, 




A rapidly stirred solution of sodium hypochlorite (50.0 
mL, 13.5% w/v) was chilled in an acetone/dry ice bath until 
solids began to precipitate. A solution of 2–amino–6–
methylpyridine (1.00 g, 9.24 mmol) in acetonitrile:water 
(3:1) (10 mL) was added to the above mixture. Stirring and 
cooling were continued for 15 minutes, after which the resulting orange solution was 
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with water (10 mL), dried over anhydrous magnesium sulfate and evaporated under reduced 
pressure. The residue was then purified using silica gel column chromatography (2% 
methanol:dichloromethane) to give a dark brown solid, which was recrystallised from 
petroleum ether to give 2.4 as a brown solid. Yield: 0.50 g (26%). M.p: 105–110 °C. 
1
H NMR (400 MHz, DMSO): δ 7.95 (t, J = 7.6 Hz, 1H, H4), 7.56 (d, J = 7.9 Hz, 1H, 
H3), 7.48 (d, J = 7.5 Hz, 1H, H5), 2.60 (s, 3H, CH3). 
13
C NMR (400 MHz, DMSO): δ 162.5 
(C2), 158.8 (C6), 139.6 (C4), 126.2 (C5), 111.2 (C3), 24.3 (CH3). ESI MS: Found MNa
+
 
235.0956, C12H12N4Na requires MNa
+
 235.0954. IR (KBr): νmax 2924, 2851, 1910, 1820, 




2–Amino–5–chloropyridine (0.30 g, 2.3 mmol) in 
methanol:acetonitrile:water (1:1:1) (6 mL) was added to an 
acetone/dry ice cooled solution of sodium hypochlorite (15.0 mL, 
12.5% w/v). Stirring and cooling were continued for 10 minutes, 
after which the resulting orange solution was extracted with 
dichloromethane (2 x 30 mL). The organic layers were combined, washed with water (10 
mL), dried over anhydrous magnesium sulfate and the solvent was evaporated under reduced 
pressure. The residue was then washed with diethyl ether (2 x 5 mL) to give 2.5 as a brown 
solid. Yield: 0.15 g (25%). M.p: 250 °C (lit
[319]
 248 °C). 
1
H NMR (400 MHz, CDCl3): δ 8.73 (d, J = 1.7 Hz, 1H, H6), 7.96–7.89 (m, 2H, H3, 
H4). 
13
C NMR (125 MHz, CDCl3): δ 161.6 (C2), 148.7 (C6), 138.3 (C4), 134.9 (C5), 115.9 
(C3). ESI–MS: Found MH
+
 253.0048, C10H7Cl2N4 requires MH
+
 253.0042. IR: νmax 3035, 




To an acetone/dry ice cooled solution of sodium 
hypochlorite (150 mL, 12.5% w/v), a solution of 2–amino–5–
bromopyridine (3.00 g, 17.4 mmol) in methanol:water (3:1) (260 
mL) was added and stirred for 30 minutes. After TLC analysis, 
the reaction mixture was extracted with dichloromethane (2 x 30 
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mL), dried over anhydrous magnesium sulfate and the solvent was evaporated under reduced 
pressure. The residue was then purified by silica gel column chromatography (3% 
methanol:dichloromethane) to give 2.6 as a brown solid. Yield: 2.0 g (34%). M.p: 250 °C 
(lit
[320]
 260 °C). 
1
H NMR (400 MHz, CDCl3): δ 8.84 (d, J = 2.3 Hz, 1H, H6), 8.04 (dd, J = 8.6 Hz, 2.3 
Hz, 1H, H4), 7.88 (d, J = 8.6 Hz, 1H, H3). 
13
C NMR (100 MHz, CDCl3): δ 161.0 (C2), 150.9 
(C6), 141.2 (C4), 123.9 (C5), 116.2 (C3). ESI–MS: Found MH
+
 340.9027, C10H7Br2N4 
requires MH
+
 340.9032. IR (KBr): νmax 1976, 1840, 1556, 1453, 1373, 1291, 1092, 1003, 
923, 850, 836, 652, 632, 548 cm
–1
. 
8.2.2. Bidentate ligands based on azobis(N–heterocycles) 
Azobis(5–chloro–2–pyrimidine), 3.1 
A solution of 2–aminopyrimidine (1.00 g, 10.5 mmol) in 
water (10 mL) was added to an ice–cooled solution of sodium 
hypochlorite (50.0 mL, 13.5% w/v) and the resulting solution 
was stirred at 0 °C for 30 minutes. After TLC analysis, the 
aqueous layer was extracted with dichloromethane (3 x 50 
mL). The organic layer was washed with water (2 x 10 mL), 
separated, dried over anhydrous magnesium sulfate and evaporated under reduced pressure to 
give the crude product as dark orange solid, which was recrystallised from petroleum ether to 
give 3.1 as orange needles. Yield: 0.79 g (31%). M.p: 198–200 °C. 
1
H NMR (400 MHz, CDCl3): δ 8.95 (bs, 2H, H4, H6). 
13
C NMR (100 MHz, CDCl3): 
164.4 (C2), 157.4 (2C, C4, C6), 132.6 (C5). ESI MS: Found [MH]
+
 254.9946, C8H5Cl2N6 
requires MH
+





Sodium hypochlorite (50.0 mL, 12.5% w/v) was chilled in an acetone/dry ice bath until 
solids began to precipitate. 2–Amino–5–bromopyrimidine (1.00 g, 5.75 mmol) in 
methanol:water (3:1) (10 mL) was added to the above mixture and stirred for 4 hours with 
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mL). The organic layers were combined, washed with water (10 
mL), dried over anhydrous magnesium sulfate and the solvent 
was evaporated under reduced pressure. The residue was then 
purified by silica gel column chromatography (3% 
methanol:dichloromethane) to give 3.2 as an orange solid. Yield: 
0.2 g (10%). M.p: 198 °C). 
1
H NMR (500 MHz, CDCl3): δ 9.06 (s, 2H, H4, H6). 
13
C NMR (100 MHz, CDCl3): δ 
164.8 (C2), 159.7 (2C, C4, C6), 121.7 (C5). ESI–MS: Found MH
+
 342.8933, C8H5Br2N6 
requires MH
+
 342.8937. IR: νmax 3035, 1540, 1393, 1371, 1269, 1258, 1113, 1008, 937, 809, 
801, 641, 633, 551, 542 cm
–1
. Analysis: Calc. For C8H4Br2N6: C, 27.93; H, 1.17; N, 24.43. 
Found: C, 28.44; H, 1.31; N, 24.75. 
Azobis(5–chloro–4,6–dimethyl–2–pyrimidine), 3.3 
A solution of sodium hypochlorite (25.0 mL, 13.5% 
w/v) was chilled in acetone/dry ice bath till solids began to 
precipitate. A solution of 2–amino–5–chloro–4,6–
dimethylpyrimidine (0.50 g, 4.1 mmol) in acetonitrile/water 
(1:1) (5 mL) was added to the above mixture. The reaction 
mixture was stirred at the same temperature for 15 minutes. 
After TLC analysis, the aqueous layer was extracted with 
dichloromethane (2 x 10 mL). The organic layer was washed with water (2 x 5 mL), 
separated, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. 
The crude residue was recrystallised from diethyl ether to give 3.3 as light brown solid. 
Yield: 0.25 g (20%). M.p: 184 °C. 
1
H NMR (500 MHz, DMSO): δ 2.66 (s, 6H, 4–CH3, 6–CH3). 
13
C NMR (100 MHz, 
CDCl3): δ 166.2 (2C, C4, C6), 163.1 (C2), 130.9 (C5), 22.6 (2CH3). ESI–MS: Found MH
+
 
311.0581, C12H13Cl2N6 requires MH
+
 311.0573. IR (KBr): νmax 1559, 1517, 1424, 1385, 
1325, 1065, 1029, 955, 801, 543 cm
–1
. Analysis: Calc. For C12H12Cl2N6: C, 46.32; H, 3.89; 
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Azobis(2–quinoline), 3.4 
To an acetone/dry ice cooled solution of sodium 
hypochlorite (15.0 mL, 13.5% w/v) a solution of 2–
aminoquinoline (0.30 g, 2.10 mmol) in acetonitrile:water 
(3:1) (5 mL) was added. Stirring and cooling were 
continued for 30 minutes, after which the resulting orange 
solution was extracted rapidly with dichloromethane (2 x 15 mL). The organic layers were 
combined, washed with water (2 x 10 mL), dried over anhydrous magnesium sulfate, and the 
solvent was removed under reduced pressure.The residue was then purified using silica gel 
column chromatography (5% methanol:dichloromethane) to give 3.4 as an orange solid. 
Yield: 0.25 g (42%). M.p: 233 °C (lit
[261]
. 232–233 °C).  
1
H NMR (500 MHz, DMSO) δ 8.67 (d, J = 8.6 Hz, 1H, H4), 8.23 (d, J = 8.3 Hz, 1H, 
H5), 8.15 (d, J = 8.1 Hz, 1H, H8), 8.03 (d, J = 8.8 Hz, 1H, H3), 7.91 (t, J = 7.0 Hz, 1H, H6), 
7.76 (t, J = 7.1 Hz, 1H, H7). 
13
C NMR (100 MHz, CDCl3): δ 161.7 (C2), 147.6 (C8a), 138.9 
(C4),130.5 (C7, C8), 129.5 (C4a), 128.5 (C6), 127.6 (C5), 110.6 (C3). ESI–MS: Found MH
+
 
285.1130, C18H13N4 requires MH
+
 285.1135. IR: νmax 3043, 1592, 1565, 1498, 1425, 1226, 




2–Aminoquinazoline (0.10 g, 0.70 mmol) in 
acetonitrile:water (3:1) (5 mL) was added to a an 
acetone/dry ice bath cooled solution of sodium 
hypochlorite (5.00 mL, 13.5% w/v). Stirring and cooling 
were continued for 30 minutes, after which the resulting 
orange solution was extracted rapidly with diethyl ether (2 x 10 mL). The organic layers were 
combined, dried over anhydrous magnesium sulfate, and the solvent was removed under 
reduced pressure. The residue was then purified using silica gel column chromatography (3% 
methanol:dichloromethane) to give 3.5 as a brown solid. Yield: 0.08 g (39%). M.p: 180 °C.  
1
H NMR (500 MHz, DMSO): δ 9.98 (s, 1H, H4), 8.43 (d, J = 8.0 Hz, 1H, H8), 8.31–
8.24 (m, 2H, H5,7), 8.01–7.98 (m, 1H, H6). 
13
C NMR: (100 MHz, DMSO): δ 164.1 (2C, C4, 
































 287.1037, C16H11N6 requires MH
+
 287.1040. IR (KBr): νmax 3023, 1931, 1683, 




Sodium hypochlorite (12.5 mL, 13.5% w/v) was 
chilled in an acetone/dry ice slush bath until solids began to 
precipitate. A solution of 2–aminoquinoxaline (0.25 g, 1.72 
mmol) in methanol:water (3:1) (5 mL) was added to this and 
the reaction mixture was stirred at the same temperature for 
10 minutes. The resulting orange solution was extracted 
with dichloromethane (2 x 10 mL). The organic layers were combined, washed with water (2 
x 10 mL), dried over anhydrous magnesium sulfate, and the solvent was removed under 
reduced pressure. The residue was then washed with diethyl ether (2 x 10 mL), filtered and 
dried to give 3.6 as orange needles. Yield: 0.16 g (33%). M.p:142–148 °C (lit 143.5–145 °C). 
1
H NMR (400 MHz, CDCl3): δ 9.62 (bs, 1H, H3), 8.39–8.35 (m, 1H, H5), 8.29–8.26 
(m, 1H, H8), 7.97–7.92 (m, 2H, H6, H7). 
13
C NMR (100 MHz, CDCl3): δ 154.8 (C2), 144.0 
(C4a), 141.4 (C8a), 137.0 (C3), 132.3 (C7), 131.4 (C6), 130.7 (C5), 129.4 (C8). ESI–MS: 
Found MH
+
 287.1044, C16H11N6 requires MH
+
 287.1040. IR: νmax 1607, 1557, 1487, 1460, 




Step 1 – 2–Amino–1,8–napthyridine: 2,6–diaminopyridine 
(2.00 g, 18.0 mmol), sodium m–nitrobenzenesulfonate (8.25 g, 36.7 
mmol), glycerol (8.44 g, 91.7 mmol), concentrated sulphuric acid (7.2 
mL) and water (12 mL) were heated, with stirring at 135 °C for 48 
hours. Upon cooling, the reaction mixture was poured into crushed ice and the pH was 
adjusted to 13 by the addition of sodium hydroxide pellets. The reaction mixture was filtered 
through Celite
®
 and the filtrate was extracted with hot chloroform (3 x 20 mL). The 
combined organic layer was washed with water (2 x 10 mL), brine (15 mL), dried over 
anhydrous magnesium sulfate and evaporated under reduced pressure. The crude product was 
then purified using silica gel column chromatography (5:1 methanol:dichloromethane) to give 
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1
H NMR (400 Hz, CD3OD): δ 8.65 (d, J = 4.3 Hz, 1H, H7), 8.07 (d, J = 7.8 Hz, 1H, 
H5), 7.93 (d, J = 9.0 Hz, 1H, H4), 7.22 (dd, J = 7.5 Hz, 4.0 Hz, 1H, H6), 6.88 (d, J = 9.0 Hz, 
1H, H3), 6.90 (bs, 2H, NH2). IR: νmax 3056, 1674, 1594, 1451, 1370, 1328, 900, 841, 523, 
503, 463, 441 cm
–1
.  
Step 2: 2–amino–1,8–napthyridine (0.10 g, 0.69 
mmol) in methanol (10 mL) as added to a acetone/dry ice 
chilled solution of sodium hypochlorite (5.00 mL, 13.5% 
w/v) Stirring and cooling were continued for 15 minutes, 
after which the resulting orange solution was extracted 
rapidly with dichloromethane (2 x 10 mL). The organic 
layers were combined and dried over anhydrous magnesium sulfate, and the solvent was 
removed under reduced pressure. The residue was then recrystallised from diethyl 
ether/methanol (10:1) to give 3.7 as an orange solid. Yield: 0.10 g (50%). M.p: 295 °C. 
1
H NMR (400 MHz, CDCl3–CD3OD): δ 9.19 (bs, 1H, H7), 8.48 (d, J = 8.6 Hz, 1H, 
H4), 8.36 (d, J = 8.2 Hz, 1H, H5), 8.22 (d, J = 8.6 Hz, 1H, H3), 7.63 (dd, J = 7.8 Hz, 4.3 Hz, 
1H, H6). 
13
C NMR (100 MHz, CDCl3–CD3OD): 163.4 (C2), 154.9 (C8a), 154.6 (C7), 140.6 





 287.1040. IR: νmax 3043, 1597, 1545, 1483, 1451, 1425, 1111, 852, 




Step 1 – 2,5–Diaminopyridine: 10% Palladium on carbon (0.01 
g, cat.) was added to a solution of 2–amino–5–nitropyridine (0.50 g, 
3.6 mmol) in methanol (10 mL). The suspension was stirred under 
hydrogen pressure of 10 psi for 3 hours. After the completion of reaction (monitored by 
TLC), the reaction mixture was filtered through Celite
®
. The filtrate was evaporated under 
reduced pressure to give 2,5–diaminopyridine as a black solid, which was used without 
further purification. Yield: 2.8 g (76%). M.p: 120 °C. 
1
H NMR (500 Hz, DMSO) δ 7.36 (d, J = 4.2 Hz, 1H, H6), 6.76 (dd, J = 8.7 Hz, 3.0 
Hz, 1H, H4), 6.25 (d, J = 8.5 Hz, 1H, H3), 4.91 (bs, 2H, NH2) and 4.24 (bs, 2H, NH2). ESI–
MS: Found MH
+
 110.0714, C5H8N3 requires MH
+
 110.0713. IR: νmax 2871, 1667, 1557, 
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Step 2 – 2–Amino–1,5–napthyridine: 2,5–diaminopyridine 
(0.48 g, 4.4 mmol), sodium m–nitrobenzenesulfonate (1.98 g, 8.80 
mmol), glycerol (1.6 mL, 22 mmol), concentrated sulphuric acid (2 
mL), water (3 mL) were heated, with stirring at 135 °C for 48 
hours. Upon cooling, the reaction mixture was poured into crushed ice and the pH was 
adjusted to 13 by the addition of sodium hydroxide pellets. The reaction mixture was filtered 
through Celite
®
 and the filtrate was extracted with hot chloroform (3 x 20 mL). The 
combined organic layer was washed with water (2 x 10 mL), brine (15 mL), dried over 
anhydrous magnesium sulfate and evaporated under reduced pressure. The crude product was 
then purified using silica gel column chromatography (5:1 methanol:dichloromethane) to give 
2–amino–1,5–napthyridine
[270]





H NMR (400 Hz, DMSO): δ 9.12 (d, J = 4.3 Hz, 1H, H6), 8.55 (d, J = 9.0 Hz, 1H, 
H4), 8.41 (d, J = 8.6 Hz, 1H, H8), 8.01 (q, J = 4.3 Hz, 1H, H7), 7.55 (d, J = 9.0 Hz, 1H, H3), 
6.01 (bs, 2H, NH2). ESI–MS: Found MH
+
 146.0710, C8H8N3 requires MH
+
 146.0713. IR: 
νmax 3311, 3120, 1733, 1661, 1502, 1418, 1327, 1289, 1112, 839, 807, 619, 540, 499 cm
–1
. 
Step 3: A rapidly stirred solution of sodium 
hypochlorite (12.5 mL, 13.5% w/v) was chilled in an 
acetone/dry ice slush bath until solids began to precipitate. 
To this was added (all at once), a solution of 2–amino–
1,5–napthyridine (0.25 g, 1.7 mmol) in acetonitrile:water 
(3:1) (5 mL). Stirring and cooling were continued for 15 
minutes, after which the resulting orange solution was extracted rapidly with 
dichloromethane (2 x 10 mL). The organic layers were combined and dried over anhydrous 
magnesium sullfate, and the solvent was removed under reduced pressure. The residue was 
then purified using silica gel column chromatography (3% methanol:dichloromethane) to 
give 3.8 as an orange solid. Yield: 0.16 g (33%). M.p: 271 °C. 
1
H NMR (400 Hz, CDCl3): δ 9.11 (d, J = 4.3 Hz, 1H, H6), 8.72–8.64 (m, 2H, H8, H4), 
8.42 (dd, J = 9.0 Hz, 1.2 Hz, 1H, H3), 7.79–7.77 (m, 1H, H7). 
13
C NMR: (100 MHz, 
CDCl3): δ 161.5 (C2), 152.8 (C6), 144.7 (C4a), 143.3 (C8a), 140.4 (C4), 138.3 (C8), 125.4 
(C7), 114.5 (C43). ESI MS: Found MH
+
 287.1043, C16H11N6 requires MH
+
 287.1040. IR: 
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8.2.3. Tridentate ligands based on azobis(bidentates) 
Azobis[6–(2,2’–bipyridine)], 4.1 
6–Amino–2,2’–bipyridine (0.10 g, 0.58 mmol) 
dissolved in methanol:water (3:1) (5 mL) was added to a 
solution of sodium hypochlorite (5.00 mL, 13.5% w/v) 
chilled in an acetone/dry ice bath. Stirring and cooling 
were continued for 15 minutes, after which the resulting 
orange solution was extracted rapidly with diethyl ether (2 
x 10 mL). The organic layers were combined, dried over anhydrous magnesium sulfate and 
the solvent was removed under reduced pressure. The residue was then purified using silica 
gel column chromatography (3% methanol:dichloromethane) to give 4.1 as an orange solid. 
Yield: 0.070 g (27%). M.p: 212 °C.  
1
H NMR (400 MHz, CDCl3): δ 8.73 (d, J = 4.3 Hz, 1H, H6’), 8.67 (d, J = 7.8 Hz, 1H, 
H3’), 8.63 (d, J = 7.8 Hz, 1H, H3), 8.07 (t, J = 7.9 Hz, 1H, H4), 7.95 (d, J = 7.5 Hz, 1H, H5), 
7.87 (td, J = 7.6 Hz, 1.6 Hz, 1H, H4’), 7.36 (dd, J = 6.6 Hz, 4.8 Hz, 1H, H5’). 
13
C NMR: 
(400 MHz, CDCl3): δ 162.8 (C6), 156.4 (C2), 155.2 (C2’), 149.2 (C6’), 139.2 (C4), 137.0 





 339.1353. IR (KBr): νmax 3059, 1919, 1582, 1557, 1478, 1430, 1271, 
1151, 1077, 992, 831, 781, 744, 667, 640, 624 cm
–1
. 
Azobis[2–(1,10–phenanthroline)], 4.2  
A solution of sodium hypochlorite (70.0 mL, 13.5% 
w/v) was chilled in an acetone/dry ice slush bath until 
solids began to precipitate. 2–Amino–1,10–phenanthroline 
(1.4 g, 7.2 mmol) dissolved in methanol:water (3:1) (70 
mL) was added to the reaction mixture. The reaction was 
stirred for 30 minutes. The resulting solution was extracted 
with dichloromethane (2 x 20 mL). The combined organic 
layers were separated, dried over anhydrous magnesium sulfate and the solvent was 
evaporated under reduced pressure. The crude residue was then purified by silica gel column 
chromatography (3% methanol:dichloromethane) to give 4.2 as an orange solid. Yield: 1.2 g 
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1
H NMR (400 MHz, CDCl3) δ 9.32 (bs, 1H, H9), 8.57 (d, J = 8.7 Hz, 1H, H3), 8.50 (d, 
J = 8.6 Hz, 1H, H4), 8.34 (d, J = 8.2 Hz, 1H, H7), 7.94 (bs, 2H, H5, H6), 7.72 (dd, J = 7.8 
Hz, 4.5 Hz, 1H, H8). 
13
C NMR (125 MHz, CDCl3–one drop of CD3OD was added to 
increase the solubility): δ 161.4 (C2), 147.9 (C9), 141.1 (C7), 139.6 (C4), 131.0 (C4a), 129.7 





 387.1353. IR (KBr): νmax 3050, 1969, 1557, 1491, 1398, 1324, 861, 
834, 795, 786, 749, 674, 629 cm
–1
.  
8.3. Ruthenium Complexes with azobis(pyridines) 
8.3.1. Complexes of 2.1 
[(bpy)2Ru(2.1)](PF6)2, 2.7 and [(bpy)2Ru(μ–2.1)Ru(bpy)2](PF6)4, 2.8 
Ligand 2.1 (0.050 g, 0.27 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride (0.39 
g, 0.81 mmol) were refluxed in 50% aqueous methanol (15 mL) for 3 days. After cooling, the 
solvent was removed in vacuo and the residue was redissolved in water and filtered through 
Celite®. The aqueous solution was loaded on a SP Sephadex C–25 cation exchanger. 
Separation of the mononuclear and dinuclear products from the crude mixture was achieved 
via a gradient elution procedure using aqueous 0.1–0.5 mol L
–1
 sodium chloride as the eluent. 
Three bands were eluted: Band 1 (dark red, 0.1 mol L
–1
 NaCl), Band 2: (purple, 0.2 mol L
–1
) 
and Band 3: (green, 0.3 mol L
–1
). The fractions were precipitated by addition of a saturated 
solution of ammonium hexafluorophosphate to each band. The resultant products were 
extracted into dichloromethane and the solvent was removed under reduced pressure. The 
solid residues were recrystallised from acetone/diethyl ether. The composition of Bands 1, 2 
and 3 were established by electrospray mass spectrometry and 
1
H NMR. Analysis of Band 1 
revealed the presence of the mononuclear ruthenium species, Band 2 as the ruthenium(II) 
precursor and Band 3 as the dinuclear ruthenium species. Yields: Band 1 = (2.7) 0.090 g 
(37%). Band 3 = (2.8) 0.090 g (20%).  
(2.7): M.p: 185 °C. 
1
H NMR (400 MHz, CD3CN): δ 8.88 (d, 1H, H3’), 8.62 (d, 1H, 
bpyH3A), 8.55 (d, 1H, bpyH3’A), 8.44 (d, 1H, bpyH3B), 8.29–8.14 (m, 5H, bpyH3’B, H4’, 
bpyH4A, bpyH4’A, bpyH4B), 8.06 (d, 1H, bpyH6’A), 7.99 (t, 1H, bpyH4’B), 7.92–7.88 (m, 
3H, H6, H6’, H4), 7.70 (t, 1H, H5’), 7.62–7.55 (m, 4H, bpyH6A, H3, bpyH5A, bpyH6’B), 
7.52–7.47 (m, 2H, bpyH5’A, bpyH5B), 7.38 (t, 1H, H5), 7.30–7.26 (m, 2H, bpyH6B, 




C NMR (100 MHz, CD3CN): δ 166.2 (C2), 163.8 (C2’), 157.2 (bpyC2’B), 
156.0 (bpyC2’A), 155.8 (bpyC2B), 154.7 (bpyC2A), 153.2 (bpyC6’A), 152.3 (bpyC6’B), 
151.8 (bpyC6B), 150.2 (bpyC6A), 149.9 (C6’), 148.2 (C6), 139.95 (bpyC4A), 139.88 (C4’), 
139.79 (bpyC4B), 139.6 (bpyC4’A), 139.4 (C4), 138.6 (bpyC4’B), 128.8 (C3’), 128.7 (C5’), 
128.30 (bpyC5A), 128.27 (bpyC5’A), 128.0 (bpyC5B), 126.7 (C5), 126.2 (bpyC5’B), 124.7 
(2C, bpyC3A, bpyC3’A), 124.2 (bpyC3B), 123.3 (bpyC3’B), 115.7 (C3). ESI–MS: Calc. for 
([(bpy)2Ru(2.1)∙(PF6)]
1+
): 743.0812, Found: 743.0808; Calc. for ([(bpy)2Ru(2.1)]
2+
): 
299.0582, Found: 299.0583 IR (KBr): νmax 3419, 2924, 2854, 2013, 1715, 1637, 1606, 1469, 
1448, 1431, 1328, 1244, 841, 765, 557 cm
–1
. UV (CH3CN): λmax 508, 279, 243 nm.  
(2.8): M.p: 248 °C. 
1
H NMR (500 MHz, CD3CN): δ 8.62 (d, 1H, bpyH3A), 8.60–8.56 
(m, 3H, bpyH3B, bpyH3’A, bpyH3’B), 8.29–8.23 (m, 3H, bpyH4A, bpyH4’B, bpyH4B), 
8.16 (t, 1H, bpyH4’A), 8.05 (d, 1H, H3), 7.89 (d, 1H, H6), 7.83 (d, 1H, bpyH6B), 7.77 (t, 1H, 
H4), 7.71 (t, 1H, bpyH5’B), 7.66 (t, 1H, H5), 7.62 (t, 1H, bpyH5B), 7.56 (t, 1H, bpyH5A), 
7.49 (d, 1H, bpyH6A), 7.25–7.20 (m, 3H, bpyH5’A, bpyH6’B, bpyH6’A). 
13
C NMR 
(100MHz, CD3CN) δ 166.18, 163.77, 151.9 (bpyC6’A), 151.8 (bpyC6’B), 151.3 (C6), 150.9 
(bpyC6B), 140.6 (bpyH4A), 140.5 (bpyH4’B), 140.4 (bpyH4B), 140.2 (H4), 139.7 
(bpyC4’A), 129.1 (C5), 129.0 (bpyC5B), 128.8 (bpyC5A), 128.7 (bpyC5’B), 127.6 
(bpyC5’A), 126.3 (C3), 125.5 (2C, bpyC3’A, bpyC3’B), 125.2 (bpyC3B), 125.2 (bpyC3A). 
ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–2.1)∙(PF6)2]
2+
): 651.0431, Found: 651.0436; Calc. for 
([{Ru(bpy)2}2(μ–2.1)∙(PF6)]
3+
) 385.7071, Found: 385.7069; Calc. for ([{Ru(bpy)2}2(μ–
2.1)]
4+
): 253.0392, Found: 253.0390. IR (KBr): νmax 2939, 2857, 1597, 1468, 1446, 1314, 
1256, 1240, 839, 765, 554 cm
–1
. UV (CH3CN) λmax 508, 280, 244 nm. 
8.3.2. Complex of 2.2 
[(bpy)2Ru(2.2)](PF6)2, 2.9 
A solution of 2.2 (0.014 g, 0.064 mmol) and bis(2,2’–bipyridine)ruthenium(II) triflate 
(0.050 g, 0.064 mmol) in ethylene glycol (5 mL) was heated at reflux in a modified 
microwave oven at 600 W for 6 minutes, at intervals of 2 minutes.. Upon cooling, the 
resultant red solution was diluted with water ( 15 mL) and precipitated by addition of 
saturated solution of ammonium hexafluorophosphate. The resultant product was filtered and 
recrystallised from acetone/hexane to give 2.9 as red powder. Yield: 0.060 g (94%). M.p: 166 
°C. 
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1
H NMR (500 MHz, CD3CN): δ 8.64–8.62 (m, 2H, bpyH6A, bpyH3A), 8.56 (d, 1H, 
bpyH3’A), 8.34 (d, 1H, bpyH3B), 8.23–8.16 (m, 3H, bpyH4A, bpyH4B, bpyH4’A), 8.07–
8.05 (m, 2H, bpyH3’B, H4’), 8.01 (d, 1H, H6), 7.85 (t, 1H, bpyH4’B), 7.70–7.68 (m, 2H, 
H6’, bpyH6’B), 7.63–7.51 (m, 6H, H5’, bpyH6B, H4, bpyH5A, bpyH5B, bpyH5’A), 7.48 (d, 
1H, bpyH6’A), 7.25 (t, 1H, bpyH5’B), 7.16 (dd, 1H, H5), 2.90 (s, 3H, 3’–CH3), 1.43 (s, 1H, 
3–CH3). 
13
C NMR (125 MHz, CD3CN): δ 164.3 (C2’), 161.1 (C2), 156.8 (bpyC2’B), 155.7 
(bpyC2’B), 155.2 (bpyC2B), 154.7 (bpyC2A), 154.3 (bpyC6A), 152.9 (bpyC6’A), 152.8 
(bpyC6’B), 150.2 (bpyC6B), 147.0 (C6’), 146.1 (C6), 141.5 (C4), 141.1 (C4’), 140.2 
(bpyC4B), 140.0 (2C, C3, C3’), 139.7 (bpyC4A), 139.2 (bpyC4’A), 138.5 (bpyC4’B), 129.30 
(C5’), 128.29 (bpyC5’A), 128.0 (bpyC5B), 127.9 (bpyC5A), 126.7 (bpyC5’B), 124.60 
(bpyC3A), 124.58 (C5), 124.40 (bpyC2’A), 124.38 (bpyC3B), 123.1 (bpyC3’B), 17.8 (3’–
CH3), 15.3 (3–CH3). ESI–MS: Calc. for ([(bpy)2Ru(2.2)∙(PF6)]
1+
): 771.1125, Found: 
771.1126; Calc. for ([(bpy)2Ru(2.2)]
2+
): 313.0739, Found: 313.0742. IR: νmax 1605, 1468, 
1448, 1207, 1124, 1086, 1025, 998, 825, 756, 648, 623, 555 cm
–1
. UV (CH3CN): λmax 503, 
382, 280, 245 nm. Analysis: Calc. for [(bpy)2Ru(2.2)](PF6)2∙3H2O: C, 39.64; H, 3.53; N, 
11.56. Found: C, 39.28; H, 2.85; N, 10.96. 
8.3.3. Complexes of 2.3 
[(bpy)2Ru(2.3)](PF6)2, 2.10  
Bis(2,2’–bipyridine)ruthenium(II) dichloride (0.10 g, 0.23 mmol) and 2.3 (0.050 g, 0.23 
mmol) were refluxed in 50% aqueous methanol (5 mL) for 16 h. After cooling, the solvent 
was removed in vacuo and purified by silica gel column chromatography using 7:1 
acetonitrile:saturated potassium nitrate. The red solution was precipitated by addition of a 
saturated solution of ammonium hexafluorophosphate. The resultant product was extracted 
into dichloromethane and the solvent was removed in vacuo. The solid residues were 
recrystallised from acetone/hexane to give 2.10 as red needles. Yield: 0.14 g (66%). M.p: 158 
°C. 
1
H NMR (400 MHz, CD3CN): δ 8.71 (s, 1H, H3’), 8.60 (d, 1H, bpyH3A), 8.53 (d, 1H, 
bpyH3B), 8.42 (d, 1H, bpyH3C), 8.27 (d, bpyH3D), 8.23–8.12 (m, 3H, bpyH4A, bpyH4C, 
bpyH4B), 8.01 (d, 1H, bpyH6B), 7.95 (td, 1H, bpyH4D), 7.77 (d, 1H, H6), 7.71 (d, 1H, H6’), 
7.60 (d, 1h, bpyH6A), 7.57–7.47 (m, 5H, bpyH5A, H5, bpyH6D, bpyH5B, bpyH5C), 7.33 (s, 
1H, H3), 7.30 (d, 1H, bpyH6C), 7.26 (t, 1H, bpyH5D), 7.18 (d, 1H, H5), 2.67 (s, 3H, 4’–
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CH3), 2.31 (s, 1H, 4–CH3). 
13
C NMR (100 MHz, CD3CN): δ 165.9 (C2’), 163.9 (C2), 157.3 
(bpyC2C), 156.1 (bpyC2D), 155.9 (bpyC2B), 154.7 (bpyC2A), 153.1 (bpyC6B), 152.1 
(bpyC6C), 151.9 (bpyC6D), 151.6 (2C, C4, C4’), 150.2 (bpyC6A), 148.8 (C6’), 147.8 (C6), 
139.9 (bpyC4A), 139.7 (bpyC4C), 139.3 (bpyC4B), 138.4 (bpyC4D), 129.5 (C5’), 129.2 
(C3’), 128.2 (2C, bpyC5A, bpyC5B), 128.0 (bpyC5C), 126.8 (C5), 126.65 (bpyC5D), 124.60 
(2C, bpyC3A, bpyC3B), 124.1 (bpyC3C), 123.2 (bpyC3D), 116.0 (C3), 20.2 (4’–CH3), 20.0 
(4–CH3). ESI–MS: Calc. for ([(bpy)2Ru(2.3)∙(PF6)]
1+
): 771.1125, Found 771.1124; Calc. for 
([(bpy)2Ru(2.3)]
2+
): 313.0739, Found: 313.0739. IR (KBr): νmax 3093, 2928, 1706, 1602, 
1470, 1450, 1345, 1251, 1155, 842, 759, 558 cm
–1
. UV (CH3CN): λmax 508, 280, 244 nm. 
[(bpy)2Ru(μ–2.3)Ru(bpy)2](PF6)4, 2.11 
The mononuclear complex 2.10 (0.080 g, 0.090 mmol), bis(2,2’–
bipyridine)ruthenium(II) dichloride (0.060 g, 0.13 mmol) and silver nitrate (0.020 g, 0.13 
mmol) were refluxed in methanol:water (3:1) (10 mL) for 6 days. After cooling, the solvent 
was removed in vacuo and the residue was redissolved in water and filtered through Celite®. 
The aqueous solution was loaded on a SP Sephadex C–25 cation exchanger. Separation of the 
dinuclear product from the crude mixture was achieved via a gradient elution procedure using 
aqueous 0.1–0.5 mol L
–1
 sodium chloride as the eluent. Three bands were eluted: Band 1 
(dark red, 0.1 mol L
–1
 NaCl), Band 2: (purple, 0.2 mol L
–1
) and Band 3: (green, 0.3 mol L
–1
). 
The fractions were precipitated by addition of saturated solution of ammonium 
hexafluorophosphate to each band. The resultant products were extracted into 
dichloromethane and the solvent was removed under reduced pressure. The solid residues 
were recrystallised from acetone/diethyl ether. The composition of Bands 1, 2 and 3 were 
established by electrospray mass spectrometry and 
1
H NMR. Analysis of Band 1 revealed the 
presence of unreacted mononuclear ruthenium species, Band 2 as unreacted [Ru(bpy)2Cl2] 
precursor and Band 3 as the dinuclear ruthenium species. Yield: 0.070 g (51%). M.p: > 300 
°C.  
1
H NMR (400 MHz, CD3CN): δ 8.63 (d, 1H, bpyH3A), 8.60–8.53 (m, 3H, bpyH3B, 
bpyH3C, bpyH3D), 8.28–8.23 (m, 3H, bpyH4A, bpyH4B, bpyH4C), 8.14 (t, 1H, bpyH4C), 
7.87 (d, 1H, bpyH6A), 7.71 (s, 1H, H3), 7.71 (t, 1H, bpyH5B), 7.67–7.63 (m, 2H, H6, 
bpyH5A), 7.54 (t, 1H, bpyH5D), 7.50–7.47 (m, 2H, bpyH6D, H5), 7.24–7.18 (m, 3H, 
bpyH5C, bpyh6C, bpyH6B), 2.10 (s, 3H, 4–CH3). ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–
2.3)]
2+
): 519.5906, Found: 519.5933; Calc. for ([{Ru(bpy)2}2(μ–2.3)]
3+
): 346.3969, Found: 
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346.3970. calc. for ([{Ru(bpy)2}2(μ–2.3)]
4+
): 260.0471; Found: 260.0471.IR (KBr): νmax 
3665, 2924, 1638, 1618, 1468, 1316, 1259, 1163, 1033, 956, 843, 766, 558 cm
–1
. UV 
(CH3CN): λmax 757, 392, 280, 247 nm. Analysis: Calc. for [(bpy)2Ru(μ–2.3)Ru(bpy)2](PF6)4: 
C, 38.58; H, 2.74; N, 10.38. Found: C, 38.65; H, 3.00; N, 10.10. 
8.3.4. Complex of 2.4 
[(bpy)2Ru(2.4)](PF6)2, 2.12  
A suspension of 2.4 (0.020 g, 0.090 mmol) and bis(2,2’–bipyridine)ruthenium(II) 
dichloride (0.090 g, 0.19 mmol) in 50% aqueous methanol (10 mL) were refluxed for 16 h. 
After cooling, the solvent was removed in vacuo and the residue was redissolved in water and 
filtered through Celite®. The aqueous solution was precipitated by addition of a saturated 
solution of ammonium hexafluorophosphate. The resultant product was extracted into 
dichloromethane (2 x 15 mL) and the solvent was removed under reduced pressure. The solid 
residues were recrystallised from acetone/hexane to give 2.12 as a red powder. Yield: 0.071 g 
(83%). M.p: 142 °C. 
1
H NMR (400 MHz, CD3CN): δ 8.68 (d, 1H, H3’), 8.55–8.49 (m, 3H, bpyH3A, 
bpyH3B, bpyH3C), 8.28–8.24 (m, 2H, bpyH3C, bpyH4C), 8.20–8.11 (m, 3H, H4’, bpyH4B, 
bpyH4A), 8.02 (d, 1H, bpyH6B), 7.87 (t, 1H, bpyH4D), 7.71 (t, 1H, H4), 7.67–7.65 (m, 3H, 
H5’, bpyH6C, bpyH6A), 7.58–7.55 (m, 2H, bpyH5B, bpyH5C), 7.50 (t, 1H , bpyH5A), 7.23–
7.20 (m, 2H, H3, bpyH6D), 7.13 (d, 1H, H5), 7.11 (t, 1H, bpyH5D). 
13
C NMR (100 MHz, 
CD3CN): δ 166.0 (C2), 163.5 (C2’), 163.2 (C6’), 158.0 (C6), 157.5 (bpyC2C), 156.4 
(bpyC2B), 155.8 (bpyC2D), 154.2 (bpyC2A), 153.8 (bpyC6C), 151.8 (bpyC6B), 151.3 
(bpyC6D), 150.0 (bpyC6A), 140.2 (bpyC4C), 140.0 (bpyC4A), 139.7 (C4, C4’), 139.2 
(bpyC4B), 138.6 (bpyC4D), 129.1 (C5), 128.4 (bpyC5A), 128.12 (bpyC5B), 128.10 
(bpyC5C), 126.9 (C3’), 126.7 (bpyC5D), 125.1 (bpyC3C), 124.9 (C5), 124.7 (bpyC3B), 
124.4 (bpyC3A), 123.6 (bpyC3D), 112.2 (C3), 24.4 (6’–CH3), 22.6 (6–CH3). ESI–MS: Calc. 
for ([(bpy)2Ru(2.4)∙(PF6)]
1+
): 771.1125, Found: 771.1144; Calc. for ([(bpy)2Ru(2.4)]
2+
): 
313.0739, Found: 313.0749. IR: νmax 1605, 1468, 1446, 1343, 1315, 831, 798, 763, 729, 555 
cm
–1
. UV (CH3CN): λmax 498, 287, 244 nm. Analysis: Calc. for [(bpy)2Ru(2.4)](PF6)2∙H2O: 
C, 41.17; H, 3.24; N, 12.00. Found: C, 41.19; H, 3.14; N, 11.39. 
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8.3.5. Complexes of 2.5 
[(bpy)2Ru(2.5)](PF6)2, 2.13 
Ligand 2.5 (0.020 g, 0.080 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride 
(0.040 g, 0.080 mmol) were refluxed in 50% aqueous methanol (10 mL) for 16 h. Upon 
cooling, the solvent was removed in vacuo and the residue was redissolved in water and 
filtered through Celite®. The red solution was precipitated by addition of saturated solution 
of potassium hexafluorophosphate (10 mL) and extracted into dichloromethane (2 x 10 mL) 
and the solvent was removed under reduced pressure. The solid residues were recrystallised 
from acetonitrile/diethyl ether to give 2.13 as a red powder. Yield: 0.050 g (64%). M.p: 212 
°C. 
1
H NMR (400 MHz, CD3CN): δ 8.84 (d, 1H, H3’), 8.60 (d, 1H, bpyH3A), 8.55 (d, 1H, 
bpyH3’A), 8.44 (d, 1H, bpyH3B), 8.33–8.27 (m, 2H, bpyH3’B, H4’), 8.25–8.15 (m, 3H, 
bpyH4A, bpyH4B, bpyH4’A), 8.05 (t, 1H, bpyH4’B), 7.96–7.92 (m, 2H, H4, H6’), 7.89–7.86 
(m, 2H, H6, bpyH6’A), 7.78 (d, 1H, H3), 7.58–7.57 (m, 2H, bpyH6A, bpyH5A), 7.51–7.45 
(m, 3H, bpyH5’A, bpyH5B, bpyH6’B), 7.35 (d, 1H, bpyH6B), 7.30 (t, 1H, bpyH5’B). 
13
C 
NMR (100 MHz, CD3CN): δ 164.7 (C2’), 162.1 (C2), 157.1 (bpyC2B), 155.90 (bpyC2’A), 
155.87 (bpyC2’B), 154.6 (bpyC2A), 153.1 (C6), 152.7 (bpyC6B), 151.6 (bpyC6’B), 150.3 
(bpyC6A), 148.7 (C6’), 146.7 (bpyC6’A), 140.1 (bpyC4A), 140.0 (bpyC4’B), 139.8 (C4’), 
139.6 (bpyC4’A), 139.3 (C4), 138.8 (bpyC4’B), 135.9 (C5), 134.6 (C5’), 129.4 (C3’), 128.4 
(bpyC5A), 128.3 (bpyC5B), 127.9 (bpyC3’A), 127.0 (bpyC5’B), 124.9 (bpyC3’A), 124.8 
(bpyC3A), 124.3 (bpyC3B), 123.6 (bpyC3’B). ESI–MS: Calc. for ([(bpy)2Ru(2.5)∙(PF6)]
1+
): 
811.0026, Found: 811.0035; Calc. for ([(bpy)2Ru(2.5)]
2+
): 333.0189, Found: 333.0190. IR 
(KBr): νmax 3669, 1709, 1637, 1608, 1543, 1469, 1458, 1450, 1314, 1295, 1243, 1116, 841, 
766, 558 cm
–1
. UV (CH3CN): λmax 517, 277, 242 nm. Analysis: Calc. for 
[(bpy)2Ru(2.5)](PF6)2∙5H2O: C, 34.43; H, 3.08; N, 10.71. Found: C, 34.09; H, 2.22; N, 10.70.  
[(bpy)2Ru(μ–2.5)Ru(bpy)2](PF6)4, 2.14 
Ligand 2.5 (0.10 g, 0.39 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride (0.38 
g, 0.792 mmol) were refluxed in 50% aqueous methanol (15 mL) for 5 days. After cooling, 
the solvent was removed in vacuo and the residue purified by silica gel column 
chromatography using acetonitrile:saturated potassium nitrate (7:1) as eluent. The fractions 
were precipitated by addition of saturated solution of ammonium hexafluorophosphate to 
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each band. The resultant products were extracted into dichloromethane (3 x 10 mL) and the 
solvent was removed under reduced pressure. The solid residues were recrystallised from 
acetone/diethyl ether to give 2.14 as a green crystalline powder. Yield: 0.13 g (20%). M.p: 
270 °C. 
1
H NMR (400 MHz, CD3CN): δ 8.62 (d, 1H, bpyH3A), 8.59–8.54 (m, 3H, bpyH3’A, 
bpyH3B, bpyH3’B), 8.32–8.23 (m, 3H, bpyH4’B, bpyH4A, bpyH4’A), 8.18 (t, 1H, 
bpyH4B), 7.90 (d, 1H, H3), 7.79–7.71 (m, 4H, H6, H4, bpyH6’A, bpyH5’B), 7.61 (t, 1H, 
bpyH5’A), 7.55 (t, 1H, bpyH5A), 7.48 (d, 1H, bpyH6A), 7.29 (d, 1H, bpyH6’B), 7.24 (t, 1H, 
bpyH5B), 7.09 (d, 1H, bpyH6B). 
13
C NMR (100 MHz, CD3CN): δ 165.0 (C2), 156.9 
(bpyC2’B), 155.9 (bpyC2B), 155.8 (bpyC2’A), 154.8 (bpyC2A), 152.3 (bpyC6B), 152.2 
(bpyC6’B), 151.0 (bpyC6’A), 150.9 (bpyC6A), 149.7 (C6), 140.9 (bpyC6’B), 140.7 
(bpyC4A), 140.7 (bpyC4’A), 140.2 (2C, bpyC4B, C4), 137.1 (C5), 129.2 (bpyC5’A), 128.9 
(bpyC5A), 128.7 (bpyC5’B), 127.9 (bpyC5B), 126.6 (C3), 125.8 (bpyC3’B), 125.6 
(bpyC3B), 125.6 (2C, bpyC3A, bpyC3’A). ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–
2.5)∙(PF6)2]
2+
): 685.0045, Found: 685.0041; Calc. for ([{Ru(bpy)2}2(μ–2.5)∙(PF6)]
3+
): 
408.3481, Found: 408.3477; Calc. for ([{Ru(bpy)2}2(μ–2.5)]
4+
): 270.0199, Found: 270.0195. 
IR (KBr): νmax 3411, 2253, 1638, 1608, 1470, 1450, 1317, 1245, 1127, 843, 769, 558 cm
–1
. 
UV (CH3CN): λmax 758, 391, 281, 246 nm.  
8.3.6. Complexes of 2.6 
[(bpy)2Ru(2.6)](PF6)2, 2.15 
Ligand 2.6 (0.050 g, 0.15 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride 
(0.070 g, 0.15 mmol) were refluxed in 50% aqueous methanol (10 mL) for 16 h. After 
cooling, the solvent was removed in vacuo and the residue was redissolved in water and 
filtered through Celite®. The red solution was precipitated by addition of saturated solution 
of potassium hexafluorophosphate (10 mL). The resultant product was extracted into 
dichloromethane and the solvent was removed under reduced pressure. The solid residues 
were recrystallised from acetonitrile/diethyl ether to give 2.15 as a red powder. Yield: 0.090 g 
(61%). M.p: 205 °C. 
1
H NMR (400 MHz, CD3CN): δ 8.76 (d, 1H, H3’), 8.60 (d, 1H, bpyH3A), 8.54 (d, 1H, 
bpyH3’A), 8.45–8.42 (m, 2H, bpyH3B, H4’), 8.31 (d, 1H, bpyH3’B), 8.24–8.14 (m, 3H, 
bpyH4A, bpyH4B, bpyH4’A), 8.10 (dd, 1H, H4), 8.03–7.96 (m, 3H, bpyH4’B, H6’, H6), 
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7.86 (d, 1H, bpyH6’A), 7.72 (d, 1H, H3), 7.58–7.56 (m, 2H, bpyH6A, bpyH5A), 7.51–7.47 
(m, 2H, bpyH5’A, bpyH5B), 7.44 (d, 1H, bpyH6’B), 7.34 (d, 1H, bpyH6B), 7.29 (t, 1H, 
bpyH5’B).
13
C NMR (100 MHz, CD3CN): δ 165.0 (C2’), 162.5 (C2), 157.1 (bpyC6B), 155.9 
(2C, bpyC2’A, bpyC2B), 154.6 (bpyC2’B), 153.1 (bpyC6’A), 152.8 (bpyC6B), 151.6 
(bpyC6’B), 150.6 (C6’), 150.3 (bpyC6A), 148.9 (C6), 146.7 (bpyC6’A), 142.8 (C4’), 142.2 
(C4), 140.1 (bpyC4B), 140.0 (bpyC4’A), 139.6 (bpyC4A), 138.8 (bpyC4’B), 129.5 (C3’), 
128.4 (bpyC5A), 128.3 (bpyC5B), 127.9 (bpyC5’A), 127.0 (bpyC5’B), 124.9 (bpyC3A), 
124.8 (bpyC3’A), 124.3 (2C, bpyC3B, C5’), 123.6 (bpyC3’B), 123.5 (C5), 117.5 (C3). ESI–
MS: Calc. for ([(bpy)2Ru(2.6)]
2+
): 377.9678, Found: 377.9675. IR (KBr): νmax 3665, 3098, 
1709, 1637, 1606, 1537, 1470, 1450, 1368, 1315, 1296, 1242, 1100, 841, 765, 558 cm
–1
. UV 
(CH3CN): λmax 523, 368, 277, 241 nm. Analysis: Calc. for [(bpy)2Ru(2.6)](PF6)2∙H2O: C, 
33.88; H, 2.27; N, 10.54. Found: C, 34.05; H, 2.48; N, 9.94. 
[(bpy)2Ru(μ–2.6)Ru(bpy)2](PF6)4, 2.16 
Bis(2,2’–bipyridine)ruthenium(II) triflate (0.08 g, 0.107 mmol) and ligand 2.6 (0.018 g, 
0.054 mmol) were refluxed in ethylene glycol (10 mL) for 3 days. After cooling, the solvent 
was removed in vacuo and the residue was redissolved in the minimum amount of 
acetonitrile:saturated KNO3 (7:1). The resulting solution was loaded on a silica gel column 
and eluted with 7:1 acetonitrile:saturated KNO3 mixture. The fractions were precipitated by 
addition of a saturated solution of ammonium hexafluorophosphate. The resultant products 
were extracted into dichloromethane (3 x 10 mL) and the solvent was removed under reduced 
pressure. The crude solid was recrystallised from acetone/diethyl ether to give 2.16 as a green 
solid. Yield: 0.02 g (21%). M.p: 278 °C. 
1
H NMR (400 MHz, CD3CN): δ 8.63 (d, 1H, bpyH3A), 8.59–8.54 (m, 3H, bpyH3’A, 
bpyH3B, bpyH3’B), 8.31–8.22 (m, 3H, bpyH4’B, bpyH4A, bpyH4’A), 8.17 (t, 1H, 
bpyH4B), 7.92 (d, 1H, H3), 7.87 (s, 1H, H6), .81 (d, 1H, H4), 7.75–7.72 (m, 2H, bpyH6’A, 
bpyH5’B), 7.61 (t, 1H, bpyH5’A), 7.55 (t, 1H, bpyH5A), 7.48 (d, 1H, bpyH6A), 7.29 (d, 1H, 
bpyH6’B), 7.24 (t, 1H, bpyH5B), 7.08 (d, 1H, bpyH6B). ESI–MS: Calc. for 
([{Ru(bpy)2}2(μ–2.6)]
3+
): 389.9927, Found: 389.9918. IR: νmax 1605, 1467, 1449, 1426, 
1242, 1107, 829, 760, 729, 710, 555, 421 cm
–1
. UV (CH3CN): λmax 764, 431, 373, 276, 243 
nm. Analysis: Calc. for [(bpy)2Ru(μ–2.6)Ru(bpy)2](PF6)4∙CH3CN: C, 34.90; H, 2.31; N, 
10.17. Found: C, 35.11; H, 2.42; N, 10.49. 
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8.4. Ruthenium Complexes with azobis(N–heterocycles) 
8.4.1. Complexes of 3.1 
[(bpy)2Ru(3.1)](PF6)2, 3.9  
Ligand 3.1 (0.050 g, 0.20 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride (0.09 
g, 0.20 mmol) were refluxed in 50% aqueous ethanol (10 mL) for 24 h. After cooling, the 
solvent was removed in vacuo and the residue was redissolved in water and filtered through 
Celite®. The aqueous solution was loaded on a SP Sephadex C–25 cation exchanger and 
eluted using aqueous 0.1–0.5 mol L
–1
 sodium chloride as the eluent. The red fraction obtained 
with 0.2 mol L
–1
 sodium chloride was precipitated by addition of a saturated solution of 
ammonium hexafluorophosphate. The solid precipitate was filtered and recrystallised from 
acetone/diethyl ether to give 3.9 as red needles. Yield: 0.14 g (78%). M.p: 210 °C. 
1
H NMR (400 MHz, CD3CN): δ 9.23 (d, 1H, H4/6), 8.61–8.51 (m, 2H, bpyH3A, H4’, 
H6’, bpyH3B, bpyH3C), 8.35–8.29 (m, 3H, bpyH3D, H6/4, bpyH4C), 8.26–8.19 (m, 2H, 
bpyH4A, bpyH4B), 8.10 (d, 1H, bpyH6B), 8.01 (t, 1H, bpyH4D), 7.62–7.51 (m, 5H, 
bpyH5A, bpyH5B, bpyH5C, bpyH6A, bpyH6C), 7.23–7.21 (m, 2H, bpyH5D, bpyH6D). 
13
C 
NMR (100 MHz, CD3CN): δ 159.7 (C4/6), 157.5 (C6/4), 157.3 (2C, C4, C6), 153.3 
(bpyC6C), 152.9 (bpyC6B), 151.1 (bpyC6D), 149.9 (bpyC6A), 140.9 (bpyC4C), 140.4 
(bpyC4A), 140.0 (bpyC4B), 139.3 (bpyC4C), 128.8 (bpyC5A), 128.3 (bpyC5B), 128.2 
(bpyC5C), 127.2 (bpyC5D), 124.85 (bpyC3A), 124.76 (bpyC3B), 124.5 (bpyC3C), 124.0 
(bpyC3D). ESI–MS: Calc. for ([(bpy)2Ru(3.1)∙(PF6)]
1+
): 812.9930. Found: 812.9925; 
Calculated for ([(bpy)2Ru(3.1)]
2+
): 334.0142. Found: 334.0141. IR (KBr): νmax 3657, 1637, 
1608, 1522, 1471, 1402, 1303, 1136, 841, 765, 558 cm
–1
. UV/Vis (CH3CN) λmax 493, 368, 
285, 269, 248 nm. Analysis: Calc. for [(bpy)2Ru(3.1)](PF6)2∙H2O: C, 34.44; H, 2.27; N, 
14.34. Found: C, 34.47; H, 2.27; N, 13.62. 
[(bpy)2Ru(μ–3.1)Ru(bpy)2](PF6)3, 3.10 
Complex 3.9 (0.08 g, 0.08 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride 
(0.060 g, 0.12 mmol) were refluxed in ethanol:water (3:1) (10 mL) for 24 h. After cooling, 
the solvent was removed in vacuo and the residue was redissolved in water and filtered 
through Celite®. The aqueous solution was loaded on a SP Sephadex C–25 cation exchanger. 
Separation of the dinuclear product from the crude mixture was achieved via a gradient 
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elution procedure using aqueous 0.1–0.5 mol L
–1
 sodium chloride as the eluent. The green 
fraction was precipitated by addition of a saturated solution of ammonium 
hexafluorophosphate. The resultant product was extracted into dichloromethane (2 x 10 mL) 
and the solvent was removed under reduced pressure. The solid residues were recrystallised 
from acetone/diethyl ether to give 3.10 as a green powder which was paramagnetic. Yield: 
0.070 g (51%). M.p: >300 °C.  
1
H NMR (500 MHz, CD3CN): δ 8.63 (d, 1H, bpyH3A), 8.53–8.52 (m, 2H, bpyH3B, 
bpyH3C), 8.46 (d, 1H, bpyH3D), 8.30–8.20 (m, 4H, bpyH4C, bpyH4A, H4, H6), 8.17–8.11 
(m, 2H, bpyH4D, bpyH4B), 7.71 (t, 1H, bpyH5C), 7.61–7.54 (m, 3H, bpyH6C, bpyH5A, 
bpyH6A), 7.45 (t, 1H, bpyH5D), 7.41 (d, 1H, bpyH6D), 7.14 (t, 1H, bpyH5B), 6.88 (d, 1H, 
bpyH6B). ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–3.1)∙(PF6)]
3+
): 613.5176, Found: 613.5178; 
Calc. for ([{Ru(bpy)2}2(μ–3.1)]
3+
): 360.6902, Found: 360.6803. IR (KBr): νmax 3665, 3087, 
1605, 1467, 1448, 1392, 1341, 1244, 1133, 842, 764, 558 cm
–1
. UV (CH3CN): λmax 612, 446, 
383, 285, 246 nm. Analysis: Calc. for [(bpy)2Ru(μ–3.1)Ru(bpy)2](PF6)3∙4H2O: C, 36.28; H, 
2.79; N, 12.34. Found: C, 35.51; H, 2.40; N, 12.64. 
8.4.2. Complexes of 3.2 
[(bpy)2Ru(3.2)](PF6)2, 3.11  
Ligand 3.2 (0.02 g, 0.06 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride (0.03 
g, 0.06 mmol) were refluxed in 50% aqueous methanol (10 mL) for 16 h. After cooling, the 
solvent was removed in vacuo and the residue was redissolved in water. The aqueous solution 
was precipitated by addition of saturated solution of ammonium hexafluorophosphate. The 
solid obtained was filtered and recrystallised from acetone/diethyl ether to give 3.11 as a red 
crystalline powder. Yield: 0.050 g (80%). M.p: 229 °C. 
1
H NMR (400 MHz, CD3CN) δ 9.31 (d, 1H, H4/H6), 8.87 (s, 2H, H4’, H6’), 8.61 (d, 
1H, bpyH3A), 8.57–8.52 (m, 2H, bpyH3’A, bpyH3B), 8.41 (s, 1H, H6/H4), 8.36–8.29 (m, 
2H, bpyH3’B, bpyH4B), 8.27–8.19 (m, 2H, bpyH4A, bpyH4’A), 8.10 (d, 1H, bpyH6’A), 
8.01 (m, 1H, bpyH4’B), 7.62–7.52 (m, 5H, bpyH5’A, bpyH5A, bpyH5B, bpyH6A, bpyH6B), 
7.23–7.22 (m, 2H, bpyH5’B, bpyH6’B). 
13
C NMR (100 MHz, CD3CN): δ 171.3 (C2), 164.5 
(C2’), 162.0 (C4/C6), 159.8 (2C, C4’, C6’), 159.6 (C6/C4), 156.9 (bpyC2B), 155.9 
(bpyC2’B), 155.6 (bpyC2’A), 154.1 (bpyC2A), 153.4 (bpyC6B), 153.0 (bpyC6’A), 151.3 
(bpyC6’B), 150.1 (bpyC6A), 141.0 (bpyC4B), 140.5 (bpyC4A), 140.2 (bpyC4’A), 19.4 
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(pyC4’B), 128.8 (bpyC5’A), 128.6 (bpyC5A), 128.2 (bpyC5B), 127.4 (bpyC5’B), 125.04 
(bpyC3’A), 124.97 (bpyC3A), 124.6 (bpyC3B), 124.1 (bpyC3’B), 121.6 (C5’), 120.1 (C5). 
ESI–MS: Calc. for ([(bpy)2Ru(3.2)∙(PF6)]
1+
) 902.8908, Found: 902.8916; Calc. for 
([(bpy)2Ru(3.2)]
2+
): 378.9631, Found: 378.9654. IR: νmax 1606, 1469, 1448, 1399, 1301, 
1116, 826, 759, 728, 647, 611, 554 cm
–1
. UV/Vis (CH3CN) λmax 499, 367, 314, 285, 269, 249 
nm. Analysis: Calc. for [(bpy)2Ru(3.2)](PF6)2: C, 32.11; H, 1.92; N, 13.37. Found: C, 32.71; 
H, 2.13; N, 13.05.  
[(bpy)2Ru(μ–3.2)Ru(bpy)2](PF6)3, 3.12 
Bis(2,2’–bipyridine)ruthenium(II) triflate (0.06 g, 0.08 mmol) and 3.2 (0.01 g, 0.04 
mmol) were refluxed in 50% aqueous methanol (5 mL) for 3 days. After cooling, the solvent 
was removed in vacuo and the residue was redissolved in the minimum amount of 
acetonitrile:saturated KNO3 (7:1). The resulting solution was loaded on a silica gel column 
and eluted with 7:1 acetonitrile:saturated KNO3 mixture. The fractions were precipitated by 
addition of a saturated solution of ammonium hexafluorophosphate. The resultant products 
were extracted into dichloromethane (4 x 10 mL) and the solvent was removed under reduced 
pressure. The crude solid was recrystallised from acetone/diethyl ether to give 3.12 as a green 
solid. Yield: 0.020 g (21%). M.p: 260 °C. 
ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–3.2)∙(PF6)]
2+
): 658.4667, Found: 658.4686; Calc. 
for ([{Ru(bpy)2}2(μ–3.2)]
2+
): 585.9846, Found: 585.9801; Calc. for ([{Ru(bpy)2}2(μ–3.2)]
3+
): 
390.6562, Found: 390.6172. IR: νmax 1465, 1447, 1388, 1338, 1310, 1242, 1163, 1113, 828, 
759, 729, 641, 555 cm
–1
. UV (CH3CN) λmax 613, 444, 386, 285, 246 nm. Analysis: Calc. for 
[(bpy)2Ru(μ–3.2)Ru(bpy)2](PF6)3: C, 35.90; H, 2.26; N, 12.21. Found: C, 36.67; H, 2.70; N, 
11.53. 
8.4.3. Complexes of 3.3 
[(bpy)2Ru(3.3)](PF6)2, 3.13 and [(bpy)2Ru(μ–3.3)Ru(bpy)2](PF6)4, 3.14 
Ligand 3.3 (0.02 g, 0.06 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride (0.06 
g, 0.13 mmol) were refluxed in 50% aqueous methanol (10 mL) for 24 h. Upon cooling, the 
reaction mixture was filtered through Ceite® and the solvent was removed in vacuo. The 
residue was loaded on a silica gel column and eluted with acetonitrile:saturated KNO3 (7:1). 
The fractions were precipitated by addition of a saturated solution of potassium 
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hexafluorophosphate, extracted into dichloromethane (3 x 10 mL) and the solvent was 
removed under reduced pressure. The solid residues were recrystallised from 
acetonitrile/diethyl ether to give 3.13 and 3.14 as a red and green solid, respectively. Yield: 
(3.13): 0.090 g (61%), (3.14): 0.02g (19%). 
(3.13): M.p: 230°C. 
1
H NMR (400 MHz, CD3CN): δ 8.62–8.53 (m, 3H, bpyH3A, 
bpyH3B, bpyH3C), 8.39–8.35 (m, 2H, bpyH4A, bpyH3D), 8.24 (d, 1H, bpyH6B), 8.22–8.17 
(m, 2H, bpyH4B, bpyH4C), 7.95–7.91 (m, 1H, bpyH4D), 7.84 (d, 1H, bpyH6A), 7.72–7.64 
(m, 3H, bpyH5B, bpyH6C, bpyH5A), 7.58–7.54 (m, 1H, bpyH5C), 7.09–7.05 (m, 1H, 
bpyH5D), 7.02(d, 1H, bpyH6D), 2.92 (s, 3H, 4–CH3), 2.35 (s, 6H, 4’/6’–CH3), 2.18 (s, 3H, 
6–CH3).
 13
C NMR (100MHz, CD3CN): δ 169.1 (C4), 168.9 (C2), 168.5 (C6), 166.6 (2C, C4’, 
C6’), 162.5 (C2’), 157.3 (bpyC2A), 156.5 (bpyC2D), 155.4 (bpyC2C), 154.5 (bpyC6A), 
154.0 (bpyC2B), 151.7 (bpyC6B), 151.4 (bpyC6D), 149.8 (bpyC6C), 141.0 (bpyC4A), 140.5 
(bpyC4C), 139.9 (bpyC4B), 139.4 (bpyC4D), 130.5 (C5’), 129.9 (C5), 128.9 (bpyC5B), 
128.7 (bpyC5C), 128.4 (bpyC5A), 127.3 (bpyC5D), 125.2 (bpyC3C), 124.9 (bpyC3B), 124.6 
(bpyC3A), 124.0 (bpyC3D), 22.6 (4–CH3), 22.0 (6–CH3), 21.6 (4’/6’–CH3). ESI–MS: Calc. 
for ([(bpy)2Ru(3.3)∙(PF6)]
1+
): 869.0557, Found: 869.0560; Calc. for ([(bpy)2Ru(3.3)]
2+
): 
362.0455, Found: 362.0458. IR (KBr): νmax 1638, 1609, 1473, 1449, 1428, 1357, 1311, 1275, 
1091, 839, 774, 764, 558 cm
–1
. UV (CH3CN): λmax 491, 361, 313, 271, 247 nm. Analysis: 
Calc. for [(bpy)2Ru(3.3)](PF6)2∙H2O: C, 37.22; H, 2.93; N, 13.57. Found: C, 37.20; H, 2.65; 
N, 13.12. 
(3.14): M.p: >300 °C. ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–3.3)∙(PF6)2]
2+
): 714.0311, 
Found: 714.0309; Calc. for ([{Ru(bpy)2}2(μ–3.3)∙(PF6)]
3+
): 427.6991, Found: 427.6987; 
Calc. for ([{Ru(bpy)2}2(μ–3.3)]
2+
): 568.5630, Found: 568.5632; Calc. for 
([{Ru(bpy)2}2(3.3)]
3+
): 379.3777, Found: 379.3774. IR (KBr): νmax 2917, 1605, 1558, 1468, 
1449, 1424, 1317, 1237, 1180, 1031, 848, 766, 558 cm
–1
. UV (CH3CN) λmax 658, 493, 389, 
287, 244 nm.  
8.4.4. Complexes of 3.4 
[(bpy)2Ru(3.4)](PF6)2, 3.15  
Bis(2,2’–bipyridine)ruthenium(II) dichloride (0.12 g, 0.25 mmol) and 3.4 (0.070 g, 0.25 
mmol) were refluxed in 50% aqueous methanol (15 mL) for 24 h. Upon cooling, the solvent 
was removed in vacuo and the residue was redissolved in water. The aqueous solution was 
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precipitated by addition of a saturated solution of potassium hexafluorophosphate. The 
resultant solid was filtered and recrystallised from acetone/diethyl ether to give 3.15 as a red 
powder. Yield: 0.15 g (62%). M.p: 230°C. 
1
H NMR (500 MHz, CD3CN): δ 8.87 (d, 1H, H3’), 8.77 (d, 1H, H4’), 8.69 (d, 1H , 
bpyH3A), 8.53 (d, 1H, bpyH3B), 8.48 (d, 1H, H4), 8.41–8.37 (m, 2H, bpyH3’A, bpyH3’B), 
8.32 (t, 1H, bpyH4A), 8.26 (t, 1H, bpyH4B), 8.16 (d, 1H, H5’), 8.05 (t, 1H, bpyH3’B), 7.99 
(d, 1H, H3), 7.97 (d, 1H, H5), 7.93 (d, 1H, bpyH3B), 7.88 (d, 1H, bpyH6’B), 7.84 (t, 1H, 
H6’), 7.82–7.63 (m, 5H, bpyH4’A, H7, bpyH5B, H6, bpyH6A), 7.52 (t, 1H, bpyH5’D), 7.48–
7.40 (m, 4h, H8’, H7’, bpyH5A, H8), 7.29 (d, 1H, bpyH6’B), 6.96 (t, 1H, bpyH5’B). 
13
C 
NMR (125 MHz, CD3CN): δ 166.4 (C2’), 162.8 (C2), 158.0 (bpyC2B), 156.6 (bpyC2A), 
155.4 (bpyC2’A), 154.5 (bpyC2’B), 153.7 (bpyC6A), 151.6 (bpyC6’A), 151.4 (bpyC6’B), 
149.5 (bpyC6B), 147.5 (C9’), 145.4 (C9), 141.0 (C4’), 140.6 (bpyC4A), 140.5 (bpyc4B), 
140.4 (C4), 139.6 (bpyC4’B), 138.8 (bpyC4’A), 132.8 (C7’), 131.1 (C7), 130.1 (C5’), 129.9 
(C6’), 129.6 (C10’), 128.80 (C6), 128.76 (bpyC5B), 128.5 (C8), 128.4 (bpyC5’B), 128.3 
(C10), 128.1 (C5), 127.9 (bpyC5A), 126.9 (bpyC5’A), 124.8 (bpyC3B), 124.7 (bpyC3A), 
124.6 (bpyC3’B), 124.0 (C8’), 123.9 (bpyC3’A), 123.7 (C3’), 114.2 (C3). ESI–MS: Calc. for 
([(bpy)2Ru(3.4)∙(PF6)]
2+
): 349.0740, Found: 349.0746. IR (KBr): νmax 3099, 1970, 1710, 
1605, 1502, 1448, 1332, 1152, 848, 761, 558 cm
–1
. UV/Vis (CH3CN) λmax 519, 371, 313, 
275, 250 nm. Analysis: Calc. for [(bpy)2Ru(3.4)](PF6)2∙CH3COCH3: C, 47.09; H, 3.28; N, 
10.72. Found: C, 46.61; H, 3.25; N, 10.31. 
[(bpy)2Ru(μ–3.4)Ru(bpy)2](PF6)4, 3.16 
Complex 3.15 (0.03 g, 0.03 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride 
(0.02 g, 0.04 mmol) were refluxed in degassed 50% aqueous methanol (10 mL) for 3 days. 
Upon cooling, the solvent was removed in vacuo and the residue purified by silica gel column 
chromatography using acetonitrile:saturated potassium nitrate (7:1) as eluent. The fractions 
were precipitated by addition of saturated solution of ammonium hexafluorophosphate to 
each band. The resultant products were extracted into dichloromethane (3 x 10 mL) and 
washed with copious amount of water. The organic layer was separated and evaporated under 
reduced pressure. The solid residues were recrystallised from acetone/diethyl ether to give 
3.16 as a green solid. Yield: 0.030 g (54%). M.p: 230°C. 
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ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–3.4)∙(PF6)2]
2+
): 701.0587, Found: 701.0600; Calc. 
for ([{Ru(bpy)2}2(μ–3.4)∙(PF6)]
3+
): 419.0509, Found: 419.0514; Calc. for ([{Ru(bpy)2}2(μ–
3.4)]
3+
): 370.7295, Found: 370.7302. IR (KBr): νmax 3099, 1970, 1710, 1605, 1502, 1448, 
1332, 1152, 848, 761, 558 cm
–1
. UV/Vis (CH3CN) λmax 685, 288, 244 nm.  
8.4.5. Complexes of 3.5 
[(bpy)2Ru(3.5)](PF6)2, 3.17/3.18  
Ligand 3.5 (0.02 g, 0.07 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride (0.03 
g, 0.07 mmol) were refluxed in 50% aqueous ethanol (10 mL) for 16 h. Upon cooling, the 
solvent was removed in vacuo; the residue was loaded on a silica gel column and eluted with 
acetonitrile: saturated KNO3 (7:1) into Band 1 (reddish orange) and Band 2 (red). The 
fractions were precipitated by addition of saturated solution of ammonium 
hexafluorophosphate to each band. The resultant products were extracted into 
dichloromethane (2 x 10 mL), wahed with water (4 x 10 mL) and the solvent was removed 
under reduced pressure. The solid residues were recrystallised from acetone/diethyl ether. 
The composition of Bands 1 and 2 were established by 
1
H NMR. Analysis of Band 1 revealed 
the presence of two isomers and Band 2 as the major isomer 3.18 as a dark red crystalline 
solid. The Band 1 product was dissolved in methanol and was converted to chloride salt using 
Amberlite IRA resin. The solution was filtered, concentrated in vacuo and the residue was 
redissolved in water. The aqueous solution was loaded on a SP Sephadex C–25 column and 
eluted using 0.1 mol L
–1
 sodium chloride. The fractions were precipitated using saturated 
solution of potassium hexafluorophosphate. The products were extracted with 
dichloromethane (2x 10 mL), dried over anhydrous magnesium sulfate and evaporated under 
reduced pressure. The solid residue was recrystallised from acetone and diethyl ether to give 
3.17 as reddish orange needles. Yields: (3.17) 0.0070 g (10%); (3.18) 0.056 g (80%). 
(3.17): M.p: 250 °C. 
1
H NMR (500 MHz, CD3CN): δ 9.86 (s, 1H, H4), 9.36 (s, 1H, 
H4’), 8.66 (d, 1H, bpyH3A), 8.56 (d, 1H, bpyH3B), 8.42–8.27 (m, 6H, bpyH3C, bpyH4A, 
H5, bpyH6C, bpyH3D, bpyH4B), 8.12–8.01 (m, 4H, H5’bpyH4C, H7’, H6), 7.91 (d, 1H, 
bpyH6B), 7.83 (t, 1H, H6’), 7.77–7.64 (m, 6H, H7, H8’, bpyH5B, bpyH6A, bpyH4D, 
bpyH5C), 7.51 (t, 1H, bpyH5A), 7.31 (d, 1H, H8), 7.09 (d, 1H, bpyH6D), 6.82 (t, 1H, 
bpyH5D). ESI–MS: Calc. for ([(bpy)2Ru(3.5)∙(PF6)]
1+
): 845.1031, Found: 845.1039; Calc. 




): 350.0692, Found: 350.0692. IR: νmax 2921, 1606, 1570, 1469, 1447, 
1408, 828, 758, 728, 555 cm
–1
. UV/Vis (CH3CN): λmax 493, 369, 314 (sh), 278, 243, 230 nm.  
(3.18): M.p: 220 °C. 
1
H NMR (500 MHz, CD3CN): δ 9.37 (s, 1H, H4’), 9.02 (s, 1H, 
H4), 8.64–8.62 (m, 2H, bpyH3A, bpyH3B), 8.54–8.53 (m, 2H, bpyH3C, bpyH4A), 8.45 (d, 
1H, H5), 8.32–8.22 (m, 4H, bpyH4C, bpyH4B, H6, bpyH3D), 8.16–8.11 (m, 3H, bpyH5A, 
H8, H8’), 8.07–8.02 (m, 2H, H6’, H7), 7.83 (t, 1H, H7’), 7.75–7.69 (m, 4H, H5’, bpyH5B, 
bpyH4D, bpyH6C), 7.44–7.53 (m, 2H, bpyH6B, bpyH6A), 7.55 (t, 1H, bpyH5C), 7.33 (d, 
1H, bpyH6D), 6.97 (t, 1H, bpyH5D). ESI–MS: Calc. for ([(bpy)2Ru(3.5)∙(PF6)]
1+
): 845.1031, 
Found: 845.1038; Calc. for ([(bpy)2Ru(3.5)]
2+
): 350.0692, Found: 350.0694. IR: νmax 2921, 
2852, 1606, 1570, 1469, 1447, 1330, 828, 758, 728, 555 cm
–1
. UV/Vis (CH3CN): λmax 513, 
368, 317, 278, 236 nm. Analysis: Calc. for [(bpy)2Ru(3.5)](PF6)2∙CH3COCH3∙H2O: C, 43.95; 
H, 3.22; N, 13.14. Found: C, 43.49; H, 3.06; N, 12.51.  
[(bpy)2Ru(μ–3.5)Ru(bpy)2](PF6)4, 3.19/3.20  
Ligand 3.5 (0.010 g, 0.035 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride 
(0.034 g, 0.070 mmol) were refluxed in ethanol:water (3:1) (10 mL) for 3 days. Upon 
cooling, the solvent was removed in vacuo and the residue was redissolved in water and 
filtered through Celite®. The aqueous solution was loaded on a SP Sephadex C–25 cation 
exchanger. Separation of the dinuclear product from the crude mixture was achieved via a 
gradient elution procedure using aqueous 0.2–0.5 mol L
–1
 sodium tosylate as the eluent. The 
fractions were precipitated by addition of saturated solution of ammonium 
hexafluorophosphate to each band. The resultant products were extracted into 
dichloromethane (3 x 10 mL) and the solvent was removed under reduced pressure. The solid 
residues were recrystallised from acetone/diethyl ether to give 3.19 and 3.20 as a olive green 
and green pwder, respectively. Yields: (3.19) 8.0 mg (13%); (3.20) 0.090 g (37%). 
(3.20): M.p: 270 °C. 
1
H NMR (400 MHz, CD3CN): δ 8.88 (s, 1H, H4), 8.67–8.52 (m, 
4H, bpyH3A, bpyH3B, bpyH3C, bpyH3D), 8.30–8.25 (m, 3H, bpyH4A, bpyH4B, bpyH4C), 
8.07–8.00 (m, 3H, bpyH4D, H5, H7), 7.93 (t, 1H, H6), 7.79 (d, 1H, bpyH6C), 7.67–7.63 (m, 
4H, bpyH5A, bpyH5C, bpyH6B, bpyH6A), 7.57 (t, 1H, bpyH5B), 7.34 (d, 1H, bpyH6D), 
7.10 (t, 1H, bpyH5D), 6.93 (d, 1H, H8). ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–3.5)∙(PF6)2]
2+
): 
702.0540, Found: 702.0548; Calc. for ([{Ru(bpy)2}2(μ–3.5)∙(PF6)]
3+
): 419.7148, Found: 
419.7151; Calc. for ([{Ru(bpy)2}2(μ–3.5)]
3+
): 371.0604, Found: 371.0603. IR: νmax 1607, 
Chapter 8 Experimental 219 
 
1487, 1469, 1372, 1243, 1218, 826, 761, 728, 689, 662, 628, 554, 421 cm
–1
. UV/Vis 
(CH3CN): λmax 515, 368, 317 (sh), 278, 247 nm. Analysis: Calc. for [(bpy)2Ru(μ–
3.5)Ru(bpy)2](PF6)4∙CH3CN: C, 40.17; H, 2.62; N, 12.12. Found: C, 40.06; H, 2.79; N, 12.60. 
8.4.6. Complex of 3.6 
[(bpy)2Ru(3.6)](PF6)2, 3.21 
Ligand 3.6 (0.05 g, 0.17 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride (0.08 
g, 0.17 mmol) were refluxed in 50% aqueous methanol (10 mL) for 16 h. Upon cooling, the 
solvent was removed in vacuo and the residue was redissolved in water. The aqueous solution 
was precipitated by addition of saturated potassium hexafluorophosphate. The resultant solid 
was filtered and recrystallised from acetone/diethyl ether to give 3.21 as a red powder. Yield: 
0.08 g (46%). M.p: > 220 °C (decomposes). 
1
H NMR (500 MHz, CD3CN): δ 10.15 (s, 1H, H3), 9.75 (s, 1H, H3’), 8.69 (d, 1H , 
bpyH3A), 8.55–8.52 (m, 2H, bpyH3B, bpyH3C), 8.39 (d, 1H, bpyH3D), 8.31–8.26 (m, 3H, 
H5, bpyH4B, bpyH4A), 8.14 (d, 1H, H5’), 8.09–8.04 (m, 2H, H6, bpyH4D), 7.96 (t, 1H, 
bpyH4C), 7.91 (t, 1H, H6’), 7.85 (d, 1H, bpyH6B), 7.78 (t, 1H, H7), 7.71 (t, 1H, bpyH5B), 
7.61 (d, 1H, bpyH6D), 7.42–7.35 (m, 4H, bpyH6A, H8, bpyH5A, H8’), 7.30 (d, 1H, 
bpyH6C), 7.11 (t, 1H, bpyH5C). 
13
C NMR (125 MHz, CD3CN): δ 161.7 (C2), 157.7 (2C, 
C2’, bpyC2A), 156.2 (bpyC3C), 155.2 (2C, bpyC2D, bpyC2B), 153.7 (bpyC6A), 152.1 
(bpyC6D), 151.7 (bpyC6C), 149.5 (bpyC6B), 147.5 (C3), 143.4 (C8a), 142.7 (C8’a), 141.20 
(bpyC4B), 141.16 (bpyC4A), 140.2 (bpyC4d), 139.7 (bpyC4C), 139.3 (C3’), 133.6 (C6), 
133.3 (C7’), 132.7 (C6’), 131.9 (C7), 131.4 (C5), 129.2 (C5), 129.1 (bpyC5B), 128.9 (C8’), 
128.8 (bpyC5D), 128.0 (bpyC5A), 127.4 (bpyC5C), 125.0 (bpyC3B), 124.99 (bpyC3A), 
124.95 (bpyC3D), 124.2 (bpyC3C), 123.9 (C8). ESI–MS: Calc. for ([(bpy)2Ru(3.6)∙(PF6)]
1+
): 
845.1031, Found: 845.1036; Calc. for ([(bpy)2Ru(3.6)]
2+
): 350.0692, Found: 350.0693. IR 
(KBr): νmax 2922, 2852, 1708, 1604, 1590, 1467, 1448, 1305, 1284, 827, 807, 776, 758, 727, 
54 cm
–1
. UV/Vis (CH3CN) λmax 541, 373, 316, 268, 246 nm. Analysis: Calc. for 
[(bpy)2Ru(3.5)](PF6)2∙2H2O: C, 42.16; H, 2.95; N, 13.66. Found: C, 41.60; H, 2.44; N, 13.21. 
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8.4.7. Complexes of 3.7 
[(bpy)2Ru(3.7)](PF6)2, 3.22 and [(bpy)2Ru(μ–3.7)Ru(bpy)2](PF6)4, 3.23 
Ligand 3.7 (0.02 g, 0.07 mmol) and bis(2,2’–bipyridine)ruthenium(II) carbonate (0.07 
g, 0.14 mmol) were refluxed in 50% aqueous ethanol (10 mL) for 48 h. After cooling, the 
solvent was removed in vacuo and the residue was redissolved in the minimum amount of 
acetonitrile:saturated KNO3 (7:1). The resulting solution was loaded on a silica gel column 
and eluted with 7:1 acetonitrile:saturated KNO3 mixture. The fractions were precipitated by 
addition of a saturated solution of ammonium hexafluorophosphate. The resultant products 
were extracted into dichloromethane (3 x 10 mL) and the solvent was removed under reduced 
pressure. The crude solid was recrystallised from acetone/diethyl ether to give 3.22 and 3.23 
as a red and green solid, respectively. Yields: (3.22): 0.020 g (21%); (3.23): 0.030 g (25%). 
(3.22): M.p: 231 °C. 
1
H NMR (400 MHz, CD3CN): δ 9.03 (d, 1H, H7’), 8.93 (d, 1H, 
H3’), 8.79 (d, 1H, H4’), 8.56–8.53 (m, 3H, H4, H5, bpyH3A), 8.49 (d, 1H, bpyH3B), 8.42–
8.37 (m, 2H, bpyH3C, H5’), 8.30–8.20 (m, 4H, H7, bpyH3D, bpyH4A, bpyH4B), 8.06 (t, 
1H, bpyH4C), 8.01 (d, 1H, bpyH6C), 7.95 (d, 1H, H3), 7.76–7.67 (m, 3H, H6, bpyH6B, 
bpyH4D), 7.63–7.57 (m, 2H, H6’, bpyH5B), 7.49 (t, 1H, bpyH5C), 7.40–7.32 (m, 3H, 
bpyH6D, bpyH5A, bpyH6A), 7.02 (t, 1H, bpyH5D). 
13
C NMR (100 MHz, CD3CN): δ 155.3 
(C7’), 154.5 (C7), 153.3 (bpyC6A), 152.2 (bpyC6C), 151.3 (bpyC6D), 149.7 (bpyC6B), 
142.0 (C4), 140.9 (C4’), 140.2 (bpyC4A), 139.7 (bpyc4B), 139.4 (bpyC4B), 138.3 (C5), 
138.4 (bpyC4D), 137.4 (C5’), 127.6 (2C, bpyC5A, bpyC5C), 127.0 (bpyC5B), 126.8 
(bpyC5D), 124.9 (C6), 124.2 (bpyC3A), 124.1 (2C, bpyC3C, bpyC3D), 123.8 (C3’), 123.7 
(C6’), 123.4 (bpyC3B), 114.7 (C3). ESI–MS: Calc. for ([(bpy)2Ru(3.7)∙(PF6)]
1+
): 845.1031, 
Found: 845.1033; Calc. for ([(bpy)2Ru(3.6)]
2+
): 350.0692, Found: 350.0693. IR: νmax 2923, 
1729, 1604, 1592, 1499, 1446, 1430, 1397, 1311, 825, 759, 532 cm
–1
. UV/Vis (CH3CN) λmax 
526, 363, 315 (sh), 268, 246 nm.  
(3.23): M.p: 272 °C. ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–3.7)∙(PF6)]
2+
): 629.5719, 
Found: 629.5731; Calc. for ([{Ru(bpy)2}2(μ–3.7)]
3+
): 371.3930, Found: 371.3938. IR: νmax 
2923, 1729, 1604, 1592, 1499, 1446, 1430, 1397, 1311, 825, 759, 532 cm
–1
. UV/Vis 
(CH3CN) λmax 645, 498, 391, 287, 244 nm. Analysis: Calc. for [(bpy)2Ru(μ–
3.7)Ru(bpy)2](PF6)3: C, 43.45; H, 2.73; N, 12.67. Found: C, 42.38; H, 2.95; N, 12.22. 
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8.4.8. Complexes of 3.8 
[(bpy)2Ru(3.8)](PF6)2, 3.24 
Ligand 3.8 (0.03 g, 0.10 mmol) and bis(2,2’–bipyridine)ruthenium(II) chloride (0.10 g, 
0.21 mmol) were refluxed in 50% aqueous methanol (10 mL) for 48 h. After cooling, the 
solvent was removed in vacuo and the residue was dissolved in the minimum amount of 
water. The aqueous solution was precipitated by addition of a saturated solution of 
ammonium hexafluorophosphate. The resultant solid was filtered, dried and recrystallised 
from acetone/diethyl ether to give 3.24 as a red solid. Yield: 0.090 g (37%). M.p: 305 °C. 
1
H NMR (400 MHz, CD3CN): δ 9.18 (d, 1H, bpyH6A), 9.12 (d, 1H, H3’/4’), 9.01 (d, 
1H, bpyH6B), 8.87 (d, 1H, H4’/3’), 8.65 (d, 1H, bpyH3A), 8.60 (d, 1H, H3/4), 8.55 (d, 1H, 
bpyH3B), 8.41 (d, 1H, bpyH3’B), 8.37 (d, 1H, bpyH3’A), 8.33–8.26 (m, 2H, bpyH4A, 
bpyH4B), 8.22 (d, 1H, H4/3), 8.08 (t, 1H, bpyH4’B), 7.88 (d, 1H, H6’), 7.84 (d, 1H, 
bpyH6’B), 7.80–7.76 (m, 2H, bpyH4’A, H8’), 7.72–7.66 (m, 3H, bpyH5B, H8, H7’), 7.56–
7.51 (m, 2H, H6, bpyH5’B), 7.45–7.41 (m, 2H, bpyH5A, H7), 7.28 (d, 1H, bpyH6’A), 6.98 
(t, 1H, bpyH5’A). ESI–MS: Calc. for ([(bpy)2Ru(3.8)∙(PF6)]
1+
): 845.1031, Found: 845.1044; 
Calc. for ([(bpy)2Ru(3.8)]
2+
): 350.0692, Found: 350.0700. IR: νmax 2922, 2852, 1504, 1467, 
1447, 1315, 1262, 1243, 1110, 826, 760, 729, 554 cm
–1
. UV/Vis (CH3CN) λmax 540, 383, 
281, 239 nm.  
8.5. Ruthenium Complexes with azobis(bidentates)  
8.5.1 Complexes of 4.1 
[(terpy)Ru(μ–4.1)Ru(terpy)](PF6)4, 4.3 
A suspension of ligand 4.1 (0.050 g, 0.11 mmol) and (2,2':6',2"–
terpyridine)ruthenium(III) trichloride (0.0038 g, 0.11 mmol) in ethylene glycol (5 mL) was 
heated at reflux in a modified microwave oven (Sharp Model R–2V55, 600 W, 2450 MHz) at 
high power for 10 minutes at intervals of 2 minutes. Upon cooling, the black solution was 
diluted with water (10 mL) and loaded on a SP Sephadex cation exchanger. Separation of the 
mononuclear product from the crude mixture was achieved via a gradient elution procedure 
using aqueous 0.1–0.5 mol L
–1
 sodium chloride as the eluent. The fractions were precipitated 
by addition of a saturated solution of ammonium hexafluorophosphate to each band. The 
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resultant product was extracted into dichloromethane and the solvent was removed under 
reduced pressure. The solid residues were recrystallised from acetone/hexane to give 4.3 as 
red needles. Yield: 0.020 g (14%). M.p: 220 °C. 
1
H NMR (500 MHz, CD3CN): δ 9.01 (d, 2H, terpyH3’), 8.81 (t, 1H, terpyH4’), 8.71 (d, 
1H, H3), 8.59 (d, 2H, terpyH3, terpyH3’’), 8.46 (d, 1H, H3’), 8.15 (t, 1H, H4), 8.02–7.96 (m, 
3H, H4’, terpyH4, terpyH4’’), 7.79 (d, 1H, H5), 7.30 (t, 1H, H5’), 6.91 (t, 2H, terpyH5, 
terpyH5’’), 6.88 (d, 1H, H6’), 6.49 (d, 2H, terpyH6, terpyH6’’). 
13
C NMR (125 MHz, 
CD3CN): δ 164.4 (C6), 157.6 (terpyC2), 157.1 (C2’), 156.4 (C2), 154.4 (terpyC2’), 153.2 
(terpyC6), 150.5 (C6’), 140.7 (C4’), 140.5 (terpyC4’), 140.1 (terpyC4), 138.9 (C4), 129.2 
(C5’), 128.5 (terpyC5), 125.9 (terpyC3), 125.7 (C3’), 125.6 (terpyC3’), 123.2 (C5), 122.7 
(C3). ESI–MS: Calc. for ([{Ru(terpy)}2(μ–4.1)∙(PF6)3]
1+
): 1443.0196, Found: 1443.0212; 
Calc. for ([{Ru(terpy)}2(μ–4.1)∙(PF6)]
2+
): 576.5457, Found: 576.5466; Calc. for 
([{Ru(terpy)}2(μ–4.1)]
3+
): 336.0424, Found: 336.0432. UV/Vis (CH3CN): λmax 772, 409, 330, 
299, 264, 240 nm. Analysis: Calc. for [{Ru(terpy)}2(μ–4.1)](PF6)4∙2H2O: C, 37.84; H, 2.29; 
N, 10.59. Found: C, 37.83; H, 2.65; N, 11.06. 
8.5.2. Complexes of 4.2 
[(terpy)Ru(4.2)](PF6)2, 4.4  
A suspension of ligand 4.2 (0.020 g, 0.052 mmol) and (2,2':6',2"–
terpyridine)ruthenium(III) trichloride (0.020 g, 0.052 mmol) in ethylene glycol (5 mL) was 
heated at reflux in a modified microwave oven (Sharp Model R–2V55, 600 W, 2450 MHz) at 
high power for 10 minutes at an interval of 2 minutes. Upon cooling, the black solution was 
diluted with water (10 mL) and loaded on a SP Sephadex C–25 cation exchanger. Separation 
of the mononuclear product from the crude mixture was achieved via a gradient elution 
procedure using aqueous 0.1–0.5 mol L
–1
 sodium chloride as the eluent. The red fraction was 
precipitated by addition of a saturated solution of ammonium hexafluorophosphate. The 
resultant products were extracted into dichloromethane and the solvent was removed under 
reduced pressure. The solid residues were recrystallised from acetone/hexane to give 4.4 as 
red needles. Yield: 0.050 g (91%). M.p: > 300 °C. 
1
H NMR (400 MHz, CD3CN): δ 9.33 (d, 1H, H3), 9.31 (dd, 1H, H9’), 9.03 (d, 1H, H4), 
8.73 (d, 2H, terpyH3’), 8.65 (dd, 1H, H7), 8.57 (d, 1H, H5/H6), 8.51 (d, 2H, terpyH3, 
terpyH3’’), 8.43–8.38 (m, 3H, H6/H5, H7’, H4’), 8.33 (t, 1H, terpyH4’), 8.19 (d, 1H, H3’), 
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7.96 (d, 1H, H5’/H6’), 7.93–7.86 (m, 3H, terpyH4, terpyH4’’, H6’/H5’), 7.83 (dd, 1H, H8’), 
7.65–7.59 (m, 2H, H9, H8), 7.02 (t, 2H, terpyH5, terpyH5’’), 6.89 (d, 2H, terpyH6, 
terpyH6’’). 
13
C NMR (100MHz, CD3CN): δ 158.6 (terpyC2), 153.9 (terpyC2’), 153.5 (C9), 
153.3 (terpyC6), 150.0 (C9’), 139.5 (terpyC4), 139.4 (C4’), 137.8 (terpyC4), 137.5 (C7), 
136.5 (C7’), 134.6 (C4), 130.0 (C6/C5), 129.4 (C6’/C5’), 128.1 (C5/C6), 127.2 (terpyC5), 
127.2 (C8), 126.0 (C5’/C6’), 124.8 (terpyC3), 124.5 (C3), 124.3 (terpyC3’), 123.8 (C8’), 
116.2 (C3’). ESI–MS: Calc. for ([(terpy)Ru(4.2)]
2+
): 360.5638, Found: 360.5640. UV/Vis 
(CH3CN): λmax 406, 329, 229 nm. Analysis: Calc. for 
[(terpy)Ru(4.2)](PF6)2∙CH3COCH3∙H2O: C, 46.42; H, 3.06; N, 11.60. Found: C, 46.77; H, 
3.50; N, 11.59. 
[(terpy)Ru(μ–4.2)Ru(terpy)](PF6)4, 4.5 
A suspension of ligand 4.2 (0.050 g, 0.13 mmol) and (2,2':6',2"–
terpyridine)ruthenium(III) trichloride (0.11 g, 0.26 mmol) in ethylene glycol (5 mL) was 
heated at reflux in a modified microwave oven (Sharp Model R–2V55, 600 W, 2450 MHz) at 
high power for 10 minutes at intervals of 2 minutes. Upon cooling, the black solution was 
diluted with water (10 mL) and loaded on a SP Sephadex cation exchanger. Separation of the 
dinuclear product from the crude mixture was achieved via a gradient elution procedure using 
aqueous 0.1–0.5 mol L
–1
 sodium chloride as the eluent. The fractions were precipitated by 
addition of a saturated solution of ammonium hexafluorophosphate to each band. The 
resultant products were extracted into dichloromethane and the solvent was removed under 
reduced pressure. The solid residues were recrystallised from acetone/hexane to give 4.5 as 
red needles. Yield: 0.18 g (87%). M.p: > 290 °C. 
1
H NMR (400 MHz, CD3CN): δ δ 9.01 (d, 2H, terpyH3’), 8.89 (t, 1H, terpyH4’), 8.67–
8.61 (m, 3H, terpyH3, terpyH3’’, H4), 8.36 (dd, 2H, H5, H6), 8.02–7.95 (m, 3H, terpyH4, 
terpyH4’’, H3,), 7.59 (t, 1H, H8), 7.42 (d, 1H, H9), 6.83 (t, 2H, terpyH5, terpyH5’’), 6.46 (d, 
2H, terpyH6, terpyH6’’). ESI–MS: Calc. for ([{Ru(terpy)}2(μ–4.2)∙(PF6)]
2+
): 600.5454, 
Found: 600.5467; Calc. for ([{Ru(terpy)}2(μ–4.2)]
3+
): 352.0420, Found: 352.0428. IR: νmax 
1601, 1451, 1385, 1090, 827, 781, 764, 735, 644, 554 cm
–1
. UV/Vis (CH3CN): λmax 773, 472, 
406, 329 nm.  
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8.6. Ruthenium Complexes with bis(pyridylimines)  
8.6.1. Complexes of 5.1 
[(bpy)2Ru(5.1–NH2)](PF6)2, 5.6 and [(bpy)2Ru(μ–5.1)Ru(bpy)2](PF6)4, 5.7 
Ligand 5.1 (0.080 g, 0.38 mmol) and bis(2,2’–bipyridine)ruthenium(II) dichloride (0.18 
g, 0.38 mmol) were refluxed in 50% aqueous methanol (15 mL) for 24 h. After cooling, the 
solvent was removed in vacuo and the residue was redissolved in water and filtered. The 
aqueous solution was loaded on a SP Sephadex C–25 cation exchanger. Separation of the 
mononuclear and dinuclear products from the crude mixture was achieved via a gradient 
elution procedure using aqueous 0.1–0.5 mol L
–1
 sodium chloride as the eluent. Three bands 
were eluted: Band 1 (reddish yellow, 0.1 mol L
–1
 NaCl), Band 2: (dark brown, 0.15 mol L
–1
) 
and Band 3: (dark red, 0.2 mol L
–1
). The fractions were precipitated by addition of saturated 
solution of ammonium hexafluorophosphate to each band. The resultant products were 
extracted into dichloromethane and the solvent was removed under reduced pressure. The 
solid residues were recrystallised from acetone/diethyl ether. The composition of Bands 1 and 
3 were established by electrospray mass spectrometry and 
1
H NMR. Analysis of Band 1 
revealed the presence of a mononuclear ruthenium species and Band 3 as a dinuclear 
ruthenium species. Yields: Band 1 = (5.6) 0.090 g (28%). Band 3 = (5.7) 0.12 mg (19%).  
(5.6): M.p: 160 °C. 
1
H NMR (400 MHz, CD3CN): δ 8.54 (d, 1H, H3), 8.51–8.46 (m, 
4H, bpyH3A, bpyH3B, bpyH3C, bpyH6A), 8.36 (s, 1H, H7), 8.18 (td, 1H, H4), 8.15 (td, 1H, 
bpyH4A), 8.09–8.01 (m, 2H, bpyH4B, bpyH4C), 7.91–7.89 (m, 2H, bpyH3D, bpyH4D), 7.71 
(d, 1H, bpyH6C), 7.66 (d, 1H, bpyH6B), 7.63–7.60 (m, 2H, bpyH5A, H6), 7.56–7.51 (m, 2H, 
H5, bpyH6D), 7.40 (t, 1H, bpyH5B), 7.35 (t, 1H, bpyH5C), 7.21 (td, 1H, bpyH5D), 6.64 (bs, 
2H, NH2). 
13
C NMR (100 MHz, CD3CN): δ 157.4 (C2), 157.2 (bpyC2D), 157.1 (bpyC2C), 
156.8 (bpyC2B), 156.7 (bpyC2A), 152.0 (bpyC6A), 151.9 (C6), 151.8 (bpyC6C), 151.4 
(bpyC6B), 151.1 (bpyC6D), 143.3 (C7), 138.1 (2C, bpyC4C, C4), 138.0 (bpyC4A), 137.9 
(bpyC4B), 137.3 (bpyC4D), 127.8 (C5), 127.8 (bpyC5A), 127.6 (bpyC5B), 127.3 (bpyC5C), 
125.1 (bpyC3D), 125.0 (bpyC5D), 124.19 (bpyC3A), 124.18 (C3), 124.1 (bpyC3B), 123.9 
(bpyC3C). ESI–MS: Calc. for ([(bpy)2Ru(5.1–NH2)∙(PF6)]
1+
): 613.5176, Found: 613.5164; 
Calc. for ([(bpy)2Ru(5.1–NH2)]
2+
): 360.6902’ Found: 360.6894. IR: νmax 1767, 1690, 1466, 
1444, 1350, 1246, 1158, 831, 760, 728, 555 cm
–1
. UV (CH3CN): λmax 438, 411, 285, 243 nm.  
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(5.7): M.p: decomposes at 260 °C. 
1
H NMR (400 MHz, CD3CN): δ 9.28 (s, 1H, H7), 
8.76 (d, 1H, bpyH6A), 8.58 (d, 1H , bpyH3A), 8.49 (d, 1H, bpyH3’A), 8.28–8.23 (m, 2H, 
bpyH4A, H3), 8.16–8.11 (m, 2H, bpyH6B, bpyH4’B), 8.07–8.02 (m, 3H, bpyH4’A, H4, 
bpyH3B), 7.99–7.94 (m, 2H, bpyH4B, bpyH3’B), 7.78 (t, 1H, bpyH5A), 7.69 (d, 1H, H6), 
7.52 (t, 1H, byH5B), 7.47–7.41 (m, 2H, H5, bpyH5’B), 7.30 (t, 1H, bpyH5’A), 6.77 (d, 1H, 
bpyH6’B), 6.71 (d, 1H, bpyH6’A). 
13
C NMR (100 MHz, CD3CN): δ 165.4 (C7), 156.7 
(bpyC2’A), 156.4 (2C, bpyC2A, bpyC2B), 155.6 (C2), 155.5 (bpyC2’B), 153.9 (bpyC6A), 
153.1 (C6), 152.3 (bpyC6B), 151.6 (bpyC6’B), 150.4 (bpyC6’A), 139.5 (bpyC4B), 139.4 
(bpyC4’B), 139.1 (bpyC4A), 139.0 (bpyC4’A), 138.4 (C4), 133.1 (C3), 130.2 (C5), 128.7 
(bpyC5’B), 128.6 (bpyC5A), 128.2 (2C, bpyC5’A, bpyC5B), 125.3 (bpyC3’B), 125.0 
(bpyC3A), 124.7 (2C, bpyC3’A, bpyC3B). ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–
5.1)∙(PF6)2]
2+
): 664.0513, Found: 664.0514; Calc. for ([{Ru(bpy)2}2(μ–5.1)]
2+
): 519.0871, 
Found: 519.0865; Calc. for ([{Ru(bpy)2}2(μ–5.1)]
4+
): 259.5435, Found: 259.5428. IR: νmax 
1720, 1603, 1447, 1422, 1119, 1087, 1068, 1025, 1000, 835, 823, 758, 555 cm
–1
. UV 
(CH3CN): λmax 524, 393, 282, 245 nm.  
8.6.2 Complex of 5.2 
[(bpy)2Ru(μ–5.2)Ru(bpy)2](ClO4)4, 5.8 
A solution of bis(2,2’–bipyridine)ruthenium(II) dichloride (0.10 g, 0.21 mmol) and 
silver perchlorate (0.080 g, 0.42 mmol) in ethanol (10 mL) was refluxed for 1 h. The reaction 
mixture was cooled and the solution was filtered through Celite®. Ligand 5.2 (0.030 g, 0.11 
mmol) was added to the above filtrate and the reaction mixture was heated at reflux for 16 
hours. The reaction mixture was then cooled in refrigerator for 1 hour. The precipitate thus 
formed was filtered and washed with cold ethanol and benzene. The crude product was then 
recrystallised from acetonitrile and benzene mixture to give 5.8 as a brownish–orange solid. 
Yield: 0.065 g (25%). M.p: > 260 °C. 
1
H NMR (500 MHz, CD3CN): δ 8.77 (s, 1H, H7), 8.56–8.53 (m, 2H, bpyH3A, 
bpyH3B), 8.47 (d, 1H, bpyH6A), 8.41 (d, 1H, H3), 8.26 (d, 1H, bpyH3C), 8.16 (t, 1H, 
bpyH4A), 8.10–8.07 (m, 4H, H4, bpyH3D, bpyH4C, bpyH4B), 7.87 (t, 1H, bpyH4D), 7.81 
(d, 1H, H6), 7.74 (d, 1H, bpyH6B), 7.65–7.61 (m, 2H, bpyH6C, bpyH5A), 7.53–7.49 (m, 3H, 
bpyH5C, H5, bpyH6D), 7.39 (t, 1H, bpyH5B), 7.21 (t, 1H, bpyH5D), 6.11 (bs, 2H, H9, H10). 
13
C NMR (125 MHz, CD3CN): δ170.1 (C7), 157.71 (C2), 157.66 (bpyC2C), 157.6 (2C, 
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bpyC2A, bpyC2B), 157.2 (bpyC2D), 153.9 (bpyC6A), 153.1 (bpyC6C), 153.0 (C6), 152.8 
(bpyC6B), 152.4 (bpyC6D), 148.6 (C8), 139.2 (bpyC4B), 139.1 (bpyC4A), 139.1 (bpyC4C), 
138.7 (2C, bpyC4D, C4), 131.8 (C3), 129.9 (C5), 128.9 (bpyC5A), 128.8 (bpyC5C), 128.4 
(bpyC5B), 128.2 (bpyC5D), 125.4 (bpyC3A), 125.3 (bpyC3B), 124.7 (bpyC3C), 124.6 
(bpyC3D), 122.8 (2C, C9, C10). ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–5.2)∙(ClO4)2]
2+
): 
656.0513, Found: 656.0514; Calc. for ([{Ru(bpy)2}2(μ–5.2)∙(ClO4)]
3+
): 404.3847, Found: 
404.3845; Calc. for ([{Ru(bpy)2}2(μ–5.2)]
4+
): 278.5509, Found: 278.5511. IR: νmax 1605, 
1497, 1465, 1445, 1421, 1079, 837, 763, 730, 621, 543 cm
–1
. UV/Vis (CH3CN): λmax 483, 
429, 285, 243 nm.  
8.6.3. Complex of 5.3 
[(bpy)2Ru(μ–5.3)Ru(bpy)2](ClO4)4, 5.9 
A mixture of bis(2,2’–bipyridine)ruthenium(II) carbonate (0.14 g, 0.30 mmol) and 
silver perchlorate (0.12 g, 0.59 mmol) in ethanol (10 mL) were refluxed for 1 h. After 
cooling, the reaction mixture was filtered through Celite
®
. The ligand 5.3 (0.050 g, 0.18 
mmol) was added to the filtrate and the reaction mixture was heated at reflux for 16 hours. 
Upon cooling, the precipitate thus formed was filtered and washed with cold ethanol and 
benzene. The crude product was recrystallised from a mixture of acetonitrile and benzene 
(1:1, v/v) to give 5.9 as a brown solid. Yields: 0.02 g (8%). M.p: decomposes at 260 °C. 
1
H NMR (400 MHz, CD3CN): δ 9.13 (d, 1H, H7), 8.70 (d, 1H, bpyH6A), 8.57–8.52 
(m, 3H, bpyH3A, bpyH3B, H3), 8.22–8.16 (m, 2H, bpyH4A, H4), 8.10–8.06 (m, 2H, 
bpyH6C, bpyH4B), 8.02 (d, 1H, H6), 7.87 (1H, t, bpyH4C), 7.76–7.70 (m, 3H, bpyH3C, 
bpyH6B, bpyH5A), 7.65–7.54 (m, 4H, bpyH3D, bpyH4D, H5, bpyH5C), 7.43 (d, 1H, 
bpyH6D), 7.39 (t, 1H, bpyH5B), 7.06 (t, 1H, bpyH5D), 7.02 (d, 1H, H11), 6.48 (t, 1H, H10), 
6.17 (d, 1H, H9). 
13
C NMR (100 MHz, CD3CN): δ 172.5 (C7), 156.8 (bpyC2C), 156.7 (C2), 
156.63 (bpyC2A), 156.60 (bpyC2B), 155.8 (bpyC2D), 153.0 (bpyC6C), 152.3 (bpyC6A), 
152.2 (C6), 151.7 (bpyC6D), 151.4 (bpyC6B), 143.2 (C8), 138.4 (bpyC4C), 138.22 
(bpyC4B), 132.16 (C4), 137.8 (bpyC4A), 137.3 (bpyC4D), 131.4 (C3), 129.4 (C5), 128.0 
(bpyC5C), 127.9 (bpyC5A), 127.4 (bpyC5B), 126.9 (bpyC5D), 125.5 (C10), 124.5 
(bpyC3B), 124.3 (bpyC3A), 123.4 (bpyC3C), 122.7 (bpyC3D), 119.2 (C9), 118.9 (C11). 
ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–5.3)∙(ClO4)]
3+
): 421.0567, Found: 421.0564; Calc. for 
([{Ru(bpy)2}2(μ–5.3)]
4+
): 291.0548, Found: 291.0548. IR: νmax 1722, 1603, 1466, 1446, 
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1317, 1301, 1272, 1084, 1001, 962, 893, 768, 622 cm
–1
. UV/Vis (CH3CN): λmax 483, 427, 
284, 242 nm. Analysis: Calc. for [(bpy)2Ru(μ–5.3)Ru(bpy)2](ClO4)4∙4CH3COCH3: C, 49.56; 
H, 4.05; N, 9.37. Found: C, 49.83; H, 4.34; N, 8.70. 
8.6.4. Complex of 5.4 
[(bpy)2Ru(μ–5.4)Ru(bpy)2](ClO4)4, 5.10 
A mixture of bis(2,2’–bipyridine)ruthenium(II) dichloride (0.10 g, 0.21 mmol) and 
silver perchlorate (0.080 g, 0.42 mmol) in ethanol (10 mL) were refluxed for 1 h. After 
cooling, the reaction mixture was filtered through Celite
®
. The ligand 5.4 (0.030 g, 0.10 
mmol) was added to the filtrate and the reaction mixture was heated at reflux for 16 hours. 
Upon cooling, the precipitate thus formed was filtered and washed with cold ethanol and 
benzene. The crude product was recrystallised from a mixture of acetonitrile and benzene 
(1:1, v/v) to give 5.10 as a brownish–orange solid. Yields: 0.030 g (14%). M.p: decomposes 
at 260 °C. 
1
H NMR (500 MHz, CD3CN): δ 9.07 (d, 1H, H7), 8.58–8.53 (m, 3H, bpyH6A, 
bpyH3A, bpyH3B), 8.34 (d, 1H, H3), 8.22 (d, 1H, bpyH3C), 8.16–8.06 (m, 4H, bpyH4A, 
bpyH4D, bpyH4B, bpyH4C), 7.95 (d, 1H, bpyH3D), 7.80 (d, 1H, bpyH6B), 7.75 (d, 1H, 
bpyH6C), 7.69–7.66 (m, 2H, bpyH6C, bpyH4D), 7.60–7.51 (m, 3H, bpyH5A, bpyH6D, 
bpyH5C), 7.47 (t, 1H, bpyH5B), 7.38 (t, 1H, H5), 7.18 (t, 1H, bpyH5D), 6.68 (dd, 2H, H9, 
H9’), 6.48 (dd, 2H, H10, H10’), 3.62 (s, 1H, H12). 
13
C NMR (100 MHz, CD3CN): δ 168.4 
(C7), 157.1 (C2), 156.9 (bpyC2A), 156.7 (bpyC2B), 156.7 (bpyC2C), 156.4 (bpyC2D), 153.1 
(bpyC6A), 152.1 (bpyC6C), 152.0 (bpyC6B), 151.9 (C6), 151.7 (bpyC6D), 156.9 (C8), 141.3 
(C11), 138.2 (bpyC4A), 138.14 (bpyC4C), 130.09 (bpyC4B), 137.7 (C4), 137.4 (bpyc4D), 
130.4 (C3), 129.1 (C9), 128.8 (bpyC5B), 128.0 (bpyC5C), 127.9 (bpyC5A), 127.5 (C5), 
127.0 (bpyC5D), 124.5 (bpyC3A), 124.4 (bpyC3B), 123.5 (bpyC3C), 123.2 (bpyC3D), 121.3 
(C10). ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–5.4)∙(ClO4)2]
2+
): 701.0751, Found: 701.0755; 
Calc for ([{Ru(bpy)2}2(μ–5.4)∙(ClO4)]
3+
): 434.4005, Found: 434.4010; Calc. for 
([{Ru(bpy)2}2(μ–5.4)]
4+
): 301.0627, Found: 301.0635. IR: νmax 2915, 2847, 1603, 1543, 
1464, 1446, 1804, 1067, 1026, 1001, 961, 768, 757, 620 cm
–1
. UV/Vis (CH3CN): λmax 478, 
425, 343, 285, 243 nm.  
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8.6.5. Complex of 5.5 
[(bpy)2Ru(μ–5.5)Ru(bpy)2](ClO4)4, 5.11 
A mixture of bis(2,2’–bipyridine)ruthenium(II) dichloride (0.10 g, 0.21 mmol) and 
silver perchlorate (0.090 g, 0.42 mmol) in ethanol (10 mL) were refluxed for 1 h. After 
cooling, the reaction mixture was filtered through Celite
®
. Ligand 5.5 (0.040 g, 0.11 mmol) 
was added to the filtrate and the reaction mixture was heated at reflux for 16 hours. Upon 
cooling, the precipitate thus formed was filtered and washed with cold ethanol and benzene. 
The crude product was recrystallised from a mixture of acetonitrile and benzene (1:1, v/v) to 
give 5.11 as a brownish–orange solid. Yield: 0.022 mg (13%). M.p: decomposes at 260 °C. 
1
H NMR (500 MHz, CD3CN): δ 9.04 (s, 1H, H7), 8.59–8.54 (m, 3H, bpyH3A, 
bpyH6A, bpyH3b), 8.35 (d, 1H, H3), 8.28 (d, 1H, bpyH3C), 8.16–7.81 (m, 5H, bpyH4A, 
bpyH3D, bpyH4C, H4, bpyH4B), 7.81–7.78 (m, 2H, H6, bpyH4D), 7.75 (d, 1H, bpyH6B), 
7.69 (d, 1H, bpyH6C), 7.64–7.58 (m, 2H, bpyH6D, bpyH5A), 7.54 (t, 1H, bpyH5C), 7.48 (t, 
1H, H5), 7.39 (t, 1H, bpyH5B), 7.24 (t, 1H, bpyH5D), 6.59 (m, 2H, H9, H9’), 6.45 (m, 2H, 
H10, H10’). 
13
C NMR (125 MHz, CD3CN): δ 168.6 (C7), 157.0 (C2), 156.8 (bpyC2C), 
156.73 (bpyC2A), 156.68. (bpyC2B), 156.5 (bpyC2D), 156.2 (C11), 153.1 (bpyC6A), 152.2 
(bpyC6C), 152.1 (C6), 151.9 (bpyC6B), 151.8 (bpyC6D), 144.6 (C8), 138.3 (bpyC4C), 138.2 
(bpyC4B), 138.1 (bpyC4A), 137.8 (C4), 137.5 (bpyC4D), 130.5 (C3), 128.8 (C5), 128.1 
(bpyC5C), 127.9 (bpyC5A), 127.5 (bpyC5B), 127.2 (bpyC5D), 124.5 (bpyC3A), 124.4 
(bpyC3B), 123.6 (bpyC3C), 123.4 (bpyC3D), 123.2 (2C, C9, C9’), 118.9 (2C, C10, C10’). 
ESI–MS: Calc. for ([{Ru(bpy)2}2(μ–5.5)∙(ClO4)2]
2+
): 702.0646, Found: 702.0646; Calc. for 
([{Ru(bpy)2}2(μ–5.5)∙(ClO4)]
3+
): 435.0602, Found: 435.0600; Calc. for ([{Ru(bpy)2}2(μ–
5.5)]
4+
): 301.5575, Found: 301.5576. IR: νmax 1604, 1492, 1463, 1445, 1423, 1243, 1200, 
1165, 1082, 838, 763, 730, 622, 543 cm
–1
. UV/Vis (CH3CN): λmax 439, 285, 243 nm.  
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8.7. Metallosupramolecular Chemistry  
8.7.1. Complex of 2.1 
[Ag(2.1)](SO3CF3), 6.1 
To a solution of 2.1 (0.010 g, 0.054 mmol) in methanol (1 mL), was added a solution of 
silver(I) triflate (0.030 g, 0.11 mmol) in acetonitrile (1 mL). Slow evaporation of the 
methanol/acetonitrile solution over time resulted in red coloured crystals, which were 
collected, washed with dichloromethane and dried in vacuo. Yield: 0.014 g (59%). M.p: 245 
°C. 
ESI–MS: Calc. for ([Ag(2.1)2]
+
): 475.0549, Found: 475.0546; Calc. for ([Ag(2.1)]
+
): 
290.9794, Found: 290.9793. IR: νmax 1598, 1467, 1443, 1238, 1206, 1169, 1154, 1021, 1011, 
798, 624, 575, 514, cm
–1
. Analysis: Calc. for [Ag(2.1)](SO3CF3): C, 29.95; H, 1.83; N, 
12.92. Found: C, 29.70; H, 1.78; N, 12.41. 
8.7.2. Complex of 2.3 
[Ag2(2.3)](CO2CF3)2, 6.2 
An acetonitrile solution (1 mL) of silver(I) trifluoroacetate (0.02 g, 0.09 mmol) was 
added to a solution of 2.3 (0.010 g, 0.047 mmol) in methanol (2 mL). Slow evaporation of the 
solution resulted in red coloured crystals, which were collected, washed with 
dichloromethane and dried. Yield: 0.012 g (59%). M.p: 242 °C. 
ESI–MS: Calc. for ([Ag(2.3)2]
+
): 531.1169, Found: 531.1175; Calc. for ([Ag(2.3)]
+
): 
319.0107, Found: 319.0107. IR: νmax 1663, 1610, 1423, 1197, 1176, 1137, 1123, 837, 790, 
722, 457 cm
–1
. Analysis: Calc. for [Ag2(2.3)](CO2F3)2: C, 29.38; H, 1.85; N, 8.57. Found: C, 
29.18; H, 1.91; N, 8.56. 
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8.7.3. Complex of 2.5 
[Ag2(2.5)](NO3)2, 6.3 
Silver(I) nitrate (0.013 g, 0.079 mmol) in acetonitrile (1 mL) was added to a mixture of 
2.5 (0.010 g, 0.040 mmol) in methanol/dichloromethane (2 mL). Dark red crystals were 
obtained when the solution was left to evaporate slowly. Yield: 8.0 mg (48%). M.p: 217 °C. 
ESI–MS: Calc. for ([Ag(2.5)2]
+
): 610.8984, Found: 610.8991; Calc. for ([Ag(2.5)]
+
): 
358.9015, Found: 358.9015. IR: νmax 1554, 1313, 1285, 1201, 1107, 1016, 860, 849, 836, 
824, 649, 541 cm
–1
. Analysis: Calc. for [Ag2(2.5)](NO3)2∙CH3OH∙H2O: C, 22.11; H, 1.70; N, 
15.04. Found: C, 22.69; H, 1.38; N, 14.54. 
8.7.4. Complexes of 3.1 
[Ag(3.1)](ClO4), 6.4 
A solution of silver(I) perchlorate (0.016 g, 0.078 mmol) in acetonitrile (1 mL) was 
added to a solution of 3.1 (0.010 g, 0.039 mmol) in dichloromethane and methanol (1:1). 
Slow evaporation of the solution gave bright red crystals suitable for X–ray crystallography. 
Yield: 0.015 g (88%). M.p: 262 °C. 
ESI–MS: Calc. for ([Ag(3.1)2]
+
): 614.8794, Found: 614.8797; Calc. for ([Ag(3.1)]
+
): 
360.8920, Found: 360.8919. IR: νmax 1560, 1541, 1401, 1134, 1070, 931, 800, 665, 619, 575, 
541, 421 cm
–1
. Analysis: Calc. for [Ag(3.1)](ClO4)∙CH3OH: C, 21.86; H, 1.63; N, 17.00. 
Found: C, 21.54; H, 1.96; N, 18.36. 
[Ag(3.1)](NO3), 6.5 
Silver(I) nitrate (0.013 g, 0.078 mmol) in acetonitrile (1 mL) was added to a solution of 
3.1 (0.010 g, 0.039 mmol) in dichloromethane and methanol (1:1). The solution on slow 
evaporation gave red crystals. Yield: 0.026 g (80%). M.p: 149 °C. 
ESI–MS: Calc. for ([Ag(3.1)2]
+
): 614.8794, Found: 614.8797; Calc. for ([Ag(3.1)]
+
): 
360.8920, Found: 360.8919. IR: νmax 1558, 1544, 1402, 1316, 1283, 1264, 1130, 937, 926, 
824, 801, 662, 570, 545, 419 cm
–1
. Analysis: Calc. for [Ag(3.1)](NO3)∙H2O: C, 21.69; H, 
1.37; N, 22.13. Found: C, 22.41; H, 1.14; N, 22.11. 
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8.7.5. Complex of 3.2 
[Ag2(3.2)](SO3CF3)2, 6.6 
A solution of silver(I) triflate (0.014 g, 0.058 mmol) in acetonitrile (1 mL) was added to 
a solution of 3.2 (0.010 g, 0.029 mmol) in dichloromethane (2 mL). Slow evaporation of the 
solution gave red coloured crystals suitable for X–ray crystallography. Yield: 0.026 g (76%). 
M.p: 308 °C. 
ESI–MS: Calc. for ([Ag(3.2)2]
+
): 794.6740, Found: 794.6740; Calc. for 
([Ag(3.1)∙(CH3CN)]
+
): 489.8175, Found: 489.8160; Calc. for ([Ag(3.1)]
+
): 448.7910, Found: 
448.7906. IR: νmax 1621, 1408, 1241, 1193, 1117, 1046, 1023, 932, 798, 762, 699, 630, 574, 
541, 515 cm
–1
. Analysis: Calc. for [Ag2(3.2)](SO3CF3)2: C, 14.00; H, 0.47; N, 9.80. Found: 
C, 14.01; H, 0.73; N, 9.53. 
8.7.6. Complexes of 3.3 
[Ag2(3.3)](NO3)2, 6.7 
Acetonitrile solution of silver(I) nitrate (0.010 g, 0.064 mmol) was added to a solution 
of 3.3 (0.010 g, 0.032 mmol) in methanol (1 mL). Slow evaporation of the solution over time 
resulted in red coloured crystals, which were collected, washed with dichloromethane and 
methanol, and dried in vacuo. Yield: 0.020 g (60%). M.p: 160 °C. 
ESI–MS: Calc. for ([Ag(3.3)2]
+
): 727.0046, Found: 727.0055; Calc. for 
([Ag(3.3)∙(CH3CN)]
+
): 457.9811, Found: 457.9812; Calc. for ([Ag(3.3)]
+
): 416.9546, Found: 
416.9551. IR: νmax 1564, 1379, 1351, 1280, 1070, 1045, 1030, 968, 821, 793, 661, 551, 541, 
407 cm
–1
. Analysis: Calc. for [Ag2(3.3)](NO3)2∙CH3CN: C, 24.30; H, 2.18; N, 18.22. Found: 
C, 24.69; H, 2.11; N, 17.79.  
[Ag2(3.3)](ClO4)2, 6.8 
Silver(I) perchlorate (0.013 g, 0.064 mmol) in acetonitrile (1 mL) was added to a 
solution of 3.3 (0.010 g, 0.032 mmol) in methanol (1 mL). The solution was left for 
evaporation at room temperature to give red crystals suitable for X–ray analysis. Yield: 9.0 
mg (54%). M.p: decomposes at 240 °C. 
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ESI–MS: Calc. for ([Ag(3.3)2]
+
): 727.0046, Found: 727.0063; Calc. for 
([Ag(3.3)∙(CH3CN)]
+
): 457.9811, Found: 457.9815; Calc. for ([Ag(3.3)]
+
): 416.9546, Found: 
416.9554. IR: νmax 1567, 1419, 1385, 1352, 1317, 1102, 1074, 1054, 1017, 969, 929, 792, 
619, 552, 540, 409 cm
–1
. Analysis: Calc. for [Ag2(3.3)](ClO4)2: C, 19.86; H, 1.67; N, 11.58. 
Found: C, 20.45; H, 2.02; N, 11.84. 
8.7.7. Complexes of 3.4 
[Ag(3.4)](CO2CF3), 6.9 
Silver trifluoroacetate (0.015 g, 0.070 mmol) in acetonitrile (2 mL) was added to a hot 
solution of 3.4 (0.010 g, 0.035 mmol) in methanol/dichloromethane (1:1) (2mL). Slow 
evaporation of the solution over a period of time gave orange crystals. Yield: 0.012 g (68%). 
M.p: 221 °C. 
ESI–MS: Calc. for ([Ag(3.4)2]
+
): 675.1169, Found: 675.1171; Calc. for ([Ag(3.4)]
+
): 
391.0107, Found: 391.0107. IR: νmax 1651, 1501, 1459, 1174, 1129, 1020, 800, 785, 759, 
719, 698, 435, 418, 408 cm
–1
. Analysis: Calc. for [Ag(3.4)](CO2CF3): C, 47.55; H, 2.39; N, 
11.09. Found: C, 46.88; H, 2.56; N, 10.88. 
[Ag2(3.4)](ClO4)2, 6.10 
Silver perchlorate (0.014 g, 0.070 mmol) in acetonitrile was added slowly to a warm 
solution of 3.4 in methanol/dichloromethane (1:1). Slow evaporation of the solution over a 
period of time gave red crystals. Yield: 8.0 mg (52%). M.p: > 300 °C. 
ESI–MS: Calc. for ([Ag(3.4)2]
+
): 675.1169, Found: 675.1185; Calc. for ([Ag(3.4)]
+
): 
391.0107, Found: 391.0112. IR: νmax 3515, 1698, 1615, 1502, 1380, 1055, 834, 784, 756, 617 
cm
–1
. Analysis: Calc. for [Ag2(3.4)](ClO4)2∙CH3CN∙CH3OH: C, 32.67; H, 2.48; N, 9.07. 
Found: C, 32.75; H, 2.48; N, 8.34. 
[Ag(3.4)](SO3CF3)∙H2O, 6.11 
An acetonitrile solution of silver(I) triflate (0.014 g, 0.070 mmol) was added to a hot 
solution of 3.4 (0.010 g, 0.035 mmol) in methanol/dichloromethane. Slow evaporation 
solution resulted in red coloured crystals, which were collected, washed with 
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dichloromethane and methanol, and dried in vacuo. Yield: 0.020 g (quantitative). M.p: 250 
°C. 
ESI–MS: Calc. for ([Ag(3.4)2]
+
): 675.1169, Found: 675.1189; Calc. for ([Ag(3.4)]
+
): 
391.0107, Found: 391.0115. IR: νmax 3457, 1504, 1435, 1222, 1159, 1024, 870, 844, 822, 
779, 760, 628, 513 cm
–1
. Analysis: Calc. for [Ag(3.4)](SO3CF3)∙H2O: C, 40.80; H, 2.52; N, 
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Appendix I – Crystallography 
Table A1 –A12 list the crystal data and X–ray experimental details for the thirty six 
crystal structures discussed in this thesis. Selected bond lengths and bond distances are listed 
in the discussion of the structures, while the remaining distances and angles, as well as the 
atomic coordinates, anisotropic displacement parameters and hydrogen atom coordinates are 
available on request from the Department of Chemistry, University of Canterbury. 
All the X–ray crystallographic data was collected on either a Bruker APEX–II 
instrument with graphite–monochromatised Mo Kα (λ = 0.71073 Å) radiation or on an 
Oxford–Agilent SuperNova instrument with focussed microsource Mo Kα (λ = 0.71073 Å) 
and Cu Kα radiation (λ = 1.5418 Å) and ATLAS CCD area detector. The structures were 
solved using direct methods with SHELXS
[323]
 and refined on F
2
 using all data by full–matrix 
least square procedures with SHELXL–97.
[324]
 Multiscan absorption corrections were done 
using SADABS or SCALE3 ABSPACK. The non–hydrogen atoms were refined with 
anisotropic displacement parameters. All the hydrogen atoms were included in calculated 
positions with isotropic displacement parameters 1.2 or 1.5 times the isotropic equivalent of 
their carbon atoms.  
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Table A1. Crystal data and X–ray experimental data for complexes 2.7, 2.8 and 2.10. 
Complex (Code) 2.7 (3SRA01) 2.8 (3SRA03) 2.10 (3SRA11) 
Identification Code 3s 3s 3SRA11_s 
Empirical Formula C31.5H27F12N8O0.5P2Ru C58H52F24N16P4Ru2 C32H28F12N8P2Ru 
Formula weight 916.62 1755.17 915.63 
Temperature (K) 110(2) 113(2) 120(1) 
Crystal system triclinic triclinic monoclinic 
Space group P–1 P–1 P21/c 
a (Å) 11.5749(3) 11.1111(4) 10.9639(2) 
b (Å) 12.0178(4) 12.1033(4) 13.8765(2) 
c (Å) 14.8598(7) 13.7478(5) 23.8383(5) 
 (°) 106.172(2) 90.518(2) 90 
β (°) 93.502(2) 105.515(2) 102.449(2) 
γ (°) 114.482(2) 111.168(10) 90 
Volume / Å 1769.56(12) 1649.73(10) 3541.48(12) 
Z 2 1 4 
Density (calculated) mg/m
3
 1.720 1.767 1.717 
Absorption Coefficient mm
–1
 (Radiation) 0.636 (Mo) 0.677 (Mo) 0.635 (Mo) 
F (000) 916 876 1832 
Crystal size (mm
3
) 0.49 × 0.29 × 0.05 0.43 x 0.21 x 0.12 0.27 × 0.10 × 0.08 
2θ range for data collection (°) 2.914 to 53.6 4.86 to 55.1 5.388 to 55.0 
Reflections collected  36586 38051  91998 
Independent Reflections [R(int)] 7576 [0.0706] 7599 [0.0719] 8120 [0.0301] 
Data/ restraints/ parameters 7576/1/516 7599/0/471 8120/0/498 
Goodness–of–fit on F
2
 1.209 0.917 1.092 
Final R1 indices [I>2sigma(I)] R1 = 0.0594, wR2 = 0.1390 R1 = 0.0388, wR2 = 0.0675 R1 = 0.0269, wR2 = 0.0631 
Final R indices [all data] R1 = 0.0705, wR2 = 0.1572 R1 = 0.0621, wR2 = 0.0720 R1 = 0.0296, wR2 = 0.0649 
Largest diff. peak/hole (e.Å
–3
) 0.95/–1.12 1.51/–0.71 0.65/–0.55 
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Table A2. Crystal data and X–ray experimental data for complexes 2.11, 2.13 and 2.14. 
Complex (Code) 2.11 (3SRA20) 2.13 (3SRA41) 2.14 (3SRA37) 
Identification Code 3sra20 3sra41a 3sra37 
Empirical Formula C62H59F24N17P4Ru2 C37.5H37Cl2F12N8O2.5P2Ru C62H56N18F24P4Cl2Ru2 
Formula weight 1824.28 1101.66 1906.17 
Temperature (K) 120(1) 120(2) 120(1) 
Crystal system orthorhombic triclinic monoclinic 
Space group P212121 P–1 P21/c 
a (Å) 13.8511(1) 12.7485(2) 11.68070(6) 
b (Å) 21.2980(2) 12.7698(3) 22.22138(10) 
c (Å) 23.7630(2) 15.1015(3) 13.93440(6) 
 (°) 90 93.4048(15) 90 
β (°) 90 111.6252(16) 94.7224(4) 
γ (°) 90 101.7779(16) 90 
Volume / Å 7010.08(10) 2212.68(7) 3604.55(3) 
Z 4 2 2 
Density (calculated) mg/m
3
 1.729 1.654 1.756 
Absorption Coefficient mm
–1
 (Radiation) 5.422 (Cu) 5.537 (Cu) 5.974 (Cu) 
F (000) 3656 1108 1904 
Crystal size (mm
3
) 0.42 × 0.28 × 0.05 0.24 × 0.19 × 0.06 0.35 × 0.20 × 0.10 
2θ range for data collection (°) 5.572 to 148.3 6.366 to 135.0 7.5 to 135.0 
Reflections collected  94373 32409 145646 
Independent Reflections [R(int)] 14148 [0.0665] 7978 [0.0388] 6480 [0.0387] 
Data/ restraints/ parameters 14148/0/989 7978/0/600 6480/0/508 
Goodness–of–fit on F
2
 1.059 1.035 1.073 
Final R1 indices [I>2sigma(I)] R1 = 0.0357, wR2 = 0.0944 R1 = 0.0340, wR2 = 0.0866 R1 = 0.0253, wR2 = 0.0629 
Final R indices [all data] R1 = 0.0367, wR2 = 0.0953 R1 = 0.0379, wR2 = 0.0899 R1 = 0.0276, wR2 = 0.0647 
Largest diff. peak/hole (e.Å
–3
) 0.75/–0.78 1.12/–1.03 0.76/–0.53 
Flack parameter –0.015(3) – – 
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Table A3. Crystal data and X–ray experimental data for complexes 2.15, 2.16 and 3.10. 
Complex (Code) 2.15 (3SRA39) 2.16 (3SRA63) 3.10 (3SRA15) 
Identification Code 3SRA39 3SRA63 3sra15 
Empirical Formula C37.5H37Br2F12N8O2.5P2Ru C62H56Br2F24N18P4Ru2 C54H45Cl2F18N17P3Ru2 
Formula weight 1190.58 1995.08 1640.02 
Temperature (K) 120(1) 120(1) 120(1) 
Crystal system triclinic monoclinic monoclinic 
Space group P–1 P21/c C2/c 
a (Å) 12.8070(2) 11.7699(2) 23.7676(2) 
b (Å) 12.8963(2) 22.2200(3) 21.8027(1) 
c (Å) 15.0747(3) 13.9621(3) 14.4797(1) 
 (°) 93.8914(15) 90 90 
β (°) 112.1769(17) 94.6873(16) 114.338(1) 
γ (°) 101.9052(15) 90 90 
Volume / Å 2226.62(7) 3639.23(11) 6836.50(11) 
Z 2 2 4 
Density (calculated) mg/m
3
 1.776 1.821 1.593 
Absorption Coefficient mm
–1
 (Radiation) 6.501 (Cu) 6.529 (Cu) 0.689 (Mo) 
F (000) 1180 1976 3268 
Crystal size (mm
3
) 0.28 × 0.13 × 0.07 0.32 × 0.19 × 0.08 0.43 × 0.41 × 0.07 
2θ range for data collection (°) 6.416 to 135.0 7.496 to 135.0 5.298 to 59.7 
Reflections collected  49987 57196 254416 
Independent Reflections [R(int)] 8040 [0.0342] 6550 [0.0659] 9553 [0.0518] 
Data/ restraints/ parameters 8040/0/600 6550/0/508 9553/0/513 
Goodness–of–fit on F
2
 1.030 1.035 1.105 
Final R1 indices [I>2sigma(I)] R1 = 0.0270, wR2 = 0.0645 R1 = 0.0303, wR2 = 0.0769 R1 = 0.0582, wR2 = 0.1752 
Final R indices [all data] R1 = 0.0300, wR2 = 0.0665 R1 = 0.0340, wR2 = 0.0793 R1 = 0.0721, wR2 = 0.1932 
Largest diff. peak/hole (e.Å
–3
) 1.12/–0.86 0.62/–0.94 2.20/–0.75 
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Table A4. Crystal data and X–ray experimental data for complexes 3.12, 3.13 and 3.14. 
Complex (Code) 3.12 (3SRA49) 3.13 (3SRA29) 3.14 (3SRA08) 
Identification Code 3SRA49 3SRA29 pjs 
Empirical Formula C52H42Br2F18N16P3Ru2 C32H26Cl2F12N10P2Ru C60H56N18P4F24Cl2Ru2 
Formula weight 1687.87 1012.54 1882.15 
Temperature (K) 120(1) 120(1) 110(2) 
Crystal system triclinic monoclinic triclinic 
Space group P–1 P21/c P–1 
a (Å) 11.6038(2) 8.7251(1) 11.7445(8) 
b (Å) 12.3877(2) 25.2174(4) 12.1239(7) 
c (Å) 12.5279(2) 17.4010(3) 14.6963(10) 
 (°) 100.0237(16) 90 101.783(4) 
β (°) 115.6257(18) 92.7580(14) 110.670(4) 
γ (°) 103.4110(15) 90 101.782(4) 
Volume / Å 1500.14(5) 3824.22(11) 1827.40(2) 
Z 1 4 1 
Density (calculated) mg/m
3
 1.868 1.759 1.710 
Absorption Coefficient mm
–1
 (Radiation) 7.378 (Cu) 6.311 (Cu) 0.689 (Mo) 
F (000) 831 2016 940 
Crystal size (mm
3
) 0.23 × 0.16 × 0.04 0.10 × 0.09 × 0.03 0.48 x 0.12 x 0.08 
2θ range for data collection (°) 7.724 to 149.2 6.176 to 135.0 5.70 to 55.1 
Reflections collected  44090 25537 36971 
Independent Reflections [R(int)] 6084 [0.0407] 6770 [0.0354] 8430 [0.1306] 
Data/ restraints/ parameters 6084/0/422 6770/0/536 8430/0/499 
Goodness–of–fit on F
2
 1.037 1.104 0.925 
Final R1 indices [I>2sigma(I)] R1 = 0.0361, wR2 = 0.0913 R1 = 0.0414, wR2 = 0.1006 R1 = 0.0636, wR2 = 0.1532 
Final R indices [all data] R1 = 0.0401, wR2 = 0.0955 R1 = 0.0469, wR2 = 0.1036 R1 = 0.1706, wR2 = 0.1894 
Largest diff. peak/hole (e.Å
–3
) 1.04/–1.17 0.88/–0.55 0.76/–1.38 
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Table A5. Crystal data and X–ray experimental data for complexes 3.15, 3.16 and 3.17. 
Complex (Code) 3.15 (3SRA02) 3.16 (3SRA23) 3.17 (3SRA61) 
Identification Code p21c 3sra23 3SRA61 
Empirical Formula C41H34F12N8OP2Ru C70H62F24N18P4Ru2 C39H32F12N10OP2Ru 
Formula weight 1045.77 1937.39 1047.75 
Temperature (K) 113(2) 120(1) 120(1) 
Crystal system monoclinic triclinic monoclinic 
Space group P21/c P–1 P21/c 
a (Å) 17.7370(6) 11.6227(5) 17.30753(8) 
b (Å) 14.3227(5) 11.6705(4) 14.29440(9) 
c (Å) 16.9777(6) 16.0765(7) 16.77249(8) 
 (°) 90 85.033(3) 90 
β (°) 102.693(2) 79.967(4) 98.8354(5) 
γ (°) 90 63.849(4) 90 
Volume / Å 4207.6(3) 1927.37(15) 4100.29(4) 
Z 4 1 4 
Density (calculated) mg/m
3
 1.651 1.669 1.697 
Absorption Coefficient mm
–1 
(Radiation) 0.548 (Mo) 4.977 (Cu) 4.760 (Cu) 
F (000) 2104 972 2104 
Crystal size (mm
3
) 0.46 x 0.18 x 0.05 0.28 × 0.17 × 0.06 0.13 × 0.11 × 0.04 
2θ range for data collection (°) 4.918 to 55.1 5.582 to 135.0 8.062 to 135.0 
Reflections collected  88085  13614 78359 
Independent Reflections [R(int)] 9705 [0.1290] 6931 [0.0680] 7384 [0.0399] 
Data/ restraints/ parameters 9705/0/588 6931/0/535 7384/0/588 
Goodness–of–fit on F
2
 0.732 1.027 1.051 
Final R1 indices [I>2sigma(I)] R1 = 0.0402, wR2 = 0.0856 R1 = 0.0516, wR2 = 0.1339 R1 = 0.0240, wR2 = 0.0604 
Final R indices [all data] R1 = 0.0909, wR2 = 0.1005 R1 = 0.0595, wR2 = 0.1427 R1 = 0.0262, wR2 = 0.0618 
Largest diff. peak/hole (e.Å
–3
) 0.73/–0.64 1.06/–0.93 0.99/–0.48 
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Table A6. Crystal data and X–ray experimental data for complexes 3.19, 3.20 and 3.21. 
Complex (Code) 3.19 (3SRA19) 3.20 (3SRA09) 3.21 (3SRA45) 
Identification Code 3sra19 3sra9 3SRA45–Cu 
Empirical Formula C76H72F24N24P4Ru2 C58H42F24N14P4Ru2 C42H38F12N10O2P2Ru 
Formula weight 2103.59 1717.07 1105.83 
Temperature (K) 120(1) 120(1) 120(1) 
Crystal system monoclinic monoclinic monoclinic 
Space group P2/c C2/c P21/c 
a (Å) 14.1578(2) 22.5647(3) 19.5939(2) 
b (Å) 24.3485(3) 14.2744(2) 13.9284(1) 
c (Å) 13.3280(1) 23.1050(4) 16.5234(2) 
 (°) 90 90 90 
β (°) 94.5387(11) 102.033(2) 101.0338(12) 
γ (°) 90 90 90 
Volume / Å 4580.04(9) 7278.6(2) 4426.08(9) 
Z 2 4 4 
Density (calculated) mg/m
3
 1.525 1.567 1.660 
Absorption Coefficient mm
–1 
(Radiation) 4.258 (Cu) 5.173 (Cu) 4.462 (Cu) 
F (000) 2120 3408 2232 
Crystal size (mm
3
) 0.44 × 0.43 × 0.11 0.43 × 0.11 × 0.05 0.19 × 0.16 × 0.15 
2θ range for data collection (°) 6.262 to 135.0 7.376 to 147.8 7.838 to 135.0 
Reflections collected  92403 32209 46811 
Independent Reflections [R(int)] 8251 [0.0511] 7215 [0.0464] 7974 [0.0372] 
Data/ restraints/ parameters 8251/0/608 7215/0/518 7974/0/626 
Goodness–of–fit on F
2
 1.169 1.025 1.096 
Final R1 indices [I>2sigma(I)] R1 = 0.0548, wR2 = 0.1392 R1 = 0.0585, wR2 = 0.1625 R1 = 0.0612, wR2 = 0.1995 
Final R indices [all data] R1 = 0.0585, wR2 = 0.1416 R1 = 0.0660, wR2 = 0.1727 R1 = 0.0647, wR2 = 0.2024 
Largest diff. peak/hole (e.Å
–3
) 1.58/–1.02 2.12/–1.07 3.75/–1.08 
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Table A7. Crystal data and X–ray experimental data for complexes 3.22, 4.3 and 4.4. 
Complex (Code) 3.22 (3SRA65) 4.3 (3SRA10) 4.4 (3SRA13) 
identification Code 3sra65 3sra10 3sra13 
Empirical Formula C39H32F12N10OP2Ru C54H42F24N14P4Ru2 C42H31F12N9OP2Ru 
Formula weight 1047.75 1669.03 1068.77 
Temperature (K) 120(1) 120(1) 120(1) 
Crystal system monoclinic triclinic  monoclinic 
Space group P21/c P–1 P21/n 
a (Å) 17.9790(5) 11.3568(4) 12.16186(9) 
b (Å) 14.3523(3) 12.5932(8) 23.23128(15) 
c (Å) 16.6077(4) 12.8533(7) 14.65098(9) 
 (°) 90 69.457(6) 90 
β (°) 103.611(2) 70.796(4) 93.1574(6) 
γ (°) 90 64.750(5) 90 
Volume / Å 4165.06(17) 1521.63(16) 4133.14(5) 
Z 4 1 4 
Density (calculated) mg/m
3
 1.671 1.821 1.718 
Absorption Coefficient mm
–1 
(Radiation) 4.686 (Cu) 0.728 (Mo) 4.732 (Cu) 
F (000) 2104 828 2144 
Crystal size (mm
3
) 0.16 × 0.04 × 0.03 0.30 x 0.20 x 0.03 0.16 × 0.13 × 0.10 
2θ range for data collection (°) 7.972 to 135.0 5.65 to 55.0 7.142 to 148.1 
Reflections collected  28009 18933  132635 
Independent Reflections [R(int)] 7479 [0.0641] 6989 [0.0310] 8353 [0.0661] 
Data/ restraints/ parameters 7479/0/588 6989/0/443 8353/0/606 
Goodness–of–fit on F
2
 1.041 1.048 1.038 
Final R1 indices [I>2sigma(I)] R1 = 0.0432, wR2 = 0.1109 R1 = 0.0457, wR2 = 0.1116 R1 = 0.0345, wR2 = 0.0850 
Final R indices [all data] R1 = 0.0565, wR2 = 0.1183 R1 = 0.0563, wR2 = 0.1213 R1 = 0.0391, wR2 = 0.0892 
Largest diff. peak/hole (e.Å
–3
) 1.36/–1.20 2.40/–1.24 0.64/–0.60 
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Table A8. Crystal data and X–ray experimental data for complexes 4.5, 5.7 and 5.8. 
Complex (Code) 4.5 (3SRA26) 5.7 (3SRA42) 5.8 (3SRA50) 
Identification Code 3SRA26 3sra42 3SRA50 
Empirical Formula C58H42F24N14P4Ru2 C56H48F24N14P4Ru2 C62H52Cl4N14O16Ru2 
Formula weight 1717.08 1699.10 1593.11 
Temperature (K) 120(1) 120(2) 120(1) 
Crystal system triclinic triclinic monoclinic 
Space group P–1 P–1 P21/c 
a (Å) 11.2107(4) 12.1396(5) 14.3792(2) 
b (Å) 12.8474(3) 12.6233(4) 13.1170(1) 
c (Å) 12.9944(3) 12.8958(5) 17.9619(3) 
 (°) 66.196(3) 76.863(3) 90 
β (°) 70.410(3) 64.151(4) 110.9563(17) 
γ (°) 71.275(3) 63.335(4) 90 
Volume / Å 1575.35(8) 1588.08(13) 3163.74(8) 
Z 1 1 2 
Density (calculated) mg/m
3
 1.810 1.777 1.672 
Absorption Coefficient mm
–1 
(Radiation) 5.976 (Cu) 5.917 (Cu) 6.123 (Cu) 
F (000) 852 846 1612 
Crystal size (mm
3
) 0.30 × 0.16 × 0.07 0.08 × 0.07 × 0.02 0.16 × 0.10 × 0.06 
2θ range for data collection (°) 7.66 to 147.7 7.624 to 135.0 6.512 to 135.0 
Reflections collected  27326 19557 42657 
Independent Reflections [R(int)] 6273 [0.0534] 5711 [0.0584] 5685 [0.0438] 
Data/ restraints/ parameters 6273/0/460 5711/0/452 5685/0/491 
Goodness–of–fit on F
2
 1.059 0.898 1.045 
Final R1 indices [I>2sigma(I)] R1 = 0.0397, wR2 = 0.0998 R1 = 0.0416, wR2 = 0.0995 R1 = 0.0356, wR2 = 0.0840 
Final R indices [all data] R1 = 0.0490, wR2 = 0.1088 R1 = 0.0559, wR2 = 0.1044 R1 = 0.0406, wR2 = 0.0881 
Largest diff. peak/hole (e.Å
–3
) 0.93/–0.81 1.38/–0.59 0.63/–1.04 
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Table A9. Crystal data and X–ray experimental data for complexes 6.1, 6.2 and 6.3. 
Complex (Code) 6.1 (3SRA12) 6.2 (3SRA21) 6.3 (3SRA34) 
Identification Code 3sra12 3sra21 3sra34 
Empirical Formula C11H8F3N4O3SAg C16H12F6N4O4Ag2 C10H6Cl2N5O3Ag 
Formula weight 441.14 654.04 422.97 
Temperature (K) 120(1) 120(1) 120(1) 
Crystal system monoclinic monoclinic tetragonal 
Space group P21/n P21/n P42/n 
a (Å) 10.56992(7) 8.3028(7) 16.6435(1) 
b (Å) 10.32936(6) 21.6575(2) 16.6435(1) 
c (Å) 13.43872(8) 10.8491(8) 9.45138(7) 
 (°) 90 90 90 
β (°) 94.8075(6) 91.6315(8) 90 
γ (°) 90 90 90 
Volume / Å 1462.08(2) 1950.08(3) 2618.08(4) 
Z 4 4 8 
Density (calculated) mg/m
3
 2.004 2.228 2.146 
Absorption Coefficient mm
–1 
(Radiation) 1.574 (Mo) 2.098 (Mo) 1.965 (Mo) 
F (000) 864 1264 1648 
Crystal size (mm
3
) 0.36 × 0.24 × 0.18 0.47 × 0.36 × 0.34 0.17 × 0.16 × 0.10 
2θ range for data collection (°) 5.524 to 55.0 5.256 to 55.0 5.528 to 70.6 
Reflections collected  181391  225517 130409 
Independent Reflections [R(int)] 3360 [0.0375] 4465 [0.0699] 5825 [0.0367] 
Data/ restraints/ parameters 3360/0/208 4465/0/291 5825/0/190 
Goodness–of–fit on F
2
 1.105 1.120 1.087 
Final R1 indices [I>2sigma(I)] R1 = 0.0180, wR2 = 0.0421 R1 = 0.0217, wR2 = 0.0552 R1 = 0.0234, wR2 = 0.0553 
Final R indices [all data] R1 = 0.0218, wR2 = 0.0447 R1 = 0.0242, wR2 = 0.0570 R1 = 0.0314, wR2 = 0.0607 
Largest diff. peak/hole (e.Å
–3
) 0.44/–0.37 0.61/–0.67 1.10/–0.56 
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Table A10. Crystal data and X–ray experimental data for complexes 6.4, 6.5 and 6.6. 
Complex (Code) 6.4 (3SRA14) 6.5 (3SRA17) 6.6 (3SRA51) 
Identification Code 3SRA14 3SRA17 3sra51 
Empirical Formula C8H4Cl3N6O4Ag C16H8Ag2Cl4N14O6 C27H12Br6F9N18O9S3Ag3 
Formula weight 462.39 849.90 1802.80 
Temperature (K) 120(1) 120(1) 120(1) 
Crystal system triclinic triclinic triclinic 
Space group P–1 P–1 P–1 
a (Å) 7.8494(2) 9.4905(1) 7.6952(3) 
b (Å) 9.4897(2) 9.7663(1) 10.4683(4) 
c (Å) 9.8974(2) 13.8808(2) 15.5297(4) 
 (°) 96.542(2) 83.922(1) 79.690(3) 
β (°) 99.529(2) 89.264(1) 84.543(2) 
γ (°) 100.811(2) 78.294(1) 75.651(3) 
Volume / Å 706.120(3) 1252.69(3) 1190.72(7) 
Z 2 2 1 
Density (calculated) mg/m
3
 2.175 2.253 2.514 
Absorption Coefficient mm
–1 
(Radiation) 2.021 (Mo) 2.058 (Mo) 6.492 (Mo) 
F (000) 448 824 852 
Crystal size (mm
3
) 0.24 × 0.22 × 0.20 0.30 × 0.12 × 0.07 0.45 × 0.33 × 0.07 
2θ range for data collection (°)  5.384 to 55.0 5.262 to 55.0 5.214 to 55.0 
Reflections collected  52040 93166 29191 
Independent Reflections [R(int)] 3232 [0.0387] 5745 [0.0389] 5459 [0.0821] 
Data/ restraints/ parameters 3232/0/238 5745/0/405 5459/0/340 
Goodness–of–fit on F
2
 1.072 1.099 1.066 
Final R1 indices [I>2sigma(I)] R1 = 0.0317, wR2 = 0.0756 R1 = 0.0419, wR2 = 0.1092 R1 = 0.0444, wR2 = 0.1165 
Final R indices [all data] R1 = 0.0386, wR2 = 0.0805 R1 = 0.0510, wR2 = 0.1181 R1 = 0.0579, wR2 = 0.1252 
Largest diff. peak/hole (e.Å
–3
) 1.09/–0.58 3.07/–1.22 1.42/–1.12 
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Table A11. Crystal data and X–ray experimental data for complexes 6.7, 6.8 and 6.9. 
Complex (Code) 6.7 (3SRA32) 6.8 (3SRA33) 6.9 (3SRA56) 
Identification Code 3sra32 3sra33 sra1 
Empirical Formula C12H12Cl2N7O3Ag C12H12Cl3N6O4Ag C20H12F3N4O2Ag 
Formula weight 481.06 518.50 505.21 
Temperature (K) 120(1) 120(1) 120(1) 
Crystal system triclinic triclinic monoclinic 
Space group P–1 P–1 C2/c 
a (Å) 8.1704(3) 8.0406(2) 17.0146(7) 
b (Å) 9.6902(3) 9.8922(3) 8.2740(2) 
c (Å) 11.2554(4) 11.7097(4) 14.5536(4) 
 (°) 73.341(3) 71.402(3) 90 
β (°) 86.035(3) 88.737(2) 115.629(4) 
γ (°) 74.892(3) 78.666(2) 90 
Volume / Å 824.20(5) 864.69(5) 1847.26(12) 
Z 2 2 4 
Density (calculated) mg/m
3
 1.938 1.991 1.817 
Absorption Coefficient mm
–1 
(Radiation) 1.576 (Mo) 1.662 (Mo) 1.147 (Mo) 
F (000) 476 512 1000 
Crystal size (mm
3
) 0.44 × 0.26 × 0.08 0.13 × 0.07 × 0.04 0.20 × 0.18 × 0.06 
2θ range for data collection (°) 5.952 to 55.0 6.104 to 70.6 5.594 to 66.2 
Reflections collected  13754 30879 19546 
Independent Reflections [R(int)] 3795 [0.0301] 7351 [0.0381] 3343 [0.0368] 
Data/ restraints/ parameters 3795/0/230 7351/0/239 3343/0/151 
Goodness–of–fit on F
2
 1.052 1.090 1.094 
Final R1 indices [I>2sigma(I)] R1 = 0.0195, wR2 = 0.0487 R1 = 0.0277, wR2 = 0.0614 R1 = 0.0257, wR2 = 0.0547 
Final R indices [all data] R1 = 0.0214, wR2 = 0.0500 R1 = 0.0348, wR2 = 0.0647 R1 = 0.0308, wR2 = 0.0576 
Largest diff. peak/hole (e.Å
–3
) 0.50/–0.39 0.72/–0.58 1.04/–0.37 
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Table A12. Crystal data and X–ray experimental data for complexes 6.10 and 6.11. 
Complex (Code) 6.10 (3SRA58) 6.11 (3SRA57) 
Identification Code sra sra2 
Empirical Formula C36H24Cl2N8O8Ag2 C38H26F6N8O7S2Ag2 
Formula weight 983.27 1100.53 
Temperature (K) 120(1) 120(1) 
Crystal system monoclinic monoclinic 
Space group C2/c Cc 
a (Å) 19.9456(5) 26.0608(10) 
b (Å) 27.1458(5) 8.8435(2) 
c (Å) 14.4557(3) 18.4677(5) 
 (°) 90 90 
β (°) 116.563(2) 111.409(3) 
γ (°) 90 90 
Volume / Å 7000.7(3) 3962.5(2) 
Z 8 4 
Density (calculated) mg/m
3
 1.866 1.845 
Absorption Coefficient mm
–1 
(Radiation) 1.339 (Mo) 1.184 (Mo) 
F (000) 3904 2184 
Crystal size (mm
3
) 0.20 × 0.13 × 0.12 0.30 × 0.20 × 0.08 
2θ range for data collection (°) 5.382 to 55.0 5.706 to 55.0 
Reflections collected  44486 29631 
Independent Reflections [R(int)] 8031 [0.0285] 9088 [0.0318] 
Data/ restraints/ parameters 8031/0/506 9088/2/569 
Goodness–of–fit on F
2
 1.063 1.049 
Final R1 indices [I>2sigma(I)] R1 = 0.0244, wR2 = 0.0621 R1 = 0.0220, wR2 = 0.0515 
Final R indices [all data] R1 = 0.0300, wR2 = 0.0654 R1 = 0.0230, wR2 = 0.0522 
Largest diff. peak/hole (e.Å
–3
) 1.14/–0.28 0.42/–0.36 
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